0001493152-14-003928.txt : 20141124 0001493152-14-003928.hdr.sgml : 20141124 20141124170331 ACCESSION NUMBER: 0001493152-14-003928 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141124 DATE AS OF CHANGE: 20141124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERA INNOVATIONS, INC. CENTRAL INDEX KEY: 0001444144 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 232517763 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53392 FILM NUMBER: 141246968 BUSINESS ADDRESS: STREET 1: 20511 ABBEY DR. CITY: FRANKFORT STATE: IL ZIP: 60423 BUSINESS PHONE: 8668660758 MAIL ADDRESS: STREET 1: 20511 ABBEY DR. CITY: FRANKFORT STATE: IL ZIP: 60423 FORMER COMPANY: FORMER CONFORMED NAME: ACCELERATED ACQUISITIONS IV INC DATE OF NAME CHANGE: 20080828 10-Q 1 form10q.htm QUARTERLY REPORT Form 10-Q

 

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2014

 

[  ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                            to                          

 

Commission file number 000-53392

 

Accelera Innovations, Inc.

(Exact name of small business issuer as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation or organization)

 

26-2517763

(I.R.S. Employer Identification Number)

 

20511 Abbey Drive

Frankfort, Illinois 60423

(Address of Principal Offices)

 

(866) 866-0758

(Issuer’s Telephone Number)

 

Not applicable.

(Former name, former address and former fiscal year, if changed since last report)

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ].

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer [  ] Accelerated Filer [  ]

Non-Accelerated Filer  [  ]

(Do not check if a smaller reporting company)

 Smaller Reporting Company [X]

   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]. 

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 34,882,522 shares of common stock, par value $.0001 per share, outstanding as of November 17, 2014.

 

 

 

 
 

 

INDEX

 

    Page
     
Part I. Financial Information  
Item 1. Financial Statements F-1
  Condensed Consolidated Balance Sheets as of September 30, 2014 (unaudited) and December 31, 2013 F-1
  Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2014 and 2013 (unaudited) F-2
  Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2014 and 2013 (unaudited) F-3
  Notes to Condensed Consolidated Financial Statements F-4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 4
Item 3. Quantitative and Qualitative Disclosures About Market Risk 8
Item 4. Controls and Procedures 8
   
Part II. Other Information
Item 1. Legal Proceedings 9
Item 1A. Risk Factors  
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 9
Item 3. Defaults Upon Senior Securities 9
Item 4. Mine Safety Disclosures 9
Item 5. Other Information 9
Item 6. Exhibits 9
Signatures   10

 

2
 

 

FORWARD-LOOKING STATEMENTS

 

This report contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this report. Additionally, statements concerning future matters are forward-looking statements.

 

Although forward-looking statements in this report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as filed with the Securities and Exchange Commission (the “SEC”) on April 15, 2014, in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this quarterly report on Form 10-Q and in other reports that we file with the SEC. You are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report.

 

We file reports with the SEC. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

 

We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, except as required by law. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this quarterly report, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

3
 

 

PART I — FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

ACCELERA INNOVATIONS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

 

   September 30, 2014   December 31, 2013 
   (Unaudited)     
ASSETS          
Current Assets          
Cash  $274,857   $185,744 
Accounts receivable, net   455,995    753,707 
Advances to others   17,540    - 
    -    - 
Advances to related parties   18,253    - 
Prepaid expenses   3,785    - 
Refundable income taxes   12,000    - 
Total Current Assets   782,430    939,451 
           
Other Asset          
Goodwill   4,403,819    5,030,576 
TOTAL ASSETS   5,186,249    5,970,027 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current Liabilities          
Accounts Payable   50,174    - 
Due to stockholders   -    419,084 
Short-Term Note Payable   -    8,041 
Advances from related parties   96,586    - 
Accrued expenses   132,628    35,418 
Total Current Liabilities   279,388    462,543 
Long-term subordinated unsecured notes payable   5,970,000    5,970,000 
           
TOTAL LIABILITIES   6,249,388    6,432,543 
           
Stockholders’ Deficit          
Preferred stock; $0.0001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding   -    - 
Common stock; $0.0001 par value, 100,000,000 authorized, 34,380,022 and 22,382,522 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively   3,439    2,239 
Additional paid in capital   18,492,738    12,227,526 
Accumulated deficit   (19,559,316)   (12,692,281)
TOTAL STOCKHOLDERS’ DEFICIT   (1,063,139)   (462,516)
           
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $5,186,249   $5,970,027 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-1
 

 

ACCELERA INNOVATIONS, INC. AND SUBSIDIARIES

Unaudited Condensed Consolidated Statements of Operations

(Unaudited)

 

   For the Three Months Ended
September 30,		   For the Nine Months Ended
September 30,		 
   2014   2013   2014   2013 
                 
Revenues  $844,008   $-   $2,500,341   $- 
Cost of revenues   600,928    -    1,726,509    - 
                     
Gross Profit   243,080    -    773,832    - 
                     
General and administrative   1,261,062    1,005,050    2,248,199    3,724,265 
Stock compensation   1,650,000    -    4,700,000      
Total Operating Expenses   2,911,062    1,050,050    6,948,199    3,724,265 
                     
Goodwill impairment   (692,668)   -    (692,668)   - 
Income Tax Provision   -    -    -    - 
NET LOSS  $(3,360,650)  $(1,005,050)  $6,867,035   $(3,724,265)
                     
BASIC AND DILUTED LOSS PER SHARE  $(0.10)  $(0.05)  $(0.21)  $(0.17)
                     
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING   34,380,022    21,511,812    32,380,439    21,509,614 

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-2
 

 

ACCELERA INNOVATIONS, INC. AND SUBSIDIARIES

Unaudited Condensed Consolidated Statements of Cash Flows

 

   For the Nine Months Ended September 30, 
   2014   2013 
OPERATING ACTIVITIES          
           
Net loss  $(6,867,035)  $(3,724,265)
           
Adjustment to reconcile net loss to net cash used in operations:          
Changes in purchase price allocation   (65,911)   - 
Goodwill impairment   692,668      
Stock based compensation   4,700,000    3,650,100 
           
Changes in operating assets and liabilities, net of effects of acquisitions:          
Decrease in accounts receivable   297,712    - 
Increase in prepaid expenses   (3,785)   - 
Increase in refundable income taxes   (12,000)   - 
Increase in accounts payable   50,174    - 
Increase in accrued expense   97,210    - 
Net Cash Used in Operating Activities   (1,110,967)   (74,165)
           
INVESTING ACTIVITIES          
           
Advances to related parties and other   (35,793)   - 
           
FINANCING ACTIVITIES          
Proceeds from sale of stock   1,566,412      
Stockholder Advances   -    74,215 
Advances from related parties   96,586      
Payment of Due to stockholder   (419,084)     
Decrease in Short-Term Note Payable   (8,041)     
Net Cash Provided by Financing Activities   1,235,873    74,215 
           
Net increase in cash   89,113    50 
Cash, beginning of period   185,744    - 
Cash, end of period  $274,857   $50 
           
Supplemental disclosure of non-cash investing and financing activities          
           
Non-cash issuance of common stock  $1,201   $- 
           
Common shares issued for cash, less exercise of stock option  $-   $20 
           
Forgiveness of debt by stockholders  $-   $100 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-3
 

 

ACCELERA INNOVATIONS, INC. AND SUBSIDIARIES

September 30, 2014

Notes to Unaudited Condensed Consolidated Financial Statements

 

1. BACKGROUND INFORMATION

 

Accelera Innovations, Inc., formerly Accelerated Acquisitions IV, Inc. (“Accelera” or the “Company”) was incorporated in the State of Delaware on April 29, 2008 for the purpose of raising capital intended to be used in connection with its business plan which may include a possible merger, acquisition or other business combination with an operating business.

 

On June 13, 2011, Synergistic Holdings, LLC (“Purchaser”) agreed to acquire 17,000,000 shares of the Company’s common stock par value $0.0001 per share. At the same time, Accelerated Venture Partners, LLC agreed to tender 3,750,000 of their 5,000,000 shares of the Company’s common stock par value $0.0001 for cancellation. Following these transactions, Synergistic Holdings, LLC owned 93.15% of the Company’s 18,250,000 issued and outstanding shares of common stock par value $0.0001 and the interest of Accelerated Venture Partners, LLC was reduced to approximately 6.85% of the total issued and outstanding shares. Simultaneously with the share purchase, Timothy Neher resigned from the Company’s Board of Directors and John Wallin was simultaneously appointed to the Company’s Board of Directors. Such action represented a change of control of the Company.

 

On October 18, 2011, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware and changed its name from Accelerated Acquisition IV, Inc. to “Accelera Innovations, Inc.”

 

Accelera is a healthcare service company which is focused on implementing its licensed proprietary Internet-based software for use in the healthcare industry The technology was licensed to the Company by our majority shareholder, Synergistic Holdings, LLC (“Synergistic”). Synergistic granted the Company a 30-year exclusive, non-transferrable worldwide license for a proprietary Internet-based, software platform that is fully functional in its current state (“Accelera Technology”) and that is designed to provide interoperable technology that is intended to improve the quality of care while reducing healthcare costs.

 

2. GOING CONCERN

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has had minimal revenue since inception and had an accumulated deficit of $19,559,316 as of September 30, 2014. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes until such time that funds provided by operations are sufficient to fund working capital requirements.

 

The Company is currently substantially dependent upon technology licensed from Synergistic. The events or circumstances that may prevent the accomplishment of our business objectives, include, with limitation, (i) the fact that, if the Company does not raise a minimum of $12,500,000 by August 13, 2015, an additional $10,000,000 by August 13, 2016, and an additional $7,500,000 by August 13, 2017, equaling the minimum funding requirement of $30,000,000 for the deployment of its licensed technology over the next three years the Company will lose the rights to the licensed technology.

 

The condensed consolidated financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

3. ACQUISITION – BEHAVIORAL HEALTH CARE ASSOCIATES, LTD.

 

On November 20, 2013, Accelera executed a Stock Purchase Agreement (the “SPA”) and its wholly owned subsidiary, Accelera Healthcare Management Service Organization LLC (“Accelera HMSO”), executed an Operating Agreement with Blaise J. Wolfrum, M.D. and Behavior Health Care Associates, Ltd. (“BHCA”). Accelera acquired 100% of the 100,000 issued and outstanding shares of BHCA from Dr. Wolfrum. Accelera HMSO as a wholly owned subsidiary of Accelera will operate BHCA in accordance with the Operating Agreement.

 

Pursuant to the SPA, the Company shall pay to Dr. Wolfrum Four Million Five Hundred Fifty Thousand Dollars ($4,550,000), (the “Purchase Price”), of which One Million Dollars (1,000,000) shall be payable Ninety (90) days from the date of Closing and, the amount of Seven Hundred Fifty Thousand Dollars ($750,000) shall be paid One Hundred and Eighty (180) days from Closing, the aforementioned payments dates has been verbally extended until the Company receives financing. The balance of the Purchase Price, Two Million Eight Hundred Thousand Dollars ($2,800,000), shall be paid in Three (3) payments of Seven Hundred Fifty Thousand Dollars $($750,000) and a final payment of Five Hundred Fifty Thousand Dollars ($550,000) beginning Two Hundred Seventy (270) days after closing, and every three months thereafter until the Purchase Price is paid in full.

 

F-4
 

 

4. ACQUISITION – AT HOME AND ALL STAFFING

 

On December 13, 2013 Accelera entered into a Purchase Agreement with At Home Health Services LLC, All Staffing Services, LLC (together, the “Subject LLCs”) and Rose Gallagher, individually and as Trustee of the Rose M. Gallagher Revocable Trust dated November 30, 1994 (“Gallagher”), pursuant to which Accelera agreed to purchase and Gallagher agreed to sell, all of Gallagher’s interests in the Subject LLCs. The Company also entered into an Operating Agreement with the Subject LLCs.

 

Pursuant to the Purchase Agreement, Accelera agreed to pay Gallagher or her assignee of $1,420,000 dollars, with the sum of $500,000 dollars within ninety (90) days of the Initial Closing Date, the sum of $420,000 dollars within eight (8) months of the Initial closing Date, the aforementioned payments dates has been verbally extended until the Company receives financing. Furthermore, Accelera shall pay a sum equal to the Net Accounts Receivable, meaning the amount applicable to the Subject LLCs as of the Initial Closing Date equal to (a) the bank account balances plus (b) accrued accounts receivable balances, plus (c) a proration through the Initial Closing Date of the prepaid expenses, bonds, and licensing fees of the Subject LLCs, plus (d) an amount equal to the security deposit on the lease for the business address minus (d) the balance of the accounts payables of the Subject LLCs as of the Initial Closing Date. For the above purposes, the terms accounts receivable and accounts payable shall be determined in accordance with standard accounting principles within twelve (12) months of the Initial Closing Date and the sum of $500,000 dollars within eighteen (18) months of the Initial Closing Date. The Initial Closing Date was December 9, 2013, the Final Closing Date is June 12, 2015 at Gallagher’s office in Mokena, IL.

 

See Note 9 for an update on the acquisition of the Subject LLC’s and employment agreements with Ms. Gallagher and Mr. Gallagher.

 

5. NATURE OF OPERATIONS AND BASIS OF PRESENTATION

 

Accelera was incorporated as a Delaware corporation on April 29, 2008. In 2013, Accelera acquired three companies operating in the IME industry and as of December 31, 2013, Accelera operated out of three service centers serving counties in Illinois. On April 11, 2013, the Company formed At Home Health Management LLC that will operate its planned home health care business. On November 29, 2013, the Company formed Accelera Healthcare Management Service Organization LLC that will operate newly acquired Behavioral Health Associates, Ltd. As a 100% owned subsidiaries of Accelera. The consolidated financial statements include the accounts of Accelera and its 100% owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.

 

USE OF ESTIMATES – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

CASH – All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had cash of $185,744 as of December 31, 2013 and $274,857 as of the nine months ended September 30, 2014.

 

RESEARCH AND DEVELOPMENT EXPENSES – Expenditures for research, development, and engineering of products are expensed as incurred.

 

COMMON STOCK – The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

 

REVENUE RECOGNITION – Revenue related to services and administrative support services is recognized at the time services have been performed. The Company believes that recognizing revenue at the time the services have been performed because the Company’s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, Revenue Recognition: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

 

COST OF REVENUES – Costs of revenues are comprised of fees paid to members of the Company’s medical staff other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.

 

F-5
 

 

GOODWILL AND OTHER INTANGIBLE ASSETS – Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at lease annually in accordance with the provisions of FASB ASC Topic 350, Intangibles – Goodwill and Other (“ASC 350”). The goodwill impairment test is a two-step test. Under the first step, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed. During September 2014, the Company recognized goodwill impairment of $692,668.

 

ADVERTISING COSTS – The Company’s policy regarding advertising is to expense advertising when incurred.

 

INCOME TAXES – Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settle. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

The Company adopted the provisions of FASB ASC 740-10 “uncertainty in Income Taxes” (ASC 740-10), on January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

 

LOSS PER SHARE – Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. At September 30, 2014, the Company did not have any potentially dilutive common shares.

 

FINANCIAL INSTRUMENTS – In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

  ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
     
  ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  ● Level 3 – Inputs that are both significant to the fair value measurement and unobservable.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014. These financial instruments include stock options granted to the officers in 2013.

 

F-6
 

  

RECENT ACCOUNTING PRONOUNCEMENTS

 

Effective January 2012, the Company adopted ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (ASU 2011-04). ASU 2011-04 represents the converged guidance of the FASB nd the International Accounting Standards Board (IASB) on fair value measurement. A variety of measures are included in the update intended to either clarify existing fair value measurement requirements, change particular principles requirements for measuring air value or for disclosing information about fair value measurements. For many of the requirements, the FASB does not intend to change the application of existing requirements under ASC Topic 820, Fair Value Measurements. ASU 2011-04 was effective for interim and annual periods beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.

 

Effective January 2012, the Company adopted ASU No. 2011-05, Presentation of Comprehensive Income (ASU 2011-05). ASU 2011-05 is intended to increase the prominence of items reported in other comprehensive income and to facilitate convergence of accounting guidance in this area with that of the IASB. The amendments require that all nonowner changes in consecutive statements. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05 (ASU 2011-12 defers the provisions of ASU 2011-05 that require the presentation of reclassification adjustments on the fact of both the consolidated statement of income and statement of other comprehensive income.

 

Amendments under ASU 2011-05 that were not deferred under ASU 2011-12 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.

 

In December 2011, The FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities (ASU 2011-11). The amendments in ASU 2011-11 require the disclosure of information on offsetting and related arrangements for financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. Amendments under ASU 2011-11 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after January 1, 2013. The Company is evaluating the effect, if any, adoption of ASU 2011-11 will have on its consolidated financial statements.

 

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive (ASU 2013-02). This guidance is the culmination of the FASB’s deliberation on reporting reclassification adjustments from accumulated other comprehensive income (AOCI). The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income. However, the amendments require disclosure of amounts reclassified out of AOCI in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be classified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. The Company is evaluating the effect, if any, the adoption of ASU 2013-02 will have on its consolidated financial statements.

 

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the United States Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

6. STOCKHOLDERS’ DEFICIT

 

The Company has two classes of stock preferred stock and common stock. There are 10 million shares of $.0001 par value preferred shares authorized. There have been no shares issued as of September 30, 2014. Preferred shares have not been defined for any preferences. There are 100 million shares of $.0001 par value common shares authorized. The Company has 34,380,022 and 22,382,522 issued and outstanding shares as of September 30, 2014 and December 31, 2013, respectively.

  

On April 26, 2012, the Company entered into an employment agreement with John F. Wallin, President and Chief Executive officer “CEO” of the Company. In consideration of the services, the Company agreed to issue a stock option to purchase 1,750,000 shares of the Company’s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (350,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (29,166 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Wallin provides that, upon completion of two million dollars in financing, the Company shall begin to pay John a base salary of $250,000 per year, to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at least annually, and increased as determined by the Board. So long as Mr. Wallin has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completion of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Wallin’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan targets to be determined by the Board.

 

F-7
 

 

On April 26, 2012, the Company entered into an employment agreement with James R Millikan, as the Chief Operating Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares if the Company’s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,000 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Millikan provides that, upon completion of two million dollars in financing, the Company shall begin to pay Jim a base salary of $175,000 per year, to be paid at the times and subject to the Company’s standard payroll practices subject to applicable withholding. Base salary shall be reviewed at lease annually, and increased as determined by the Board. So long as Mr. Millikan has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completing of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Millikan’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan Targets to be determined by the Board.

 

On April 26, 2012, the Company entered into an employment agreement with Cynthia Boerum, as the Chief Strategic Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,666 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Ms. Boerum provides that, upon completion of two million dollars in financing, the Company shall begin to pay Cynthia a base salary of $150,000 per year, to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at lease annually, and increased as determined by the Board. So long as Ms. Boerum has not been terminated for cause, as defined in the employment agreement, she will be eligible for bonus compensation, payable immediately following completion of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Ms. Boerum’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan Targets to be determined by the Board.

 

On January 1, 2013, the Company entered into an employment agreement with Patrick Custardo, as the Chief Acquisitions Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $.0001 per share, vesting over a four-year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,666 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Custardo provides that, upon completion of two million dollars in financing, the Company shall begin to pay Patrick a base salary of $150,000 per year, to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at least annually, and increased as determined by the Board. So long as Mr. Custardo has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completion of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Custardo’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan Targets to be determined by the Board.

 

On October 4, 2013, the Company entered into a Standby Equity Purchase Agreement with Lambert Private Equity, LLC, a Delaware limited liability company (the “Investor”). Pursuant to the Investment Agreement, the Investor committed to purchase, subject to certain restrictions and conditions, up to $100,000,000 (which can be extended to $200,000,000 under the same terms) of the Company’s common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by the Investor pursuant to the Investment Agreement (the “Equity Line”).

 

F-8
 

 

The Company may draw on the facility from time to time, as and when it determines appropriate in accordance with the terms and conditions of the Investment Agreement. The maximum amount that the Company is entitled to put to the Investor in any one draw down notice is no more than $2,000,000 and not exceeding 285,710 shares. The purchase price shall be set at ninety percent (90%) of the lowest daily volume weighted average price (VWAP) of the Company’s common stock during the fifteen (15) consecutive trading day period beginning on the date of delivery of the applicable draw down notice. The Company has the right to withdraw all or any portion of any put, except that portion of the put that has already been sold to a third party, including any portion of a put that is below the minimum acceptable price set forth on the put notice, before the closing. There are put restrictions applied on days between the draw down notice date and the closing date with respect to that particular put. During such time, the Company shall not be entitled to deliver another draw down notice. In addition, the Investor will not be obligated to purchase shares if the Investor’s total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company’s common stock as determined in accordance with Rule 13d-1(j) of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the facility unless there is an effective registration statement (as further explained below) to cover the resale of the shares.

 

The Investment Agreement further provides that the Company and the Investor are each entitled to customary indemnification from the other for, among other things, any losses or liabilities they may suffer as a result of any breach by the other party of any provisions of the Investment Agreement or Registration Rights Agreement (as defined below), or as a result of any lawsuit brought by a third-party arising out of or resulting from the other party’s execution, delivery, performance or enforcement of the Investment Agreement.

 

The Investment Agreement also contains customary representations and warranties of each of the parties. The assertions embodied in those representations and warranties were made for purposes of the Investment Agreement and are subject to qualifications and limitations agreed to by the parties in connection with negotiating the terms of the Investment Agreement. In addition, certain representations and warranties were made as of a specific date, may be subject to a contractual standards of materiality different from what a shareholder or investor might view as material, or may have been used for purposes of allocating risk between the respective parties rather than establishing matters of facts. Investors should read the Investment Agreement together with the other information concerning the Company publicly files in reports and statements with the Securities and Exchange Commission (the “SEC”).

 

Pursuant to the terms of a Registration Rights between the Company and the Investor (the “Registration Rights”), the Company is obligated to file one or more registrations statements with the SEC to register the resale by Investor of the shares of common stock issued or issuable under the Investment Agreement. In addition, the Company is obligated to use all commercially reasonable efforts to have the registration statement declared effective by the SEC within 180 days after the registration statement is filed.

 

As an inducement to Investor to enter in to the Investment Agreement and as consideration for the Investor making the investment the Investor received 285,710 shares of common stock and 100% warrant/option coverage. The option to purchase shares certified that for good and valuable consideration, the receipt and sufficiency of which was acknowledged, Lambert Private Equity, LLC is entitled effective as October 4, 2013, subject to the terms and conditions of the Option to purchase from the Company up to a total of 14,287,710 shares of the Company’s common shares at the price of the lesser of (a) $7.00 or (b) 110% of the lowest daily VWAP for the common stock as reported by Bloomberg during the thirty (30) trading days prior to the date the Investor exercised the Warrant prior to 5:00 pm New York time on September 3, 2018 the expiration date.

 

On November 20, 2013, the Company entered into an employment agreement with Blaise J. Wolfrum, M.D., as the President of the Accelera business unit “Behavioral Health Care Associates” reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase Six Hundred Thousand (600,000) shares of the Company’s Common Stock under the terms of the Company’s 2011 Stock Option Plan at an exercise price of $.0001 per share. The Six Hundred Thousand (600,000) shares shall vest over the course of the Three (3) years, earned annually, at Two Hundred Thousand (200,000) shares each year; after the commencement of employment so long as he remain an employee of the Company. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from the agreement shall immediately vest and become fully exercisable. The employment agreement with Dr. Wolfrum provides that the Company shall pay Blaise a base salary of $300,000 per year to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Mr. Wolfrum will begin receiving compensation at the time Accelera completes the Due Diligence, Valuation and Audited Financials of the Behavioral Health Care Associates business performed by an Accelera appointed audit firm. The Board of Directors will implement a bonus structure based on goals, objectives and performance.

 

On December 13, 2013 Accelera entered into a three-year Employment Agreement with Rose M. Gallagher as the President of Accelera’s At Home Health Care business unit reporting to John Wallin, Accelera’s CEO. In consideration of the services, Accelera agreed to immediately grant Ms. Gallagher 585,000 common shares at a price of $0.0001 per share, and an option to purchase 1,000,000 common shares at a price of $0.0001 per share, to be vested Two Hundred and Fifty Thousand (250,000) shares annually for 4 years, beginning March 12, 2014; the final vested shares on March 12, 2017, all the shares will be issued in accordance with the terms of the Accelera’s 2011 Stock Option Plan. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Additionally, Accelera agreed to compensate Ms. Gallagher $150,000 per annum, which is payable bi-weekly in accordance with the Company’s customary payroll practices. The Company has not paid Ms. Gallagher the amounts due under this agreement.

 

F-9
 

 

On December 13, 2013, the Company entered into an employment agreement with Daniel P. Gallagher, as the Director of Marketing and Business Development of the Accelera business units “At Home Health Services and At Home Health Management” reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase One Million (1,000,000) shares of the Company’s Common Stock under the terms of the Company’s 2011 Stock Option Plan at an exercise price of $.0001 per share. The One Million (1,000,000) shares shall vest over the course of the Four (4) years, earned annually, at Two Hundred Thousand (250,000) shares each year; beginning March 12, 2014; the final vested shares on March 12, 2017. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Additionally, Accelera agreed to compensate Mr. Gallagher $100,000 per annum, which is payable bi-weekly in accordance with the Company’s customary payroll practices. The Company has not paid Mr. Gallagher the amounts due under this agreement.

 

See Note 9 for an update on the acquisition of the Subject LLC’s and employment agreements with Ms. Gallagher and Mr. Gallagher.

 

During the nine month period ended September 30, 2014, the Company agreed to issue 796,671 shares of its unregistered common stock for an aggregate of $1,566,412.26 previously subscribed for by investors.

  

7. Stock-based Compensation

 

The Company recognizes stock-based compensation expense in its statement of operations based on estimates of the fair value of employee stock options and stock grant awards as measured on the grant date. For stock options, the Company uses the Black-Scholes option pricing model to determine the value of the awards granted. The Company amortizes the estimated value of the options as of the grant date over the stock options’ vesting period, which is generally four years.

 

The Company has estimated the value of common stock into which the options are exercisable at $4 per share for financial reporting purposes. This amount was determined based on the price our stock was sold for in past private placements, the minimum stock price required for listing on any Nasdaq market, and the amount also approximates a $85 million valuation for the entire Company, which is considered “micro-cap” by most equity analysts. The stock based compensation expense is an estimate and significant judgment was involved in attempting to determine the value of common stock. The Company’s common stock has never traded publicly, and no stock has traded in private markets either, except for privately negotiated sales to the founder and other private investors of the company and the founder of the technology from which the company subsequently licensed rights. The Company does not have any offers for purchase of its common stock in any stage, and no stock is registered for resale with the Securities and Exchange Commission.

 

The Company believes the only material estimate used in estimating the value stock options was the estimated fair value of the common stock, and that assumed volatility, term, interest rate and dividend yield changes would not result in material differences in stock option valuations. Based on the assumed value of common stock, the grant-date cumulative fair value of options granted during the nine months ended September 30, 2014, year ended 2013, and the year ended 2012 was $16,640,000. The Company recognized stock-based compensation expense of $4,700,000, $6,940,000 and $5,000,000 for the nine months ended September 30, 2014, and years ended 2013 and 2012, respectively, which were included in general and administrative expenses. As of September 30, 2014, there was $8,960,000 of total unrecognized compensation cost related to unvested stock-based compensation awards, which is expected to be recognized over the weighted average remaining vested period of approximately 2.25 years.

 

The following is a summary of the outstanding options, as of September 30, 2014:

 

       Weighted Average
   Options
Outstanding		   Intrinsic
Value		   Exercise
Price		   Remaining
Term
                
Options, December 31, 2012   3,000,000              
Granted   3,185,000    4.00    0.0001   3 years
Exercised   (785,000)             
Forfeited/expired   -              
Options, December 31, 2013   5,400,000    4.00    0.0001   2.7 years
Granted   1,000,000              
Exercised   -              
Forfeited/expired                  
Options, September 30, 2014   6,400,000    4.00    0.0001   2.25 years
Vested at September 30, 2014   4,160,000    4.00    0.0001   2.25 years
Weighted average assumptions in the calculation of option value:                  
                   
Historical Volatility   268.0%             
Risk Free Rate   0.83%             
Dividend Yield   0.00%             
Forfeiture Rate   0.00%             

 

F-10
 

 

The Company has reserved a total of 8,595,630 shares of common stock for issuance under its stock award plan, and 8,595,630 of these shares remained available for future issuance as of September 30, 2014.

 

8. Related Party Transaction

 

The Company and Synergistic Holdings, LLC (“Synergistic”), a controlling shareholder of the Company, agreed to cancel 796,671 shares of the Company’s common stock owned by Synergistic and forgive certain indebtedness owed by the Company to Synergistic in the amount of $1,018,618. In addition, the Company entered into an oral agreement to amend the license agreement entered into between the Company and Synergistic to reduce the total amount of reimbursable distribution and commercialization expenses due under the license agreement by $585,181 to $29,414,819 and defer the commencement date of the agreement until the payment dates for the following amounts:

 

  (a) $5,000,000 no later than December 31, 2015;
     
  (b) An additional $7,500,000 no later than December 31, 2016;
     
  (c) An additional $10,000,000 no later than December 31, 2017; and
     
  (d) An additional $6,914,819 no later than December 31, 2018.

 

9. Income Taxes

 

The Company has not recognized an income tax benefit for its operating losses generated based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the periods presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses and other temporary differences, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not. As of September 30, 2014, the Company had a loss and for the period April 29, 2008 (date of inception) through September 30, 2014. The net operating losses resulting from operating activities result in deferred tax assets of approximately $2,590,000 at the effective statutory rates which will expire by the year 2032. The deferred tax asset has been off-set by an equal valuation allowance. There are no current or deferred income tax expense or benefit recognized for the period ended September 30, 2014.

 

10. Subsequent Events

 

On October 6, 2014, the Company entered into an employment agreement with Daniel Freeman as the Chief Financial Officer (“CFO”) reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase One Million (1,000,000) shares of the Company’s Common Stock at an exercise price of $.0001 per share. The One Million (1,000,000) shares shall vest with respect to 23.33% immediately after the effective date of the agreement, thereafter the remaining shares granted under the agreement shall vest ratably on a monthly basis at the end of each month over the course of a 46-month period. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from the agreement shall immediately vest and become fully exercisable. The employment agreement with Daniel Freeman provides that the Company shall pay Daniel a base salary of $200,000 per year to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Mr. Freeman will begin receiving compensation at the time Accelera completes one million dollars in financing. The Board of Directors will implement a bonus structure based on goals, objectives and performance.

 

On August 25, 2014, the Company entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with SCI Home Health, Inc. (d/b/a Advance Lifecare Home Health) (“SCI”), Ethel dela Cruz, Virgilia Avila, Ma Lourdes Reyes Celicious, Cristina Soriano, Michelle Cartas and Jimmy Lacaba (collectively, the “Sellers”), pursuant to which the Company agreed to purchase, and the Sellers agreed to sell, all their SCI shares, collectively representing all of the outstanding shares of common stock of SCI, for an aggregate purchase price of $450,000 (the “Stock Purchase”).

 

F-11
 

 

Pursuant to the terms of the Stock Purchase Agreement, the purchase price was paid as follows: (i) $20,000 via wire transfer concurrently with execution of the Stock Purchase Agreement, and (ii) $430,000 via wire transfer upon approval of the required license transfer by the Illinois Department of Public Health. Pursuant to the Stock Purchase Agreement, revenues generated by SCI, but received by the Company, after the closing of the Stock Purchase will belong to SCI, and SCI agreed to reimburse the Company for expenses generated by SCI after the closing of the Stock Purchase. The Stock Purchase Agreement contains customary representations and warranties and is subject to certain events of default.

 

On October 1, 2014, AOK Property Investments LLC (“AOK”), a third party lender, lent the Company and its subsidiary, Advanced Life Management LLC (“ALM”), an aggregate of $500,000. In consideration of AOK’s delivery of an aggregate of $500,000 to the Company and ALM, the Company and ALM executed and delivered a promissory note (the “Note”) in favor of AOK in the aggregate principal amount of $500,000. The Note is due on January 15, 2015 and bears interest in the amount of 500,000 shares of the Company’s common stock, which interest is due and payable on or before January 15, 2015. If the Company and ALM fail to pay any portion of principal or interest when due, interest will continue to accrue and be payable to AOK at the rate of 1,667 shares of Company common stock per day until all principal and accrued interest is fully paid. There is no prepayment penalty; provided, however, that the interest is due in full at the time of any prepayment.

 

If an event of default under the Note occurs AOK may accelerate the Note’s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. Pursuant to the terms of the Note, an event of default occurs if (i) the Company or ALM fails to make any payment required by the Note when due, (ii) the Company or ALM voluntarily dissolves or ceases to exist, or any final and nonappealable order or judgment is entered against the Company or ALM ordering its dissolution, (iii) the Company or ALM fails to pay, becomes insolvent or unable to pay, or admits in writing an inability to pay its debts as they become due, or makes a general assignment for the benefit of creditors; or (iv) a proceeding with respect to the Company or ALM is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law.

 

A portion of the proceeds of the loan from AOK was used by the Company to fund the Stock Purchase, which closed on October 7, 2014. The Company intends to operate the newly acquired business through ALM.

 

On October 16, 2014, the Company received Notice of Default under the Purchase Agreement executed between the Company and At Home Health Services, LLC and All Staffing Services, LLC on December 13, 2013 (the “Gallagher Purchase Agreement”); Notice of Default under the Employment Agreement between the Company and Rose M. Gallagher dated December 13, 2103 (the “Rose M. Gallagher Employment Agreement”); Notice of Default under the Employment Agreement between the Company and Daniel P. Gallagher dated December 13, 2013 (the “Daniel P. Gallagher Employment Agreement”); and Notice of Default from Rose M. Gallagher as Assignee of Share Interest under the Employment Agreement between Shawn D. Gallagher and At Home Health Management, LLC (collectively, the “Notices of Default”).

 

The Notices of Default allege, among other things, that the Company (1) failed to issue shares in accordance with the Purchase Agreement, whereby the Company is alleged to owe, pursuant to options contracts there under, Rose M. Gallagher, Daniel P. Gallagher and Shawn D. Gallagher a total of 3,000,000 shares of Company stock; (2) failed to make, pursuant to the Purchase Agreement, two deposits totaling $920,000; (3) failed to become listed, pursuant to the Purchase Agreement, on the NASDAQ on or before approximately April 13, 2014; (4) owes Rose M. Gallagher approximately $114,500 in expenses personally funded on behalf of the Company by her; and (5) failed to pay salaries pursuant to Rose M. Gallagher Employment Agreement and Daniel P. Gallagher Employment Agreement in amounts totaling $73,500.03 and $36,000 respectively. The Company is in discussion with the Gallagher’s, At Home Health Services, LLC and All Staffing Services, LLC to terminate this acquisition.

 

F-12
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Our Business

 

Accelera is a healthcare service company which will focus on integrating its technology assets into its newly acquired companies, Behavioral Health Care Associates, Ltd., At Home Health Services LLC and All Staffing Services, LLC to reduce operating costs and expand operations. The technology was licensed to us by our majority shareholder, Synergistic Holdings, LLC (“Synergistic”). Synergistic granted us an exclusive, non-transferrable worldwide license for proprietary Internet-based, software called “Accelera Technology.” Accelera Technology is intended to improve the functionality and performance of healthcare services by making clinical healthcare data available to healthcare consumers. This relevant data is intended to serve as the backbone for self-management tools that are designed to allow these same healthcare consumers to facilitate the self-management portion of their doctor-prescribed care plan and focus on the most costly disease states. This is intended to be accomplished through the proprietary technology, which is designed to identify and measure the severity of the sickness level based upon evidence-based clinical and medical rules and is designed to delivers the results to insurance companies, doctors, hospitals, and employers.

 

The Company will not be able to commercialize its Accelera Technology without additional capital. If the Company does not raise additional funds of at least $430 million for the advancement of the Accelera Technology over the next three years, it will lose its rights to the technology. The Company will require significant additional financing in order to meet the milestones and requirements of its business plan and avoid discontinuation of the license. Funding would be required for staffing, marketing, public relations and the necessary distribution to expanding the scope of its offering to include the global market. The Company intends to seek an aggregate of $435 million in 2014 and 2015 through the sale of equity or convertible debt securities. The issuance of these securities will dilute existing shareholders’ interests in the Company. The Company intends to approach hedge funds, venture capital groups, private investment groups and other institutional investment groups in its efforts to achieve future funding.

 

Significant Developments

 

On August 25, 2014, the Company entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with SCI Home Health, Inc. (d/b/a Advance Lifecare Home Health) (“SCI”), Ethel dela Cruz, Virgilia Avila, Ma Lourdes Reyes Celicious, Cristina Soriano, Michelle Cartas and Jimmy Lacaba (collectively, the “Sellers”), pursuant to which the Company agreed to purchase, and the Sellers agreed to sell, all their SCI shares, collectively representing all of the outstanding shares of common stock of SCI, for an aggregate purchase price of $450,000 (the “Stock Purchase”).

 

Pursuant to the terms of the Stock Purchase Agreement, the purchase price was paid as follows: (i) $20,000 via wire transfer concurrently with execution of the Stock Purchase Agreement, and (ii) $430,000 via wire transfer upon approval of the required license transfer by the Illinois Department of Public Health. Pursuant to the Stock Purchase Agreement, revenues generated by SCI, but received by the Company, after the closing of the Stock Purchase will belong to SCI, and SCI agreed to reimburse the Company for expenses generated by SCI after the closing of the Stock Purchase. The Stock Purchase Agreement contains customary representations and warranties and is subject to certain events of default.

 

On October 1, 2014, AOK Property Investments LLC (“AOK”), a third party lender, lent the Company and its subsidiary, Advanced Life Management LLC (“ALM”), an aggregate of $500,000. In consideration of AOK’s delivery of an aggregate of $500,000 to the Company and ALM, the Company and ALM executed and delivered a promissory note (the “Note”) in favor of AOK in the aggregate principal amount of $500,000. The Note is due on January 15, 2015 and bears interest in the amount of 500,000 shares of the Company’s common stock, which interest is due and payable on or before January 15, 2015. If the Company and ALM fail to pay any portion of principal or interest when due, interest will continue to accrue and be payable to AOK at the rate of 1,667 shares of Company common stock per day until all principal and accrued interest is fully paid. There is no prepayment penalty; provided, however, that the interest is due in full at the time of any prepayment.

 

If an event of default under the Note occurs AOK may accelerate the Note’s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. Pursuant to the terms of the Note, an event of default occurs if (i) the Company or ALM fails to make any payment required by the Note when due, (ii) the Company or ALM voluntarily dissolves or ceases to exist, or any final and nonappealable order or judgment is entered against the Company or ALM ordering its dissolution, (iii) the Company or ALM fails to pay, becomes insolvent or unable to pay, or admits in writing an inability to pay its debts as they become due, or makes a general assignment for the benefit of creditors; or (iv) a proceeding with respect to the Company or ALM is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law.

 

A portion of the proceeds of the loan from AOK was used by the Company to fund the Stock Purchase, which closed on October 7, 2014. The Company intends to operate the newly acquired business through ALM.

 

4
 

 

On October 16, 2014, the Company received Notice of Default under the Purchase Agreement executed between the Company and At Home Health Services, LLC and All Staffing Services, LLC on December 13, 2013 (the “Gallagher Purchase Agreement”); Notice of Default under the Employment Agreement between the Company and Rose M. Gallagher dated December 13, 2103 (the “Rose M. Gallagher Employment Agreement”); Notice of Default under the Employment Agreement between the Company and Daniel P. Gallagher dated December 13, 2013 (the “Daniel P. Gallagher Employment Agreement”); and Notice of Default from Rose M. Gallagher as Assignee of Share Interest under the Employment Agreement between Shawn D. Gallagher and At Home Health Management, LLC (collectively, the “Notices of Default”).

 

The Notices of Default allege, among other things, that the Company (1) failed to issue shares in accordance with the Purchase Agreement, whereby the Company is alleged to owe, pursuant to options contracts there under, Rose M. Gallagher, Daniel P. Gallagher and Shawn D. Gallagher a total of 3,000,000 shares of Company stock; (2) failed to make, pursuant to the Purchase Agreement, two deposits totaling $920,000; (3) failed to become listed, pursuant to the Purchase Agreement, on the NASDAQ on or before approximately April 13, 2014; (4) owes Rose M. Gallagher approximately $114,500 in expenses personally funded on behalf of the Company by her; and (5) failed to pay salaries pursuant to Rose M. Gallagher Employment Agreement and Daniel P. Gallagher Employment Agreement in amounts totaling $73,500.03 and $36,000 respectively. The Company is in discussion with the Gallagher’s, At Home Health Services, LLC and All Staffing Services, LLC to terminate this acquisition.

 

Results of Operations

 

The following comparative analysis on results of operations was based primarily on the comparative financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the financial statements and the notes to those statements that are included elsewhere in this report. The results discussed below are for the three and nine months ended September 30, 2014 and 2013. For comparative purposes, we are comparing the three and nine months ended September 30, 2014 to the three and nine months ended September 30, 2013.

 

Revenues

 

For the three months ended September 30, 2014, the Company generated $844,008 in revenues from operations, as compared to no revenues for the same period in 2013. For the nine months ended September 30, 2014, the Company generated $2,500,341 in revenues from operations., as compared to no revenues for the same period in 2013. The increase in both periods was a result of revenue from of Behavior Health Care Associates, Ltd of approximately $1,949,000 which was acquired by the Company in November 2013 and revenue from All Staffing Services, LLC of approximately $527,000 which was acquired by the Company in December 2013.

 

Total Operating Expenses

 

For the three months ended September 30, 2014, total operating expenses amounted to $2,911,062, as compared to $1,005,050 for the same period in 2013, representing an increase of 277.2%. The increase was a result of increases in stock based compensation, license fees paid to Synergistic and general and administrative expenses. For the nine months ended September 30, 2014, total operating expenses amounted to $6,948,199, as compared to $3,724,265 for the same period in 2013, representing an increase of 186.6%. The increase was a result of increases in stock based compensation license fees paid to Synergistic and in general and administrative expenses.

 

Net Loss

 

For the three months ended September 30, 2014 and 2013, net loss amounted to $3,360,650, or $0.10 per share (basic and diluted), and $1,005,050 or $0.05 per share (basic and diluted), respectively. For the nine months ended September 30, 2014 and 2013, net loss amounted to $6,867,035, or $0.21 per share (basic and diluted), and $3,724,265 or $0.17 per common share (basic and diluted), respectively. The increase in net loss was a result of higher total operating expenses, partially offset by increases in gross profits as discussed above.

 

Liquidity and Capital Resources

 

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. As of September 30, 2014 and December 31, 2013, the Company had a total of $5,186,249 and $5,970,027 in assets, respectively, and the Company had liabilities of $6,249,388 and $74,215 as of September 30, 2014 and 2013, respectively. The Company had working capital of $503,042 and $274,857 in cash as of September 30, 2014, and a working capital surplus of $476,908 and $185,744 in cash as of December 31, 2013. As a result, the Company’s current cash position is not sufficient to fund its cash requirements.

 

5
 

 

The following is a summary of the Company’s cash flows provided by (used in) operating, investing and financing activities for the nine months ended September 2014 and 2013:

 

   2014   2013 
         
Net Cash Used In Operating Activities  $(1,110,967)  $(74,165)
Net Cash provided by Investing Activities   (35,793)     
Net Cash Provided By Financing Activities   1,235,873    74,215 
Net Increase (Decrease) In Cash  $89,113   $50 

 

Our principal sources of liquidity are our cash and the cash flow provided by acquired companies and equity financing. We believe that further equity financing is needed to satisfy our anticipated cash requirements through the next 12 months. We expect to incur losses for at least several years into the future as we develop and deploy our products and services and we are unable to estimate when, if ever, we will generate revenue or have a positive cash flow.

 

As of September 30, 2014, we had a cash balance of $274,857, net accounts receivable of $455,995, advances to related parties and other assets of $51,578 and goodwill of $4,403,819 for a total of $5,186,249 of assets. We have an accumulated deficit and no means to pay liabilities in excess of our assets. If we are not successful in raising additional capital, we may not be able to pay our liabilities that arise and may have to cease operations.

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Going Concern

 

The Company’s auditor has expressed substantial doubt about the Company’s ability to continue as a going concern. The Company has conducted minimal operations since inception. Minimal revenue has been generated by the Company from April 29, 2008 (Inception) to September 30, 2014 and these revenues have come from newly acquired companies. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and\or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. As reflected in the unaudited condensed consolidated financial statements of the Company included in this quarterly report on Form 10-Q, we reported a net loss and net cash used in operating activities of $6,867,035 and $1,110,967, respectively, for the nine months ended September 30, 2014. We had a working capital surplus but, stockholders’ deficit and accumulated deficit of $503,042, $1,063,139 and $19,559,316, respectively, for the nine months ended September 30, 2014, and revenues of $2,500,341. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might arise as a result of this uncertainty.

 

Critical Accounting Policies

 

We have identified the following policies below as critical to our business and results of operations. Our reported results are impacted by the application of the following accounting policies, certain of which require management to make subjective or complex judgments. These judgments involve making estimates about the effect of matters that are inherently uncertain and may significantly impact quarterly or annual results of operations. For all of these policies, management cautions that future events rarely develop exactly as expected, and the best estimates routinely require adjustment. Specific risks associated with these critical accounting policies are described in the following paragraphs.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash

 

All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had cash of $185,744 as of December 31, 2013 and $274,857 as of the nine months ended September 30, 2014.

 

6
 

 

Research and Development Expenses

 

Expenditures for research, development, and engineering of products are expensed as incurred.

 

Common Stock

 

The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

 

Revenue Recognition

 

Revenue related to services and administrative support services is recognized at the time services have been performed. The Company believes that recognizing revenue at the time the service has been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, Revenue Recognition: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

 

Cost of Revenues

 

Costs of revenues are comprised of fees paid to members of the Company’s staff other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.

 

Goodwill and Other Intangible Assets

 

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at lease annually in accordance with the provisions of FASB ASC Topic 350, Intangibles – Goodwill and Other (“ASC 350”). The goodwill impairment test is a two-step test. Under the first step, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed. During September 2014, the Company recognized goodwill impairment of $692,668.

 

Advertising Costs

 

The Company’s policy regarding advertising is to expense advertising when incurred.

 

Income Taxes

 

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settle. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

The Company adopted the provisions of FASB ASC 740-10 “uncertainty in Income Taxes” (ASC 740-10), on January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

 

Loss Per Share

 

Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. At September 30, 2014, the Company did not have any potentially dilutive common shares.

 

7
 

 

Financial Instruments

 

In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

  ●  Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
     
  ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  ● Level 3 – Inputs that are both significant to the fair value measurement and unobservable.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014. These financial instruments include stock options granted to the officers in 2013.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Because we are a Smaller Reporting Company, we are not required to provide the information required by this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal accounting officer concluded as of the Evaluation Date that our disclosure controls and procedures were not effective such that the material information required to be included in our SEC reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to us, and was made known to them by others within those entities, particularly during the period when this report was being prepared. Our disclosure controls and procedures were not effective for the reasons discussed below.

 

  ● Material Weaknesses – We did not maintain effective controls over certain aspects of the financial reporting process because we lacked a sufficient complement of accounting personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements. We also are not maintaining adequate segregation of duties. Due to the limited number of accounting personnel, proper segregation of duties is not possible.

 

We expect to be materially dependent upon a third party to provide us with accounting consulting services for the foreseeable future. Until such time as we have a sufficient number of accounting personnel with the requisite expertise in U.S. GAAP, there are no assurances that the material weaknesses and significant deficiencies in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements which could lead to a restatement of those financial statements.

 

Changes in Internal Control over Financial Reporting

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

8
 

  

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

To the best knowledge of the sole officer and sole director, the Company is not a party to any legal proceeding or litigation. We are, however, currently involved in a dispute with Rose M. Gallagher and Daniel P. Gallagher related to our acquisition of their interests in All Staffing Services, LLC and their employment with that company, as discussed in Note 9 – Subsequent Events in our audited consolidated financial statements included in this report. As discussed in Note 9, we are in discussions regarding the termination of the Company’s acquisition of At Home Health Services, LLC and All Staffing Services LLC and the employment agreements with Ms. Gallagher and Mr. Gallagher.

 

Item 1A. Risk Factors.

 

Not applicable to smaller reporting companies.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

As of the period ended September 30, 2014, the Company agreed to issue 796,671 shares of its unregistered common stock for an aggregate of $1,566,412.26 previously subscribed for. The issuance of the Company’s shares of common discussed above was exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) of that act.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

 

Exhibit No.   Description
     
31.1*   Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014.
     
31.2*   Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014.
     
32.1*   Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
     
101.INS**   XBRL Instance Document
     
101.SCH**   XBRL Taxonomy Extension Schema
     
101.CAL**   XBRL Taxonomy Extension Calculation
     
101.DEF**   XBRL Taxonomy Extension Definition
     
101.LAB**   XBRL Taxonomy Extension Labels
     
101.PRE**   XBRL Taxonomy Extension Presentation Linkbase
     
*   Filed Herewith
**   XBRL Information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

9
 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: November 24, 2014    
     
  ACCELERA INNOVATIONS, INC.
     
  By:   /s/ John F. Wallin
    John F. Wallin
    President and Chief Executive Officer (Principal Executive Officer)
     
Dated: November 24, 2014 By: /s/ Daniel Freeman
    Daniel Freeman
    Chief Financial Officer (Principal Financial and Accounting Officer)

 

10
 

 EX-31.1 2 ex31-1.htm EXHIBIT 31.1 Exhibit 31.1

 

Exhibit 31.1

 

CERTIFICATION

 

I, John F. Wallin, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2014 of Accelera Innovations, Inc. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have;
   
  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation.
   
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);
   
  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  

Date: November 24, 2014  
   
/s/ John F. Wallin  
John F. Wallin  
President and Chief Executive Officer (Principal Executive Officer)

 

 
 

 EX-31.2 3 ex31-2.htm EXHIBIT 31.2 Exhibit 31.2

 

Exhibit 31.2

 

CERTIFICATION

 

I, Daniel Freeman, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2014 of Accelera Innovations, Inc. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have;
   
  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation.
   
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);
   
  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

   

Date: November 24, 2014  
   
/s/ Daniel Freeman  
Daniel Freeman  
Chief Financial Officer (Principal Financial and Accounting Officer)

 

 
 

 EX-32.1 4 ex32-1.htm EXHIBIT 32.1 Exhibit 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Accelera Innovations, Inc. (the “Company”) for the quarterly period ended September 30, 2014 as filed with the Securities and Exchange Commission (the “Report”), I, John F. Wallin, Chief Executive Officer and I, Daniel Freeman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: November 24, 2014 /s/ John F. Wallin
  John F. Wallin
  Principal Executive Officer
   
Date: November 24, 2014 /s/ Daniel Freeman
  Daniel Freeman
  Chief Financial Officer

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference. 

 

 
 

 EX-101.INS 5 accel-20140930.xml XBRL INSTANCE FILE 0001444144 2014-11-17 0001444144 2013-12-31 0001444144 2014-09-30 0001444144 2013-01-01 2013-09-30 0001444144 2014-01-01 2014-09-30 0001444144 2013-07-01 2013-09-30 0001444144 2014-07-01 2014-09-30 0001444144 2013-09-30 0001444144 2012-12-31 0001444144 accel:SynergisticHoldingsLLCMember 2011-06-12 2011-06-13 0001444144 accel:SynergisticHoldingsLLCMember 2011-06-13 0001444144 accel:AcceleratedVenturePartnersLLCMember 2011-06-13 0001444144 accel:AcceleratedVenturePartnersLLCMember 2011-06-12 2011-06-13 0001444144 accel:StockPurchaseAgreementMember accel:BlaiseJWolfrumMDMember 2013-11-20 0001444144 accel:LicensingAgreementsOneMember 2014-09-30 0001444144 accel:LicensingAgreementsTwoMember 2014-09-30 0001444144 accel:LicensingAgreementsThreeMember 2014-09-30 0001444144 accel:StockPurchaseAgreementMember accel:BlaiseJWolfrumMDMember 2013-11-19 2013-11-20 0001444144 accel:PurchaseAgreementMember accel:RoseMGallagherMember 2013-12-12 2013-12-13 0001444144 accel:HomeHealthManagementLLCAndAllStaffingServicesLLCMember 2013-04-11 0001444144 accel:BehavioralHealthCareAssociatesLtdMember 2013-11-29 0001444144 2013-01-01 2013-12-31 0001444144 accel:EmploymentAgreementMember accel:JohnFWallinMember 2012-04-25 2012-04-26 0001444144 accel:EmploymentAgreementMember accel:JohnFWallinMember 2012-04-26 0001444144 accel:EmploymentAgreementMember accel:JamesRMillikanMember 2012-04-26 0001444144 accel:EmploymentAgreementMember accel:JamesRMillikanMember 2012-04-25 2012-04-26 0001444144 accel:EmploymentAgreementMember accel:CynthiaBoerumMember 2012-04-26 0001444144 accel:EmploymentAgreementMember accel:CynthiaBoerumMember 2012-04-25 2012-04-26 0001444144 accel:EmploymentAgreementMember accel:PatrickCustardoMember 2013-01-02 0001444144 accel:EmploymentAgreementMember accel:PatrickCustardoMember 2013-01-01 2013-01-02 0001444144 accel:EquityPurchaseAgreementMember accel:LambertPrivateEquityLLCMember 2013-10-03 2013-10-04 0001444144 accel:EquityPurchaseAgreementMember accel:LambertPrivateEquityLLCMember 2013-10-04 0001444144 accel:EmploymentAgreementMember accel:BlaiseJWolfrumMDMember 2013-11-19 2013-11-20 0001444144 accel:EmploymentAgreementMember accel:BlaiseJWolfrumMDMember 2013-11-20 0001444144 accel:EmploymentAgreementMember accel:RoseMGallagherMember 2013-12-12 2013-12-13 0001444144 accel:EmploymentAgreementMember accel:RoseMGallagherMember 2013-12-13 0001444144 2012-01-01 2012-12-31 0001444144 accel:BlaiseJWolfrumMDMember accel:StockPurchaseAgreementOneMember 2013-11-19 2013-11-20 0001444144 accel:BlaiseJWolfrumMDMember accel:StockPurchaseAgreementTwoMember 2013-11-19 2013-11-20 0001444144 accel:BlaiseJWolfrumMDMember accel:StockPurchaseAgreementThreeMember 2013-11-19 2013-11-20 0001444144 accel:BlaiseJWolfrumMDMember accel:StockPurchaseAgreementFourMember 2013-11-19 2013-11-20 0001444144 accel:RoseMGallagherMember accel:PurchaseAgreementOneMember 2013-12-12 2013-12-13 0001444144 accel:RoseMGallagherMember accel:PurchaseAgreementTwoMember 2013-12-12 2013-12-13 0001444144 accel:RoseMGallagherMember accel:PurchaseAgreementThreeMember 2013-12-12 2013-12-13 0001444144 accel:EquityPurchaseAgreementMember accel:LambertPrivateEquityLLCMember us-gaap:WarrantMember 2013-10-03 2013-10-04 0001444144 accel:EquityPurchaseAgreementMember accel:LambertPrivateEquityLLCMember us-gaap:MinimumMember 2013-10-04 0001444144 accel:EquityPurchaseAgreementMember accel:LambertPrivateEquityLLCMember us-gaap:MaximumMember 2013-10-04 0001444144 accel:EmploymentAgreementMember accel:DanielPGallagherMember 2013-12-12 2013-12-13 0001444144 accel:EmploymentAgreementMember accel:DanielPGallagherMember 2013-12-13 0001444144 us-gaap:MinimumMember 2014-01-01 2014-09-30 0001444144 us-gaap:MaximumMember 2014-01-01 2014-09-30 0001444144 accel:DecemberThirtyFirstTwoThousandFifteenMember 2014-09-30 0001444144 accel:DecemberThirtyFirstTwoThousandSixteenMember 2014-09-30 0001444144 accel:DecemberThirtyFirstTwoThousandSeventeenMember 2014-09-30 0001444144 accel:DecemberThirtyFirstTwoThousandEighteenMember 2014-09-30 0001444144 us-gaap:SubsequentEventMember accel:EmploymentAgreementMember accel:DanielFreemanMember 2014-10-05 2014-10-06 0001444144 us-gaap:SubsequentEventMember accel:EmploymentAgreementMember accel:DanielFreemanMember 2014-10-06 0001444144 us-gaap:SubsequentEventMember accel:StockPurchaseAgreementMember accel:SCIHomeHealthIncMember 2014-08-25 0001444144 us-gaap:SubsequentEventMember accel:StockPurchaseAgreementMember accel:SCIHomeHealthIncMember 2014-08-24 2014-08-25 0001444144 accel:StockPurchaseAgreementMember accel:AOKPropertyInvestmentsLLCMember us-gaap:NotesPayableOtherPayablesMember 2014-10-01 0001444144 us-gaap:SubsequentEventMember accel:AOKPropertyInvestmentsLLCMember us-gaap:NotesPayableOtherPayablesMember 2014-09-28 2014-10-01 0001444144 us-gaap:SubsequentEventMember accel:EmploymentAgreementMember accel:RoseMGallagherDanielPGallagherAndShawnDGallagherMember 2013-12-12 2013-12-13 0001444144 us-gaap:SubsequentEventMember accel:EmploymentAgreementMember accel:RoseMGallagherDanielPGallagherAndShawnDGallagherMember 2014-12-13 0001444144 us-gaap:SubsequentEventMember accel:EmploymentAgreementMember accel:RoseMGallagherMember 2013-12-12 2013-12-13 0001444144 us-gaap:SubsequentEventMember accel:EmploymentAgreementMember accel:DanielPGallagherMember 2013-12-12 2014-12-13 0001444144 accel:BlaiseJWolfrumMDMember accel:StockPurchaseAgreementFiveMember 2013-11-19 2013-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 34882522 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1. BACKGROUND INFORMATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accelera Innovations, Inc., formerly Accelerated Acquisitions IV, Inc. (&#147;Accelera&#148; or the &#147;Company&#148;) was incorporated in the State of Delaware on April 29, 2008 for the purpose of raising capital intended to be used in connection with its business plan which may include a possible merger, acquisition or other business combination with an operating business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 13, 2011, Synergistic Holdings, LLC (&#147;Purchaser&#148;) agreed to acquire 17,000,000 shares of the Company&#146;s common stock par value $0.0001 per share. At the same time, Accelerated Venture Partners, LLC agreed to tender 3,750,000 of their 5,000,000 shares of the Company&#146;s common stock par value $0.0001 for cancellation. Following these transactions, Synergistic Holdings, LLC owned 93.15% of the Company&#146;s 18,250,000 issued and outstanding shares of common stock par value $0.0001 and the interest of Accelerated Venture Partners, LLC was reduced to approximately 6.85% of the total issued and outstanding shares. Simultaneously with the share purchase, Timothy Neher resigned from the Company&#146;s Board of Directors and John Wallin was simultaneously appointed to the Company&#146;s Board of Directors. Such action represented a change of control of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 18, 2011, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware and changed its name from Accelerated Acquisition IV, Inc. to &#147;Accelera Innovations, Inc.&#148;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accelera is a healthcare service company which is focused on implementing its licensed proprietary Internet-based software for use in the healthcare industry The technology was licensed to the Company by our majority shareholder, Synergistic Holdings, LLC (&#147;Synergistic&#148;). Synergistic granted the Company a 30-year exclusive, non-transferrable worldwide license for a proprietary Internet-based, software platform that is fully functional in its current state (&#147;Accelera Technology&#148;) and that is designed to provide interoperable technology that is intended to improve the quality of care while reducing healthcare costs.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>2. GOING CONCERN</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has had minimal revenue since inception and had an accumulated deficit of $19,559,316 as of September 30, 2014. In view of these matters, the Company&#146;s ability to continue as a going concern is dependent upon the Company&#146;s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes until such time that funds provided by operations are sufficient to fund working capital requirements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is currently substantially dependent upon technology licensed from Synergistic. The events or circumstances that may prevent the accomplishment of our business objectives, include, with limitation, (i) the fact that, if the Company does not raise a minimum of $12,500,000 by August 13, 2015, an additional $10,000,000 by August 13, 2016, and an additional $7,500,000 by August 13, 2017, equaling the minimum funding requirement of $30,000,000 for the deployment of its licensed technology over the next three years the Company will lose the rights to the licensed technology.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">USE OF ESTIMATES &#150; The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">CASH &#150; All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had cash of $185,744 as of December 31, 2013 and $274,857 as of the nine months ended September 30, 2014.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">RESEARCH AND DEVELOPMENT EXPENSES &#150; Expenditures for research, development, and engineering of products are expensed as incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ADVERTISING COSTS &#150; The Company&#146;s policy regarding advertising is to expense advertising when incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">INCOME TAXES &#150; Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settle. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of FASB ASC 740-10 &#147;uncertainty in Income Taxes&#148; (ASC 740-10), on January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">LOSS PER SHARE &#150; Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. At September 30, 2014, the Company did not have any potentially dilutive common shares.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">RECENT ACCOUNTING PRONOUNCEMENTS</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 2012, the Company adopted ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (ASU 2011-04). ASU 2011-04 represents the converged guidance of the FASB nd the International Accounting Standards Board (IASB) on fair value measurement. A variety of measures are included in the update intended to either clarify existing fair value measurement requirements, change particular principles requirements for measuring air value or for disclosing information about fair value measurements. For many of the requirements, the FASB does not intend to change the application of existing requirements under ASC Topic 820, Fair Value Measurements. ASU 2011-04 was effective for interim and annual periods beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 2012, the Company adopted ASU No. 2011-05, Presentation of Comprehensive Income (ASU 2011-05). ASU 2011-05 is intended to increase the prominence of items reported in other comprehensive income and to facilitate convergence of accounting guidance in this area with that of the IASB. The amendments require that all nonowner changes in consecutive statements. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05 (ASU 2011-12 defers the provisions of ASU 2011-05 that require the presentation of reclassification adjustments on the fact of both the consolidated statement of income and statement of other comprehensive income.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Amendments under ASU 2011-05 that were not deferred under ASU 2011-12 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2011, The FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities (ASU 2011-11). The amendments in ASU 2011-11 require the disclosure of information on offsetting and related arrangements for financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. Amendments under ASU 2011-11 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after January 1, 2013. The Company is evaluating the effect, if any, adoption of ASU 2011-11 will have on its consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive (ASU 2013-02). This guidance is the culmination of the FASB&#146;s deliberation on reporting reclassification adjustments from accumulated other comprehensive income (AOCI). The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income. However, the amendments require disclosure of amounts reclassified out of AOCI in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be classified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. The Company is evaluating the effect, if any, the adoption of ASU 2013-02 will have on its consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the United States Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company&#146;s present or future consolidated financial statements.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3. ACQUISITION &#150; BEHAVIORAL HEALTH CARE ASSOCIATES, LTD.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 20, 2013, Accelera executed a Stock Purchase Agreement (the &#147;SPA&#148;) and its wholly owned subsidiary, Accelera Healthcare Management Service Organization LLC (&#147;Accelera HMSO&#148;), executed an Operating Agreement with Blaise J. Wolfrum, M.D. and Behavior Health Care Associates, Ltd. (&#147;BHCA&#148;). Accelera acquired 100% of the 100,000 issued and outstanding shares of BHCA from Dr. Wolfrum. Accelera HMSO as a wholly owned subsidiary of Accelera will operate BHCA in accordance with the Operating Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the SPA, the Company shall pay to Dr. Wolfrum Four Million Five Hundred Fifty Thousand Dollars ($4,550,000), (the &#147;Purchase Price&#148;), of which One Million Dollars (1,000,000) shall be payable Ninety (90) days from the date of Closing and, the amount of Seven Hundred Fifty Thousand Dollars ($750,000) shall be paid One Hundred and Eighty (180) days from Closing, the aforementioned payments dates has been verbally extended until the Company receives financing. The balance of the Purchase Price, Two Million Eight Hundred Thousand Dollars ($2,800,000), shall be paid in Three (3) payments of Seven Hundred Fifty Thousand Dollars $($750,000) and a final payment of Five Hundred Fifty Thousand Dollars ($550,000) beginning Two Hundred Seventy (270) days after closing, and every three months thereafter until the Purchase Price is paid in full.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">COST OF REVENUES &#150; Costs of revenues are comprised of fees paid to members of the Company&#146;s medical staff other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>6. STOCKHOLDERS&#146; DEFICIT</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has two classes of stock preferred stock and common stock. There are 10 million shares of $.0001 par value preferred shares authorized. There have been no shares issued as of September 30, 2014. Preferred shares have not been defined for any preferences. There are 100 million shares of $.0001 par value common shares authorized. The Company has 34,380,022 and 22,382,522 issued and outstanding shares as of September 30, 2014 and December 31, 2013, respectively.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 26, 2012, the Company entered into an employment agreement with John F. Wallin, President and Chief Executive officer &#147;CEO&#148; of the Company. In consideration of the services, the Company agreed to issue a stock option to purchase 1,750,000 shares of the Company&#146;s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (350,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (29,166 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Wallin provides that, upon completion of two million dollars in financing, the Company shall begin to pay John a base salary of $250,000 per year, to be paid at the times and subject to the Company&#146;s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at least annually, and increased as determined by the Board. So long as Mr. Wallin has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completion of the Company&#146;s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Wallin&#146;s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company&#146;s achieving 100% of certain financial metrics plan targets to be determined by the Board.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 26, 2012, the Company entered into an employment agreement with James R Millikan, as the Chief Operating Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares if the Company&#146;s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,000 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Millikan provides that, upon completion of two million dollars in financing, the Company shall begin to pay Jim a base salary of $175,000 per year, to be paid at the times and subject to the Company&#146;s standard payroll practices subject to applicable withholding. Base salary shall be reviewed at lease annually, and increased as determined by the Board. So long as Mr. Millikan has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completing of the Company&#146;s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Millikan&#146;s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company&#146;s achieving 100% of certain financial metrics plan Targets to be determined by the Board.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 26, 2012, the Company entered into an employment agreement with Cynthia Boerum, as the Chief Strategic Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares of the Company&#146;s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,666 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Ms. Boerum provides that, upon completion of two million dollars in financing, the Company shall begin to pay Cynthia a base salary of $150,000 per year, to be paid at the times and subject to the Company&#146;s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at lease annually, and increased as determined by the Board. So long as Ms. Boerum has not been terminated for cause, as defined in the employment agreement, she will be eligible for bonus compensation, payable immediately following completion of the Company&#146;s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Ms. Boerum&#146;s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company&#146;s achieving 100% of certain financial metrics plan Targets to be determined by the Board.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 1, 2013, the Company entered into an employment agreement with Patrick Custardo, as the Chief Acquisitions Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares of the Company&#146;s common stock at an exercise price of $.0001 per share, vesting over a four-year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,666 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Custardo provides that, upon completion of two million dollars in financing, the Company shall begin to pay Patrick a base salary of $150,000 per year, to be paid at the times and subject to the Company&#146;s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at least annually, and increased as determined by the Board. So long as Mr. Custardo has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completion of the Company&#146;s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Custardo&#146;s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company&#146;s achieving 100% of certain financial metrics plan Targets to be determined by the Board.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 4, 2013, the Company entered into a Standby Equity Purchase Agreement with Lambert Private Equity, LLC, a Delaware limited liability company (the &#147;<i>Investor</i>&#148;). Pursuant to the Investment Agreement, the Investor committed to purchase, subject to certain restrictions and conditions, up to $100,000,000 (which can be extended to $200,000,000 under the same terms) of the Company&#146;s common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by the Investor pursuant to the Investment Agreement (the &#147;<i>Equity Line</i>&#148;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company may draw on the facility from time to time, as and when it determines appropriate in accordance with the terms and conditions of the Investment Agreement. The maximum amount that the Company is entitled to put to the Investor in any one draw down notice is no more than $2,000,000 and not exceeding 285,710 shares. The purchase price shall be set at ninety percent (90%) of the lowest daily volume weighted average price (VWAP) of the Company&#146;s common stock during the fifteen (15) consecutive trading day period beginning on the date of delivery of the applicable draw down notice. The Company has the right to withdraw all or any portion of any put, except that portion of the put that has already been sold to a third party, including any portion of a put that is below the minimum acceptable price set forth on the put notice, before the closing. There are put restrictions applied on days between the draw down notice date and the closing date with respect to that particular put. During such time, the Company shall not be entitled to deliver another draw down notice. In addition, the Investor will not be obligated to purchase shares if the Investor&#146;s total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company&#146;s common stock as determined in accordance with Rule 13d-1(j) of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the facility unless there is an effective registration statement (as further explained below) to cover the resale of the shares.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Investment Agreement further provides that the Company and the Investor are each entitled to customary indemnification from the other for, among other things, any losses or liabilities they may suffer as a result of any breach by the other party of any provisions of the Investment Agreement or Registration Rights Agreement (as defined below), or as a result of any lawsuit brought by a third-party arising out of or resulting from the other party&#146;s execution, delivery, performance or enforcement of the Investment Agreement.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Investment Agreement also contains customary representations and warranties of each of the parties. The assertions embodied in those representations and warranties were made for purposes of the Investment Agreement and are subject to qualifications and limitations agreed to by the parties in connection with negotiating the terms of the Investment Agreement. In addition, certain representations and warranties were made as of a specific date, may be subject to a contractual standards of materiality different from what a shareholder or investor might view as material, or may have been used for purposes of allocating risk between the respective parties rather than establishing matters of facts. Investors should read the Investment Agreement together with the other information concerning the Company publicly files in reports and statements with the Securities and Exchange Commission (the &#147;<i>SEC</i>&#148;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the terms of a Registration Rights between the Company and the Investor (the &#147;<i>Registration Rights</i>&#148;), the Company is obligated to file one or more registrations statements with the SEC to register the resale by Investor of the shares of common stock issued or issuable under the Investment Agreement. In addition, the Company is obligated to use all commercially reasonable efforts to have the registration statement declared effective by the SEC within 180 days after the registration statement is filed.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As an inducement to Investor to enter in to the Investment Agreement and as consideration for the Investor making the investment the Investor received 285,710 shares of common stock and 100% warrant/option coverage. The option to purchase shares certified that for good and valuable consideration, the receipt and sufficiency of which was acknowledged, Lambert Private Equity, LLC is entitled effective as October 4, 2013, subject to the terms and conditions of the Option to purchase from the Company up to a total of 14,287,710 shares of the Company&#146;s common shares at the price of the lesser of (a) $7.00 or (b) 110% of the lowest daily VWAP for the common stock as reported by Bloomberg during the thirty (30) trading days prior to the date the Investor exercised the Warrant prior to 5:00 pm New York time on September 3, 2018 the expiration date.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 20, 2013, the Company entered into an employment agreement with Blaise J. Wolfrum, M.D., as the President of the Accelera business unit &#147;Behavioral Health Care Associates&#148; reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase Six Hundred Thousand (600,000) shares of the Company&#146;s Common Stock under the terms of the Company&#146;s 2011 Stock Option Plan at an exercise price of $.0001 per share. The Six Hundred Thousand (600,000) shares shall vest over the course of the Three (3) years, earned annually, at Two Hundred Thousand (200,000) shares each year; after the commencement of employment so long as he remain an employee of the Company. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from the agreement shall immediately vest and become fully exercisable. The employment agreement with Dr. Wolfrum provides that the Company shall pay Blaise a base salary of $300,000 per year to be paid at the times and subject to the Company&#146;s standard payroll practices, subject to applicable withholding. Mr. Wolfrum will begin receiving compensation at the time Accelera completes the Due Diligence, Valuation and Audited Financials of the Behavioral Health Care Associates business performed by an Accelera appointed audit firm. The Board of Directors will implement a bonus structure based on goals, objectives and performance.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 13, 2013 Accelera entered into a three-year Employment Agreement with Rose M. Gallagher as the President of Accelera&#146;s At Home Health Care business unit reporting to John Wallin, Accelera&#146;s CEO. In consideration of the services, Accelera agreed to immediately grant Ms. Gallagher 585,000 common shares at a price of $0.0001 per share, and an option to purchase 1,000,000 common shares at a price of $0.0001 per share, to be vested Two Hundred and Fifty Thousand (250,000) shares annually for 4 years, beginning March 12, 2014; the final vested shares on March 12, 2017, all the shares will be issued in accordance with the terms of the Accelera&#146;s 2011 Stock Option Plan. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Additionally, Accelera agreed to compensate Ms. Gallagher $150,000 per annum, which is payable bi-weekly in accordance with the Company&#146;s customary payroll practices. The Company has not paid Ms. Gallagher the amounts due under this agreement.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 13, 2013, the Company entered into an employment agreement with Daniel P. Gallagher, as the Director of Marketing and Business Development of the Accelera business units &#147;At Home Health Services and At Home Health Management&#148; reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase One Million (1,000,000) shares of the Company&#146;s Common Stock under the terms of the Company&#146;s 2011 Stock Option Plan at an exercise price of $.0001 per share. The One Million (1,000,000) shares shall vest over the course of the Four (4) years, earned annually, at Two Hundred Thousand (250,000) shares each year; beginning March 12, 2014; the final vested shares on March 12, 2017. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Additionally, Accelera agreed to compensate Mr. Gallagher $100,000 per annum, which is payable bi-weekly in accordance with the Company&#146;s customary payroll practices. The Company has not paid Mr. Gallagher the amounts due under this agreement.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 9 for an update on the acquisition of the Subject LLC&#146;s and employment agreements with Ms. Gallagher and Mr. Gallagher.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine month period ended September 30, 2014, the Company agreed to issue 796,671 shares of its unregistered common stock for an aggregate of $1,566,412.26 previously subscribed for by investors.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>9. <font style="text-transform: uppercase">Income Taxes</font></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has not recognized an income tax benefit for its operating losses generated based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the periods presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses and other temporary differences, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not. As of September 30, 2014, the Company had a loss and for the period April 29, 2008 (date of inception) through September 30, 2014. The net operating losses resulting from operating activities result in deferred tax assets of approximately $2,590,000 at the effective statutory rates which will expire by the year 2032. The deferred tax asset has been off-set by an equal valuation allowance. There are no current or deferred income tax expense or benefit recognized for the period ended September 30, 2014.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">REVENUE RECOGNITION &#150; Revenue related to services and administrative support services is recognized at the time services have been performed. The Company believes that recognizing revenue at the time the services have been performed because the Company&#146;s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, <i>Revenue Recognition</i>: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">GOODWILL AND OTHER INTANGIBLE ASSETS &#150; Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at lease annually in accordance with the provisions of FASB ASC Topic 350, <i>Intangibles &#150; Goodwill and Other </i>(&#147;ASC 350&#148;). The goodwill impairment test is a two-step test. Under the first step, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit&#146;s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed. During September 2014, the Company recognized goodwill impairment of $692,668.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">FINANCIAL INSTRUMENTS &#150; In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 &#147;Fair Value Measurements and Disclosures&#148; (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity&#146;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 24px; line-height: 115%">&#160;</td> <td style="vertical-align: top; width: 24px; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 &#150; Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</font></td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%">&#160;</td> <td style="text-align: justify; line-height: 115%">&#160;</td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 &#150; Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</font></td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%">&#160;</td> <td style="text-align: justify; line-height: 115%">&#160;</td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 &#150; Inputs that are both significant to the fair value measurement and unobservable.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014. These financial instruments include stock options granted to the officers in 2013.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of the outstanding options, as of September 30, 2014:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="9" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Outstanding</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Value</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Price</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Remaining </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Term</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options, December 31, 2012</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,000,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,185,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(785,000</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/expired</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options, December 31, 2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5,400,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2.7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/expired</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options, September 30, 2014</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,400,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2.25 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Vested at September 30, 2014</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,160,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2.25 years</font></td></tr> </table> <p style="margin: 0pt"></p> 17000000 0.0001 0.0001 0.0001 0.0001 0.9315 0.0685 1.00 1.00 1.00 22382522 34380022 18250000 100000 P30Y 30000000 12500000 10000000 7500000 22382522 34380022 18250000 100000 10000000 10000000 0.0001 0.0001 0 0 100000000 100000000 5400000 6400000 3000000 350000 200000 200000 200000 600000 250000 250000 1000000 3650100 4700000 1650000 150000 100000 4550000 1420000 1000000 750000 2800000 550000 500000 420000 500000 750000 -785000 0.0001 4160000 4 0.0083 0.0000 0.0000 2590000 1000000 3185000 <p style="margin: 0pt"></p> <p style="font: 10pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt">Effective statutory rates which will expire by the year 2032.</p> ACCELERA INNOVATIONS, INC. 0001444144 10-Q 2014-09-30 false --12-31 Smaller Reporting Company Q3 2014 5000000 -12692281 -19559316 8595630 17540 18253 3785 12000 939451 782430 5030576 4403819 5970027 5186249 50174 419084 96586 35418 132628 462543 279388 5970000 5970000 6432543 6249388 2239 3439 12227526 18492738 -462516 -1063139 5970027 5186249 0 0 21509614 32380439 21511812 34380022 -0.17 -0.21 -0.05 -0.10 -3724265 -6867035 -1005050 -3360650 -692668 -692668 3724265 6948199 1050050 2911062 3724265 2248199 1005050 1261062 773832 243080 1726509 600928 2500341 844008 -74165 -1110967 97210 50174 -12000 3785 -297712 -65911 -35793 74215 1235873 419084 96586 74215 1566412 50 89113 185744 274857 50 1201 100 20 3750000 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>5. NATURE OF OPERATIONS AND BASIS OF PRESENTATION</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Accelera was incorporated as a Delaware corporation on April 29, 2008. In 2013, Accelera acquired three companies operating in the IME industry and as of December 31, 2013, Accelera operated out of three service centers serving counties in Illinois. On April 11, 2013, the Company formed At Home Health Management LLC that will operate its planned home health care business. On November 29, 2013, the Company formed Accelera Healthcare Management Service Organization LLC that will operate newly acquired Behavioral Health Associates, Ltd. As a 100% owned subsidiaries of Accelera. The consolidated financial statements include the accounts of Accelera and its 100% owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">USE OF ESTIMATES &#150; The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">CASH &#150; All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had cash of $185,744 as of December 31, 2013 and $274,857 as of the nine months ended September 30, 2014.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">RESEARCH AND DEVELOPMENT EXPENSES &#150; Expenditures for research, development, and engineering of products are expensed as incurred.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">COMMON STOCK &#150; The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">REVENUE RECOGNITION &#150; Revenue related to services and administrative support services is recognized at the time services have been performed. The Company believes that recognizing revenue at the time the services have been performed because the Company&#146;s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, <i>Revenue Recognition</i>: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">COST OF REVENUES &#150; Costs of revenues are comprised of fees paid to members of the Company&#146;s medical staff other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">GOODWILL AND OTHER INTANGIBLE ASSETS &#150; Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at lease annually in accordance with the provisions of FASB ASC Topic 350, <i>Intangibles &#150; Goodwill and Other </i>(&#147;ASC 350&#148;). The goodwill impairment test is a two-step test. Under the first step, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit&#146;s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed. During September 2014, the Company recognized goodwill impairment of $692,668.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ADVERTISING COSTS &#150; The Company&#146;s policy regarding advertising is to expense advertising when incurred.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">INCOME TAXES &#150; Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settle. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of FASB ASC 740-10 &#147;uncertainty in Income Taxes&#148; (ASC 740-10), on January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">LOSS PER SHARE &#150; Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. At September 30, 2014, the Company did not have any potentially dilutive common shares.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">FINANCIAL INSTRUMENTS &#150; In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 &#147;Fair Value Measurements and Disclosures&#148; (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity&#146;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 24px; line-height: 115%">&#160;</td> <td style="vertical-align: top; width: 24px; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 &#150; Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</font></td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%">&#160;</td> <td style="text-align: justify; line-height: 115%">&#160;</td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 &#150; Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</font></td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%">&#160;</td> <td style="text-align: justify; line-height: 115%">&#160;</td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="vertical-align: top; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 &#150; Inputs that are both significant to the fair value measurement and unobservable.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014. These financial instruments include stock options granted to the officers in 2013.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">RECENT ACCOUNTING PRONOUNCEMENTS</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 2012, the Company adopted ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (ASU 2011-04). ASU 2011-04 represents the converged guidance of the FASB nd the International Accounting Standards Board (IASB) on fair value measurement. A variety of measures are included in the update intended to either clarify existing fair value measurement requirements, change particular principles requirements for measuring air value or for disclosing information about fair value measurements. For many of the requirements, the FASB does not intend to change the application of existing requirements under ASC Topic 820, Fair Value Measurements. ASU 2011-04 was effective for interim and annual periods beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 2012, the Company adopted ASU No. 2011-05, Presentation of Comprehensive Income (ASU 2011-05). ASU 2011-05 is intended to increase the prominence of items reported in other comprehensive income and to facilitate convergence of accounting guidance in this area with that of the IASB. The amendments require that all nonowner changes in consecutive statements. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05 (ASU 2011-12 defers the provisions of ASU 2011-05 that require the presentation of reclassification adjustments on the fact of both the consolidated statement of income and statement of other comprehensive income.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Amendments under ASU 2011-05 that were not deferred under ASU 2011-12 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2011, The FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities (ASU 2011-11). The amendments in ASU 2011-11 require the disclosure of information on offsetting and related arrangements for financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. Amendments under ASU 2011-11 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after January 1, 2013. The Company is evaluating the effect, if any, adoption of ASU 2011-11 will have on its consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive (ASU 2013-02). This guidance is the culmination of the FASB&#146;s deliberation on reporting reclassification adjustments from accumulated other comprehensive income (AOCI). The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income. However, the amendments require disclosure of amounts reclassified out of AOCI in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be classified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. The Company is evaluating the effect, if any, the adoption of ASU 2013-02 will have on its consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the United States Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company&#146;s present or future consolidated financial statements.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>7. <font style="text-transform: uppercase">Stock-based Compensation</font></b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes stock-based compensation expense in its statement of operations based on estimates of the fair value of employee stock options and stock grant awards as measured on the grant date. For stock options, the Company uses the Black-Scholes option pricing model to determine the value of the awards granted. The Company amortizes the estimated value of the options as of the grant date over the stock options&#146; vesting period, which is generally four years.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has estimated the value of common stock into which the options are exercisable at $4 per share for financial reporting purposes. This amount was determined based on the price our stock was sold for in past private placements, the minimum stock price required for listing on any Nasdaq market, and the amount also approximates a $85 million valuation for the entire Company, which is considered &#147;micro-cap&#148; by most equity analysts. The stock based compensation expense is an estimate and significant judgment was involved in attempting to determine the value of common stock. The Company&#146;s common stock has never traded publicly, and no stock has traded in private markets either, except for privately negotiated sales to the founder and other private investors of the company and the founder of the technology from which the company subsequently licensed rights. The Company does not have any offers for purchase of its common stock in any stage, and no stock is registered for resale with the Securities and Exchange Commission.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes the only material estimate used in estimating the value stock options was the estimated fair value of the common stock, and that assumed volatility, term, interest rate and dividend yield changes would not result in material differences in stock option valuations. Based on the assumed value of common stock, the grant-date cumulative fair value of options granted during the nine months ended September 30, 2014, year ended 2013, and the year ended 2012 was $16,640,000. The Company recognized stock-based compensation expense of $4,700,000, $6,940,000 and $5,000,000 for the nine months ended September 30, 2014, and years ended 2013 and 2012, respectively, which were included in general and administrative expenses. As of September 30, 2014, there was $8,960,000 of total unrecognized compensation cost related to unvested stock-based compensation awards, which is expected to be recognized over the weighted average remaining vested period of approximately 2.25 years.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of the outstanding options, as of September 30, 2014:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="9" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Outstanding</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Value</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Price</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Remaining </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Term</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options, December 31, 2012</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,000,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 12%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,185,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(785,000</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/expired</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options, December 31, 2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5,400,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2.7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/expired</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options, September 30, 2014</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,400,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2.25 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Vested at September 30, 2014</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,160,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.0001</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2.25 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average assumptions in the calculation of option value:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Historical Volatility</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">268.0</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Risk Free Rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.83</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Dividend Yield</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeiture Rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reserved a total of 8,595,630 shares of common stock for issuance under its stock award plan, and 8,595,630 of these shares remained available for future issuance as of September 30, 2014.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average assumptions in the calculation of option value:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Historical Volatility</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">268.0</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Risk Free Rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.83</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Dividend Yield</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeiture Rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> 0.0001 0.0001 0.0001 4 4 4 P3Y P2Y3M P2Y8M12D P2Y3M 4 85000000 16640000 16640000 16640000 6940000 4700000 5000000 1750000 1000000 1000000 1000000 600000 1000000 14287710 1000000 1000000 3000000 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 P4Y P4Y P4Y P4Y P3Y P4Y P4Y 0.2333 29166 16000 16666 16666 200000 P48M P48M P48M P48M P46M 2000000 2000000 2000000 2000000 250000 175000 150000 150000 300000 200000 73500 36000 1.00 1.00 1.00 1.00 100000000 200000000 450000 P36M 2000000 285710 585000 0.90 0.0499 285710 1.00 Common shares at the price of the lesser of (a) $7.00 or (b) 110% of the lowest daily VWAP. 2018-09-03 P6M P6M P6M P6M P27M P27M P27M P27M 10610000 796671 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>10. <font style="text-transform: uppercase">Subsequent Events</font></b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 6, 2014, the Company entered into an employment agreement with Daniel Freeman as the Chief Financial Officer (&#147;CFO&#148;) reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase One Million (1,000,000) shares of the Company&#146;s Common Stock at an exercise price of $.0001 per share. The One Million (1,000,000) shares shall vest with respect to 23.33% immediately after the effective date of the agreement, thereafter the remaining shares granted under the agreement shall vest ratably on a monthly basis at the end of each month over the course of a 46-month period. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from the agreement shall immediately vest and become fully exercisable. The employment agreement with Daniel Freeman provides that the Company shall pay Daniel a base salary of $200,000 per year to be paid at the times and subject to the Company&#146;s standard payroll practices, subject to applicable withholding. Mr. Freeman will begin receiving compensation at the time Accelera completes one million dollars in financing. The Board of Directors will implement a bonus structure based on goals, objectives and performance.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 25, 2014, the Company entered into a Stock Purchase Agreement (the &#147;Stock Purchase Agreement&#148;) with SCI Home Health, Inc. (d/b/a Advance Lifecare Home Health) (&#147;SCI&#148;), Ethel dela Cruz, Virgilia Avila, Ma Lourdes Reyes Celicious, Cristina Soriano, Michelle Cartas and Jimmy Lacaba (collectively, the &#147;Sellers&#148;), pursuant to which the Company agreed to purchase, and the Sellers agreed to sell, all their SCI shares, collectively representing all of the outstanding shares of common stock of SCI, for an aggregate purchase price of $450,000 (the &#147;Stock Purchase&#148;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the terms of the Stock Purchase Agreement, the purchase price was paid as follows: (i) $20,000 via wire transfer concurrently with execution of the Stock Purchase Agreement, and (ii) $430,000 via wire transfer upon approval of the required license transfer by the Illinois Department of Public Health. Pursuant to the Stock Purchase Agreement, revenues generated by SCI, but received by the Company, after the closing of the Stock Purchase will belong to SCI, and SCI agreed to reimburse the Company for expenses generated by SCI after the closing of the Stock Purchase. The Stock Purchase Agreement contains customary representations and warranties and is subject to certain events of default.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 1, 2014, AOK Property Investments LLC (&#147;AOK&#148;), a third party lender, lent the Company and its subsidiary, Advanced Life Management LLC (&#147;ALM&#148;), an aggregate of $500,000. In consideration of AOK&#146;s delivery of an aggregate of $500,000 to the Company and ALM, the Company and ALM executed and delivered a promissory note (the &#147;Note&#148;) in favor of AOK in the aggregate principal amount of $500,000. The Note is due on January 15, 2015 and bears interest in the amount of 500,000 shares of the Company&#146;s common stock, which interest is due and payable on or before January 15, 2015. If the Company and ALM fail to pay any portion of principal or interest when due, interest will continue to accrue and be payable to AOK at the rate of 1,667 shares of Company common stock per day until all principal and accrued interest is fully paid. There is no prepayment penalty; <i>provided, however,</i> that the interest is due in full at the time of any prepayment.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">If an event of default under the Note occurs AOK may accelerate the Note&#146;s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. Pursuant to the terms of the Note, an event of default occurs if (i) the Company or ALM fails to make any payment required by the Note when due, (ii) the Company or ALM voluntarily dissolves or ceases to exist, or any final and nonappealable order or judgment is entered against the Company or ALM ordering its dissolution, (iii) the Company or ALM fails to pay, becomes insolvent or unable to pay, or admits in writing an inability to pay its debts as they become due, or makes a general assignment for the benefit of creditors; or (iv) a proceeding with respect to the Company or ALM is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">A portion of the proceeds of the loan from AOK was used by the Company to fund the Stock Purchase, which closed on October 7, 2014. The Company intends to operate the newly acquired business through ALM.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 16, 2014, the Company received Notice of Default under the Purchase Agreement executed between the Company and At Home Health Services, LLC and All Staffing Services, LLC on December 13, 2013 (the &#147;Gallagher Purchase Agreement&#148;); Notice of Default under the Employment Agreement between the Company and Rose M. Gallagher dated December 13, 2103 (the &#147;Rose M. Gallagher Employment Agreement&#148;); Notice of Default under the Employment Agreement between the Company and Daniel P. Gallagher dated December 13, 2013 (the &#147;Daniel P. Gallagher Employment Agreement&#148;); and Notice of Default from Rose M. Gallagher as Assignee of Share Interest under the Employment Agreement between Shawn D. Gallagher and At Home Health Management, LLC (collectively, the &#147;Notices of Default&#148;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Notices of Default allege, among other things, that the Company (1) failed to issue shares in accordance with the Purchase Agreement, whereby the Company is alleged to owe, pursuant to options contracts there under, Rose M. Gallagher, Daniel P. Gallagher and Shawn D. Gallagher a total of 3,000,000 shares of Company stock; (2) failed to make, pursuant to the Purchase Agreement, two deposits totaling $920,000; (3) failed to become listed, pursuant to the Purchase Agreement, on the NASDAQ on or before approximately April 13, 2014; (4) owes Rose M. Gallagher approximately $114,500 in expenses personally funded on behalf of the Company by her; and (5) failed to pay salaries pursuant to Rose M. Gallagher Employment Agreement and Daniel P. Gallagher Employment Agreement in amounts totaling $73,500.03 and $36,000 respectively. The Company is in discussion with the Gallagher&#146;s, At Home Health Services, LLC and All Staffing Services, LLC to terminate this acquisition.</p> 796671 1018618 585181 29414819 5000000 7500000 10000000 6914819 20000 430000 500000 2015-01-15 500000 920000 114500 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>8. <font style="text-transform: uppercase">Related Party Transaction</font></b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and Synergistic Holdings, LLC (&#147;Synergistic&#148;), a controlling shareholder of the Company, agreed to cancel 796,671 shares of the Company&#146;s common stock owned by Synergistic and forgive certain indebtedness owed by the Company to Synergistic in the amount of $1,018,618. In addition, the Company entered into an oral agreement to amend the license agreement entered into between the Company and Synergistic to reduce the total amount of reimbursable distribution and commercialization expenses due under the license agreement by $585,181 to $29,414,819 and defer the commencement date of the agreement until the payment dates for the following amounts:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 24px; line-height: 115%">&#160;</td> <td style="width: 24px; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(a)</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$5,000,000 no later than December 31, 2015;</font></td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(b)</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">An additional $7,500,000 no later than December 31. 2016;</font></td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(c)</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">An additional $10.000,000 no later than December 31. 2017; and</font></td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(d)</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">An additional $6,914,819 no later than December 31. 2018.</font></td></tr> </table> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"></p> 1667 753707 455995 8041 -8041 0.20 0.20 0.20 0.20 2.680 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>4. ACQUISITION &#150; AT HOME AND ALL STAFFING</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 13, 2013 Accelera entered into a Purchase Agreement with At Home Health Services LLC, All Staffing Services, LLC (together, the &#147;Subject LLCs&#148;) and Rose Gallagher, individually and as Trustee of the Rose M. Gallagher Revocable Trust dated November 30, 1994 (&#147;Gallagher&#148;), pursuant to which Accelera agreed to purchase and Gallagher agreed to sell, all of Gallagher&#146;s interests in the Subject LLCs. The Company also entered into an Operating Agreement with the Subject LLCs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the Purchase Agreement, Accelera agreed to pay Gallagher or her assignee of $1,420,000 dollars, with the sum of $500,000 dollars within ninety (90) days of the Initial Closing Date, the sum of $420,000 dollars within eight (8) months of the Initial closing Date, the aforementioned payments dates has been verbally extended until the Company receives financing. Furthermore, Accelera shall pay a sum equal to the Net Accounts Receivable, meaning the amount applicable to the Subject LLCs as of the Initial Closing Date equal to (a) the bank account balances plus (b) accrued accounts receivable balances, plus (c) a proration through the Initial Closing Date of the prepaid expenses, bonds, and licensing fees of the Subject LLCs, plus (d) an amount equal to the security deposit on the lease for the business address minus (d) the balance of the accounts payables of the Subject LLCs as of the Initial Closing Date. For the above purposes, the terms accounts receivable and accounts payable shall be determined in accordance with standard accounting principles within twelve (12) months of the Initial Closing Date and the sum of $500,000 dollars within eighteen (18) months of the Initial Closing Date. The Initial Closing Date was December 9, 2013, the Final Closing Date is June 12, 2015 at Gallagher&#146;s office in Mokena, IL.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 9 for an update on the acquisition of the Subject LLC&#146;s and employment agreements with Ms. Gallagher and Mr. Gallagher.</p> 8595630 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">COMMON STOCK &#150; The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.</p> EX-101.SCH 6 accel-20140930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Background Information link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Acquisition - Behavioral Health Care Associates, Ltd. link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Acquisition - at Home and All Staffing link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Nature of Operations and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Related Party Transaction link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Nature of Operations and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Background Information (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Acquisition - Behavioral Health Care Associates, Ltd. (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Acquisition - at Home and All Staffing (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Nature of Operations and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Stockholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Stock-Based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Stock-Based Compensation - Schedule of Outstanding Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions Value (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Related Party Transaction (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 accel-20140930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 accel-20140930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 accel-20140930_lab.xml XBRL LABEL FILE Synergistic Holdings LLC [Member] Legal Entity [Axis] Accelerated Venture Partners, LLC [Member] Stock Purchase Agreement [Member] Stock Purchase Agreement [Axis] Blaise J. Wolfrum, M.D [Member] Business Acquisition [Axis] August 13, 2015 [Member] Finite-Lived Intangible Assets by Major Class [Axis] August 13, 2016 [Member] August 13, 2017 [Member] Purchase Agreement [Member] Purchase Agreement [Axis] Rose M. Gallagher [Member] Home Health Management LLC And All Staffing Services LLC [Member] Behavioral Health Care Associates, Ltd [Member] Employment Agreement [Member] Employment Agreement [Axis] John F. Wallin [Member] Title of Individual [Axis] James R. Millikan [Member] Cynthia Boerum [Member] Patrick Custardo [Member] Equity Purchase Agreement [Member] Equity Purchase Agreement [Axis] Lambert Private Equity, LLC [Member] Related Party [Axis] Amount Payable Within Ninety Days [Member] Amount To Be Paid On One Hundred and Eighty Days [Member] Amount To Be Paid On Three Payments [Member] Amount To Be Paid In Beginning Two Hundred Seventy Days After Closing [Member] Amount Payable Within Ninety Days [Member] Amount Payable Within Eight Months [Member] Amount Payable Within Eighteen Months [Member] Warrant [Member] Equity Components [Axis] Minimum [Member] Range [Axis] Maximum [Member] Daniel P. Gallagher [Member] December 31, 2015 [Member] Award Date [Axis] December 31, 2016 [Member] December 31, 2017 [Member] December 31, 2018 [Member] Subsequent Event [Member] Subsequent Event Type [Axis] Daniel Freeman [Member] SCI Home Health, Inc [Member] AOK Property Investments LLC [Member] Promissory Note [Member] Short-term Debt, Type [Axis] Rose M. Gallagher, Daniel P. Gallagher And Shawn D. Gallagher [Member] Amount To Be Paid In Three Payment [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Accounts receivable, net Advances to others Advances to related parties Prepaid expenses Refundable income taxes Total Current Assets Other Asset Goodwill TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts Payable Due to stockholders Short-Term Note Payable Advances from related parties Accrued expenses Total Current Liabilities Long-term subordinated unsecured notes payable TOTAL LIABILITIES Stockholders' Deficit Preferred stock; $0.0001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding Common stock; $0.0001 par value, 100,000,000 authorized, 34,380,022 and 22,382,522 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively Additional paid in capital Accumulated deficit TOTAL STOCKHOLDERS' DEFICIT TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common Stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Cost of revenues Gross Profit General and administrative Stock compensation Total Operating Expenses Goodwill impairment Income Tax Provision NET LOSS BASIC AND DILUTED LOSS PER SHARE WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Net loss Adjustment to reconcile net loss to net cash used in operations: Changes in purchase price allocation Goodwill impairment Stock based compensation Changes in operating assets and liabilities, net of effects of acquisitions: Decrease in accounts receivable Increase in prepaid expenses Increase in refundable income taxes Increase in accounts payable Increase in accrued expense Net Cash Used in Operating Activities INVESTING ACTIVITIES Advances to related parties and other FINANCING ACTIVITIES Proceeds from sale of stock Stockholder Advances Advances from related parties Payment of Due to stockholder Decrease in Short-Term Note Payable Net Cash Provided by Financing Activities Net increase in cash Cash, beginning of period Cash, end of period Supplemental disclosure of non-cash investing and financing activities Non-cash issuance of common stock Common shares issued for cash, less exercise of stock option Forgiveness of debt by stockholders Background Information Background Information Organization, Consolidation and Presentation of Financial Statements [Abstract] Going Concern Business Combinations [Abstract] Acquisition - Behavioral Health Care Associates, Ltd. Acquisition - at Home and All Staffing Nature of Operations and Basis of Presentation Equity [Abstract] Stockholders' Deficit Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock-Based Compensation Related Party Transactions [Abstract] Related Party Transaction Income Tax Disclosure [Abstract] Income Taxes Subsequent Events [Abstract] Subsequent Events Use of Estimates Cash Research and Development Expenses Common Stock Revenue Recognition Cost of Revenues Goodwill and Other Intangible Assets Advertising Costs Income Taxes Loss Per Share Financial Instruments Recent Accounting Pronouncements Schedule of Outstanding Options Schedule of Weighted Average Assumptions Value Statement [Table] Statement [Line Items] Number of shares agreed to acquire by entity Common stock par value Number of stock shares for tender issuance Number of shares agree to issue for cancellation Equity ownership percentage Common stock, shares issued Non transferrable worldwide license for proprietary Internet-based, software platform Future minimum estimated amount for increase finite lived intangible assets StockPurchaseAgreementAxis [Axis] Business acquisition equity ownership percentage Amount agree to pay by the entity as per purchase agreement PurchaseAgreementAxis [Axis] Goodwill impairment loss EmploymentAgreementAxis [Axis] EquityPurchaseAgreementAxis [Axis] Issuance of stock option to purchase of common stock, shares Option exercise price per share Issuance of common stock in vesting period Stock option vested, percentage Issuance of Stock option vested shares, number Remaining shares granted under the option vested on Monthly basis Remaining shares granted under the option vested on Monthly basis period Completion base level for finance Base salary Annual bonus targets, percentage Value of common stock agree to purchase by the entity Common stock agree to purchase by the entity, period Maximum value of stock that company entitled to put to the investors Maximum number of shares that company entitled to put to the investors Percentage of purchase price based on the daily volume weighted average price Maximum percentage of shares held by the company for fullfill the investor's condition Number of shares issued by the company to investors Issuance of warrant/option, percentage Option issued to purchase common stock, description Warrant expiration date Lock up agreement for sale of shares Leak out agrement for sale of shares Stock-based compensation expense Agreed to issue of unregistered common stock, value Agreed to issue the share of unregistered common stock Option exercisable price per share Proceeds from issuance of private placements Cumulative fair value of options granted Share based compensation amount Unrecognized compensation cost related to unvested stock-based compensation awards Weighted Average Remaining Term Vested, Options outstanding, Ending Balance Number of shares reserved for issuance under stock award plan Remaining stock available for future issuance Options outstanding, Beginning Balance Options outstanding, Granted Options outstanding, Exercised Options outstanding, Forfeited / expired Options outstanding, Ending Balance Options outstanding Vested, Ending Balance Intrinsic Value, Options outstanding, Beginning Balance Intrinsic Value Granted Intrinsic Value, Options outstanding, Ending Balance Intrinsic Value, Vested Options outstanding, Ending Balance Weighted Average Exercise Price, Options outstanding, Beginning Balance Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Options outstanding Ending Balance Weighted Average Exercise Price Vested, Options outstanding, Ending Balance Weighted Average Remaining Term, Options outstanding, Beginning Balance Weighted Average Remaining Term, Granted Weighted Average Remaining Term, Options outstanding, Ending Balance Historical Volatility Risk Free Rate Dividend Yield Forfeiture Rate Cancellation of shares Amount owed to forgive indebtedness Reimbursable distribution and commercialization expenses Defferrd reimbursable distribution amount Deferred tax assets, operating loss carryforwards Effective income tax statutory rates, expiration year Deferred income tax expense (benefit) Current income tax expense (benefit) Stock option vested, percentage Leak out agreement for sale of shares Value of common stock agree to purchase by the company Purchase of common stock value was paid, concurrently Remaining amount paid at the time of license transfer Debt instrument, principal amount Debt instrument, due date Issuance of common stock, shares Accrue interest payable at the rate of share of common stock Deposits Personal expenses funded on behalf by company AOK Property Investments LLC [Member]. Accelerated Venture Partners LLC [Member] Accrue Interest Payable At Rate Of Share Of Common Stock. Annual bonus targets percentage. Behavioral Health Care Associates Ltd [Member] Blaise J Wolfrum M D [Member] The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). Changes In Purchase Price Allocation Common shares issued for cash, less exercise of stock option. Value of common stock agree to purchase by the entity. Common stock agree to purchase by the entity, period. Percentage of purchase price based on the daily volume weighted average price. Completion base level for finance. Cynthia Boerum [Member] Daniel Freeman [Member]. Daniel P Gallagher [Member]. December Thirty First Two Thousand Eighteen [Member]. December Thirty First Two Thousand Fifteen [Member] December Thirty First Two Thousand Seventeen [Member]. December Thirty First Two Thousand Sixteen [Member]. Deferred reimbursable distribution amount. Effective income tax statutory rates expiration year. Employment Agreement [Axis] Employment Agreement [Member] Equity Purchase Agreement [Axis] Equity Purchase Agreement [Member] Home Health Management LLC And All Staffing Services LLC [Member] Issuance of remaining shares granted under the option vested on Monthly basis. Issuance Of Share Of Unregistered Common Stock1. Issuance of stock option to purchase of common stock, shares. Issuance of warrant percentage. James R Millikan [Member] John F Wallin [Member] Lambert Private Equity LLC [Member] Leak out agreement for sale of shares. Licensing Agreements One [Member] Licensing Agreements Three [Member] Licensing Agreements Two [Member] Lock up agreement for sale of shares. Maximum number of shares that company entitled to put to the investors. Maximum value of stock that company entitled to put to the investors. Number of stock shares for tender issuance. Option exercise price per share. Option issued to purchase common stock, description. Patrick Custardo [Member] Maximum percentage of shares held by the company for fullfil the investor's condition. Personal expenses. Proceeds From Advances To Related Parties And Other. Proceeds From Stockholder Advances. Purchase Agreement [Axis] Purchase Agreement [Member] Purchase Agreement One [Member] Purchase Agreement Three [Member] Purchase Agreement Two [Member] Remaining amount paid at the time of license transfer. Remaining shares granted under the option vested on Monthly basis Period. Rose M Gallagher Daniel P Gallagher And Shawn D Gallagher [Member]. Rose M Gallagher [Member] SCI Home Health Inc [Member] Share based compensation arrangement by share based payment award fair value assumptions forfeiture rate. Share based compensation arrangement by share based payment award options outstanding intrinsic value granted. Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Of Vested Option. Share based Compensation Arrangement By Share based Payment Award Options Granted Outstanding Weighted Average Remaining Contractual Term. Share based Compensation Arrangement By Share based Payment Award Options Outstanding Weighted Average Remaining Contractual Term. Share based compensation arrangement by share based payment award options vested percentage. Share based Compensation Arrangement By Share based Payment Award Options Vested Weighted Average Grant Date Fair Value1. Share based Compensation Arrangement By Share based Payment Award Vested Options Outstanding Weighted Average Remaining Contractual Term. Stock Issued During Period Shares Cancellation. Stock Purchase Agreement [Axis] Stock Purchase Agreement Four [Member] Stock Purchase Agreement [Member] Stock Purchase Agreement One [Member] Stock Purchase Agreement Three [Member] Stock Purchase Agreement Two [Member] Synergistic Holdings LLC [Member] Stock Purchase Agreement Five [Member] PurchaseAgreementOneMember Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Increase (Decrease) in Accounts and Notes Receivable Increase (Decrease) in Prepaid Expense Net Cash Provided by (Used in) Operating Activities Proceeds from Related Party Debt Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Development Stage Enterprise General Disclosures [Text Block] Stockholders' Equity Note Disclosure [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOfVestedOption Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedPercentage EX-101.PRE 10 accel-20140930_pre.xml XBRL PRESENTATION FILE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!F'MSGR0$``(03```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/PC`4AN]-_`]+;\W6 MM2JB87#AQZ62B#^@K@>VL+5-6Q#^O=WXB"$((9)X;EA@[7D?>O%D>WN#15U% M<["NU"HC+$E)!"K7LE23C'R,7N(NB9P72HI**\C($AP9]"\O>J.E`1>%W/%#J\@)JX1)M0(4[8VUKX<-7.Z%&Y%,Q`.*TKBK@$'H MWH3FSN\!ZWUOX6AL*2$:"NM?11TPZ**B7]I./[6>)H>'[*'4XW&9@]3YK`XG MD#AC04A7`/BZ2MIK4HM2;;@/Y+>+'6TO[,P@S?]K!Y_(P9%P7"/AN$'"<8N$ MHX.$XPX)1Q<)QST2#I9B`<%B5(9%J0R+4QD6J3(L5F58M,JP>)5A$2O#8E:. MQ:PP"3N'[6- MHR1`]_:$`X)*8]O1]N?//UO>[N9I5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B M9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%H MT9,9J&74"T\U<%J"`=[!ZH^^CSYLK$SO+ M=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'!Q0]47P```/__`P!02P,$%``&``@````A M`%"KK)4XNI9!KFWZ`L!7;Q):,I#[R]Q4F.`V$[27LQ2`)K\:SZ]F1 MUMN?KDV^M/.--;F`22H2;0I;-J;*Q&PO=V]R:V)O;VLN>&ULE%9-<]HP%+QWIO_!XWOC#YPTR00RH4D; M+FFFT.2H46R!-46#2"R`;K?;MVWWVU?6F$-Z*:<.5'/K1 M2>A[3*8JXW(Q]/_.?GX[]SUCJ<1+'9_4_:RF> M.%N;W:9ZZ6V>NN:9S>%^&(;=M7O&%[G=7@3X`.$W M"L(YS;41"+C*F@,F4()48H\?^A`(&.S`#!-'I_@LS4`J<"DTD02O)) M,N\HF`R(WRESN@\SINERH54%ZNYD!>ON2H'N=ML;1^!:?BG(4RUJRG1O%V[' M]_U#;]+7BAM>>YN,64Y77&DJR#VCPN8$'X[[<7X,AEIRKPK6V.1&"#*U&`;W MXV(?YH':2C.BYN1WR72;N`9G3`TW&`8W)`KW<:96IZU@;)&[%7SVME[@K8[[CDN/39Q@&T:. M#P^H!Z6\B%XM"39FY#CSXSA`-RWE`A>68&=&CC5[N=AN)P]4U_Y:(6VCGD". M-X\GI2?0`"D-(WEO`F(@-RL8*,8*P6(/Z'C+0)5N[2D5*;QTU%_U M4[OQ:;!]Y1K]`P``__\#`%!+`P04``8`"````"$`+;TX:E@$``#<#P``&``` M`'AL+W=O.$8I-1VDIM<'[\??X^QT_K;V]5:;S2 MAA>LWIAXB4R#UCG;%_5Q8_[\\;P(3(.W6;W/2E;3C?E.N?EM^^LOZRMK7OB) MTM8`A9IOS%/;GE>6Q?,3K3*^9&=:PS<'UE19"X_-T>+GAF;[[J6JM`A"GE5E M16U*A54S1X,=#D5.$Y9?*EJW4J2A9=9"_/Q4G/E=K%^!`#+O1T,/&?,*K%#NFM5UW`_1/0:]\\-G@)W;]K2GV?Q0UA=&&/(D, M[!A[$>CWO6B"EZW1V\]=!OYJC#T]9)>R_9M=?Z?%\=1"NEUP)(RM]N\)Y3F, M*,@LB2N4J__9Q4\"I$GH;(Q?=,`%QSR\[KUG+7U"D.:WY#H`>*J2'Q'Q``* MV>3>\"&+U5?2.R&R!XYZ6S!80UN/$W6/7L`B^GN_D6P`[=X.4?N-QX3GJ4@R M1C21=$P,1!0[]E?L"!@J;!"]YZNQ11)Q!HB>BT^)Y%,BG2(4>Q#(_&P)>&/" MV/7)\0+-GD2"KA`#QT%(`V()P-]>PT:J1C+4("Y"MJ/7WJ2(X@\FUGQ_`M;\ MA6ILD40\.=$0"HGN3P*3_H8:V">>B[1>TDD1Q9_W%7\"5OWYVMA'$I'^B&.C M0`-B"4SZ&VKXOAW8^NR;U%#LP;HV/WT"UNQIA1-)1-K#Q,/(TV*+%0(A%W[5 M$DB&!"%.@$,]?4/"]HD#*>XU%'OBE#+8`J;72@%K]K3@(XG<[$%=P4_?<;>N MQY*83-]0Q/&%AB:2#@D;NL$#0O$7?L6?@#5_MAI]))%;=8;X0?J&!(;OHS6#HZU:*&Y,Z7#AA<335]CX)C.9PALS(9-.RRA9 MQ&*KGUVF':W9_"C_K@JC&S/E(9[!)#.8=)I1C8ICP7RC\A`QW`Y][2028K#DJXP4>G&"U04U59KIPQ?E@OE%YFE",ZL<:+)FP MVQ@7:*DMO+'^/=*B3W2`:`JI#N"/$-0D0E4-O8ESM0W3:GIQA3O,:/71MO;H MQLA993MV@!#15N!880AV,0ZPQB0*8Q/0<6Q]"U$8T$&AAS\6"VE87IKDG:*B MS9'&M"RYD;.+N!#9D(J^M;^L/1%QUM;:([R"&\"X/1&7.]%N]2_`W>J<'>F? M67,L:FZ4]`!=H:4/)Y9&WL[D0\O.W0UGQUJX574?3W"+IG"W0$N`#XRU]P?1 M07\OW_X'``#__P,`4$L#!!0`!@`(````(0#[ILD:J0(``,H&```9````>&PO M=V]R:W-H965T,U6)OBGQ[U]WDSE&QM*^HIWJ>8F?N<'7JX\?ECNE'TS+N47`T)L2M]8. M"T(,:[FD)E(#[V&F5EI2"T/=$#-H3JMQD>Q(&L6T^B>4M&,R!3;)+Z"35#]MAPI0<@&(C.F&?1U*,)%O<-[W2=--! M[J=D2MF!>QR\HI>":654;2.@(][HZ\Q7Y(H`TVI9"4C@RHXTKTN\3A8W!2:K MY5B?/X+OS-$],JW:?=&B^B9Z#L6&;7(;L%'JP4'O*_<(%I-7J^_&#?BA4<5K MNNWL3[7[RD736MCM'`*Y7(OJ^98;!@4%FBC-'1-3'1B`*Y+"G0PH"'T:_W>B MLFV)LUF4%W&6`!QMN+%WPE%BQ+;&*OG7@Y(]E2=)]R3POR=)\FB:YL7\`A;B M'8T!;ZFEJZ56.P2'!C3-0-T13!;`[))E4!_O(V1]+RID="1KQU+B`B-8;F![ M'E?9[&I)'J&F;(^Y\1BX!DP2$`3Q4QB6?OKNG!SFW""IT'*+(`[]WX#'3(\P+XB0H0"X/ZL`EAG2A?&D\/5/V MF#P>=R"-9O,P?Z(+*2_7=>!SW5G@]8D]9J\[C[+XY)=\GF1AP8F1V?\8<>!S M(T7@]48\9F\D#I,GHG!*+T_OP.>B+U7UHA[SCJCO*?Z5DUPW_!/O.H.8VKI^ MDAE:W3L1N%"6@E`VWX=ZH;T1O4\1J6QE$!9=>^&?F!5#P6L01@&NE[&'@VEWX"JW^`0``__\#`%!+`P04``8`"````"$`$```&0```'AL+W=OZ.M"N-1C.[UP2N$G2FL#(A1\8Y[JNES9-H]/-(^XQ4I:P)T#J_*HALOJ M:/.RHE'2#,HSVYG-`CN/TL+$"*MJ2@QV.*0Q?6+Q.:=%C4$JFD4U\/-36O)K MM#R>$BZ/JI=S^1"SO(00^S1+Z_K+L6!5M,]@WF_$B^)K[.;B)GR> MQA7C[%!;$,Y&T-LY+^VE#9&VZR2%&0C;C8H>-N8C687.S+2WZ\:@_U)ZX=)G M@Y_8Y:\J3?Y)"PIN0YY$!O:,O0CIET1\!8/MF]'/30:^5D9"#]$YJ[^QR]\T M/9YJ2+P M_/G,)2`W]I37SZD(:1KQF=1F(EDQ5$OOJ#L^D<&S,,G!)! M'D64C3DW#?""0Y9?MZ[OK.U7R$S<:G:H@==.0U1%>*MPO5YC`W&'#5;*V,/I MO-()L:`3Z16X._Q"1M%@PP&%W]$J)&":3"(,]$87V)5(#(*E)'LQ[^,C)&H\ M2:,IPGL*A1&"Z(PN;*7[KHE!&Q.,Z/+E^F[G`3*B)F@R[GLS\: MH3""9S+C?38AUMD\]RPB4+7Z97V(*/L`FQSJ9E;H<:\*;W MMK<%X5""^`_S.W"PZV3CQ`+\=7+%(!TRT`Q$S5W(NQ+%0E%0I7/F?GJ%6*>; M:W2H07^"P:4G*_3%J;`M5;9I#HI!.N-"8T0-,GHD$(M0582H&/%8@22P864' MIU$VHW3,I0JQ:T6+9AMKVRAL;\J(_6I6"<7Y/3G'!$][Y7P)-'MVK6CXX;A/ M.HFH.CV\2B:.C-(VN:=[VHKNDPZ*^D*%KF*;A_U+ M3JLC#6F6<2-F9]'"$3A%NF^[]O+1:1K$[@9T=V5TI/]&U3$MN)'1`PR=67/8 MP17VAWA1L[+ICO:LAKZN^7B"/IY"_S"S0'Q@K+Y>B`ZT^\_`]B<```#__P,` M4$L#!!0`!@`(````(0`V-'\'YP,``#<.```9````>&PO=V]R:W-H965TRS*Q+_.TH8P>N0%VIECHE'EEKDQPVFVR'`@P[%I#CEO]P5[' MMJV;NTT;H)\YN;+1;XV=Z?6/)L^^YQ6!:$.>,`,'2I]0^BW#(9AL3F8_MAGX MN]$RG,(=T^$"'8.GN-"$LAHF!C.#XZI;2`!<"W5N98&A"1 MY*4]7O.,G[>Z&QC^PG)MD&L'POACCI:ZEEX8I^5_0M02#29.9P+'SL0.#&?I MVW[P"1>WZ!GEA4''/.]>S-N8S M5$G::<*IQI85^UZ!)8&V43\PME4FQ;T&*Q*8!C!(_!CL=O'UZT M4TB@P:^`XB055$E7*#1!FTH["#PD54#O2R(AF8E%/&LBH<*>-\[I?"Y1K"(J M]18*C4#T%K=2.58$JQLQB(1B#G#LH1:,Q(=-F?)\N+_KX"25\VU7:_?V4&A$ MS=I68-](I9#,8$1W%?&<0@)=_0HH3E)!%W)!AD(SIG"]I:S93S5*6413A>NM M9)=XJGESD5AMV'74K-[?B=I9"JVOW'YA)Q+UN_17?N`JDGTG&4?D;9W=@Q\7 M",^W]_?E>-9%IL460:GA#]"*QD)ZM/A*\Q%"&XWKG*45DAF4J'.9D6"__GY` M!*WHQT5S5Y+F1/:D*)B6T@OVVB[LFEXA.\-.&X. M$Z!MKY,3^2MI3GG%M((Y9C"VJ1CC`B:3_/MTTRT/_4GN5W8NDIG6PX>6%]'J5M#M M;W_M7@9_;@['[?[U;FA#S>MZ_[!]?;H;_O<_WK?Y<'`\K5X?5B_[U\W= M\._-GT?'ML%D]G%^T>QF9X_%LM%MM7X>BPN+0I\;^\7&[WCC[]8_= MYO4DBAPV+ZL36__C\_;MV%3;K?N4VZT.?_QX^[;>[]Y8B>_;E^WI[W/1X6"W M7H1/K_O#ZOL+V^Z_C,EJW=0^_Z55?K=='_;'_>/IBI4;B15M;_/-Z&;$*MW? M/FS9%O#=/CAL'N^&OQN+VKH>CNYOSSOH?]O-S^/%GP?'Y_U/_[!]2+:O&[:W MV7'B1^#[?O\'I^$#;V(O'K5>[9V/0'$8/&P>5S]>3M7^9[#9/CV?V.&>LBWB M&[9X^-O9'-=LC[(R5^:45UKO7]@*L'\/=EL>#;9'5G^=__MS^W!ZOAM:LZOI M]=@R&!]\WQQ/WI:7'`[6/XZG_>[_`AFRE"ABRB+7;.WEP355@D MSZMR\U[%FE[-I]/);'[=?UT,M@O%%O%]^>5-,MYW#-NXILQ75L=J5N=BLUB; M?L^.Q%$Z'W1G=5K=WQ[V/P?LD\36ZOBVXI]+8V&PBLWA%@?G/0`?'7]VX'F5 MWWF9NR$[7.S0'EEH_[PW;\S;T9\L:&MIEFTSFZK$;@B/%:_K-`V_ZAKJ2]Q& M-"_Q1(/($Z_ATX:`-H1-C5_O8L['ZOM$C6G>)Z8-"6U(FP9-V:PQ3=F<-A2T MH:0-%6VH+QI&[#B_'VR6/.5@=W^FFV/*-3^FS:HMFX:+[5%WDMT6LYE*G#8A M.7';@A;QVL0D4?([R)RL2R`,VUL7J;74]0U[F*B'B7N8I(=)N\R-NLY9#Y/W M,$7;6..)^EYEVY@SLCY5AYF3SW&M-TJ,V=GN$S'F6HDQ;;!I@T,;7-K@T0:? M-@2B0S'J8O(IBRAZEZF%IOE&Q-/I4M MKI5LT0:;-CBTP:4-'FWP:4,@&M1LD?-?V,-$/4SXEK)%FVP:8-# M&US:X-$&GS8$HN%7]REL&BZ_),E.B!K3=!7BIN'R1;_VRKEOEW29^?N>.YNT M,4WAC#;DM*&@#25MJ&A#?=&@'+#9IPX8UW=#]CWVWIN8DDU>"C([=Y"-L?A' MW6);$):J7U54X>`B+BSBX2(^+!)`$4(101%#D4"10I%!D4-10%%"44%1ZX02 M7W8Y]HGS#=EL+@51^P8D<[8PNC-LCRHNK.+UJ.+#*@$4(101%#$4 M"10I%!D4.10%%"44%12U3B@)Y@/;GXCPF9,,DWPNI?FPAR"7ZP(,2KBXA`=* M^+A$@$F(281)C$F"28I)ADF.28%)B4F%2:TE:HSY:'?_/@.?AR&G8G/6RK%` MXF1L3:SY>&R2@0A;%M)F&9=Q<1E/$K$VIFG-S2E=&Q^7"3`),8DPB3%),$DQ MR3#),2DP*3&I,*FU1,TT'PW_1*;%X/GET,.,C(DM#6'TD19&&VE:+=8% MT5_B&6+LGD7A?3S,&M.+/(DT@;,Q<3!Q,?$P\3$),`DED1<,$W-^?6V0[[$( MEXDQ23!)U96YGO*A3778,E-)U]AGCDF!2:F0V?F-U%6I%"''8552:XD:;!8[ M)=@@T)RKW6AK3"9,EX9`VD!#XN`J+B8>)CXF`28A)A$F,28))JDD'UW(9&!Y M#I878'D)EE=@>?WQR M)=%LKH.KN+B*IU29=JV+KQ!VBQ+_1^V_!?B-0DPB3&),$DQ22>35>6?W^?(0 ML7OB6YN<*S6Z1`%%J8CNOK.R'AUK6BLU3%6HB>:3+5](M)BC41--;N]9&KJ) M''EZAL3!55Q,/$Q\3`),0DPB3&),$DQ2242BS1N#WL.;*<#@65,_PCD!,UJA M0*!40-Q8R-FF=ZZP6_-Q_UIB%Q)CXF`28A)A$F,28))JDD\W,W6IPDR9DXPR3'I,"DE$03 MA@J36DO40']N[M!LSQU:!AV[DTBS#38F#B8N)AXF/B8!)B$F$28Q)@DFJ22R MYZ'V/\\]OTP1QGFTFO0]5-%1HX"B5(2X2E'?I9)"$Y5:2]0LLPZ$TOO0#W*8 MG).3LTD^^$N)-"MH8^)@XF+B8>)C$F`28A)A$F.28))*(@DP*3$I,*DUA(UW"QZRIFYW\B=R5]& MS]!DE',ID3;L-B"7G7'U"']:8*E"><% M;4P<3%Q,/$Q\3`))9+#GT]:=2"$N$F$28Y)@DF*289)C4F!28E))(G;N=,XO M1M7KR%I;1(TUG[VA0]0]8BTF?90A:I,.49L":<_7D#BXBHN)AXF/22#)^Q0S M&>H)<8D(DQB3!),4DPR3'),"DQ*3"I-:2]14=TTD]DAUQT2B28;TER:<);0Q M<3!Q,?$P\3$)))&IGES=W+C?R&5%B,M$F,28))BDF&28Y)@4F)285)C46J(F M^VM3BF;'E*+9FGF!\X6VK*,YI3N8N)AXF/B8!)B$F$22?-R9B7&1!),4DPR3 M'),"DQ*3"I-:2Y1<\QO_6_T0_'\#G%]&AT3(M_)2(DUH;4P<3%Q,/$Q\3`), M0DFZ!XHC7"#&),$DQ23#),>DP*3$I,*DUA(UTW0RL=\EH]4QJ6B1'OY2(FVF M11T-<7`5%Q,/$Q^3`),0DZB#6!:9`(@[$!WFPR3%),,DQZ3`I,2DPJ36$C7: MGYM;M#KF%BW2Q5Q*I,FKC8F#B8N)AXF/28!)*,GT?+/%Q+(FY"(ZPC5B3!), M4DPR3'),"DQ*3"I,:BU1XTQG&_6#>E;'+*-%YA*6$FGC+.IHB(.KN)AXF/B8 M!)B$F$28Q)@DF*289)CDF!28E!V$?=;54;NJ#ZH!4F/-DJ5TJD&L.2>=:8M\ M,2XM@329M3%Q,'$Q\3#Q,0DP"3&),(DQ23!),':^9T>-FRW-9;!)W)P>95QDP*3$I,*DUA(UVEW3BSVBW3&]:+6&]002]ZE?W\QF].>: M;?98%-ZAT08;%7%Q$0\3'Y,`DQ"3"),8DP23%),,DQR3`I,2DPH3_A2=C^,B M8BV>DB,>F++;')XV]N;EY3A8[W_P)^"P'[^YOWUO%H_G\U+XV%??X1;E+',1;LD2?M.J&Q8(\H:;?'QH(]F*3=GK+' M"'6U+\W%LFM];'-A=[4[YH+]['B[OFLNV*^/L_;1^P:PIP2]K9XVZ>KPM'T] M#EXVCVP?CJ_XHW@.XCE#XB^G_=OYN33?]R?V?*#S'Y_9\Z`V[%DNXRN&'_?[ M4_,7_@;O3YBZ_P<``/__`P!02P,$%``&``@````A`-%)@M>;`P````P``!D` M``!X;"]W;W)K&ULE)9=CZ(P%(;O-]G_0+@?$114 MHFY&$37933:;_;BN4+49H*2MX\R_WU,J",41Y\89#D]?SGG/H73Z[2U-C%?, M.*'9S+1[?=/`641CDAUFYI_?X=/8-+A`68P2FN&9^8ZY^6W^]T:#[/8EP0*-3BC.A1!A.D(#\^9'DO%1+HT?D4L1>3OE31-,<)'8D(>*] M$#6--/*WAXPRM$N@[C=[B*)2N[AHR:B!G*42;=<\L286*,VG,8$* MI.T&P_N9^6S[6\^TYM/"G[\$GWGM?X,?Z7G-2/R=9!C,AC;)!NPH?9'H-I8A M6&RU5H=%`WXR(\9[=$K$+WK>8'(X"NBV"P7)NOSX/<`\`D-!IN>X4BFB"20` MOT9*Y&2`(>BM^'LFL3C.S('7OPZA^JFUBLT)KHPBS;C:-8L"L6I-'S7RWMYA)Q33< M'33=E9,W@-?[OLMR4<-E/;#4`X$>6.F!4`^L]5J"ZO?=&ZL7M4! M?758OVG#DX?#:J(*^;4"P):J\P,M@TT;T89C>X]H6.M]QEH):]9.M'XN%*.\ M??(FCN=IK]52$?<*##I%5MTB81O17%IW$IM.`DXZTI-Z-=>G**?5249]HU/, M#GB)DX0;$3W)4\H$IK"*J@-4Z/BP@\%G1XNO'1\VLG8<#ES/M^(+VX2<2/! M>RB]WQO!G#)UA%,7@N;%"69'!1R]BG^/<-+&\-GO]P#>4RK*"_F`ZNP^_P\` M`/__`P!02P,$%``&``@````A`(8"R+O9`@``:@@``!D```!X;"]W;W)K&ULG%9=;]HP%'V?M/]@^;WY@I"`"%59U:W2)DW3/IZ- MXR06<1S9IK3_?M$-]@Q+-08#ED4G+)[27>"-<:1 M*%83`_IUQ5M]9!-T#)T@:KMK;Z@4+5!L>,W-2T>*D:"+Q[*1BFQJ\/T<3@D] MNEY[L]]8%HMN\\]STV5XCOG8VX)M;QN[%;-V-\X;A6\WFIPW M.KJ_WM`691BZO!I)HI[?:7"8Z0DF[A%G5@%R:G6<`ELT5)#V_$Z!PZ3=8L2! M??6`,P&P`4\%7+=NP8/&Z="ZPXRP/COO/,ZZ+1HH2(;6'6;660^G,"O?\PX; M]M3[.`6V:*`@G?39NO`=9D0&]H1XX_&[O@JV:*#@(@.'<1EU@C.= MPXU70,` M`$\+```9````>&PO=V]R:W-H965T;;$J$2FO=FO[YX_'F\BVE*952@M1L;7]RI1]NWG_ M;G40\DGEC&D+&"JUMG.MZZ7KJB1G)56.J%D%_V1"EE3#K=RYJI:,ILVBLG!] MSPOFV`-TO9$Z3(W=S,Z(O>2*%$IEV@,[%1,>:8S=V M@6FS2CDH,+9;DF5K^XXL[TE@NYM58]`OS@[J[-I2N3A\E#S]PBL&;D.=3`6V M0CP9Z.?4/(+%[FCU8U.!;])*64;WA?XN#I\8W^4:RKT`14;8,GU]8"H!1X'& M\1>&*1$%)`#?5LG-U@!'Z$OS>^"ISM?V+'`6H3V3.E';BAM*]DK+DFE7M\`W?KJU9-,Q@WO%C!HA!TQ=>\^D0O0Q@=MV`AY&#CA>U(V:"=@)%OEY\LVJ8 MPU!]"T+Y!$M_ZCF]VA/3>\Y*\+8!#7H8/1PXT(*F6##H9]/V/L$^UN\X(PL0 MA!8$,9E').[R[#MP5;9P[W06P_'L6>W/U@-OD?`R[UOU$2",+F[\?S2WL`YQH\]DLF M=^P#*PIE)6)O9A8"YT;WM)NG[OQF(NK^@'&FICOVEDX('D@< MB/!&B[H9*K9"PR#37.8PN#(XFCT'P)D0^GAC1JYN%-[\`0``__\#`%!+`P04 M``8`"````"$`A#D2!;("```2!P``&0```'AL+W=OM*UNI.%/1!6'JQ_OAAM=?FUC9".`(,G2UHXUR?Q['EC5#,1KH7';RIM%', MP=+4L>V-8.5P2+5QFB2S6#'94<^0FU,X=%5)+JXTWRG1.4]B1,L-[.T3 MF^*GT"EF;G?]&=>J!XJM;*5[&$@I43R_J3MMV+:%O.\GYXP_<0^+(WHEN=%6 M5RX"NM@+/C7X\UN*O1W])[;1^\]& MEE]E)\!L*!,68*OU+4)O2MR"P_'1Z>NA`-\-*47%=JW[H?=?A*P;!]6>0D*8 M5UX^7`G+P5"@B=(I,G'=@@!X$B6Q,\`0=E_0%`++TC4%S6;1=)YD$X"3K;#N M6B(E)7QGG59_/&@RB/)<@[0KYMAZ9?2>0+D!;7N&S3/)@?AE+2`"L1L$%W1. M"82QX-_=.ILO5_$=),T?,9<>`\^`F01$#$%#9(AV>F0$8V1T!:5<^HUQF/3E M,-G_A$$PV#H2GZ99X/61/>9\A)D&Q+,$`3).$,N=0=.\;3$>&DH<[,L62>#W M"CQF,10@G2X3^`7$,P70%H<*L.%\>X06?$\2LD![@.,C3?^*ZC5YT`FNS(XU MI3-L^'>,P7.#BM`"CSOC:F6+5[H`>G;LQ-LU0/!A#0Z[P&/&^6:O%`&G]\DW M#,&'H<]#<;W5'O-F:#^#_$57PM3BDVA;2[C>X7Q)H7/";AA]FQ1OU^'^--_, MA@$27L!(ZEDMOC%3R\Z25E1`F41SJ*#Q0\TOG.Z'\;+5#H;1\+>!;X^`VYM$ M`*ZT=D\+"!R'K]GZ+P```/__`P!02P,$%``&``@````A`*V$">F=!P``83$` M`!D```!X;"]W;W)K&ULG)O;@>*^ M`6,@0(5T-?A\JJE=>\]<.V""JP%3MM/I?OM9L@R-9&_])KD(07Q:.JQ?R])" M>?[Z\W3L_4CR(LW.J[XV&/5[R7F;[=+SVZK_O_]:7^;]7E'&YUU\S,[)JO\K M*?I?7_[\X_DCR[\7AR0I>V3A7*SZA[*\+(?#8GM(3G$QR"[)F3[99_DI+NEM M_C8L+GD2[ZI*I^-P/!K-AJYA67>Q4:VWZ?;Q,BV[Z?D7'(C>7*,2^I_ M<4@OQ=7::=O%W"G.O[]?OFRSTX5,O*;'M/Q5&>WW3MNE^W;.\OCU2./^J4WB M[=5V]:9A_I1N\ZS(]N6`S`UY1YMC7@P70[+T\KQ+:01LVGMYLE_UOVG+:*SU MAR_/U03]G28?Q=W?O>*0?=AYN@O2LB"H/&[6MR@-_ MY;U=LH_?C^5_L@\G2=\.);E[2B-B`UON?AE)L:49)3.#\919VF9'Z@#][IU2 M)@V:D?AG]?J1[LK#JJ_/!M.GD:X1WGM-BM)*FE-GI'PY5([H9&==& M)M3[^O/Q8#R?:M/9`U:HO:HKLYL57>_Z,KU^?ART**H>T.O52/=)6-25 MZ?5:N7OW-7(\]P/-]+7ZXX[0KI[0J.FKF0=Z00[DO?CMR>YR&')I54HUXC)^ M>:R)C=6#L)J/+;3DMS&(DMN6V,=+0 MO2;3Z+/?9/2%-#]!DVG8"9M,PT[4PMR-?4@BN2F%Y/N`4AC-E,*B&I/.6B[8 MR`6&7&#R`NKBS<'Z2)ITJP-CMS#S)]%Y3@?&[V,`LI\+MMC"[:\=J8B:,]25&R,]>S:0,"!A:/KM8"KE3"2]B(>-.A#(H!$"(E(10CZH#2)H(]N@8/5DG4B M;8/6G%'I!!(&)$Q(6)"P(>%`PFT2^D*:$:_)2/LM'Q(!)$)(1"I"$`=+APGJ M4&\P*ER2A2Z'CQI2Z0(C!D;,%D37I:>;U06R6R#)<0Y&W!:DT1^O!9*:\C$2 M8"3$2*1$1)VPW%+WIXS&4U'"X60AG9#6-:34";>C0`QLQ6Q!=%U:NE87R&Z! M).)@Q*V1>;4KH:_ZZ$<\J7K8B(^10&CG2:>-N=A,*`#ZK-&/ M2-F(*`Z6UKH71[>M"/N*1=Z++.1,1PTI1<+M*!`#6S$Q8F'$QHA3(_Q<-FDY M,;G8B(<1'R,!1D*,1$I$%`KYZ#-"8=6DW1GR,!!@),1(I$5$G+(_VB8#"TV_W3QU*:HB3MF;? M[:M%L,&(@1$3(Q9&;(PX-5('E.J0*X[9Q48\C/@8"3`28B12(J)06)KM7BC@ MF,.SFV!P3"LW.B0*3K`6M-E<*K!0(1`ULQ,6)AQ*Z1:;7CG(Q'\C[< MP39*-IM)>1\'FW`QXF'$QTB`D1`CD1(19#)^+-]:X>*)9C*2 MTD#K&E*=:#!B8,3$B(41&R,.1ER,>!CQ:X1+==%R=@JPD1`CD1(1!2(G6KO% MD7$SX3J1KZVL:T@I%)QPQ59,C%@8L3'B8,3%B(<1'R,!1L(:X4D]36-)'?$$ MQFZP__]3)Q<*OZ'.[_V>DOPMV23'8]';9N_L]OF$MF^WTMO-^&\3=G=3*E]K MRW5;^49;TNVO)F]H2[H$1N7#FR&ZX'Z)WY(PSM_2<]$[)GOJPFCP1&?GG%^1 MYV_*[%+=3G[-2KK:7OUYH']E2.C6V&A`\#[+RNL;UL#MGR->_@4``/__`P!0 M2P,$%``&``@````A`%ITOA,&!0``@10``!@```!X;"]W;W)KC\?S@K=?WJN+\U8T;2GJG4M6ONL4=2X.97W: MN7__]?00N4[;9?4ANXBZV+G?B];]LO_YI^U--"_MN2@Z!R+4[FR`[]1=7%H[Z_]JJLK%V,L&GFQ!#'8YD7 MCR)_K8JZPR!-<RVO[$:W*YX2KLN;E]?J0B^H*(9[+2]E][X.Z3I5O MOIUJT63/%YCW.^%9_A&[_S$*7Y5Y(UIQ[%80SD.AXSG'7NQ!I/WV4,(,9-J= MICCNW*]DD]+(]?;;/D'_E,6MU;X[[5G@S`KCS7+3=4RE#ND[^VG:B^AF^0P5PAR1W$)-([1/")>"#O4R/,7-&`^".+93I@-AP$)_4&X(@X*?+TS" MEK#8$H8("B-AP'US/,5Q4/>9=#8@AK+U$F42-I4Q8MXY040IBVC`S/$4Q^4-;PH55#,H+2+2F?"0/PR@D#GV?#E%,>8O\@&`SA\^A-]E]5S&3 MBXMA[B.F/&`69$_2UK:P4I,09%1J?!):^R95@"Y.VSJFND76()^_+'5V[T\4 M\S\WQWVK&%6>)/:C80JFO$7^0,8&P8>.H$IOT@&4/&107N1K,4QQBRR"C#V" MVQZA&+QQO`ZB849!AV;!K>**U$,RI,M>9Q$$^%L(HN+3(-BM]>[,A_:/2ZQ8O3& M8B4XG43,[,G^K7F:7&0.W6W:>BEV?=W;N%5GB6)TF5KSQ5J<9DRA$,@6&OY8 MJ+S*JD;;1B@RN-R,,VL\-<8IU<9-@8L<1+XU6\("ZX$S48SJ,Q&/:"`QO)HQ,MQ=K;$)T75,:32XD2EQD9/0 ML9,$MI,H!G/X0/PU(]H"*H481S&R)6J3,/597C*S)>*;@[Y;[/>Q!$Z09#W@ MR_?])T$3N?LDB(=(>,9RS4[%[UES*NO6N11'V-?^2FZ8!H^0\$U6*?K]Z^%F@APA<5?BAG4D M16]$H-O%YT_S#>//HB9$.I#0B1354O8SSQ-%35HL7-:3#D8JQELLX9*O/-%S M@DL]J6V\T/<3K\6T0R9AQB_)8%5%"W+/BG5+.FE".&FP!']1TUZ\I[7%)7$M MYL_K_J9@;0\12]I0^:9#D=,6L\=5QSA>-E#W:S#"Q7NVOCB(;VG!F6"5="'. M,Z*'-4^]J0=)BWE)H0+5=H>3*D5WP2P/?.0MYKI!?RC9B+WWCJC9YBNGY1/M M"'0;[I.Z`TO&GA7Z6*J/8+)W,/M!WX$?W"E)A=>-_,DVWPA=U1)N=PP5J<)F MY=L]$05T%&+<,%9)!6M``%Z=EJJM`1W!K_K_AI:R3E&4N/'8CP+`G241\H&J M2.04:R%9^]=`P3;*A(3;D`CLM^.A&T[B($[^G^(9(UW@/99X,>=LX\"N@35% MC]4>#&:0K"J+H#_'*X.2U)P[-4E/!5K`[7A9Q*.Y]P(=++9(=HB$-I$?(>(= MXH'>SA$JO]Y138):D//A^!&OR\@,,MI'=@*:R,\1EB*LLZ]XOGT*3A%D?Z@E M]L*90::ZM\&7FT%W\Y/#EA14=KF4@@=2XX&401(CY9L_&\G/(I8<;/S+Y10\ MD)O8*V<&&6DYWQ[+CX]9.LDU.@H>Z$SM)3.#'--L[UEQ?I,K>"`5#'ID$'L_#<3S\XRE-[U&3\$#O<$#*C.(T8M& MT<3WPP&2[R-A&$W">`^QY.!XNJ)YFA[H18/N;9FS?A9S0M"<>N90Z/&*?,=\ M13OA-*2"YY/OCN';P\V99RXDZ_7#?\DDG%7Z;0V_30B<#+X+<,68?+]0I^KN MU\[B'P```/__`P!02P,$%``&``@````A`$^@M'+G4```CP@!`!0```!X;"]S M:&%R9613=')I;F=S+GAM;.R=V6XC29:F[P>8=W`DHI$*0%)*BKTR*QL,+1&J MCI#4DB*K&X.Y<)$NB1447<4EEKKJ-YB+N1@T4`/TL_2CU)/,]Y]C9F[N)!7* MKLJLSND"WOBJJ<;\>#,=7O_[J MW?G!QO.OBNFL'`_*43VN?OW5YVKZU=]__]__VW?3Z:S@V?'TUU]=SV:WO_KF MFVG_NKHIIYOU;37FE\MZ?G-3#L=? M%?UZ/IZQ[I/GK#,?#W\_KW;]J\=;S[[Z_KOI\/OO9M_OU?WY336>%>RCV!_/ MAK//Q>'8%V#?WWTS^_Z[;S34A[\HWM;CV?64H8-JT/WUK+K=+!YMK1<[6]N/ MNS\>U1\VB^UGRW],V^C=:QM?=R'QTMLZ'WZ.^WIKB[,^?LR_ MW9_2F;7=G#D`Y&(ZJ2;'+QJ[JR2)$ MSF[*D0:<5K?U9`:V%[OUS6TY7A@985S?W-3CXFQ6]]^O%V?7Y:2:%L?SF=$& MCW=WD>`:CA*`=0`F3[MCO_['1]VONH\;))8_O`R-=VM083RM!IQJ/*U'PP%P M&!0ORU$Y[E=L'T*<%FOOSO:*!P\7UJ[Z$,BVT<#"QN(-]:93IN@^NEM.K[O? M]?I&Y--B4O6KX8?R8E2M%^-JMC!N\$&;FQ:SNJAGU["D[HBO__W?_OW?NE_V MLL5MRI=7"\R>3ZK8<#HKJ$QQJNOC[:74YA]&QP6((#[RIBEGY:7'8 M>3T#-^\&Q+$.4!B0NAM^5=>#C\/1J/O]^?%Y[TW1.SO;/S_K_A87>S,L+X:C MX;+#)3"?E)]UA.X4>W..4\/+0>#K>C18`M^S:TAAX[R:W!1']:PJ5LR4('XY MJ6^XU3MASK8F]EX=O#L\/]Q<@;(0=X/)UL5==#OO#!10%@2XK.-3`P?AM\6!K M4ZR552?%AW(TK[XMMK?6^4K_%E/G$N5\!F"'?Z@&WQ;IR^%T*K!(H-6KN0@\ M25S'+FW):NNLUBS7K+->/'J\_N@Y/^WLV!([.WS<67_"Q["IY>L7Y:Q`/LZJ MFPO0-PI)FV(/ZO5O`V=8Y^JGMU5_-OQ0C1;89F\P`$WK,91B-#<<%_WR=@CE M=!$3#)G?S!V)!LOA[K=W=GZ\^P^OC]_L[9^><47[!X>[A^?=V18NNN@=[17W M>O2>3/,$UH]V4\?.<[Q>CRC9X&]W(V%X$+XM#%XQ MU"@FS7SGAI=*RG1]TX+[.[ZM)J6P63)S7,Y![6JP\NH?W5O]?-3=_:&+G;3Z M'6AR6GVHQO-%Z;1;HYBSY\F*WU]-ZNFT.)G4EXO\[54UYJ`CH_=R<#,*P&*)^#2Y4`2KGY2?M^\-0 MMDIWS-'^>?'F^&R!K[_LG1WN&@_8.WSS[GQ_ST85)_NGQ=GKWNE^=Y[?[A^^ M>JUAO1]0P5_M%T?OWKYD\/&!CS\KCM^=GYW#5`Z/7G4?7L%!TG4:,DE'*@Y& M]<=[(=,Q.\4$.'I5]';/#W]8*KN.JEDQXE:[V^D-?C>?SHP)(?E1OVJ8$,H- MRI>-ESZ@O_O:T5S:(EP:ZRW@^J^Z\^U>E^,K9"RC;N>3_G4YK8K;R1"%$EVZ M[B]%`T>4"X8.[D27;.ZP`W"F-"73T''4:#ZF/0K%J\M+Q(\!M>S_?@Y>&(TN M[!O1A?G)9MEXN:B-=H\)NJ7AMU]0&?.Q*`?W41_S1])N5J@MG;&Y)M7=M9#` M4.M=N,B&]'J2T4N5QL.C'_;/OH!=2=TS'&HI>W8SIJMW=W-P>-0[VKT;;:'E M?E4-IH7ID=,2S.12C7-WIS,LCFUHL+/`/CL8Q1``$=8EXO'XAEO7K(V?SV M=F2Z!ZQ\@"4-;T!#U@/C>KQAU#X[O_\.KT^!UJXN'1P?'I6_.X M='>`EEKA+RB9;%Q_<&4`I\RXO[E>R!%534:?P0$?)%N[EW&DXO`''UNL_>E? M_AA'_>E?_F\!.%`E"[Y%Q[G%_<"7#XN/I9ALOY[@FS`K!\:E829(!(`]C*Z/ MZ*$%QD$/%CPJ=E[(7M]ZKLW86#CT;>V0G92P1BXW*.!,/0.!V",4?5$ESH]X M&$N=9\Z/P]EU,82U7LQY4E"_Q7-0?+P>]J^+F_*S=C>:#V#\!8M,AS*9`<%5 M-5D'A1(KUO&,/33S@#$7,MW2*DS;,/RXW(*GZWA<_&8^KHKM1^:6P`0Y^XRN M(D?:L%^\QI[E@-/UXLV;78/Q29!/$X-G>36!T>BXMCG@AHNO8Z4!58$X7<._ M3EO8W6CAC=&'B62ZZ&;1F]G#4]QYQ6QX@X,C7K)0X0=T&A$@EL.,38=M-INR MV\#<6G_VQ`U'W\MP4CSY\W?I%(=C903K!NJ;Q4&-M/XHA.#`8(AY69P-,4MQ?5?U?,H$ M1A/:E)TB:4#KQ?GP!B3_7!Q5\OFPW>&5`&52K0NCEW4Y,=:]-T0?F]63JG9.MSZ-2OE`VAQ$Q!01XOB[[I<+H^ MR'TVJ4>=FUQ&><=L5/X`+EA.2SYECD=T(,/P+**I..17$&Z1P],M[;L%ZVD3'?13X. MIUC)](=<4W%=E:/9=5]L=UI-/DCO!8W%M`-C9-2E_+N``QZ*/>-26)2FO8YX MPGRRH"4\VT]Y*`Q'"=]P%7E:7\Z,L8MLF0D*,&!G:P_'`[1Z`'0.N&95_WI< MC^HK]@#>I"4X;'Y'R,IZ/H%S_PY'%,$30V$7G'=1O*15QF?%2\&MC/%>*8HA MM&0K@7,"J$=;&Y_EN:\^(22FR&TT=K0'XS/RGYF']6,]&>$'18:$39OD0IZL M!`[F?(0.TF@FJ*P$]_D($D7_-C96C@0WP1S7H`44IG+'M*1O<9Y`YS+" M6([/-H@T#!C9SP?MTEB122H)NPSN<0L:$*4J=\]C#`,NOY^7>&P-GPUW$*), M8'Q*F)'=;!_3?;I`@*\@?44G8.&3!<7H>')5CH=_,,Z^GCG[15.BE1,G?9>W M4%3CB=HX$M/(Y0>5/A6`.:LF-]RFW=,9&9#U*+DI#+Q*67G>LC!`=6(_QFG!RWQ M^X1-M&'F^,L1QYD](!JZG)OV,M`<]:W96(V98&MI%/3\WC#`O;PX%F3:C4J4 M0E&F0@4Z0C3S;N<7T'U1H2N*'\F';Q:JB]FI@B]EXT*68:W);1K7*.$FR*!N@FN#4-7SCL1.>8F,VU2,#G&7/D7@-+`B@$,B`']H3@_[QPWXD]1089 M5(J,__H%"K>Y``1&?S@!B36GQ=%T.BGKD)>&&/R=6D?#Z74TEB48HMY=U!>_ MB';0QAHE#B_ M<9(B$A%")`BFWOP*>18U^R<8$!!C<_4/LH#*PNBG&NWDFSWQ;/7T1/:Y*ABR M\1CH5`R";44$RR[2MDH()-H)T;""+D=U#^;H>-JT^"$09((:%( M>#-#!^-JF.C1QRQOE=3AO MZK>>,JZ:^?<,H[@9@"'S%)L4`U0:X?2ZGH\&+0#R^WQL^L3=#'4!H?/_A&6XNX_ MOCL\PXU[?(0Z^K^+E_NO>S\<'I\2^GV]WWMS_KK8Q2NM,/#Q[F'O?/^,E<_W M%E8^'A.B_>`!N1W/97G4&)WRJ_3GKO";ZZR(]G#1DRELI+\F1)2"=])+"I`Q MV)1P\$0Z&>S.XA,F7E;CLLKG^\LZ,2Y2I+L\:B=%Z_?GAUK.>@P M[7$<`RP09;,_XSHO1\8_?K-9_+8>74[F-^O%V\V]3:/Z>&EW7IGI?"]?[]H9 M`7]TXP1'P$`1U&3-AF@JTG=9<-:U9L-63>C":&^2MI;-KE.ZDO)Q.31%*6DO MQ@5Q^Z;S\&T@!G],*&/<*C,:(`WHIKDL@%&2KH, M3R7MQL4]#T;WJX:WP8TWXF.=(&P[3F=8@X/!IZ;T%I[ M]+`YQGUA^F#M00*J0%?:(0SKHMIQ/P2+Z`78HFML.]EY%N^DO$3Q M+N3S!BE4Q=D7BY06EN$H&N]-JV5 MX_8@,.PKU,;%Q+#'BS*@=UZ\/GX+T\<%W7OSAFR%W@$!E(7P(DQ_+V9A!$?H MHX:+H.%Q)MT<=%TV>-'AJ+VPSR#G`M>>BE/#XK.-0SWFY)#LDU=U5E]5`ILC MN@3'W)1%_3I-$N14RLPK<+N\LK%X*X@]#5"YD"F&"M/B?(+"ASX$-@F#[9&W M6)KQJ8+8-N%$V=DVU$A]T`@\Y:5LOWCQV'A[>LHYS6W&_ISE)#;;.%P9A!-) M>BF7E28HF@%3O*7@#M!@CVF`&7#F!\`E:6%0;3\'@U-HM$+)<*R+]K7<(>H6 MYNH:VZ!GB[,G=$TWG,GHYBSB].D(TL;DI936AI?2[N#!]OIC=`AE+`V5 M7SO"'A<,'D2%/8PPFP`>0;"JS9[#G1Z.L>9*LN0"<]Z#_SGBQ`D[2\8)*U/[ MUIX_+`*E=B8,A&T9IS\+RSV83X##Y`:^GH&W$:*E@)T2"LR98'D%*X=I%T8\:;!<'@LM!7R^#J-LR6G:M=(OLHAR_-]4!KE8$ M2:'@S1QI??%0OU@,6XS&+/!A#[K.=7&,ZK]A(N"F.S ME61)5!.?$$Q$M.8VC4!P62'9PB,Y!<752:^1'6A&0W-,+1Y\!68P*YM*#@M] M/[(0?[32DD6+*8D/;"I+3T!@7@WN"-$$CZ!V+-W:%RY#@14W^6455.9G:11F@[R9]HU0I,RA$]YG7>>-2-);K.DFV M%Q9D>.1@.R!6V.8B$LL>"MRQ@4^4LYCXF['H6OX:Y3-,U MO\582%M=V-%1:7XV%@MZ?G3EO2RG')KO3S)O;EEF;!0T7;ZB&7A%[E072%MGSSVDT4X["4&\BOHSAE MEJ_4(W,EM@PYV=**FHMTKZ49NJ>?*#R>A;/'&DF_A?G?]",\?:7XO[FQ< M?90RICB]%,9H1T-H02GL^CUPA(`!;BE;$#BY!>P:&U/6:?S+KO_H<1*8$T_D M]AJ<@5H$P!5K$H5"?3&_$W+.5#)'*QTKB#;A3Q[:SN(-E9R9)"$X4VVV"THO M4.6[,Z,HI4F]E3_&O#;G[-L$71".;#U8:0`1INRIOX9FS"X$DI?;N$+87X=3 M7WGFI5V+@A.^,X'G'9H4GS`G9$$*1B1:H#'@:+/[0[(U/A@T@9OR?56@GUK< MV]UM*'OS&PMXR/"!76*9X.4UDD-:D_3/`M$_QPJ,5WF(`)B[Y?2YG4[$V>0? MA,A6/N.K.&-U=;\!-ZLNA9K='$=?MK>8UFJ[BT4%Q8#H`>0M>/E#!E[@5`_D ME9EA?O##E'"^LCKD1!P,@<$DQB5DM"28+:#`;N_LM5U[#X-`Z5,X-5E*PAX= MY;IB.OA)->U/ZH]XPG4CH"3_ZZ$WX+=J# M^>.4BX,`M*M(QG3F+96V)DNDW"H^(C(!_>`YM7J$D] M!(@!>Q6Q1%ZF8)N-8,X'V\^?K#][_#CH50M`\>C=?G&ZOWO\ MZJCQ:6.^*S4=BAL9CP4Q@D`._*B56@Z*DMXRF35C0'4='P9/S8S4.QW#`G9I MFF;;N$1=0+<1[0(>SS8"PXO3Z:X"!VG-JP7NFAO$[I=*Q]#`<$6F`L;);JFQ M(T0(Z5-99Z,N,:4]R^I2?M4^E`2NE.(4$@&Y%M\[VRV>;CW9H-KR;(<`F.,N M<-<_)_QG^`VEK7]0A1&ELEM?\:E/SH<9&S?%@44N4@05>DB M1:6,"W$REU9DC"!DS'%8?2+C;ZH'>&)Z/?1PM/RJ-?%[D9G]%N*3F$),`CI= M#C\)DR3`@CUE%K>^6!M^>`B540S:CW%Q/:$,<*J7+B21(2#1;XN1N9C1.,-U M@IW$OT6$[(DNIJ+"JF!)VLGE99!?`TM"X_3N MSDH1<^"-,!N:RD!ZZW!T8P>)4XB:E,5V(1EGUV(26T^)D"U(_*T]X6)2/D"> MH="@L]`(2QE?%#!27!']>``\$\_0"5PO,C')62,4`@`;X"T6A@+<%5SKU?'Q MWF\/<;/*W7I\_IKBCD-,HJ-7AR_?6."-^DMCQTUEBMB6T(`KYM[%_TSO<3KW M[`A`,JYOR&BX0),CQ4)RP+-N+6RJ: M4(9=P.2ITNP3MPSNX0K"?RF M2:CWW+21X1^?DY>M5P(':)I(8GQKTW;MR:T.N80D\4] M_D0,S9*[`0^`D3/:&<95NH]4WX0SB(0'F$R):Z;>P!=^:U]MHNRC2CE:#2>, MT4_N"+FD-BIP$@A!=],HNO1-L.E`(T^C,J53.(BM.?DLH><\:,WM+GT1M\4N M#WV^^ZQ@:I]IO8NS2RM"NHG+1'J-B^2XYQP\:2>=4Q@CX7!@>C4Q)E?P>H:[A8Q:W%E3B:P],!_+'V'39/X)M&/6LI&R(4L7!IV%YK M(%`G,#;:]N(-F#Z03BR&9M>D-%"1;!>\T&`<[(BR?&`3YR@,93]X M^F)G_>G3YTMUA-X>18GGI(]81N99D%/G`#S724T7E5"XPC-L4!J`C"CW^EL7 M1%#*BS%12II?S*2`02PW5F@_HA#E>>^?]ETZ'GJIJBDT9O,DJU,TI*OFI[Q$ MK^6+<;('BL'X7>D',/L2!B"F)]TI2Y\;H%59J(*J\4JJ7Q@!MF+HZ[">=9A, M7K?YI5B"&98BCY\FF,/9;T!.$_C3^?=AKXD;.%-E9U&Z(W%RAXD!`B"(C)H# M-APO1@B<_O-3K)J19UW[<))WU4-P%I@PNNULSAOETL@V3TC/BG?,15GA4H`+ M8*WSK&G"7!GJ*?:KE?(8*N@*5QQ,2JAT#I`'J/,LFM%L5&T6/Z#J.O<73_CH MMJH9Q*B=)'S2`0B7B&S7)JL+=&26.8KZ,@CPJVTD!(+`V[YHG:_9/4KZ2#;B M@CYXWI`$.$Y-F1[ANQ7ZS+/'6QA?J`]_)($<4I'[1C5.14#R(KU8D_;C MH\F8@$/^ID2!PIMBCN.M9WZ3D=IEEDB+:]0S&%9$$-D5?`RX%F2Z^*;)KB1" MFP5Q9-E,JN$E)\W<[RZYF]P(81HN$2-ZAQ@3S\?9!H0L246-&[2(3P=C=,TC+A]JRE.(BV2;,82L=*/(A4(AD9\HK9$+_ M:+BX`L-N/VK+:"&K3MQFQA_-$9BVQ7VC>91"UQ*&1!NP,6%4O-Z4I9LJJ[A/WRNU$3-*T/$;D9YGV7UH`68?:&+9 MGZ;0D'D^&5[,16_1VZ$,T0[+*X]+;Q@;DVFYT-1 MJ'E9!0B.2>V7J@X,-UWOU[.9(BSX0'#\CR="O*05P\#_,$?0-ZIG9CZ8R;M< M`+897"Y@$',>D'3A"Z_H]69H5E*E$PEJ"`KEWC,L M,EVK_]+M*;$G1,9(23"3?1E@=^GQ9]5Z0G#)M8?%\QV3@::)2Y*3JME84TX8 M>ZF>L]\*T""4Y@K2(`#BW@4@: M1?1HQ:*QEN1<8R1V)&:A''S""UN)3\I\@`,;D/4PR MJJ=IJ48B,P\SX]NR:NY,885X2:)`;0ES8&93=\Q28AC`3^?,4,AY8TH"`9`XF:G0(R/0I(#70$&&3[DHW"PJ)TKIKVZ18^/ZSM06N%-D+`0I@ MZ:6$;"L\@7PN@[=.D%8I#G9Z*B^:>LU,L59?R`=N3',X1L),'P(./*2DC0C@ ML)X9]>G_RHD_VDVEI9V,?OS^!+8+\X4TS1R1126VJ817N-9V5#TE!E86`?1^ M/T<0(-V%>,;KK11*!5]"+@\:N:-.SM9`\:!C1#(I.&MO%$LJN-)(SNC*BVLN M'#,^^"BXECPHYP>)+&0I#"0>!HI/#B^$'I1Q?5QHDO*G__._NKP\;--TD7?W M!T%PVJ.)D;$0F@.$($Z71HP8$[APF:.J4MLZ-!U_*?`65'W?Y(YM\M"P-CBW MS4W5O2[K6N!16;`K'C#M.`/Y:C9!Z8+;3^[51I'A?J./>_0YKSUK+Z\IH^=E MZ>&$\6U\^K:#<)HBP4OK?G&^B)CIC)(1OLBWK"L[2^$4CK4I) M6EIL-@&6C9-!H%^!Q2 M,>#L%(\70NB7R(8X,+`%S0@.B_)W7!+MIQE M@KA2T?BB8B\_XY0MK42I"!36,+'XF1$(+B^Z1&*U:(EID:J\'2B>7D?]!T=0 MMM3"Z8D'*[).'UNZJEAWH9/3XR/^WMTW=;#+9_;-0I`A$,UIIB6[3S<0;>FH M9/7.WI&VMVE]"#:V<*^1#N-M9LVQU0LEKSRFQC1V#PNJC+'=1I,I3CV3)H*@ M>+=Y1AREUSNQ@8<'IV?P;"W,MK99%/:;?4*QO(5K&?RT8[<;KKAFA/@@1M[U MBREC08$[%(V0@@2`D1-WJ;Z'IOIRF.7(*+?`!V)-2L-&'0QHZB9!N,[D90L9 MCJ)/4XE!F<#*J,B;#"_E]W;U8\5B48DV4*W'9A*ND6!IH+:Y"J9@3%9*Z6+1 MMR85O:$.:%8L3:01,L5;R'V7>N[YMJ!\2%"1,MFD/P3C0NIO2*;U/F?#;V+=N?N@158^_)=.Q MT?_=NYY28K;)"A#RN9Z35'ZS$G#1A'MMVV]P`RT$=D5CP?54*42I(W!CG*"> MAJRU!7K^C],GVSYQVD@.*Q'TA$XII`T!D$/W(F?4]:1%74_D@%)`(]?M9?/3"4.EE0@YPT'CHKH2%6P* M(MD]R*N04$#7GR%U*%%LL4/QS.7@]8#MSL[6PU\QH[SEH$78=G.[>P*#4+3- M4P7I[BV>5DMJ>`_M`HZQJ)D:EI;Z*7@8=NG6`.E2YO?.D[$;5O\D8\';.^XK M=HV][=1M./,3!WIS`T(88]0)&7'^M4J1,1ACR\1DUUF1.P+(61#>7EQK#B];Q%W7\J%K5(*>?+$]J$OJ;EI/)FCQP"6E-ES*TXJN@L;@4TT.TLP8A6GM@J^VI+.$4Y09I MV$"ABZC;/R.B1M4RI/@[HQ9+D@*!D*D4S0-FW+"(W$^++6,I7="'HDA2N#E_ M?I-&:>8P#2!H<8=EH%T@>7#WH+J86!P)+O_H3B[_:&,++G]*0J^L`/& M[F2MGA.528C5'!+"HA/"712EO:/DF>LZN!J-3V1V+<#)>!F;+$ MHF7?66!1)T#RI"+91)J:(X239)NQ;R;3:$2"N["8$0,I8D6R<24RPG9C_#0* M/W;GDY!C%/D.VOP#1'S._4)&6<'+')%V3XX_1.^FUSP\HASAX`7*(UYD\RY*XA$/[ZKLI M3G"HH117E]/WJD3$+^[8"O_%H88#]S#4'!A.[C8!Z@W;%3\(9H@H*6\&\(YW(W*Q+9#9`X*T,OC3*OL ME'!5QF9N76\3MH=N5#^>S>XCTI2R'GSB@$67OF2@0R3%-I30IK1 M$O"'/-U[PIZE:'-P_RR0];-8K"$D,!*<2#X@()W1\S#0SLQ1&/MI-B&J!];%Z)*9[C7 M(2((EIX@T:>@NOH=%O%$0!2N:GQ$%!#.N^J@[O:)#12:6D)P*VG&"\+Y&,4- MI\:HV"%>B73NN*4@4LYOC(GX-D&2)>6@;BE:B\\#FL5@!`[';A>;)]>VM4O` MXA**BE9@\+'AK/SC[KX:Y@BO1)&!*BSB+!I@BBA]?8!".(I-./&'X5EK`X,= M$:CG[(`MU,;V@85LY6-'N,EFIL05J^3?ZJ\E3/0F+JS3]L1B M6Y;MK2"8"B,LK.E!,K-VKN.YO9]$!.C( M%<+PX*?V3\VB>IO%9X(ZMZ8LYN9E+<02;Y3FCB6,/SKF.$9U4/8YP;0DE%/% MKP$;IX`U%-%B9".4M!9KD#+Z4%T%UI"P@>R$7"1Q+]Q9N'6]P(D/.(B1CVOT M=]Y^^C2>#'CY`$)(,SM=)5J@)3X]__R7".3'SS>LDT*PZJ@2KF>_S6<_:=)'V" MD^&ZJ0N(?[O:'-QVS6*3%^2643#K33T#8BDBZ`BRFL947^WT%94/5T4(+*%: MB?N27A6U>#'MR'1C5PL.'U1V@4*0B03DNS4MPZB%*CRC:++X2XPA2CZ4!@98 M'L0>R+HC(3?S6+*:1;3#;:F8R0/J$2L9DRUG1);T([).`#2Y,WI?C--V]EC6 M04+WJA0?+I*^YMF^XN[!RU`1P$94`B#2]1*`Z`)P]]I`60E9NFU00"P;`S%9 MDVH$;C,F`WE,]+)$%]AB++&5SFW54RRA28&P<4S'LR4,W*B!>)E]9@L9'0G_P`=[%9W?)+.A ME_5%UY9CKRN3R9:/VLQ@8HL$_=7W3FMCVNBX>QYFR`(7A(*N`(N5%[J:E&&" M44QRY\0HM),62"3<$C)A07#=1*6$Y]GCO@$+BFB5V.PLAIJ:\]_@(1KVO6*= MK%#?I"/N*C3XKI/Z\Y<3E1A8T^+4VUB]+\>&-W8HDY*A.P+'P2L#.6"YM60C M2!Z-T$!5)XB-3-;N'_^DXC,VC(3H6+?3&=,N1&C$/06]\!OOSQ6<"^7]J`0J[;;/9GUB`1JC\0D7H^5]7A.Y^ILTAU>8OZ\J:IJ)X M-0+T#)6=U^*26_Z+$*!+T.YO`M2N,_'OG][^1(`^_9O]:3[D.^Q/'&).<3^' M^(PTOD2$!I_&+\($_?-E:`/UOZ`$)?WZ%VV#)J#\5Q.@G4!OVXUS?W_M22F# M^#WO^<8/,QFH>#R7H5GS7]X#_TNP0W]2,>HO_('?6''8.;3S,[MQ?SEVZ-_$ MZ'W*[YIP%S1;U3\_<:>T0WME;CU96/,GZB;D+82`8:OIN^]" MR2'-JU)CB"A[K@[A MXSE-B6J:-+J#U]RG:QY153+)A0H[FS*"!T'^VK`FQNDO1%7KZX?+O$>Y&4_6 M$PE6^`-=B=#P1T_=2TN*8GQ]V*6U1<)_H1@7L5AJAE*?/3DX4AY1?%6POB2V M255#").CS7F>>_@:E869?!A1/(OM!L]]A%W*OTD@YI4.>AZ="WGU\,5PKDH6>K2"P]Z-1 MFK/'$A4PO24]BOP",0U"M4J;ROLHZA(UMHO+$?66T8[K(C;`C.C%:T4D9!3&II:M0<4==44D(R?IP7!V$WDYH>;-=B]Y M,9"W@'^B)HI-%4-.H8&@FPR]@`,QDT(YI)`^L/,P7N:1[T+2H1%O12J*$:Z] M,X)[413#'K$T!._D9:%`5F1R:VDP)[]2P+Y5W@2PRW[77':U^EZ3ER-R.@;D M8.B,%,W8Y=.T[7I(UJ*JGEK%GC:]TG+#:LU^M=.L*M MO'`V;(.1C&"SX2OEC&MEFYK>WUG6,F>RM2;%^74?L M`M536H2(^C5F>]CM6%B(B94?Y1@OB%GQNY=[S6=T*B8I$+Q-KU5L6]R.JT+Q M"]AS1D3AVKF5D#\J]I!1C<5H8^YH1\190#S,6=-7Z`J.8)>3""6P\/!:PDBE MALPKLH6\KPVO>U-K$FOJS%F=$X@]>:+%RG[:"'OZ(N6=BNU8@DC M.YTCA[8?#3:VUWZ7Z#'+ODR9ESW/9]I^0:Z<_!.6F:Q6I8=PHY!VV[X.8T7< MH=(SHHY@"!%P+C'F^3@T^U-^'T_!MI)P7251U]C"Y=S>EP*-T?S>,CT,]7GM MAEK12,0;R591UNI38'7?=1(*SOEI&<].:X0,8T_RL7DC:XC8'"_>J,22.G(4 M[./;H4,NK$?]$&Z\;8;1;U(X'#>A/>!+S)X@&!O6&4!Y2Y3];%UW$$YDN41% M547^#/M,:BO=8.?6:5RW(QI59['`BR[@+J1KA=P:G]BX2AQ@YTOM-P6II>!@ MY=-,(HCA4O5;369')'9D[?CC9N]0%9YYP#9TYZC(%AV MV$Z"IEDI*_'$&F\@EM302YWCXFV3(,*NP02K6Q!NI_X_NCJNQRXFT+'.P=U2W;RP>C>#F@AXJ\!THV$MBOC"O56[=E`,OLH-5V?MA[CJM[4P,/E/>[?6E ML7.+[[UY-RN?96L9+PQX%;:O70(*^JX9@AMG'Y/T1R\F*R01=KGR%(Z]%/H@ M8,98&COB3G@VYP;CA/N%!(JZSYCHX;U(D`G2(3LD68=*+R3?3:W[8R:2&:SH[/N>#7M+&`$NB$CEAT9P8VXXHQ#CY`#6_4Y4PKK`V8ZBTD+P MRB%=\UUXPZFT#C&0Y>0>7\36I*`YZ\A+QX`>EY->-A79HK]U&?E&3V<0'93P M7"E'HV0:^9N#;`>9U!&5),G#C#'G_Z]AC)_M[[JTR&S_G]>^,,`M4Z$QS& MF$[*?6<][\&%@":!&A2L:9S%(WQD`US*I!:-2SP/DA$N,1D#GO M+'5#($]17SH=.Q7`8T]-T#PSZ7MB%+`-M>LT'Q3[2]#D;T0JT&8]_E[)OX3Q M\%]85%:]@/#/GM!-E_8Z>:V4F0/:JMHRFW"VJE$UJVH=QQ':]H>=J?73 M2^3[9N>Z(TW-(QH"`'`ZAN`"7>T:E1*>E-?FKIEBP46;"5+!S[F2=L$F M@W\OXOZQ5[7FITYJ7$1>]P2B!UJ9!="EK?'.\V>9ER+.%IYH^0Q"H8]L*17@ MRW_!%/H@`P-TX9->7_C@&?5.DM=Z4>'V]E:RKUH>#+DH+$-;$[1O.>O]``&\ M'-5TU:".U5$>E-:][\THP&HU\ MR>]^5]G1BA=HIVCV":J+IT:'2Z$.L!I14]2\G<#:RU.(M/B>L%VIIM3#AY>D MJTRIE7MM%1*QX(DZ)EUUG-]LU!;11+0`)_Z\"J:SX:?TAN#TTN.UI^%-Q\': MC*OE*,O?RLL^L[*FAM@$.1(N[CR]KEE9L]BF_%>%%EF&ZLS>#AU?GMR`)CCO[078X(-; M/YJ%UEVII$G$IJ(_X\.LF:5!\9K;6`\"A+SVR4!@Q1VTW`M;#+"CE;_L?;7KQ!>FJ@86 M6O*6&OX?XP'[[N2NZOP9-9%30V'O+6F3XE-6H;^ M3+W"=4%6%Z4^;AC,\&0O!H*57=7X0+!PK?0170V+P,B^_W1F<1W%JR)T+"=(=>^R7E)F?B*S-IQ@5\5LN9UD0( MG?L(FOA,YCW)*<^*-XOV^UR?$*91W:C8(H".#`Q>TR@Y#[9""3=T8@,0NV`2 M][Y$V=Q.,:$?.:43GT0#V'-.56-D\%KK@`C-9])6:8"KCVNA.C&Q^B@=3*=Z MO-CEYZU:TQ8J>T;8/?[6[DU58UZ4RX+AX("@-?091Z6XS;ALJ,;U8C+(,X1*SHNWR-'M/,"'X+)U7]W43 MN]9B$<3JQXOA!@V*W^/:60'874^=<-4\>4(72DN=YX3!%@13F,4X>WM7NMG8 MYT1OXHCJ$GM*0NQ>S*5M_)L%:>@!6DN+:MA*FM8=7WN\2YTNNB<9J))6&UFE M%`_0DLZ\$@[;/G!9=1F]%QTJ6T6(U>*_7'#D,Z"RJJ3=GY[6UZ M'>M_%GWXF)BTE=-`I&N)S206T%;.#$&X_Y]?$?["-ETON4L#/E`_@;7'#R,7 M^Q$*L%-8`HFY_UT!OB"R,C9':HN__1A6^/\GCR(M[A4LOJ1=]B2E"5G5WE^3 M1[5V]1_B42&55^$I2#$KJ;*^J9E9[^8YT5>-CVS3.!6^@MJ%7?'L!=4S MS[:3K/2^:VIV+1><-1#I!S7"3$]YF.!]Y16*E$+;8F,/MM>?/'VZ_GA[9W/G M*2H&A?S(=/@]SI[8V5O/H5>ZOPQ%<8'_FF6[H]U`!/2^M8 M<21^[9$%V^W5E.O%F83[ANN;)^5GL=/I'3UVGM$\0$<,3^0S=_=PG@$43YJ_ MX%#NWN9Q@-9L++Q91?)/?9%2,$,GR!IF)=48?2DT9@X,,.NORS+!=;<'4 MU$(RQ+]QI;#$ISA`Y.G-K_;F.=IP>(J3_VX.'O5C:L_3QA>\P:X18W$!F[,^ MP2N^"4JB?&86.*H)G@JI4D:4(9T\D,G"#ML)W4;:PAQIC1_S#V&I>/SX?M(` M!%_3#A2^:<[A&7I"]!9,D!BILXM;SIE^XB_P5$I%ZO:RB);Y52OOIMF;%DL' M;-$(QA()/_9.*PU*^\;ZR3J&R.I[\-BXDBFJIN8V70\:*R)&^@0RJ3#^]B0Y M:!.TL=F,<,+]!EAH;&6(R0J!`EO2[IK,,A27,F%""V]_.9C$I`_ZE.E MYFR:@'=EF<["8LHK.BJG@_+W.,6ER[@5H5.';5J#YD]3> MQ)S4GM?`U'I0CF0@)?IC^NR^HD<.!H':PPM-)_7_H^[<>N)(LCS^5>J!D;&$ ML0%C8#VR5(UQ-[.^K:&[M5KM0P%E-S-T85$47N:;[+?=W_^F_:E MVU1F1IR(.''NER>GDZ\29:`LUE1#M2O1*;S)7FSP[0OQ#>J_E@!EGE"#D']S MCW*GDM&?%V=?3!;3-D+`+B]DV)MELAE$_1(S.DCOXFY)6X5?,V0_ M]@$#,'-$GZCOJLIF&0W6>^$-'68X1S\`,)1(,Y4##)%D.K'P"I@>W>H,KB@7 M\^)HT[D!5D=::P_1'F'81+%%K/2JME#GKE?+3\/CZ^GI;S-:0'\)`93Y'L0/ MQ14X*,X9@.A-#?T&'%J[$QG2V:%<'MO+L2F&40$KN(&TJ!C"S<2BJN5&V^GP M.I3V"]82@9IVCRM4,#>-A%U1UC:S"&A%RQW+#?N*G',F&L$Y09^KV$ MVY9B%BK.](>2."6@(G/H`J_E&%U_8KZ.4*E9X0O=9KU=B(_`/C".>6:LA%:FIA+Y07 MO5AH=SBZP`OML\F96(!'I;/M07CA&,=F5NS;2X"%9-M&[:[MO?#X81$$<\MU M.M1U=D9=MP$0[`0,:.C"W*G\VU"I;R]=BHCKX"X+O$[?Q=AO.HL$32^Y7`(M MF*9<-A"%*U@5%Q>!=MOWMO?&YP!_\67$W=\APBE8N*S_%["5NSFPATW3FU]C M`[PQ#`$J5LF@_1VG/YC+=![:2N<.?A]R*<)[C7-(@!-Q:41!5:^_^D6WMOJQ M'Y:#Z&2JWG[U48[6ZL?^(3ZE4G75ZZ^.H6+U;V'Q:]A/$&CPKXY"(<7-^LT? MU4YO>E;_O.5'7?\<%]*\O[KCAM;Z@\?U#V\NKS[#EJ=G3\V_VL[\I/YB<"U; M]9N;ZSO]8*JGX9SDINC[^!B2O!^8O&0P*"O&-FU/('30C]VU[;WMM1=;,4E"JRP9G(DN M%K2#'R=8)ETG5%L;HVYT#IZHL!A0YM%$3&G^E=R13L(T]TWL22:N$4K0I@F& MR$U#SJ+N_%&I`Z-C+LA<%?TN9_4>#;YXEVZ]NYZ4\Z43E+NL/3BZI26%C!%0 MHY^\@B!NH[=O]T=J:E\\558:V\9V6_5'2IF&NJLQWM+EUW""O)G"4F68LZR`P4Z-@U#3MI3+I@CN$ZZ1)WY]\X^*H<7YRC'"70D: M%">/@>79QN[:BPWV\1"]HS=\OC9/TZ/J(MN[-8>%X-LU#%)W\;CS]5`P8`DD MXQ'91;"5#>B,/D-,$ZG?3P@!L-`TRF_#3NC[JO03':DNA(>6G?_5O9A1R$", MB[="&]3"B::W(O_6QNZ&EK1"\='GQ/SL;NS9R-9XPBF-YH@Q`29*^A4JUKQ` MT\1JP3SX&DS#TWNN7>C7S-Y]8?.&1!$<5-^/0HQ#Y9!D(UD._;+F2MLOZT^) M+JI_&N?3YC17=M:V@W][<&SK/_6B'?MTV=@;YA$T^?/NP7>L:UH-Z>K9L@D0 M=\-)W3U^;#"?Q9=#;UYBO:[K>?,SO-#6JDGD>[B4]IZN$`@XI1PYK;/KX8[S MC4\NID+&YQP1F_5UT:W::3HJ:.ZEK-[#8)*+U>*@R3ZS`">]C;?B^:%5_&DV M?'&!R8EI:<+L^&GJ@Q[FA3@$(N]"*W*Y8*[!,:RVFA>*((-QF`,?,14-6JEY MW*-)UM'D$/6>Z#D@7+SERT1-.K`SH74KCE.SP-6]2N@Y[JHBLT(5^9L-T&T/ M:2F82B!)B,>%UN@6)X)+Z97NA(!+&C)YK07VS).S"M./A=E2!U!%D.U>\8I1 MQ>ZN,'+93EQP1#VC;S6QC&EQU);D652%CS"([W?@M>RR0"%T;6@%E?/AQDK?N_)Z?UL=[0:*1O80!);HP=\L0Z9'8G-4 MZ3THU^[3@>:#E!1PXY7U_1VIBWU;R,EUE2=22;?W0BKIM:TAAX;*!+Y`NKL= M$6W(/0A!I_+#NX@L!-6R31G??+:UZ;"W$]LMM2Q(,/M)1&W,>4I&Z<-P&XCC M44`7A,B:7I.RSC:GP8LK'AB3'L?N\@6.5(_L\-91C4V)ZJV&%81@/BH+BCOV+ID MLL)M7&>S;FZM;VW]H5,X.H<[YFL4;[].(,4@&%&%1J7PR&SN,$=#[IJY,)MO MYV,Y`KF$YLOF:B*_8<_@E-W7R!\P,AD[PH46>6]+NVO$'`$Z&3U_\80M)'O8 M6=;_&Z?S^W]R/?KB$,,YE*%>=B9B"2??68,^A*7$FWN?.,OP21MG&8M:<:). MHYWQ_2OB+.-Z`@___CC+2[G45608A.\KN^^7^I\?]#A>?%D@A6W2LA*3[IV$ M.X1\D_R%`1]KP3C%.\;/C]E M//PTA%Q>PW5T$_[$_;@E,^5T0!3?V0H`F?[][DM]EC(Q_[?1ZCFI,[2C52SJ#S.>J$J3[>!PVN8H@'6_5<[+A#0[CJQ[)ZKO&?TSZZ?P)K.&`B*?;%.&3R M9$?30H(G")R'ZH%S"8M[/56^K)D%.(;0BLJOQ#I_=G=N&%*B8:8S=;^*"IV; MC'2J6$1`CI`H%J8/N,@*$_N.92\"VE13!:IG20[08$,770VA8[9P17L,^\\Y M1X27^)HL+S5\]X7`J6(%5:8[LL9)B[Q_CKN@9_]Q$UM3'!85-&8:(4I6UE$B MJD_P1E88K<37?D]"(?YZET6HZ/C#OQ/G+4T'BZ?G4^FTY\FVR`M.-D*=`3!< MKUY(S,?!SO]="HK;:8#S/9"3N'2.KLLD3B_/C&!"\6:X<@RGH@%S_/9=F*2\ MWRQQ)9AZ^H/$#;;_50A(KE#3H1#%"%)*RV,7G$SK%[D$GA\EVW()I?SS5AA= M?T%IZ&A,0A4Z&RKW--600DB::@72"S]/;D`IIM;>\K=F+8B6=^#F,F9#85[E M,>]J+)V]K(`PX50OU3G?ML%T8JY.)21`5#IV98-1&XF[^D([SRC\1F\RZ3X:ZK.( M-IU:OHHJ*1XGK,0,#JR\\,[;Y=8-.H>$:##BTJ_XEZ`[,;.E&5AYH`T/0KDT M:LVR05GLG2*P+Y[T:(3RD<<]QL"3_,9UC,YIYH+ MI\:F<&2HTK"Y:$C%^8WLT:0G],3\HY5M*6;_QR3B M]],$`P@E5C^`,+6\2M-!5\`L+[2".@_I(4#13(\F42P`O9L;,"U2PZP7%N*1% M$$?N#+M&#C"70!#L[K%+65BL3)M`;`U%6]X)8F6I0\")O;=K#(NB;)+DBN). MZQ+%"V1GZXH(1=VLGYA^8+)&9O)U,T&B9\`;2I+!O&BQ)Z,EI(_`K[EF M.R6>DG]Q[:;_@YA*$I,7]/+L$UT;6JDC>2`_V_VD%!Q;QDLIE(Q]8D.X.MRP M8&3M`<"^D]2H#70(0JT:0%ZR":Q=I;FX[$`*_Q7P;N9:>*-E)TT..Q$?S`!: M?E,338FILG,7UF@1,0,"1Q:BM]E\5!A%PXM:VS#:=Q[F8!(:;WZ9&;>+AK)H M0X,\T/ZU;BDY@(,TB.XP0YG M!A>7[*!EJ^L22CJVB*^ND"<$^HP-QI"Y*T!%MB39C[7!-F(F_8XK@2YU[0=O MM`C,C-D9T"VW?M-GTV^@[N34.GK#,6*"2;006E2.+@4@YRFD^6:H?6T"84BK:>5Q*4C`G4@"J2+.YBWS?#H.J\VEVU&]&NF.LQ-EHQ-<'E2('[2.1!XLA6RK[I M($)>[(BO*&OYNDS],*3I8E66P$,,0:FJNT2,T<`AM]L<<%L'T-R58^>FH$[Y MJG3\J86=HLC75=D2BXU7=W7CL8F*(`FW5X$;*<8#>@R';>J(MD@L:@$OJ:@+ MU-$AL9&1B"AL5JBMER$R1^*EJED936??;;OIXP[A&;TK=I.XJC:MS>YEW\ZS MF&O7NK>DGIN*/O=L2TAD7/Q<-H:7I'Z6>R`VT@55%+9OU>J3>89382[69!.* M,JSLNS$T`61%C]Z/CUZ/_T-4&-80REUV?5W>B#=0 M'A*PE.K%CF/8JK>Q=I)M8-!#91'S3:HX0OD<`<)2$W0,^`(8Y6);D'KOE2Y/WXGWOBQ4-1&Q/(>=+:UL M'6*GL5:VO-$=6EN*1ZVXF(D@R#F4P[.6W28"Z``2!9?^AE+=O=-=5F"7?IA3 M<,DD<"+=F#BL2R+^"`JAG#4W_+U$9"-*'S@4CV>VU1#2S*<W[;GW>O7C MI2R8TWD3"_$SMXFW#S!J6AK$'ZN"DI]PT4^4SVS;CH!_4(R6`/@7S5/W\1ZH(F?8I>#YP!E$A4Q^LA01N'KI]EY>$C0`943D%>;.5B2 MQ-AQ;DN/":=H2U\/:OO3DU8V6CV6:-X>%!E.A#6IK-?G41$V.PKAE,WXQ>LI M`#*$[(JI+90@HAKF?8&SKWX@I^H+WGKV^%!%)D$-F0A67T^QF5W,R:VY$M+= M3#&M_WST>K32X-6?%K-UZK&:H+;1`-<3.F?6K?]Z9P&R_UU_P+8&3?%L]`O[ M+-Q7P!X1>%P[R6%#7[ZO.UQGVV.0/^719TCTS7K6@,K&#-#9KCP-HGZKF,$L MTX&;F&8Q-4=FC'J\XTOG0`9;9K<:PD,`+VS_Z^]#Y7+%^UW-?SO_*C>FL+"- MRGY5+H6Z]CZ=,?4FV/2]F$LPAE^9FOCM\NJ"2W>6X]X$&:H%>C@(<24K);2+ M^`V/C&>"R\_79/FA?P"Y\*<&_1&!J)8;4#_X42VUX<,6?O00A'NS,*R(66*8 MX(R@H<>Z!4X@HVSA?X;B(:D3]HRJY1E3B7YX#%$-4_!S!6S>'L2U[GLO[OG> MSO![F0&,GBPOF<)%N,;R]8!+2LDLA>79)=VJ5VT4JD>\&02WOV[6X.MC/Y>/ MH1?UKZ2'P:W?DS^,Y>?UY):XW2%JX%\>7[(GD(%S&`'*(4[2LHK'@?*VOF<@ M+PH%6$;G'P#$X0RKHP*\P[RC>NN.#.U.*M=0 MR`^*.I)![3ZD(IQ+HD62UX($[V129A8H34YTLU>U6S4*C3L(C%71G+*-(-2+ ML:TT&!>\-NIG.<]&[Q3,,1\=2#2M84$-3PRIP?56B!_S:*-)> M/T5:6C3**.#@R271D3)0$VI%@;`6SE@?DQ$^C\V?/\)"0M%EJB?U(FD_(F(2 M6Q\]PY.GC+=Z],"T'X!Q=Q6X'$*67T.]Q:'G[T)'A<'GH;O'T'/#BDVWPS5I M3+V:V-!(%F_W9GWT*VHE]'_P-6]POYZ[;0^]N7];]O&]8T`$U&=>I*DYI(]5 M)\/!48:I5'WN?2KKT!(.53Q7T2S(^BY]NE%$HB$:\ZF%T/#LM/"81:FNGM?U M`[E/J9F+Z(/,QL"BWR8%UJ^74Y?#RPZ@0"]Q'CZF9V']Y:-0"JOY?2!]S>6+ ML#`-;<:/00FV!*SGTQ3BXJTE:B!RQEZ0?6-ZKLP8'LC<@40V%:/'V*DMLO#O M/N#@+NYZ2..\GA$1_BMU]Z2'*6@?-S_*N$7@R+T#MM0?8`K`9"=+2Z/9C*T% M>ZB!AP2/\PP]:EA],"51V-A!B2PB1)SLR`DU/"Q`E@%'Z"7?&C!]2)8:7-6C MOPL4BY@:+)7IXIA=$ZB_RI=B\DLT0^%NDJ:T]\TZL>$ MXQHQW6>_F#I:,ZL)L'MT(!H".9]E`;:U:`EG%/=$>I$7$.#;[.[BWY7U&543AO`Y%IN]"Q$#-SF6.-O-QVC[F3-BE MGADJ\&,FCGJ''NV'-X/.#1JP:M]]SD-_?&^5Y<9,%]DP%M2R?'$-TEOE6':* MM.I4N+J.R`9H_C<#W[ M."4OVAD)^0:+-JWU&U3J(70B1K7O'*P&Q`$7#>S6;7J((+>Q&87R7I6BRUK- M5+*$NV(3='>L.9RT0Y'-\V%5]:9>T/[B=QI(R>@F8WHP1FE+G'&EZ/GZNR.A MC[$,2W"4U=:M>1-3H^O7?Z;$5BI5H(NH@CU#(TY,C/G8RS@&/A<%O#M MQ9B=BP2L2;>3"/(#;*V'Y3W:=*O2:&L`G=,+DC)3;AA.J#5MK>+M]_$*@6CIW)%$:USO^_N1I6>J1+FW?TEQLY0A,+$ MHK5H@N\BZM)=K(89#6Q@]=K`;`^$V*]8/^!W#]5'`TN^^`Y9[DI5FZL9WE*E,3;D& M2S*D3^[A2-H7G:=FIBD^<#O7W^JIQFX2QK5M4B$TVBH=E!4.ZD]27$ZP?`W; M]3$!*<]8F;J#U0-Z>6D]Q;!+H'YSV"E0O[D[;)L8AA;;G.1EF01RRG"0Z!I6 M2)J-HNF.E9;^D)-CV^KL;,+Q4$PX2UBX91*3JG-URVF)=383'[#MEC8CQXU` M4.ITE:&K>G))MI9'J3[F/$CUY7UR>^O!TI(*@,*VT8-E.L-6>-VX0O<]FZ1< MQ-)OFKS9AVR\VQ]#/D&]A'KD0?11@"#R*N>%XZ!.0QBR7/%!#,9_KYCYH?=P ME>%YVC83Z?,&Q)Y$K\&1?+$A(K`>*1C=8B;>$#2-%:\_ID@F;:3I.IIK:%1N M:O(X-&M\]/Q>^IOG9$CDO%L;?*"!1G(]!I%ZNY)1&CHK^I"L-6Y4B8SZPQUFFEZ(D8])#4E!+<>LYR9URV+"ZM^Q"%E<58ZT M4OBMVX%">!56F^;0GL[GUZ_^3P````#__P,`4$L#!!0`!@`(````(0!A"OF3 M_0H``&9A```-````>&POGZ/_>F>5K5@]R*:VT#MH8.8L4 M=^:;;V9GGUS??+OV/>VS$\5N&(STSF5;UYQ@%L[=X&FD__71NACH6IS8P=SV MPL`9Z:].K'][^]O?W,3)J^=\>G:<1`,103S2GY-D>=UJQ;-GQ[?CRW#I!/#- M(HQ\.X'+Z*D5+R/'GL=8R/=:1KM]U?)M-]!3"=?^3$2(;T@C"RIQY`77=,>Y;+9A=;XGUW%H5QN$@N05PK7"S/7VU_]^/7>BM70V2"#ZIE7K8KQ<+7J>169L'M MS2(,B"$&T(1L7;\$X9?`PN\@&,`\?.SV)OY%^VQ[<*>#\&:A%T9:`EX&^]B= MP/:=](F)[;G3R,7'%K;O>J_I;0-OL,#(GO-=;*4:SJMGBFARFP8(@[.I MBW>H33Z89./-:IOLGW;8Q.GJU>LZAC].%[.BVBYINK;C8HO#8W05OB)ZHJ?I M2+B4KVR?=5D:/E<-P`HGET47JFY%_>Y;^'...#ES@W8:CS&I7-)G5:_, MC8^N[\3:@_-%^R'T[0")I8T:>YIKD[G`DR^><[]\\45DU8H^M.?"R(J!1=?S MBIYAMX=])[AS>P.=U,2)`@LNM.SSX^L2>DX!]*>1_E;Z7,W33Y']VC%8_T&L M0!QZ[AQ1/$U8?RUK+R=7]];DGNDER$11[!%J69/^"83>CX<3^4@GPZ%LH88% M/Y*%ON_ACV2A%OPWD<9IEC%-62`+>5KBXOBJ?=D?#H>#SM5@,!B:W8YI,I*G M642[P=Q9.SCDDD;3-H(>(!AV!\,K`X"TS0%3=58$70#0[_4&O<[0,.%_EJ)/ MCT`VISU=M5<)`D5>)0@4>95U\5L2,G]64V"V0W%=)0@4>94@4.35ON0,W%?N M58)`D5<)`D5>91-3$NLJS"(JKJL$@2*O$@2*O"JM\YEEX*%RKQ($BKQ*$)S; MJ_FP:G)_;[%IBNV>F;3^<:8+._'-=;%1(XQ3IV$TA^6>?`VCTX4Q8GKO]L9S M%@F,2"/WZ1E_)^$2_IV&20*+([<94.V"2I]IVYN_*WK2MT[XQ+H!&Y MK3><5LL:B-I(28C:2` MH(VDA*B-4'5V5:ZY8074Q>8GG<@ MV>";>_PP&*`H+4CPD`R?I2=<+TA7#(2S'6_MEIH-2V3I$;6"<`O0=C6*6>L( MC>W,\;Q/V/S]?5&TN#")=7NS7I#E?=AS@>O?N'L`/\),7U>\]]"GR'3[!T\D$B>`Y1K^Y1S_P),S',?IAFF>G/X`7I?HAN(3URXP' MW!*3!36X@`9U%1Z9"&`PGR,`)ZA`@%MX,@X@/%4@@$%2C@`"M$0`<"JBXIAZ MT"'9#&*@5`GZ3Z42DDS7%0`.$KE MOA2K*L40MT--*RF`BPH*+&AUY31YG7TY7QDA).D"AI(12`-5C,B+2I)S06<) MH)J1L<1^"`D*3$6J(0`<)1"((SJ*VM\.Q:"H!:;1H*@)IA"X-OB,=8)Z@FLA M%6$`/$IJ1=E/Z'`MQAEI(!!494@2#8:J%$DQJ,J1I2L,52F20%"5(:DG5*5( MBD%5CB2N4)4B"01@1$F&I)Y0E2(I!E4YLG1%5U6*)!!494CBB>Z)4V2+3INF MDZAD_K2'[R7MFWH$!^7#_TU?K1>U$ZF=?8,FD)473T=/Z<@1?,'&4F0HC>#L M?.Y4>PXC]Q<89.++4S.83'4B'5^V2]P9O?,ELI>/SAJ&HNDJSWIQE($UF$K] M,).M:TV42^?G""P"GJXAHM9R-JBOG9C?B`Q^@A( MJB)8O#?,',I3-@@-0KE=S='X]"-'Q M6>2(%`9;N>7249M,:'3(]L5;(N(M8:$)3E&,-HJ+_V<-ME^DJA.&,T92\U@3 M!TG/&C1`\TYJ$T#2V3@9(%P%J&IGQMGB0VVO32;"[N9L3Q5"BZW/U.)KXCX: M3TJPD!XN#:4:++O[V1;T`7$8E?5KQ-BBWF2;OIKU:DY-X)'P.$XW9_54QIH* M+/MBK1K+VXFU4SOSC<<:A7=L4U637Y1G$BXDZUHNOET0;L>:M!/[0^]$X*BS MCTW+')DUO0">2Z&YO0/@<72>H`M`V3NDJG"M&D??K\#=')]P:E5EKX_WM[RZ MLZ^MJ0'7O+$1ADQCXH"0K0B)-T8Q'Z];X'X=%$.:FK(!2;8;O*JO)I2E#DD# M-$UQ@.JRP$%!*15A39I70!FLFU4Y\6R4T8K,._5_!^&A71^.KT-#K%8YUBX5 M:PELZ1466\FK*_R+*\72K(9G2L$9F.W?:Q?:^QG6W"+/=G"I?N5Z\+HYYBY< M-I_!>D'HC].;V4)GE:PB$`UL+HDL2.U-98&$M-H9N)6"R()IO*:R0'TJJPO6 M$EGP5D]C6;"])9.%&UU*7"8L9C7%!44R63SW/4'NS5U^9%O"2EQHL@@N*JOT M([;)1!:8W%16Z4=P')4%)C>55?H1$!)9)BAI*JOT(WB!RH)P:RJK\*,)CB.R M8->#D*RKG7[D8Q7W;XC@HK)*/_*QVA6,52JK]",?JVAR4URE'T$JX79-07;']CS/NGS`8#LC`@/. M')RM/#C%.L0SL-G^)!RL$H-P-ZJ0I&=G]J)-X'730A!?'[`9%1%TOUYZ=F`G M8?2JX9ZD0ASO])Z@N#^%8<$1+\&`2Q%`W\&)X7`8N0:\I`SQ,8S[49J(*>H" M3P^^H-!$#)1.T?#QAZ.E)F*@="J&3ZK8?Q(1\R%8K@H/\;D4FVX1$1_=X,69 M\Y'#,VP`2!%)#\XJB>PB_O@J90@2\X`O*1$SQ3G[W*7HP'@*BYL[!77O)8?#G2 MR\]_9F>B0#!E3WWO?@X3)F*DEY\_XF$S4(OA_79(-Q]C.,`$?FNKR!WI_[X? M]X=W]Y9Q,6B/!Q=FU^E=#'OCNXN>.1G?W5G#MM&>_`_!F`*#,V`_^IO#?2R44*G^T8`-AP]$)N1"LN_D#"[7\!``#_ M_P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE M;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)` MTDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B M?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K> MG$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[ MGM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\ MTG7I@O%TS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM M9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV M[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S M*EAX.(N#UO5D"53,+2L?VW9`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`E>\,`U!!7?4 MYK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@R ML6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N M?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3A MG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28& M80-1?F#R`Y+<(?%^"PZ&`"%5)U=U*N])JC]W;[TP,(39EF]Y`#G_^^3SV MV#._>2[RX(DK+609$]KKDX"7JM1;SDT`#J6.R=:8:A:&.MWR@NF>K'@);]92%BDH?W8JTBUW!U..NNDIE M48'%2N3"O-2F)"C2V<.FE(JM:9@!%@V@/%US&YI;.$#DBXF-<)^BWX7K>N`[V5^T]*9%]$R2';,$^& MK7[PG*>&9S!S),`964GYB)\^P*,^!-&U`(/HO\MCR/MZVKZI M(.-KMLO-=[G_S,5F:R#2"-*`V9AE+W=OH\FO2-AKU5_BYY`(;%%+WK*'88_.6^-)*1G5A#NF4>N\3^[[-?@$, M3\S.FP**/;!39=D:L))V8.J527(NN<`V?0\;BCVVDZUELQ*'S2N4Y%QR,G'* M@,*9UCUQM=JC\RIP>=`X>%ZU)*]H+O'AYMN:6#P,!\#\QJYOM^SV5D*]>EQ2 MJVESGACJ1"<'R;A>GH/A9!*-HM,*=?.(FW6+\PT^N[6W^2*_;*G5M/DBOVY? MT9S&X/+AEMV=SV[P#M]IX'850M^$*]7A\ZH(>RM?X_/9EL@>\`57&Y[P/-=! M*G?8XE!(??.TZ=D.S53S`KJ?BFWX5Z8VHM1!SM?P:;^'C8JR_9.],;*JVX>5 M--#WU)=;:(XY',?]'HC74IKC#1[V3;N]^`<``/__`P!02P,$%``&``@````A M`$6^SX&H`P``T@T``!D```!X;"]W;W)K&ULE)=O MCZ(Z%,;?W^1^!\+[E7^"CE$GHPQ*LC>YV>SN?5VA:C-`":WCS+>_IU19VF&` M\05*_?7A]#FG];A\?,LSXQ57C-!B93H3VS1PD="4%*>5^>MG]&UN&HRC(D49 M+?#*?,?,?%S__=?R2JL7=L:8&Z!0L)5YYKQ<6!9+SCA';$)+7,`W1UKEB,-M M=;)866&4UI/RS')M.[!R1`I3*BRJ,1KT>"0)#FERR7'!I4B%,\0A?G8F);NK MY"5NB0P;K?G"E*[MKUS0?YG"05 M9?3()R!GR4`_KOG!>K!`:;U,":Q`V&Y4^+@RGYQ%/#.M];+VYS?!5];Z;+`S MO>XJDGXG!0:S(4TB`0=*7P0:IV(()EL?9D=U`OZMC!0?T27C/^AUC\GIS"'; M/BQ(K&N1OH>8)6`HR$Q<7R@E-(,`X&KD1%0&&(+>ZO%R)-0 M69DSTP`?&13(Z]H-YDOK%;*:W)A-!Z,2VP["5Y%0(G!M/>A!99Y',-$(9C>" MV8]@XG[&@D0TV8`JT[,Q_;32[^:+2<)\4?DB&QM]8*L/A'(``OMCX\S6;.QB M7)6)NAA/979=S%1E]EV,EOJXBPD:'<5&V*1M&[L/BKM]`E;LTP>V^D`H!U3[ MG":4.@G/(YAH!+,;P>Q','$_H]@'IU/;/G$F>'!J]]LH)JU,2%*KI&:J)QO) MP+5AM"1O!XE0$KY=GS*ZZ8/3HT%B-TCL!XFXCU"LALW=MKK?8@%K%@?:KMU( M)JC=\:;>W+9=;=-NVXCK>G/7UY&PC3BV>*F9?)8`+/.S3$:#Q&Z0V`\2<1^A M&!U\Q6@!JT8'VJFVD4BOSVWD$Y_;2*?/$NCS>9#8#1+[02+N(Q2?H0=H%_2X MLT-,4OUV9WK[()D>)[:#1"B)>;TYIK[?4==M0B9$J_RH3++`9;5KT)T]T"-KX MQEELNL:WS@)^]D17WDR`EKI$)_P/JDZD8$:&C_`H>S*#+5C)IES><%K6;>6! M7W&_&`YM_8^G\```#__P,`4$L#!!0`!@`(```` M(0`M48U(O`,``!(-```9````>&PO=V]R:W-H965TH'KX*:@)6EV"_???YX>)J[#!6I* M5-$&+]PWS-VORS^^S(^4/?,]QL(!A88OW+T0[;''->(>;7$#5[:4U4C` M3[;S>T.-2X$5J$X0H)B)_O2=#^U#0N@6)#:F(>%.BKE,7LV^[AC*TJ<#W:SA"Q5E;_;B0KTG! M**=;X8&%[ M>OR3D?([:3!D&^HD*["A]%FBWTHY!)/]B]E/J@(_F5/B+3I4XF]Z_`N3W5Y` MN1-P)(W-RK<,\P(R"C)>E$BE@E80`+P[-9&M`1E!K^KS2$JQ7[AQZB7C(`X! M=S:8BR84<<884,W?CYL.6GA MPBJ]U%GI76D&VK1C+&)]E\@TD:HN",>!>G4V5,+R(1'#*$32-SI<%PG;!E-S MY95FICJX_.$]ORJP]?#E;/AR?O.RX0EV6=^3W''W>TY.LKV-+6^:@2!N%N\N MD=TEW?,)= MKU_/X1Z5L.UO:OG3S)"_NT2FB210C1YXTS@<3?LO<\G\=75O-G+IK%$^"('I?6N_1/A)%\21*;"3K(R$` M1I,JE5PCUY-L6)Q^QJ*$38NI=9M?:63081^YX;"/W'"HD0\XA$.<445Y1QK! M-A^NIIIE>HW2BV>^E`:U@7O226<`R:X@46JUA3R*WEY*5U0?-?7QI\9LA]>X MJKA3T(,\1L:P5[K1[HC[&,GGO#6^"F?PT+\<7X/;#N-]-@!-IBW;X!V([ MTG"GPEM8*O#&D%^FS[3ZAZ"M.HQMJ("SJ/JZA_\>&,X7@0?PEE)Q_B$7Z/[- M+'\!``#__P,`4$L#!!0`!@`(````(0`(>Y#6V@(``#H(```8````>&PO=V]R M:W-H965T&ULE%7;;IM`$'VOU']8[7M8P+<8&4=.H[216JFJ M>GE>PP*K`(MVUW'R]YUA,3&VF]`78X:SY\R9&8;5S7-5DB>AC51U3`//IT34 MB4IEGPJ M45M'HD7)+>1O"MF8`UN5C*&KN'[<-5>)JAJ@V,I2VI>6E)(JB1[R6FF^+<'W MI5*<(!E)UID,=T$T6T04+9> MM07Z+<7>'/TGIE#[SUJF7V4MH-K0)^S`5JE'A#ZD&(+#[.ST?=N![YJD(N.[ MTOY0^R]"YH6%=L_`$1J+TI<[81*H*-!XX0R9$E5"`O!+*HFC`17AS^UU+U-; MQ'0R]1:!OYPL@&4KC+V72$E)LC-657\J75GL#0@*1I.(Y@$`'Q94/@!+$;!,=T00GD:J`+3^L@G*[8$U0N MZ3"W#@._KY@>P4"T5P:U\G.@*W7NIW5UH%&2,,\'$OCN(9S',UW&HSGVBSZ.G<1 M>&..\OJ'X?E0]>U90O!0JHNT0S\H)`S80. M8/4.J-'2+!CAJ#UXHH)<$!IZNC[QY#:UVV25T+GX),K2D$3M<`N'L)OZ:/^% MV(2X/D[CTV@#6O"`]4]@`;[2`_>1[,)R94O9P@P+]5W_]%P``__\#`%!+`P04``8`"````"$`E.ZR M0;0"```V!P``&````'AL+W=O7E#C/FYS7II$9?92.7JT^ M?ECNC+USE92>`$/C,EIYWZ:,.5%)S=W$M+*!7PIC-??P:4OF6BMYWAW2-4NB M:,XT5PT-#*D]A<,4A1+RQHBMEHT/)%;6W(-_5ZG6'=BT.(5.R,99O:LC[(3[GXL#=?1S1:R6L<:;P$Z!CP>AQS@NV8,"T M6N8*,L"R$RN+C*[C]'I!V6K9U>>/DCLW>">N,KO/5N7?5".AV-`F;,#&F#N$ M?LTQ!(?9T>G;K@$_+,EEP;>U_VEV7Z0J*P_=GD%"F%>:/]Y()Z"@0#-)9L@D M3`T&X$FTPLF`@O"'C"8@K')?970ZG\PNHFD,<+*1SM\JI*1$;)TW^F\`Q9VI MP-59N^&>KY;6[`BT&]"NY3@\<0K$!T^!H7?YFDEPAR1K9,GH!26@[Z"P]ZLX M7BS9/51#[#'7`0//)TR/8."FMP0VAI9>+L]!&<&HC.5"*]0_-)U/,&Y8`Y'V!F/6*4($!.3Q#!T!Q(ZZEN1[4-H!.D85"&TMCN9([C M]LH4'LJ,YSH7?9WW$;@%3[Z2^.6$YV/5MSN*X+'4/A(&>3@I,'#/LXGG<"?> MRP;/C27VD>'8Q,DK@X/K>'!EWLX&P6.I?>0XF\68-_3F\OUL\-Q88A\99S-] MUINPI\(RT-*6\I.L:T>$V>(.2N`6]]%^/:X3O&C/X^?INEN;K/\!UE;+2_F= MVU(UCM2R`,IH<@&=L6'QA0]O6G`.R\MX6%C=:P7_3Q(N?/.R0(``.P'```8````>&PO=V]R M:W-H965T&ULE%5=;YLP%'V?M/]@^;UQ(%\-"JG25=TJ;=(T M[>/9`0-6,4:VT[3_?O?BA$*2=NP%P>7XG'ONO5Q6-\^J)$_"6*FKF`:C,26B M2G0JJSRFOW[>7UU38AVO4E[J2L3T15AZL_[X8;77YM$60C@"#)6-:>%<'3%F MDT(H;D>Z%A6\R;11W,&CR9FMC>!IQ(B2.\C?%K*V1S:5#*%3W#SNZJM$JQHHMK*4[J4AI40ET4->:<.W)?A^ M#J8\.7(W#V?T2B9&6YVY$=`QG^BYYR5;,F!:KU()#K#LQ(@LIIL@N@T"RM:K MID"_I=C;SCVQA=Y_-C+]*BL!U88^80>V6C\B]"'%$!QF9Z?OFPY\-R05&=^5 M[H?>?Q$R+QRT>P:.T%B4OMP)FT!%@684SI`IT24D`%>B)(X&5(0_QS0$89FZ M(J:3^6BV&$\"@).ML.Y>(B4ER:XFM3ON^'IE])Y`OP%M:X[3 M$T1`?#D72`*Q&P3'=$$)R%@HX-,Z""8K]@2FDP/FUF/@^HII$0Q$6V50&ZZ, M8%3&JF`JMS[0E0DORTSZ,ECTZ9M%/QK%0U#>KHE@VO+[##QFVL',6D3/*$"& M&T4P]`+LO=;OK,8>-$`:C`Z71G`CW1;Y$(%)[R3SALOY_T@AN"]UB/AA[8X) M3%O7`O8OG$+MWY]4/-47.$2Z$Q,$\\L=PXT[^*-`<%_J$#GWLNSS-@M@L<2O M_1]V\&!?XQ#IVUE?1%E:DN@=[LT05E(;;7?Z)L2M<1J?1AO0@A>L?0.[MN:Y M^,9-+BM+2I$!YWBT@.X8OZW]@],U)`H;5SO8LLUM`7]5`6MI/`)PIK4[/J!` M^Y]>_P4``/__`P!02P,$%``&``@````A`(YQM+WT`@```@D``!@```!X;"]W M;W)K';`@%7`R'::]M_O7IND(;"6OI!P@' MQ.-U(E-1YS'Y_>O^ZIIXVK`Z9:6L>4R>N28WFX\?U@>I'G3!N?&`H=8Q*8QI M5I3JI.`5T[YL>`V_9%)5S,"KRJEN%&>I7525-`J".:V8J(EC6*DQ'#++1,+O M9+*O>&T(E,Y"_+D2CCVQ5,H:N8NIAWUPELFJ`8B=*89XM*?&J9/4UKZ5B MNQ)\/X53EARY[4N/OA*)DEIFQ@U[2)06FS3H5X`#+[BF>Q60;KF[# M":&;M2W0'\$/^NR[IPMY^*Q$^DW4'*H-^X0[L)/R`:%?4PS!8MI;?6]WX(?R M4IZQ?6E^RL,7+O+"P';/P!$:6Z7/=UPG4%&@\:,9,B6RA`3@Z54"6P,JPI[L MYT&DIHA)%/F+,%A.%L"RX]K<"Z0D7K+71E9_'2ALJ1Q)U)+`9TLRF?NS13`) M0?,-$NH2LO[NF&&;M9('#YH&)'7#L`7#%1`/&P(GB-TB."8+XD&N&G;A<1,& MBS5]A,HE+>;68>#Y@CDA*(B>E$%MO#*"41E+BZGD'6B$-/3#>&D$6^E3<=L(').S9*Z'7<[? M(X7@KE0;L9W>:0_HLG,+]L2%,Q]2>[U'<5U7HHV<]PJ.F\@55SG_Q,M2>XGR7/@#.P=I2[P]R+D0U4'ZX0:>#NL5\+^*_!8R+!;C=BM[4>VS#QF.YM5'Z!_2O'1:J^M]E!__-*4V]_*DX!H0YYD M!E[J^E6BW[?R([C8&5W]W&?@C\;:BEW^=NS^K#]^%>7^T$&Z`_!(.K;^$BB%R/`6Z]B+9[+J5) MVRK>VJZN_D6H]V@PPI41#]2K[_F"QP$+PA];<5!1[^!3WN6;55-_6%`U<,_V MG,L:9$NP?/$,=0R^WG(5?)1&'J65M1W9%GC10G[>-U&R="$TYF4%Y'XD1C2H*WTZ$U+D[`I+?*)-$106ICP,(Q-($-@ MCC2YX+3I,2U-PJ:TF$I#!*7YD2M_B#:=\,+`91IA1"TQI'K:1*_ZYS"@:(8#"!/HHB1ELD4H>N_57=,#N39 MV>UI(B\RDYH8/&/1XE/$+'ER MD#=:H,B@/"A\VM<9&R^+FZD%%^Y0)VDSM0D)3CUU"AFTJ'];`@TMJ&7.3D!1G9C*1SVYM,W;7KNAIBQ&77&>%]<$7.JW+4OV'AA)'27*49%SPLB2F2*T!VX67IW[0R&\QXJ>UCQ M"5T:BM%O?@T-/@9,(F;TR-Z8WA<,9[U1>^3>J6(P>O"P'OKCH3Q[9?"[5D9/ MD\:E*T,Q>O2TU&'X%(,N1#YG5Q^-X/&[-D9/F^I\VAF*P3LG81`3^9D"=/FW MQ,GQ/GNJ<$F;XA(R,5+%J+[P6>+2!YI,(7/DR>D]7Q[.>J/PZ#[CR"AYL>N3 MJ9@I8(XX8'1Q\Y[@N;R*Q)!N-<6@2,:](([(^,D,9*KZ[EH;\G]F(DY_EL3G M*06ANA@>XD?:T(K?/^<'UYUGML5="X/CI-=3RUR2NE1!*FQQ$/ED*F:*T).K M];6I[ZZ-P<<;@[FCOD4(]?'(!X7FLV"FS/P@NSU-M9'5D"IH6IN\[=K&"*(!V:5 M:/8B$\=C:Q7UFSSMX]#UPZ?#2>0CEX=/Y/,43BC[XSQG^`(.",_Y7OR>-_OR MU%I'L0.3[B*"B=+@$2.^Z>IS?TSW4G=P--B_/,!1L(##+770V M'"YO_@,``/__`P!02P,$%``&``@````A``XO/W_9`@``T@@``!D```!X;"]W M;W)K&ULC)9?;YLP%,7?)^T[(+\7`A321$FJ)E6W M2JLT3?OS[(`)5@$CVVG:;[]KWY1BBE#R0"`Y]_"[Q\9F=?M:5]X+DXJ+9DU" M?T8\UF0BY\UA3?[\?KBZ(9[2M,EI)1JV)F],D=O-UR^KDY#/JF1,>^#0J#4I MM6Z70:"RDM54^:)E#?Q3"%E3#9?R$*A6,IK;HKH*HMDL#6K*&X(.2WF)AR@* MGK%[D1UKUF@TD:RB&OA5R5OU[E9GE]C55#X?VZM,U"U8['G%]9LU)5Z=+1\/ MC9!T7T'?K^$US=Z][<4G^YIG4BA1:!_L`@3]W/,B6`3@M%GE'#HPL7N2%6MR M%RYW"Q)L5C:?OYR=5._<4Z4X?9,\_\$;!F'#,)D!V`OQ;*2/N?D)BH-/U0]V M`'Y*+V<%/5;ZESA]9_Q0:ACM!!HR?2WSMWNF,@@4;/PH,4Z9J```CE[-S&'1D:NY,D2T%M8+!>-E$ M:;P*7B#![*S9CFAQ<390NHNCFP\?!@]SZ>)=E:(I2Z MWVVG<"!!TH>885O4C-\9V:84#MO<9;LL0%,T9!P&B)IS M@.,S$"7C;3B09B_L+373`1KQ$&[N#MT6->-WQ@"G%`[;PF6[+$!3-&0-=("-N2[ALM_3`GJ@\\$9Y%2M@C9OY\.#-;NF0_B0@C]?F&VO>YM9/,?``#__P,`4$L#!!0`!@`(````(0!J M&L8M<`@``'$H```9````>&PO=V]R:W-H965TV+K8N2!)D9C8MD`+%$4OSUI;282U+4-2-KM_WS,4*C0X;B[8]?=MO)Y[)IJWI_-TTNYM-)N5_7FVK_?#?]Z\\//UQ- M)VU7[#?%MMZ7=].O93O]\?[[[V[?ZN93^U*6W00][-N[Z4O7'6YFLW;]4NZ* M]J(^E'M$GNIF5W3XM7F>M8>F+#:ZT6X[2^?SY6Q75/MIW\--\YX^ZJ>G:EVJ M>OVZ*_==WTE3;HL._-N7ZM#:WG;K]W2W*YI/KXQZAI[N;S<5 M1D"R3YKRZ6[ZD-RH13:=W=]J@?ZNRK>6_7_2OM1O/S75YM=J7T)MS!/-P,>Z M_D2IOVP(0N-9T/J#GH'?F\FF?"I>M]T?]=O/9?7\TF&Z%Q@1#>QF\U65[1J* MHIN+=$$]K>LM".#?R:ZBTH`BQ1?]\ZW:="]WTVQYL;B<9PG2)Q_+MOM049?3 MR?JU[>K=/WU28KKJ.TE-)_AI.B$*1QIDI@%^VJ=>)/E\2<\\TBPWS?#3-GLW MV5D_<*VC*KKB_K:IWR8H3@RM/114ZLD-.K8"]C0&2;^E**2D3AZHE[OIY70" ML5J4P>?[)+V^G7W&U*U-SF,D1V:L;`;-$W6K&#`#WX$TE/X?2%,O1-H^[M$" M;A2IQ]!FV":*`8(AIM9GF'^S+JV*U`@5R%5,,^35>[[YY]Z@7U`RV.3+]).D9\2!F(/Q]M[I2LN9G^WTT")8! MQSB;>SH.2;:9XHB@LQQ#AY(E'8-<#Z6X"A#%$?%L*,JEZ-]@S/C(5YBZD:P, M4+.D8A(D4((HCXMD8!'^V%FF.@ATI$G4C M61E$BN3;QI`TB,01033!&LB9'E=)9TM"%F(ZA9`2D"1`ILNFB:2ZNJ;E@/%(_Z)]@V=@%I*"+?U7DKNZ$8Q#DB_9,.-[0C!CVEPP M[N-&L`!2"8P1I("G;I"S9DN5>20X)O.LKT=;;D M9"')ZSG-,I`4G!R'$9`2JZ='&.7L:ZV0N1#F[.-JRYOV%U64ZOH2$@ M29?\F=$]_I*FQLTY)V[P1J\`4K9A9,+(2VHA46"YOWEU64XP MTU>$[ZAE(`V7`0NY:EJ%D!*0G+'8,I#KDXVQZT`:K@,6DHKY.UF7Y13[YCJ0 MDD&S&3Y18L;.>8EQAS4ZV?& MXEF)68@+%BP$2F1)`A'77R1ZJW&\W+/0Y2VD#TS[ZW,C.6SB4S$*=IH/Z,59_=V89+^NM/$H@9_Q)'F:=.&;/0 MYRW$N9@L4&)B!)*9+"F9V\5)QJ.L/PNMWT* MZ5M(>IB_/)U1T4C!_ M=^JRG&!#0W\9RD>9NL[VJM[8-1T50@I`4D"GK'K5_(Z.>=LFE9/3S$+2<6\C=;*90WO MI(`DX5&NOPA=WT)<,9/E("6R)(&(ZU_JK>G(K0-N/01Z&4CJY7;I_8[?-N1T MAX:#A_4W(OHO^;NR>2Y7Y7;;3M;U*]UV0$7%'\OR&5@E0#2(+1/1^-X@L$=';WB!RB8C^1A]$KA"Y MBC[G&A&MG]\F0QOL&B/<,K3!KBT2R:$;]DZQ"'3##B86@6[86L0BT`V+>"22 M8J0X7HE%P!J''+$(6.,T(1+)P!I_YL?__RJ2J$U#M(C;=`D.CL)6N`3;*1%`J7QL3,6@=+]=TO_^0F4 MQB?`6!LHC0]Q8007LQZBLT:/C^0_TC3'<#PZ]N2'_.:AO_CEDR5WB'6$68Q. M(N8P.H68P>@$8O[T],V&!^/"UZ%X+G\KFN=JWTZVY1,L-)C<7SN;:RN]<:F;958YDN29-) MWCX-`A#0^#FRG4HN8OMCHT'V`0V`X'SZ]8_]\^#WYG##O\[V_A+\OAX'C:O-QOGMN7YG;X9W,<_OKYW__Z]*,]?#L^- MCK?#I]/I=34:';=/S7YSO&I?FQ>Z\M`>]IL3_7EX'!U?#\WFOFNT?QY-QN/% M:+_9O0REAM7A/3K:AX?=MO';[?=]\W*22@[-\^9$]W]\VKT>M;;]]CWJ]IO# MM^^OOVS;_2NI^+I[WIW^[)0.!_OM*GE\:0^;K\_TW']XL\U6Z^[^`/7[W?;0 M'MN'TQ6I&\D;Q6>^&=V,2-/G3_<[>@)A]L&A>;@=?O%6]70Q''W^U!GH?[OF MQ]'Z?7!\:G]$A]U]OGMIR-KD)^&!KVW[38@F]P)1XQ&T#CL/U(?!??.P^?Y\ M^D_[(VYVCT\G:MNTSW0#]?[#?B=`@BVS^ MN!U.J./=_>GI=CA=7,VOQU./Q`=?F^,IW`F5P\'V^_'4[O\OA3RE2BJ9*B6S MLY+)U"BYT)"ZZ'JGGZKW"=WG]>S3Z/?*3&V2N:N1X9+K+6$ MR`*AUG=!X(+0!9$+8A^"P`6A"R(7Q"Y(7)"Z('-![H+"!:4+*A?4%F#FIDP% M<\\H!?O'8QW?HA6-O"R^Y]R<=U+&LY/`$5F?1&#`XI0Q.VM",TG MK;B^=N+Z+'2.:R`!D!!(!"0&D@!)@61`0 MYG96Q(IK(#Z0`$@()`(2`TF`I$`R(#F0`D@)I`)2VX09E:*.&57$]70IEH@? M#6RAB1M<$1[82R>PST+GP`82``F!1$!B(`F0%$@&)`=2`"F!5$!JFS`?B)4A M<\+ER.[$N:4ULF(;D8\H0!0BBA#%B!)$*:(,48ZH0%0BJA#5#'$KBX61/7[\ M_5#WY!J+9H4Z:.\T(B=;H_B-$^Q&2C?T$06(0D01HAA1@BA%E"'*$16(2D05 MHIHA[A2Q?+*=\D;HR]46,[Q"=N@#\L4$7HQ.1BI`%"**$,6($D0IH@Q1CJA` M5"*J$-4,<2N+5=('K*P6579X*\3">SEVP_LL9<(;4"`VL;@O0D01HAA1@BA% ME"'*$16(2D05HIHA;GBQ&/J`X=7:R3:\1#,3N&L/D(\H0!0BBA#%B!)$*:(, M48ZH0%0BJA#5#'$KBZ60;66YN7@E=D9/3[OMM[N6QF0:LWL&EREM(JJM1:'% M*:L23>0FM]@I7(LM!)*RD*_0;'JN!@&B$!M&B&+=D%QLRLC2XWF6&"F=9RFB M#%&.J$!4(JH0U0QQ?XA5U"5__-:^_LP?-/$\.T0MQNQLD,@R]5IL)I-#+.1K M)-Q_WB9>.KN2@9'21@PU,IZ,$,4:4<>6>F<7.C%26GVJD=D\S1#E&G'USCY' M8:2T^E(CH[Y"5"LTH8)HW;V9E7-/BL78)4^^+[/4DLYVI$26U]9B0]-UI$(\ M&Z8\&P+=<';.OU`CVY&@/M927+VSEYH8*6WI5".C/D.4:\35.PO[PDAI]:5& M1GV%J%9H0M74^,R75.M+VI$+F9M<>(%^AV?+LHP!1B`TC M1#$V3!"EV#!#E&/#`E&)#2M$-4/<^F+I9UN_IQ#9`Y]:*=I6EFC"8ND&YE]* M2K[?E6^V``4T">Y*V*)[?S8==__QG`JUC-$4(8H1)1J902C5R.C*$.6("HV, MKE(CHZM"5#/$/#'YV%*[$^=S`H4F%.,F[6Z<"KW64F;:YB,*%)J.I2>\Y9Q\ MX7@"FT6(8D2)5NYURIWRE&*##%&.J.!JO>`71W.);2I$M5;#RM"-J='<:^[2 M_7+^T.1,!#BMA_20>J>0DS].)5EK*1-=/J)`H2D;>&\<,X2Z(<]8I[A$6LKT M&"-*-#*)D&ID&F:(+N$8MK>WC[6_-O,2-QO2:1DVO. M5&BM&D[L7),-IV9*$"BI*9L4WCC5.$1=$:(84:+5=R=\N@5%BE(9HAQ1@;I* ME*H0U0QQ%XDU]R47O:_^B\F&ZR.)G,PR\\G.%FO5D(J<3DD?4:"1K$SS65]E MTC)&4X0H1I0H1&DKCHTXZ9IB@PQ1CJC@:OO&0V4@<\,5JJFU&IJE6F7E)[,Y M86SFS3?&0R'NC(<2.9D%54Q)V9D%*.CNAMX:R"KF]08<,<48&Z2I2J$-4,\;P2VP%V7KWA";E[P"J31*(+R_%0F924"2)?O*(A MKUHI%2CD5"88XZ!AA+IB1(E&IG2D&IG[RA#EB`J-C*Y2(Z.K0E0SQ'TA=@)L M7_R],B3W$YB+)'*2!1:WCF&XE8^M#)8SZ)7JN& M%#NF_,B&4^.N0$G-Y$"VZ"\_JC^C*4+E,:)$H9^5'U";H8X<4<'5]I4?T%RA MFEJK(>'S*#09FWK`'2O6]_^L8]6.@3UCEX@EW61L%@AJ7J&DC!=]T8+&Q9G9 MM`TTFLC2[RU$C>(A$BH95J%`>8Q2B4+3GZRS0$>&.G)$!5?;YUC07*&:6JNA M"?$['"MV!ES'BM!@^?I&B9.["RQ'U8:#7>(F8RAQ2LIDED_.@!*GD*D;(4I% MB&)$B49&5ZJ1N8D,48ZHT,CH*C4RNBI$-4,LS6A"Q;UQV?"=.)_E*41=Z&%O MCC-\)?+OGM<6E,H0Y8@*U%6B5(6H9HA[QMU,>,,S MN&D@5BAB[<+#V%FHK+64B2`?4:`0_>@\XY1UW8#W!&Z!-7JL&YK.$XU,D*<: M&:D,48ZHT,CH*C4RNBI$-4/<+?2,'TD8(>[4"XFHJQIT3W9&<+-,RP88ZH0%TE2E6(:H:X6\1R^P/CF%R=LW%, M(OIZQ)1Q0+[8V13S7B,5(`H118AB1`FB%%&&*$=4("H158AJAKB5Q<+W`U:6 MZV1F985H@FE5"[,#)Q<<-"7JLL8.?D`!2H6((D0QH@11BBA#E",J$)6(*D3B MRU7SV-+P\DM4^9'?OCD\-NOF^?DXV+;?Q5>FTVL:CL]8?@)[YTU6XI0:13%< MF=*5[A4R7)G1E6X?W[TRG=,7M5VTPY6%_M;6O4(7NF'"Y=1E_J<1*=A5N(@ M!6JB0S$K<9X"K]#9&'KLOM[IL`5=Z6M#QV)6XD0%:J/3,2MQL`*OT)$N&X>**''W7&Z@_RP M7/YQ4L>XOK8G^B"&PO=V]R:W-H965T M__6915:K#KW:;W9V+:?MSYB\ILPZ9*MW]\6._ZWVOCZ=M<[CO M.S?#?J\^;)K'[>'YOO_7G]$GK]\[G=>'Q_6N.=3W_9_UJ?_'PS__ M7NKZW".%P^F^_W(^O_J#P6GS4N_7IYOFM3[07YZ:XWY]IE^/SX/3Z[%>/UZ< M]KN!.QQ.!_OU]M#G"O[Q(QK-T]-V4P?-YMN^/IRYR+'>K<]T_Z>7[>M)JNTW M'Y';KX]?O[U^VC3[5Y+XLMUMSS\OHOW>?N.GSX?FN/ZRH^?^X8S7&ZE]^07D M]]O-L3DU3^<;DAOP&\5GG@UF`U)ZN'O.]=-]_[/C5^YM?_!P=PG0 MW]OZ[:3]W#N]-&_QP]UD_K M;[OSOYJWI-X^OYPIW1-Z(O9@_N//H#YM**(D<^-.F-*FV=$-T/][^RT;&A21 M]8_[ODL7WCZ>7^[[H^G-Y'8X>)/)>.K=?EQD*D3H7R'B7GTC,Z%!_PH-Y_H;<49"A?T@9*8WSG@X MO2(DCGP<]H,0F=V,W>O13*(\G%[7;%XZ/E.6 MZ>;):0?`K_)/B6TD"Z!#4(;1#:(;9#8(+7!T@:9#7(;%#98V:"T0:4!(]PT!2'< M8UI4NM7URPTK$\\OV\W7 M><.+S8Y!/:(ZA5MD91>"J**L`Q(WGKITE-3 MNFB-I/0*A$H@%2>NOB@E"&9"\]=*E;\V[+EHC*;T"H1)(Q8E+)9,V MVE0M8^3-H8;^W<1];,9=9,S42:36LP6B0*"QIU8]1!$ZQH@2=$P1+=$Q0Y2C M8X%HA8XEHLI`9O19$Z>O=QW;"O7T,]'5:H<#W.!7&/TS^QJ25KQ%RR\ M%>9:I"ZU0FDUO33A M7-B9`*48E1)$J11W+N+6+K1$APQ1CJ@P99WPDZ6\0I\2425EZ.FT,*IMV,P: M:PNOR)KH(O7YPY$U?ZS=8\%>M+&LJ=$5(`H%&I&Q=NM6&"+I:,Y8:U.)I96Z M8H(HE4A-A*5$RC%#E",J)%):*XF45HFH,I"9'GI&(SW_537M,!5K;^'(FFM6 MU;,0CL9@@W7*),)66H9=(6E5]5V;-\_&87$U;Z+@8H%%IB%W.ZZPEPB^4M*/$$42K%]7D% M6ADZYH@*U%JA58FH,I`YKUB+>T4F>$=L9((C:_[`SB2LU!`/V!MC;4 MX>VPD2*.K,D"VY"P4N,Y$%K&-L2M1JH1BH25MG_%B!)$J937YP;<1(:..:(" MM59H52*J#&3F@S6HD`\ZU:4ECKUCDUO.QU^X.;SE-7(CNF#:W=MUDX[^S2)Z M(1R-PHX[CE2Z0F$UYN7XM'O[$==3@S1&\011*M"OMA^0S5`C1U28LEW;#RB7 M*%-)&5H:M#"JKL9(K-OY,N%_2>Q%T:PK!#(FG3M4#0*O*Z25RF(@T%B]A`TE M?A0X9HAQ18>QM@KZGNE'U3\YNC:/9^URK=!3)*#W=HEQ[22JUX M`:)0(K6?1Q(IQQA1@BB5Z*)E/CYKT/7'_\U`Y/V\OE^PUZ6L:E(+Q@)1@"@4 M2&OP(K2*$26(4D/+?$#6I5[Q@+RI-1Z0(RNI5KNS8'\VB\<`42B0V+/"PI<+)&.:FBF\F*7"L\<**P)NB(HO&'(&B;6 MH%_05Y0P3`"%PDH.$[O8Z+P21`1D$[QX*J^DC1'^E2;_8&]?'Y_K1;W;G7J; MYAO[`I/6OH>[%O//0^=3GP[+:9.U^&?7\3_3%?`OM'_3%Z67(LORH<,>/Z3# M$/2AHQN?G=7@7^@@QFEW77@^]NGC%W283WSZ6`/YTO/I1!!YYOET+H@\]WPZL.W@,Y\.!)&O/)^. M!9&7GD^'@\B#6Y^^+$">W/IT,(]\[OGS+IV%YR^Z>.#Y=$R..L',IV-8Y)'G MTV$L\MCSZ4@6>>+Y=%;>P6<^G<42'[0C@CXD?ET_U\7Z^+P]G'J[^HF&^?#R M.<&1?XK,?SF+SPJ^-&?ZA)CZ#?IPE3X9K^E#C2%K2Y^:YBQ_81=H/T)_^`\` M``#__P,`4$L#!!0`!@`(````(0#VRG55L@@```0J```9````>&PO=V]R:W-H M965T'6`'&"QV M9I[5MI(8;5N&I72Z_WZ+%&_GD+%C3;_$/FV:PPDIONSVN^Z'3#H>'3;K7Y^/S;GZLL>XOT=IM=&YY135939#I\7Z[PPB$[*-S_?0PSJ)U.9N.)X_W4J`_=_5; MZ_P_:E^:MW^==]O_[(XUU,8\B1GXTC1?1>BO6P&A\\3K_5G.P._GT;9^JE[W MW7^;MW_7N^>7#M,]PXC$P-;;'V7=;J`HTMS%,Y%IT^Q!`']'AYU8&E"D^BX_ MWW;;[N5AG,SO9HMI$B%\]*5NN\\[D7(\VKRV77/XJP^*5*H^2:R2X%,E$10N M=$A4!WSJJ]Y%Z70NKGFA6ZJZX5-W^S#923]PJ6-9==7C_;EY&V%Q8FCMJ1)+ M/5HCL1:PIV$D?4]12"F29"++PW@Q'D&L%LO@VV.<+.XGWS!U&Q63^S$1C2AT MA)@GD;9T@`GX&M)0^B>0%ED$:7VY7`/.*!A#':&[E`Y`&&)J.9$$/<10AQ*,"))\LA&HM$5&.%4(U9+2E, MD*'J(H1J!&OF7`=4"IF&JYQ.F>1L:?W[RH;8]F;;H`H>V$;G'V\N+N]>$7*@-REH""J]IPNX4)W MM`NF)!#E*]R#\QU`5J3Q;B[F7;F81A%U\>8R,59M%Z+LA8Q--[Y6XH#MQ;,!8LM$DK^^:JXA7-R0Q5,@*R0V2GJBW"J3/7,I;3=/;N$IC/TPIXN5.SE. MIR&J-O.3PD99M=]UNABY7+Y7RH&(9H:@(+<<>%`I+X..?CU*`F8UB^1&[#(7 MV9%RT5!B'W@TA$KA^!6[ZTH=A2KO1-G%0NZHA/G5%9K*.9QIE`G`W*6IHOKC M7GF,J*/F8C"40,ARYCA5O7;@F?@.HR&7BXJZ(IF*HI+9/2YE?)/I)+[I:,BE MJ:)N]*&20)1`P#5FH'[CLU'B.X:&(+ZC%M^MVR@]I))`E.S/<8PDZ!AV M14NGS774)<>P,9:]:R*4/7.,*W/MNT)BBKNCZ(QOR6V4Y60Z`J*<1`5W7.P* M)U7OW1*G('?]>5`I[D!A)[XKI`%7B!;+`<\P,A.U"0WAZG8)SOBNVD89P0A$ M!$M%_?ZP8#*:<1()M!1RI14ZRFI8$H@2"'G",,%\DT@51`7CFVH;904S'?D* M2V]R!!G-!%.UWJI3Z"@+E02B@HEZ[,R8>.H<=@"4JLKN+'\-4<'XMMA&6<%4 MKL`=<9,EB)_MV$9-0U:=PH=*`E'!`I8P[$$W]5U!0U0POK.U458PE2L@&'.% MRS4L-<5?I\XUY`JFHBQ4DB@J&"OL\EQC%0UY\DK]JJ\AJAC;=10V2@^K)!`E MC%SN+7%%,1'-[DD%67F*U(-*`A$">.F"$!"*+>2^]L9]ATQ$N6D(?)RB;[?X M?6+ MK%[+`BWRV=)K6:)E&>RS0HM4F?>93?6[*ZPE2Q;K#&,),$!+B2U+J`4,L'$( MM8`![#O0DH(!C#+4@O=JX&"AEA@MLGXRUGF:H$5NMKV6%"UI,-L,+?*Q@/7) MXMDZPV%$@`%:2ARBA%HP<\$^60Q%L2L-]8&B.",(M4!1/*"'6J`H'I,#+0FX M8:L>:@&W((,L6F&DP5E`2]GON)@Z.-L%@U"?+(Z0+:@U6DJ.X4`O4"?;)(LP*EA(_\(:R03?\\AIJ@6[!;%F4X#K!64!+V1\G\#F-H&BP3S9? M9\%Q0K2@SA`F%)\MUUEPU4*NH,)8?J%XO'27A37$`$(ZB>45PB%%:&UE*\;5GCY3#YD]=3TW3Z"Q;`Q+R_^?A_````__\#`%!+`P04``8` M"````"$`PA]RJEH$```L$P``&0```'AL+W=O\Y0]\O12LDHU200K M$@7SE^>\EK=L9>J2KDS$RZ7^DO*RAA3/>9&K=YW4]\IT^^U4<9$\%Z#[C:R2 M])9;?QFE+_-4<,F/:@'I@F:B8\V;8!-`IL,NRT$!+KLGV''OWY/M0QC[P6&G M%^C?G%UE[[,GS_SZJ\BSW_.*P6I#G;`"SYR_(/1;AB$8'(Q&/^D*_"F\C!V3 M2Z'^XM??6'XZ*RAW!(I0V#9[?V0RA16%-`L:8::4%S`!>/7*'%L#5B1YT^_7 M/%-G^+191/$R)`#WGIE43SFF]+WT(A4O_VM!;:HF"6V3P'N;)%R[)@F:"6E] MCXE*#CO!KQXT#5#*.L$6)%M(;!<$2A![C^"]'_L>S%5"%5X/JW@7O,+"I2WD MH8'`:PA=IIP#@V"]SZ\?I]\9`IL,*L> M)K(S`\1=((*A!""KHQXM;8-Q8(:6FV469.P6MY!%D\TO-E#63WIA[!;$9A?K MU82B67Y!QH9Q"PUZ8LHQR(]:AAYHM(?5-":>9'26:6CTD.T6&A>.XD;O.2XV M(XEVVM'9[F&1AMLDZY!+:Y![P@>#3]I2#W2H+':QO=3 MR?!0-+S0HV=@UJ=8^*@06JBI#8%;F)I"BTV$(77847JD06.SB7CB/=)@MCE'/''@"&,(YQE'!IM M:)HT#KAL&#VWXMBE'\?&H7.9FF+S$-7<333_W4LF3NP75A322_D%[QTH_!OO MHMV=R+W>RF9\M;UO[DJ"[A>XJZB3$_LC$:>\DE[!CI!SJ4LDFMN.YHOB-4P4 M;BRX@EL*_?$,MU(,_I(OT32/G*O;%]S#W3W7X7\```#__P,`4$L#!!0`!@`( M````(0#U-,2BC0(``(L&```9````>&PO=V]R:W-H965T(^M8D[-: M-R+#+\+BQ\7'#_.C-CM;">$0,#0VPY5S;4J(Y950S$:Z%0U\*;11S,'2E,2V M1K"\VZ1J0N-X2A23#0X,J1G"H8M"J!8JMK*5[Z4@Q4CQ]*AMMV+8&W\_)F/$S=[>XH5>2&VUUX2*@(R'1 M6\\/Y($`TV*>2W#@RXZ,*#*\3-+5#)/%O*O/;RF.]N(WLI4^?C8R_RH;`<6& M-OD&;+7>>>A3[D.PF=SLWG0-^&Y0+@JVK]T/??PB9%DYZ/8$#'E?:?ZR%I9# M08$FHA//Q'4-"<`3*>DG`PK"GKOW4>:NRO`HCL9T,KM/`(^VPKJ-])P8\;UU M6OT)J.3$%5CHB07>9Y9I-)G%HP$D)&34&5PSQQ9SHX\(A@8D;@"V^KK= MUC:`!DC#4`V7]N!.NB_N*0+GY"*9\=LNI^^1\N!KJ5.DF_2KZL&475KP1VXT MHOY\_6=(_<9KC5/D:ECHZZ:%PQ_.AA*F%)]$75O$]=X?;`K3WD?[.V=)_4"^ MCH_393>HI/\`=T'+2O&-F5(V%M6B`,HXFH$7$VZ3L'"ZA&PO=V]R:W-H965T7E M9;.]L_KZWM3>&^UYQ=JU'P43WZ-MP*#0\K5_%*++PI`71]H0'K".MO#-GO4-$?#8'T+>]924 MPZ"F#N/)9!8VI&I]J9#UCVBP_;XJ:,Z*4T-;(45Z6A,!_OFQZKA6:XI'Y!K2 MOYZZ+P5K.I!XJ>I*?`RBOM<4V;=#RWKR4L.ZWZ.$%%I[>+B2;ZJB9YSM10!R MH31ZO>9EN`Q!:;,J*U@!QN[U=+_VMU&61ZD?;E9#0/]4],RM_SU^9.=?^JK\ MK6HII`W[A#OPPM@K4K^5",'@\&KT\[`#?_1>2??D5(L_V?E76AV.`K8[A17A MPK+R(Z>\@$1!)H@'&P6KP0#\]9H*CP8D0MZ'SW-5BN/:GR9!O$BC=`9\[X5R M\5RAIN\5)RY8\Z]D1>C*J,1*!3Z52A19*G=&3M5(^-3S!XLT36:+.4Q_9V"B M!L*G'C@+TOED&OW8=RA#&#+-B2";5<_.'AQ46"7O"![[*`-A'::T8>+]7KH0 M"(IL467MSWT/DEN`XQ`V]Q,2W;D5 M,KWLD41BN-&L0Y2XX>0W29VZU%#ELEK*'<@UP!68&M_\"S% M,[Q7OW/=ZC#PR593MR!1TF?@IDM`HC(4)0UV<-UE+PW(=8U&U M'/\@,E6";9L*LFU>07ED0ZX!+*.6@<A1'K MW@[\1OL,V&=^.,1YGT%7< MP*=9/BQJQ-\FV5:VVZ,O=DF6)[>$T@SNK1L3S#*X4V[@\RP?FJ2Q_B*#V@K\ MT'P!;79'#O1WTA^JEGLUW4,HDP#[VEXVZO)!L`["@EZ;">BOAW^/\(.*0L\W M"8"\9TSH!YS`_$3;_`<``/__`P!02P,$%``&``@````A`.!=0MV$`P``40P` M`!D```!X;"]W;W)K&ULE%?+;MLP$+P7Z#\(NL=Z M^!4;EH.D0=H"+5`4?9QIB;*(2*)`TG'R]]TE9564Y%B^V-9Z.+-#[J[IS=UK MD3LO5$C&R\@-)K[KT#+F"2OWD?O[U]/-K>M(1E&1>Z'O+[R" ML-(U#&LQAH.G*8OI(X\/!2V5(1$T)PKREQFKY(FMB,?0%40\'ZJ;F!<54.Q8 MSM2;)G6=(EY_W9=\\E8>,&TW M"0,'N.V.H&GDW@?KAS!PO>U&;]`?1H^R]=F1&3]^%BSYQDH*NPWGA">PX_P9 MH5\3#,%BK[?Z29_`#^$D-"6'7/WDQR^4[3,%QST'1VALG;P]4AG#C@+-))PC M4\QS2`!>G8)A:<".D%?]?F2)RB(W7$[F2W\:`-S94:F>&%*Z3GR0BA=_#4@[ M:DC"F@3>:Y+I8BR)9Q+2_AZ)(MN-X$<'B@8D946P!(,U$`\;`B>(O4=PY"Y= M!W*5<`HOVS!<;+P7V+FXQCP8#+PVF*!!>"#:*(/:>&4$HS)N+:;R8`)MF7!8 M9GJ-#((C%UZ;Y,-PV?`:98.9M3#S!F$9!,AX@PB&,P!;+>GNWAK0"&DHJO'2 M"-;2S>;6$6B35C*WPRX7UT@AV):J(Z;]VN4!5=:V@!TW\U<3P+]?H[C.EJ@C M5JV$JV$W.+!'MP.";2D3"?MN5C:OGA_+%0Z+"W9PH:U11RP[4W_83@!'.-Z/ M1MMBIY">1%9U!Y!`FQHMA0%,M4N.],*."G)!R/9T9FY@C[2%WR\'C>ZHU;-C MP%-G6&A/*^BW"QIF)(!4TT%!';(=G1E1`?;UZ*K3Z(XC,QA@_R`!^Y2PE5O4 MVM'B=L0IU3.@[:D.V9ZF9RKOJKD0]`?#*33@:6`T+&8C+/5'0S`T&Z:S,Y:N M&@Y!?SJ<0@.6!N9#.)]/EI>[J3\@@L$)<>9'"F:552#O5[I&V[5W"O5-A=C5 MG=J;^HL1IO3*C@R20<@NOO\_D*;JS07.7'`**O;T$\USZ<3\@)>S$*XL3;2Y M.-[K$N_&9^M[R`+;J?D&+G05V=/O1.Q9*9VYNFFR*E MS4!E3PX$)P[?8G*W!9LTY$:[_7NSKJL3?1+R$LZY7\X]J68[TR2?X%&WMB8L MRTD"5K9*VTU-GI?S](8D&(15HFDMU&0/2&;\\J*2KI2MAT??.O!!`R:19+&4 MKB;;$%Q)*Q`5KD^34U$(020=`#,'4CD0Q( M)4>D^_!-#U"20@,&;$#*,D:_O0&\P3\'>N7,:738N[C3$/>11'-T[U*.Q MZ[JLF_0Q8GY&5XN'IW[55-M#5Q((/_33"`R+6.5:@[K=\]V;;Q+$;45_:Y62 M?;I2>A`!5!+?*X_I3LK+Y.Y^.2>\R-DT92PMILNB*/.K>%XK>G(-\WP$FB'` MOXDG`.]S__QS_@4``/__`P!02P,$%``&``@````A`+2/7WV_`@``90@``!`` M"`%D;V-0&UL(*($`2B@``$````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````G%;?3]LP$'Z?M/\ARCND=&@:R`VBP`;2!F@I[-$RSJ6Q MZMC!=J*6OWZ7A+8)=9'@)?*/^\[?W7T^AYPM"QG48*S0:A(>'8["`!37J5#S M2?@P^WGP(PRL8RIE4BN8A"NPX5G\]0NY-[H$XP38`%TH.PESY\K3*+(\AX+9 M0]Q6N)-I4S"'4S./=)8)#I>:5P4H%XU'H^\1+!VH%-*#UNZS3E/- M&W[V<;8JD7!,SLM2"LX<1AG_$=QHJS,77"TY2!+U-PFR2X!71KA5/")1?TH2 MSB1U.:^!.F\"*%TS;.`R>F(6&SB2LF1%, M.:35F'63=BQ+ZTS\3YN%S0&<)1$:=(OML&_;'XOC>'S26N!H:-EXZ)C@QI#C M3#@)]BZ[9\;Y*)_T.;*8S8UADY?NE/H=WM[T-ML5,F14#M6T*D#C-%[F6*;8(>@EX?X7?=VN(?MKJ M%GCW;>O?R^,OR+;RC?)6=&88&O,F=J_U#?8CC&W&EK"'8_5DX;G"ED*O:OSZ MK=X/WE_C/4$AER>\.EZV?EE@ZAP3T@\9R&-M26^9:4I4>T_I%W]7+_Y@^IA= MP?@Q[R=M[.7FD\PVJOV07?&\HCX$2?#Y2:M/0/P)V"O5EIOWF+Y>MW&_5M/? M?Y*W"A[@^J<,^OF;#OY;J(5]*&?Z$F_7^HD:+I(D9P92;-[K_>T"N<;7R'HVPC?RMX:B;;_!_%_````__\#`%!+`0(M M`!0`!@`(````(0!F'MSGR0$``(03```3``````````````````````!;0V]N M=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L` M`````````````````@0``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`%"K MK&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#8T?P?G`P``-PX``!D````` M````````````4!D``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`(8"R+O9`@``:@@``!D`````````````````FBX` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`*V$">F=!P``83$``!D`````````````````)S@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$6^SX&H`P``T@T``!D````````` M````````!Z\``'AL+W=O&PO=V]R:W-H M965TY#6V@(``#H(```8 M`````````````````-FV``!X;"]W;W)K&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/EY\\[)`@`` M[`<``!@`````````````````T[P``'AL+W=O/:^ MHVH%``"A%@``&`````````````````#\P@``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``XO/W_9`@``T@@``!D````````````` M````G,@``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`,FQ*N[^"0``R2X``!D`````````````````,.$``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/4T MQ**-`@``BP8``!D`````````````````W_@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.:BH"\R`0``0`(``!$` M````````````````D@,!`&1O8U!R;W!S+V-O&UL4$L!`BT`%``&``@` M```A`+2/7WV_`@``90@``!``````````````````^P4!`&1O8U!R;W!S+V%P ;<"YX;6Q02P4&`````"8`)@`\"@``\`D!```` ` end ZIP 12 0001493152-14-003928-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-14-003928-xbrl.zip M4$L#!!0````(`'2(>$7!(JN)V'T``/[E`P`2`!P`86-C96PM,C`Q-#`Y,S`N M>&UL550)``,[JW-4.ZMS5'5X"P`!!"4.```$.0$``.Q=:7,B29+]OF;['V(U M/6/=9H``2:6CCC$*H2JJ=8U05?=^:@LR`XBN)(..R$1B?_VZ>^2)4E>U$`+E MVE:/1,;I_MS]N4>0>O?OZ[''ID(;J?SW&XU:?8,)WU&N](?O-[[VJJU>N]O= M8/_^\-__Q>#_WOU/M:#T6_:->R%^ MHHZD)S1KJ_'$$X&`!W:F`[9=:_99M?J`8;\)WU7ZZT4W&784!).#SUZ`/LX MY`&TP:@WCAH;#UPOH`'H4GFJU_OU>OP__6Z[?[NNJ\] M>8#_9:`*WQQ<&_E^([/%JZV:TL/-9KW>V/S]Y+CGC,285Z5O`NX[8B/NY4G_ M>U&_QO[^_B8]C9O>:(F3QW-L;>+C/C?IR+C`.]K?6`D\=8.D0[;QSJ9]F&LJ M"YN^L4UEW-05<^V,<&I#-=V$!YNHH&J]4=UJQ,VU&-RZY#>;\#1N*(W:;C9V M[]J?;1%W"$UUR/DDZ3#@ID^-HP<%BX$G6GG"%/:A)P6=?.7[X;AX76Z@-X/9 M1&Q"HRJT$EHZ2;_[.^4[P!KPX^+5T9."U7''$5[2@W[;C*UH([8*1-*!(;Q> MB`$C$!Z,2#74HQKWJ%T;=R-ZCC.^WS`2/<8&VXS'LF;B*#\0UP&3[ON-ECD; MT,(:C2JH)VJ8-!5^((-9\FGRN73QR4""6Z*EB9RT8E2UN[]N?``C;6QO;\._ M=YOSG=/I-@OGBV:;@*256[`*,IK@0[J!9(KHR?SXN9'B#R-YW"NDK6JCB=I; M62%%&UBHD`#B^]44OJLGI&@#BQ'2D59C4@3X@7HC4/;G%108"$4'&-@_I-N) M1TJ?W>@&+"33*2OG^,F3RGD[(^?5!&9.SML_(N?M9Y`SZ')WO?"\^U+QO+M> M>'Z\G!>*YR32KZ)LE0IP7 MBG2Y4"]4XN6EX"7C-.84OQ#/.J?X%LH#BX+"_0;K#K4X!XB"=-9:_P_8];K" MX/[844+BA4!B-2+)%E;'FO4DD@3*^7X>:F?$C6@-M1`H"2NIN,U'CTLCOORF MO($.QR>'JPVJ**04[CL7=.Z0S/W0>LA*H@+WP!&$GJ-V&$/P6#HH-7^8*,*<^6*U@1BK_TCZ,A#'QS0D8'$7>)8(C`66B]],#`NKU0)C`)QE,`8P4\E-`H%LJ[@ M2*K2>":X'U6E2P94,J"_R>\C0#WV7"!'G!9T_D+%S!CIS4RF>`_(+Y01)Y^X MY_'A2.AU@/B=Z%XHL._(7(O$O&PH-Q^=JD;06O31"][EB/'Y68W%9\&]8'3" M?3XDG4&RW_+=EN?U`CX80'#K"3V%0+?6M8\?$\12$T92Y*)OY(!OW4\BMACQ MJ52:>U92;:Z1'RE'`DS-<>"N+3H>N/.EUP_V%TSXLM=J5O%T\BFNU>0.-1=" M-YIHVLT=DK/]^4UL@IWQQ%,S"KO%A..+&OE'OT$DE/YJ6Z,UO(+]9NWR5G$\ M+96^E($GS@9=WY53Z8;:1B.1C82Y.)`CH.R]!^4R@+!#ZNN+R*<)_B='7B='U)`'MF1^,)/^H!-8H M2S0_!YH+9%XZW!*A)4)7S]W:"D?SP6`^YX&6SO=VB%MP5_S$?V7@7"CUY5:6 M$37/6$HL45JB]/%N]T>_%ID%]Z*.B^O5^E9<)X>?MQ-P_Q7"=N\Y-#[F^%MP MKN44UF:[K/S96X3DXOWGP'Z7B!9^DGRG[)=]I(RH>O1Q!<)OP2RCA/B+@WCL MTR^$A_?Y\2+_[%)SWW`';P*9C[/LDQ=K`?D3SBR4G_M*V[VT9!WOLZT`+RGO ML?WP]U1*2)>07OZ74^Z_8WDO3M?OEN4*H+2\<_FH%UN5<"[A_#B7VUST%Z"; MF2+<:KYM9+X,__AZ4/,9[O/=D544A_J[OT:S-E_27-`W5![NEG[TZSI+^U[H M"T\S%H/WM?GNZ%^?K]2N+N*7]RW>5XGY(Q6N>**S\I!/55`B M_I$%JJ+<\=8O"*\\?7_R[^$^);9?+E=_8;6I)T;URI/T):+Z<8!^,61\S0&] M^BQ\=2#]'??J*=VUGPSV`I M'WZ-7G05-\N!8]E6^DHNPB66>2)].5Z3[Y>\",MX(K4(?>E\,[+6R7/>ZND6.S+ID\O+,GYP6M2 M):1?,:2?^:I4P5^Z6R]R_E(IZ6K\@;X[X;$.7/2E,K`7#H_BUZ@?"H>D(1SW3&]GT`]/M(WRVZF\63(Z^\@*YG$WFN&VAQ)[RG'QE M\OVYGW0BZJ,`US;,>5Q]*02D-:$T.:+^TB MS!]=VLW:WP))7^,Q5M4Z^_5<*Y@UF'7]J3`!-C$W+[&SYF;X`BS@'A4]\07,D=+!I=#C0]$O\$;WP&#IY'!!?X(LC6_[U>9>II[1 M>%A\*ZULZ<&N-+"GB'L(_Q\I=BS\G28W[J(]3>$C_]64^=LF+=_MC?B5?[@F MUWY>@IVN3&WDQZ!1WK:[A;B61EL:;6FT1;1VX?<)GRM\EG;V2NVL#'T/,[ZG M#8/K=26]-+^5NQ;_]PUP^WD,\$E?'B6G*_ZFAM5_>52B@F4C_@6\/"KTI87[ MU][A#42.!3>A%A^D4=O-QNX!M(D'BQ_EI\#1;AD?F+,6YM8I(B%0HQ^>`]9W M?LL\Y`8+9(M]3\.QT#Q0!3!\A`SFUU@T:F;20^&KL?3OF_9^NA!I&SF"D>.N6?>;W1/CS8^;&WO[35WFA!-'C99O+38M1V*J?#4 M!"V^%_"A@!&$GFCP9Y^$#TKU#J5Q/(4;-9>PR(\>C)I;\>W?M=GX\"\O>#MA M)IAYX,G'7`^E?\#JDV#C7\/@+3[L`>W9)7A$PT[% M%;M08^Y7[`<5U@/K'[QER=!O&:ZKRCTYA%__A/`D![-DMC[^T*BQCZWVKY\N MSKZ>'C(0XMG%2>NR>W9*Z^D_Z\JB#Z6/H0L:U7:D;U?+QY.W_VB\J3^SE%H8 M3$#MK.O[:LKI=2@5^,6I5=A`:3!S;\;B1H%P:3F9L&A8]YMMSWZ.]K"]FXP: M?[+WEBG-@I%@:1M\P0GW9VF37]@5-TSZCM(319/!+]2)7HW"U(`="H]?`<"9 M\ED+0.O1C'8"61CVT!"IR>3X1`;<@Q$#""PP=*!87[#0 MV%D`W[Z@E\&P*QF,F`P,ZTDHFR!OQ3%JUBX"&L?PL6`! M;+R2M1SV#20,7I7A2X9@1W8/F?41,#7;JNSNV-7994G-=AZ\8%K&/8M&*W&X M#POS"(8T1).!;H#Z`[` MAZ$'$$MOP]Y'Q;5+7@]0ZP#E,;22+VKDL]\@O06WA1LR^57`IA1*QD+J=H7< M'!TV%(*+LWJ')4Y@E8)&X@QVX@^%58X?:.7-J?MU.ZPSD!^F<0#RR&=E1,,& MTB,9MH7&;-4!N-&2$+9`PURD8J@LC#F9-BCA;A(,DWA!\5`X6D!.-<,V-X,C MHL0JS*5!??1'A+0[`GD:QV$I-R/Y37Z0.MG7J_M$.A)LDXWHHIZ#*H`@-)6. M0%=&&"#V0(N!E@/E$.\`H'C0W!-0'"LEKOHZ7P15/L< M'QDU"$C1Z,EAI)@F9>8'$<$RH>LE.C/AC'SEJ>$L\8+)-'DGP?H`J5##UO]4 M&A(+Z\I&X/21V=P>"#)!.-,H$X9KN("[#J&&%F*3:T$6T#_?6/OLM-VY*!-%F`,="7D# M\^/H785H>!#X(:&1`;/,.TL7[DDP7+/J.S5FO,1&D>Q9.E'\;1@P3B5Q+R< M?!!F/2,)XH`Y/+3YF'F`.QE`0FS[YZ5I_8[!\!0I,XI-@Y!XM9OZ#B*+4^`/ MPLZ'K<`[?\]FW#ZD-Q!P`&'(LI&&)'[?<(^8RR3L@R=G@MY9![$3W*X=DQB/ M44!?N.O*R#>#FR8:3HS&IM<0']+'R9H-A#('46XS=@*:`,_OXT5#6D0(.O"8 M0=J+^9K%(8YO8E?M4DC,2!6#>SA`L$2T#9O?V+06E&L2\E\Q-\[!*@FG``,3 M]NDV!_@)^"T!NU4*`3Z)B2E7(85G>(2%+;UQP&"IQ9$:#!K'!:U;76*]9D+N MP/H7Z\$\:48$7\`>TIVD.J/Z?V(5:`J[C-T&EGHJ%HB>'(-R$0<5]K/\A08< M@`705("R7$;$7`6+`*A1"0KM;VS?WV1=3+.R$Z7T@*]6.`2AQ26/G0HYIP3P MM)*?&O6D"'"CQYL*65^N%_MI]_8I=BMH;*`PF_(G2XM-*P-?6NY6,CDM)JZS M@=ZB\UYLE:.O&?T!;['-?3Q^#/`=XPQ)GKGI\3VLVN&G&M\58&)V6C#J*S>J M^X(O2P-O[/'SV"1D)I5,Y-XNSF%#M<:W81,VK/RU<%")<;2A_-*#X&TS52IT M#JB1=FU4%P'L*`()'ZLP7L;-GA1?/6F'EHG9HOJQ/NL+,&6#A-Z,5.BY^61% ML-"W#/K.>%K(@.\BK_-$]ZL19X,.:`!+1>;9J>VF#_D*Z/3O0^=KK\/.CEBG M=]D]:5UV>G&BOP-]$%:6F9%B8M@402JJF&,:A7BP=6SPK*'-8R&/@!Z0V!HV MM-D$UJ4<9&!I3?^K+_$WJEX0"%ICV(;#8]]C8#\^9";C."R`CL?\._C[1`_D M\Y!"3BR2"#I\,!!.$,%VHC35KRP$<18+3NJ:11W^[B9`B.M9#N2J.DPO,9:3A`2 M[3"AAWDKV8HK018ZKC&B:TUD5V@2>9C/&T&;FU'+=_%_\.7"4^!NL.9SV*HS M6U[:]W2VT6[U/F?MH849"&RV$G/,$<37D?#_$X41UPX=$B3N-+9.&#;4 MR'=2OHJ5L"0QQAHB.%'<#_1)ONB3'D%!P)7(&D#UH8ZJ"S94CT'6 M(^)7'E(D6U?P#U@QTS% MI&/-TO9=8<1?='J=UD7[,VN='K+#SK?.\=GY2>?TDG5^/^^<]G+A@59$&X>8 MB54AJKGI2#Z5;%)HR:CP87HAT&\QFV^ZH1-8_$1^#;TWIB-!Y M@?E&"LD]N1H)_V[MW"/J>8@\=IT_PF`FB*];%94Y=4VX0!8M;B03Y8GL(:J=+DVPWQ')WB,4DK)W' MWII:6::0E%&")$18TB`PA8X.!`N?10/8WMG/H_4Z7&LJ$]JSVX1Y%;(H$@@( M`S]/-YIA.?8^1Q12XMW8+L5\+CF]M,*SA2MLC^*B*]*.R&1&R(TRFZA$MSTH M)Q72WN"@_I1MP&I=K+8'DDXCT$XH,M]"+7620&%TU@Q:!9ZHL6\@F91J:SE M:9/HIS/@+$7AKJ($A6X0H:WBA=P$)$>MWD?6ZK79[G:]VJAGCDA#3#*1_058 M.XUM_Q+-+'/_Z>>T[R\5)&E?N!^B.HGTU'=O5K2I=@3`&?JH,@N2!%DSF^=& M5A@1I.0T,4G*TTDA1Z#1P+9@C/@Y]J+*L4^!@>*VC1$6/]`D].<6@6#K0UXW MD%35MPN-"ON1AZ/".PZ.1Y'8(#=*W#MMEB10I`.ZD_(`:2070.+P!<8%/W#/ MVMUCY=,=1"N^$G2(GE]S9M=4XJ<5),4KRK>2UNG5%,AZ-5XAT?;OBZ$9WC8J MNG`M-5T?7)S8?G_5Z[+QSP7J? M6Q>=;'3^R(UTL-9H,'^VYU1T94?2A:])&-BR/]TH1DG[(K#->1!HV0^#M.B4 MWE2RI^0&.R+6K@2][A0X+E;.AB)I&UUSRMPG@O"7I/9Q0G\H/5I&O$IV#^* M1)&<48EKH1UIKU[:^UMJDAY'7=F_79=60&!XD(Z)C#$]EYG8-S_,BYA.W:R$ MR!9LE.:I?M!1D">*>6OE@4(I2FOQ>**:-+=+#N,$A@JGF?M;#O><,+Y/UPH* MC@SSEX)M9!_(R31Q/_4F.9 MWU+J;S(N!J_"#4/I4JDL8@/$Z")'9*\+\>CH++4(K,[Y+N3-\77,G[O0ZQ=+ M"GTVP$W9#&><;@JIUI3C320JHT5/K.>(CES^O[TO;6HC21K^*QU^/!$0(32Z M`7MW(F0!8V8QL(!GWOVTT9)*T.M6M[8/L/;7OWE455!C8"Y2XU*(+CQ!V_MM:9!9LVS7+"DUD^%(@'K`:\U$H7\Z0 M-NV4M&GG\O302++E(3:X0V/'$RH'B8[(Q3@=V^&SA4%J5H=GE0D\(QL]-DI` M5+),"C'CR$W+-A(K#LD:6YTDV&B_:0L3!1B[5W8BKR5+R2,T,)D\L`2>/`2- M^%$=^6%N#J';H$4TRC0K).G/Q.`R@UZBG:MU$'.X1\6H9@YN-&K['V!4ROG4 MR>;);F-E*+%K6N?@0]D=O1&9$V>U&>>T&5>Q*B#0N6#4?*P8/,!"H7+XRNQM MD)9!-/4&1VK"&:$%DYYH`Y+=H"/9U'*"S')2!_=2?E!2"CS;]V7">$J@Z*U3 M5&'0F_G;'-KX5,6I:V4BD*.)Q&`$4WYG%9;+`EGJ"YKI[9>\-P@)S'O M\A*3ZX641,&'/MDN"?G;!P$>KQ*5=1*52;ZVM,^N1B.,-*.FZ<5$6_R/V_-VS/A$@H`4/0W<4L9L(H MB)5<)R`$I_K$(0I2F6Y6>"I",38,Q40JS"!#)#K4GX+#]S)#T;$Y^_$9[N:: MF01I+\&TTM9,HL5J1YJ9K%TP9!_Y1$$F]?&J*2\1'JBDF#NW".)LB8H='R_! MQV>B'RC#LUEH^9A\W#RH@>5SHT^V*.^)DW\2.P5-D')6B>)@')8X&*@@,06E M`QR[8UEQ;*8"(I!F*OE0N$Y?ICE;7/\G89QK<5``S$RDGV/0[G6O>N?[AI.4 M%39J*2H_T?`%525.SGU-X,0HH)Q)UUT7&B_69_])@"%=T39Q@26;DAW+."\9$^5PB M\JN:6-A.#X0\%B&0U2&?`2$/`GZP@@L?,?`TQIQ@?`6D5G@0"'D`JM-Z&(E# M0[?0Q*J,R<@V'HK(=EQ)@J&TBTDH:9M]DA.-TK\V9:+>3HX#E_2\&\O*PBAC M[)C$I^6ABO+L9.)2];`15S@/N#[$R`HU@\NR\HYDI#PQ(;&YE]1J(-I/L:L" M?CC'1T/KS@Z_87!I(/9Y$V76*!Z[1F0MH M.W#BPC+$9];XK1#GSQX6J$Y8O:1OQ8]6[0>&5+?WSZ_GM^?8%"9U4'CZN?OG M^=5-]\+Z?-J]N/O,A[YXG-B]O06QCSG4%>OB[J2Z*Q&D2OA+_U%Y-15I$>E2 M6?$=@T=4"D^MB@@:U;/#TBW,K+THU2?F]KJ;+:VE+-D''X_*N`4%EA,Y0P?, M,&.^STDA[)>$*V]E9?95<&][SO\2NRA3QYP,\^7VR@"@8JS#LZ[T:7P"/T7= MN$6<]4?5DEWB*M:7ZDF5P/\D0"XXP-X,H=5#$,%'\X&K(U5Z=!$-4RUU/GWN MF7BH)NN4?4V&L(TUW<"B7BO9;`/'92ON)-#`)J,3+(@"SJ>8@76S!0?K3S9F M!`_O4*VE'[!=JML8%"#O)R[K`4X(8YOU!C5YN.ZFCXQAS_`LVYXJZ\S8,-") M<6!]`P6B>P@5A[M?>^56ES1Q:@Z0S/::Z\ M!N4J4M0/.\W'[E<>:U`UJ1ZXKFK%]B7(?3R+X@/]2U`F`,W>,?PXM*=A$>9_7O-_60Y MQ?C-T\U[`[ET1D8+<=5`.EVN%`DJ`C0,?%RH>H]ODX;]:1RJ_6'[?Z`VB#+6 M`.W35+&"\NL"P8\GNY!&*SH*"B78`J+0C"IG`>6J9?PPNAK=VJ[X@3+0,>L< MZ\=N3O\\O?R:3GFF#'"S@HFCS0'W0,'.$M1M:"2$Q#G6Q81$WMS!+NS%]6AF\%>RZ0X>X\G":A^$:1N#L%,I?K@8KGPSHRX*,<7E*3/I)4M9MT:RV2E5 MS./%.=M@E*^/T+1MWJE:MW=7O7]\OKHX.;VY34C#.CD].^^=WZUD=__0_GEQ-8&;;W5$Z+/)PO6:-I?9)3,?WL@F>[M!F MC"BSZN+HP0\HXUP.IKN`R#,Q,Y60"X)F]-NXSHY-(^G48^S?X%FJ](\`D76:!`.&PWXV*BTX>-\ZSNSV%0-&R=& M92OC*IC0K&-H6QER>N7@D^P+:C4ZE7PJ"(9!=7JGXV'*K&<)W;2>>S$F/AQU MVCNKRF9[G"M"/<=I&XYAMF(=9$RKA-!>< ME^W#TLUDC%:11%=@>IDIMM1?2IDW==U$Y MQ>N0*;_R$!(\T/_HDSVA)MEKIM:^;SEC-`"XS2-;A$E,&+?.+-_6-%#)6I&< MQX:EO@8/RU9F\D#?`,)8*>PO.#]3#/O9;*'"A[X=@O6YUSBNU#L=-1KBEA[8 MEY7E\N233"=A8P-:_%4AO'5TP)\5OL$20+1J04-G#N"^4#N$BCI3X'8H>*JA M#&G^T---'GNRR:-1DE9154HZHUNZ;IALI/E&FTZA1(")>D(&/M$7=/K`7=PIBP`;-XNZ%7&H@V!XK]J9XIXAT5?D\0L9M[(O0$0"C1)K)*7.;,J9 M')K`O(![\*@"Q#Q)`>-MF12IN@XC7AZX%U\5"QLTF-KG`[/3$4^"8'*%35N` MQR[N5)U&<\H:*=^AP`Y)I$EE5)[27L$*\RW71[<\Q%U0_4>5]ZO5,+_-<6IJ M,QMC`U0:F/6S(L&"/:Y86#8A3]0%R'8JK\-A^KX7<^&#`')D^UY%%`P"(U!& MNI=MAA2*L5Z808!S$K&S9/XG,D"24 M>B7-D$S'G^28W$B3U,8,GVN<7N6M$FM]%DFFA[4SBR=352_2*K%>VB)1,=;$ M*K&>8Y$T:LM;)*9!:`C)35LD]8X!J3J%3ULEULM:)`H115:)];(6"1M!.:M$ ML^4+V"0$PA]8H9`Q2ZSW]I=2%4EOYA- MPLR2MTNLO$W"!+X9FT1G->7LDA2IOH!5PI#D+9/Y/4V7M4KN=E;):UDEO2G( M>L<&%`LZXD[9)+<1G@#?.X.W8Y/,Y,F=3?+:-DE'1TEV-DD)FR2L2J9\B2B) M%`,,2-XJ>?E`R1:9)&U@]JF1SL+).=9;+I:(GBS)>*EBB) M\*JV"4%2>)"S@FVRZB$.`6$>Y.BMV/J0R6L9)P:2=N;)SVJ>J!O^6N7,$^X, M`HQPFS41\Q!X,?I3C5@M^1&/[IY1`R-[H\#.7$]-@ZPF@M%Q_>DKCCYP`I"Q=+(2,;)LB*65]\,4QJLT1WDPC M;<&DEP9_S;VP^3%U\Y%I-TAT:B;46)^4V*B9A"`I\`+8>P8M;"&7;T\&)39! M'`;VDU'!2PS(N0;YDW=;=CJDYME1(EI#OFT6C'%N]U58$$.DG.$615I%FYZ4 M4H_M[W2!CRR6R-VGYG!IB;9M0A&A6>-Q:0@P)E6.[AW7 M?M%<#7R'MN?0=M`,]=UXG&^P*7-:<>B]/__J7I<5"?)R#F')"B(RE9D*0AL\@(#JRFI[($Y9$DQEX6N?E\4A(15.,!>X3$0:^0Z2Z3 M6]$Y97N(/L91A7`_D3LO?S==(MIQ_`TGL%TP%H=3MO5"W^6+XM`7(,LU0!64 MY+IG9TS&PBLJP+YYHAG4'5)\T0LME7:#[5[88S#'T/7Q-#R\?NQU,?*E0RC] M&3-E%Y],:Q/9;`,]`BP)Z8OH2<@>W#G*I4U1-&K,P#]DT;?O#BJ6B=, M'_J6N"*7@RWG%(])$H#)9=D"@,:T8>[]>7)G5T;7DGDHQ_7[(*7LC-[-)%)H MC6_0>;$3+@N6/+KRD.J5\%H3=G?P/RC0N*.QO'>D53T^UHY]SJ4OFUJ:O?A\>U/?^HQG8J,K6%=E=CAK4CYLM%KIC,A8*$&J(0,3F!"&0 M)@QO1X%T!QN#+CN)5`=K#*CH<,,,+;]GXQ6)`6VV^`YV-EO4R"#[W,GV44]=E:"?#.=A68(KH5LDPJ)CGYJL39M(T848XYTR>Z3\+9J,8+*2]UD M(F]G>:)>0>95[MQ?2,I&NFN1X*#[C.U0CT7B`:%(KFZF>^NS^X57EPP89R`7 MOJ4,LJ1>2:,>9)2^3TU?-K MKTJ5]M^.3 MOX9,RX:H-#O:,_6=27PS[8%9&V(.:O&`A1N4LRQ3!CJ2#OK1RB@@O]DT&L-B M0CKM\=T^'"PR+4407AIV=<2HC>^4E2TK#I'!Y>4,7`:@8V8EA-B\M<68%H$W M(V(`/9#N`QX]^-R>$:QDXA;5_"@;%6-K5]O,0^RGAD6=B74M!35B0S9&K!_5 MS.+_.8$V)R3D[T+7NC\MN2X`5CS03:DT)6&O>0Q=R\#UW/`BW[6:.>U6%YGI M$BDX/A<,L=` MMP'CB]UA^GO?YWI@VMRJ-HT,# M_27S"V3=,F^I3BR@")U`"0\)L[[EQ]\HY`(4ZAG%J?3EAWQ<<#WB2.Y`J?;":"Y/<'FGY[-2^Z9 MT5=+Y_@D*<22XG1;JK[LXV+%'KBV1F,MV8T+ELO]N#CQ.-V3RZCC3N4&47VH MJ@_OG5Z9C;">F1XDLREGI@C=.M]S/8"LO8[1>FE^<$[>RT+M1(PSM93',T,< M8.=@^:(4/]=XJEPV\8C%=CGXC30<%3Z3$@E,0RU]DGY&LGTR_-<3Z@(/2I*( M4IV%D@D;F0G)W\51/AKFADP7T,&(3(I+F!3'ZARCA(R%R*"S:IUQ&`L-PXII MS66<6YN0M-?9EVE#V-7E`(1Y.E^'\V[OGJA5$O=PVFL$_>T`XS3)2^0@ M*Q&:/HG42%XE)4GI\*7*RHM2DHP,KI72D/2QV&PY8O9.2V4A%03W,<59RIU\ M!E&SELX@,A*(F(-?H!(\G4#TQ5@:'B+(2>?0Y2.5Y.Y26E(W'E)ZPIG*-M$")!&N!$5QP\-$-,L0()^!VY[1 MXW`R\1U*U+-Q+CR='[,8X6N98+H3ZM2$<0(Z.=%W/>*>49(.=I0?8#]51@@= MM<,"[GV`MP)>SG_8*`OEG8LZ&/D"NGP;U7;28[DIKV5/.GGF$UZH_1HGCYXF M3)=)=[G!T."7JO4[<)5]_\`Q\9S6UJTG#9;H1M9GY'63@!352`?7B>:HYJ(Q M2V;P)C28Z&=#&E$"*::P$QC)RMI'7(N9,YUM0S'6T65I)AYZ*/VH7BQH!R M4J5?O/3CAZP`#!VHTN)D)&-NJD3&QC-W%VT4@B1GIZQ;_5J+5&\F#78I]=O5 M+=;=:2$M:D$NJ(XB(J?,AIUWVG8,G(;ZYTUFX+CK9U2<( M.1U5?'4O)=2F`-1DHGKKXW7ER@XUDY*WTI?:/O'\'*_JQ/8YW9I*1T:OE=&K,O>S*R!,[\E+9S7XXN9R3'/ M+M?`OK*J.VNF_VT9)\R04Z4=,6LM3M@,P(V*^UBO/5GNE\ MI6^MRJ@8J[1Z69^PUY4_BP7^JK[6(F&O8G%:X`=I@5_+"GQK,\)>IMJ5$/@I M`-^LL'\-$7\K\#I!V.1CV=-2W<4F4Y7LI(S-%&6WDJ(O+GKI:H5AH?@/DW)A MPRCW,CNWVQ2Y*2=)Z!G352VS>LNB!#06Y0LN_\YJEL/C3J5S6#?4A4-7CJFC M0)%NS*H(PKZ'<>YE[\+W]4J[TZFTZHUJHR,95(#K'8?NE#KU#P*G+P_O^U-] M_%_H5`61@H^`']B[C*8 M`_)J,,0$1Z+L[X+/D?%UO8B?_+:0(J6!_;GO/>RRR\>6%-^+[.]&QBH?XR%_ M^+KG&>?@J9;;&#U2P1V\Y(8R4N17'S%Q$R8NO^Q8%7:W3>VGHHGC(N4%!RA M";-2>I26K:P*#G,8P%H)H-T9K:73HOG!1@,/\4B0IS=6= M"Q0CR`[?QV`8)DX6]K&^F[5IF0S*Y'1B7O1H).C+ACH-2OM8EFK(M?P^ M$AC(Q90E!A1_H$@>?!',T2NB?#/+W_/U%7]X\;R:(!$!"!&8O90:JMC.H!G8 M*!U0,/5QT1X4:;QYBBNKY&ZXD?\-SXYK^G&N>)!7.U@WI[VKWR]S-V+)I1,L MQH4'H>FXVT,L!>'L'"0RT(O@I"?/.&%*SAMG#_J1).%0GPBDO0QYY9J1_ZV& MY!LK"8\^*Z%6O/V4>PP]BF2RT% MGEWAZ/).2'VU+8$COL-.A/B2@UZVPT$:Y%1_0`PWI-^\!RO`Z3B]"Z)SA^'AW^_NCKYZ_SB MPNI>GEA7=Y]/;ZSSR[ONY>_GGR[HYKK3NUN&)&%LA1A9[$)"/_K.D! MW9X_=@:&EC?M$JF*]+UD#K705L'"07*/3L*]ZBI%O'`%Z)F/&^A$B/.WZ.!4 M3.R`E5HB/ZHIR'6;!+(1@>B<@/W=;$>G-&-R7%Q%0-(U%W0K)?(LW[:-K>43 MEDUH*+2*D(E@\WV8"2>;=\S!L#!@ZEHWE'+W\GV.WB;+B#`(AQN$;3$.P#.< MT%=5ZZN.&G+9,O[$=LT(WI7,I&N45[>&,@DYON^]A5>U4L(979+R%),:S1U!0D6SR6EX7K! MR7UF>?A-A:,1H,.$>*2-S(#8YH3]!.-`X>H%IB'SX61K[@UF2;=],)+XR^VH M+.!#0]U#)#ECQ^7T!SM;ZJO&END"/%I(;&Y.I/)MD,*3-^0UUH7K,;(U4\`E MJ#@K09D&(F*^>XZN/,9MPLB+'3Y8(ZQR!8_$G89.F"+[[$;D)N`:RK"0ZC4Y M#GW!'K"GRE6$:?K(N%-BR^8<%VF1:2(L8!^*$G6.&Y5.YZA0FY97CEFUBEC& ME!!Q-=(Y('@A;Q!3D)'??L,:]>S\LGO9.^]>@"*]O;OY^N7T\BYU^]FYD1W-?-+-K'(PGC+4/&L<,H];4W-.L7TP:WS=<#LQFM M\I-8"&-21])GIG@PH\X)1S!JY_D+=*?-OCM:3J@;DT?)==U/,E@4PC91Z1<6 M,+":+D)PSQ_J`C'69*!V]ZVC1LTXB"0Q011L?3&Q0[?&T>/.`H.LB]K M*L/4OH0R*5C6`K$8)"G-A=5]Y4+)9'@5T26S"\NKY`UY'%ZDCB5)[Y<].N!S M(AYV7^7@P2?8@HE-;0+&/B;)#1\!.?:]\&.LZL*S6ZTX$[?=*%MENPCT;P!Z M#Z,G2:*>+JR1XW"5/$Q'1,00&(3%6="61!+7(":!+C1A$G1Q\,`!]P:TQI31 M!#2,^QCSTVKNO?I^P?SD<(QE"J'14;`)$MK_Y3MV9@-'0B/-W8+P3G M#?W#/;^/OJ*,!$[B*.3++O<:^Q31P$S^E'>()?TF%,QSRX.JTEO[9.D9)6OV MHPWJE>%A>\()!O$869$`CKT\R,S!!EDF.*:0FKRPD6_.[`>^#2R+((5FHL@] MI<3AC`_._0."16GR,FX:>[I[U7]C'_\AF@S9OB;_GY'`%AM;](-$3&1*IO$%*S!3B`GV/H5#G(U09_>$-'7AQJXV! M<-T01"7PS-_?U=[1YPF6=,G/^0A^#R#H!T[%^BS<1X&[`K`"NQ](@)^<8?3P M@>IO/EI]D@@'Z/;;DU!\L-1?[Q*`$)9`?T3[@+X:JKGE@(W6Y/M'V'5/'#Q0 M"Q>8H][^I6BUT7#.<(]8W`.DI#`9^1,-]-PY,LQ=G8DR M^C,H3TH;HI[G#[O,+A<.N]V8^!E8IY&VZTFUJ+8?H/NS'(1!$1DZ`792W*?Y MR%!3*Z)Z7\7U8Q8$M^(5X?Y'V?.4IM(C@H(B6UK;P9BQ M3$=IV+@P"'Q08GPZ/#5G-ZW#_I2>Q(,-"D,%&W"J/BYB1]?E4;&2F;4IXE%R>!DY;IDG;DO<>D&C`/O3"T6"I`F+OI?O`@AK$+[]QB8APVQA[VC+HU MRE+CW.>PRTD2TSM$P(]PB'=GGBSSH0\0P=A.>DH:-XIS'&Y-P;UA;!QK;$A"X>V& M;7=M$"/U:AL(+@0I-4QS[`(8GJ/._U+];;NRO^U2UN?/1\9;LW%2(UFY#>L' MUJ^I;5I]"D/TKVZ,[G9W!=2?>Q'XEZ$SV.3^DJFTV]F7W=E353.WP8V]IH[8 M/^#&;MMFWNB+GC:XFW#N<16 M;&0PQ*"I%>CJBXT@M:D*W'\X'+[BAKPVM-L[V$^,QSE2<9-R^^G!B<0*5M1S MA,KO'`Y?4J1L@V)]*:%;YU98;Q!#;P7'K>H.O1M$+_=3>X,(?B%GN\F=?];I M"J]HE6\P++23\+,PM'>X3@'_'$CV?^@]>F.R>8>:;0IIO(9I?.8'(X&=@7_E M=A(O+T(7QZ-?.N:].3%\\`:%WTY&[%#S)L3GZ]B>,Z/`S3?(ZR\C!=N5UDHQ MWFW`T%O!\2[O`OP7A[J,4:U(".2O15V%Z@>USD&]05V%^._FO_G>S'_?3CT1X$5^ MSN"S[V+/AO#BHO>%]-4[ZA%/`_$,[ZRA&#ACVPW__N[\\NS=;_7#&OU/@I;U M+"*+&KZ)EE!Z;0=7P6V$O?*H$<&U".C-U+J[X=4($U%@T0?-NK&.K[`V%JGV_QBV28Q:LYKA9;R>K*0W:)M>TW%[-7EJM<_3J M2P/Y5#]HU/1V$9W(VTFZZA9<7I-ZYI-K.Z'XXR_?'07Q^,M)Z177JZ:8?JWU MUEJP9+46O$&=+U!/[D^'3>QZPZ[K`JN,1D"QZMKU979W.]:*>WNL]TT\V(^. M']@NK[@'K-\-0W_@8-_%BVCXTHLS1--,\V&F&ITA_AJ-YE&CW6@4"L"2^GT1 M,'EE.0.89JMY5*MM%ICU&E.`N[0QM7Z`-R%Q9BVGMM)BNO)BMC,'QA<7V#0Y M>]^/:CXG>\]]#<4H=B^>:+(?,I`7F>ZWRK([Y[\,I!O(<[O\&J1 M$K`?/@_I.78VVOYM6HD84ST7K'6JDS6"]=**98V@;Y.*F;.LZT!>XVP\WHW! MC`KHBKKG4'!>*LR?[/F@E:;B]8+V8K&8S:3/(%.UUL@RT' M2VGB6PF6'$^OF4GGB8_9?+`D5$OSYVI0%4>BN\FMVY^FR2/7]A2_ZC[9P5#& MJ0UQR5'99V&XWSE/RCK+_6.FATE.UR.IZX M/H]4;-S\X3]X9W_9KNMX9>V:9GN'.$"U(L> M'/N3+]"@_JE1UZ0K51JE47=MXSV!WWKP"6;*1P%^,N2EG+F%R%O5D^O\J-AK M&%[\0NS=^*'X\CNH"OO^002E*>^'U!;+XN[$]ASA7N^P)XW4>NV@UOFWG/3? MMW$_%/^-8:C3QQSJ2N+V#'\KKXCK6V+^%1T*-(UKMIIE8NN==JV^>"VK`U1T M[]<\@%J'I9#[+`P=+L#0]]#YX#GNW]]%02S>6;\^:_6'RZR^WBG%M,]9/;DY M(%J]GBQ2R4JK/.1)9=SH7OW>.-%2I2C%$/A\ZRNV,_]J(9"ZL?U(_5 MPM8>=2Y@NW9FKQ:!O:9ESMJ_!2MX$K+ MG5$>O@[)KG6A)8\T&T=O?U//_+@,IVZ9("J2-#.%5#D.S1Y/OZ45EN/,5Q*V MZUEA299\I5U<*TV'0".&YQ[!L<"-> M`_1R^_9LT,,%L%.S.0UH)KM.;3;=6;C\(I8XSG_!=:Q[][D&E3=>#.#/.Q^_ M>N8Q[Z9I]CE0ESZ<;=4[ZXU.E85:8*#X)3XR< M&5[!PIC_(LVVQ&PE`OIKG&T-T?KEUK8H7+]I&R%M4_T>`)VL;H1O^N"J`-A7 MPL=*'EFSGO7(-HGHY'`DGFAB1(3:./(#Z8HL\+$C_F7L(.R&_];R1K_ M&4T!DNX$OV('`ZMGNTX_<"K69^$^"NQ$4[%N;2\\H!X%'RT]`?QO77EU=_=N_.KRYO*_"A5_W;K[,& MST_>`]((;/?<&XKO_Q#3TK.CB]9JM>#_S=DRHYG3G?B#F.)6TTGY-=9K!__D M\9-5J>`,X<5P0]^.D>6:'L9+<@GN`]ZT9,_``- M!0LED>U-36I(#5VT:0P>(_L,OBNM0G[[9S.]8;F19D^'V%AN,OR[:#H]4F'T M#E`C`X\%8;,E"R67J[F?E0Z>4ZL+P%@#!7#%X]A%N,"& M=`9.8O;$B6R7 ML7PC0A$\"B#/^'5XYW=' M(\=ULM)I_G8OLDA+CEXJ/>6PW3(67C!RSNN*!7+AC:#]0^9R1"B%Z!K7N.PT MI19[U&@;@8]Y4Q24&4UL9R@=CO4OM_3XI>O+;UQJXN/F<:MMR-W4H$O/6&:IAT>-EBF9YL[X MN^\/R2I?<7GM6K/6/C0$MQIPF8E*I02V:LVC^O'BB7BY*Z_G^+!6:QQFL5=^ MDC)K:=>/.HW6\<))!@,\20W!QT3R7+\$*3]!J575ZH`%,OO.OP+% M,0!S"RM)07\^^.X0/CV3\5KUX]I1*R6Z%\RT'MA6#!G19"^@(9>8I,RF'W?: M1YT,DDMI1R`/@'%XX=A],!I66VY:@[5;]:,4^16/_RQ`2JF:9J/36`62]>&B MU6FT6X;9LJZY2\6_#X^;1T=+S2U324Y$?^45D]PNRD_!09>=L)2T6VK"!`>K M+K#3:L[&0.I;:[C48]^>>]%-777*]T6@A)K=.LFX2P>':#F[O><'V(R)G/ MBR9:!V`KF=S+`E;4TF-=/:$6=`Y9LLW/NEI"K0Y5)@DLU0+9>.V3'3H#0/Z) MX\:EDGE*`MZHMVO'G;IA^Z\&T.:6M=+!;;/1/*JE!/ZV+6O^.?WLW:K7C^J- M[5W6_(2`6;N5:ZBVGF6I@+AJM/1L)IJ3*WI0J]8-6;Y@ZC5`NC"M9`ZDC?I+ M0KHP)64.I+7V"^-T?CK+O-VOK0SII8@XR'I1*EFCA)G3/&RT&AT#=ZDIEIY_ MV9KD@\Y1Y[#67-O\)9*:LF9>K0W_N\;U+U65?-!L=FJ=TO.K\"Q02*;=YOEX M8CO!.!MB6%\>VZI3+T\1QXU.Q_`[RDR\1CP]-R?N&7A:CG+6@2>=-"D/I=8B M4W(B)3?+2F`L2TB=X]91_?AXW6`L*V'J(%U2`F9MV%B*7!K'=?!H&TN`\;OP MX`DDI^YP['B4DH4I8_+YC5#*@CG7`.*R5-1H9*AH\R`N3V$9%?8B6%RN^4:C MDZ:^94'$?,_KP-][9*6KBVY41)JUD[JI5: M6\\/HZO1C7@47KRJQ%@<;%XPQ[)[5S\$F51+A8"-&599XG,WL,P2E]K"3JUV M;)ZFS5VA_'I5VV#1XN8-O[2T!EW;;*42\GCP)=?TW`U;L*:E]NJHU:K5CA8O M"1R'GAT^`"-B%=/PT_1KB$WYM9Z7%\IECZ]6=1P/6_6,VUAR]O7"O;1[40<[ MZ+ASN`[(P4\+A!V*$\'_GGOY4^G-516M-/6RZ#H^;-33&5X+IRT%JIG$\I(H M6C3OLOC)I.TNF@ MBV8L3\]@15_ZT/#0_,08QD`TN5AO0U78M6C&-'R@\P9"#$.<.LDX3V>:`6*OH@=1 M6#'W;`0]%X"ED=5L'QXW%;*6F;VDU7+F>##,VJVMPU:COMC8*IA\O6`O[4DU MFNVCP^8Z`+\!T4A%H2'Z*7J'IKELLU6;HV826^?-E\\72.AH$[!ETD'G33>; MO8QD#$7K:Z3,4O,]&[@U%,B;LZJBH:N1D>2U%KIO=SHM4V\MG#7G\0.7@.C! M?S!SYM%VD12YSBVK!->QC6;X<)FYUPWWLI@^`MW7W"3HW8AZ28!L>E8F8_VH M?=AJ+0(T,]G:("R78=P"&%\+PO70Z*:@RU]?4ZYAQ;PN=/S]F1]<^MX`(.KY M7@@Z,5C1&EU+E[ZE85JM5T8CU2IM98#R;6CZT;D7PL)1;RLVAY?OG4?AB?4D M3-3336@6S+@6$)^A]:13P'HFC5'D@@N84363NQH9?1'7@:F&;D6T_/R;@/_9 M:-2Y94FZYIWP@!H+:Y]?J$*^J5J(EH0Q=]@\S]B*.0NWW6&W)K%&U[# MVP`8?;P:22/==NEB0C*-3YQPX/HA0'X'R_[D+F$^K:^QBN<'@`_KSAF#T7@I MGJP;?VQ[%?ZB8F4[JWRT$+P#VW7NX>-_8"N;4NCJS MKJY/;[A3B=6]/+$^=6_/;PD>^.WZYO3V]/*.?B:0^Z\!O/S2@6W&<6O5MN/Q M@NSQY./_U3NUU\&GHF_KR0XMQQOXP<0G:K?@LVV=@.OR!`1*P*@?D7?A_[J3 MP'&MQG'%:M1J1U7KW+-0ZE0L/:8M[]:V(FPJ#%2'K3S0;?55W!ZFQ%XXUOF7 M4_AS"(`%4\OV:'9_!-,/B,6L9KU"(&0FX'%@`C^.\'F>!]L.4/-00#4P*G^F ME/#8(Z\9)CW':]M\)ZQ:5VHE]7I%+@`ADGU'K!%@&B;H1M9G?\QX^"QL-WJP MOMB>S6V1+)`%\)(=<9L?"97E1*$U<6W/@_3ZNF'H#["I M`1#4132LPA=`$:!;?['\)U@3@1'&?5#VCAW0MHXTC%7K[H%DK116,,-(R29J MD<3""4G.C8>"EFO+,*$Y#A$#(C*9US+GK!(4MT#7SL@9V(`"!S=](#&GA\1A ML%U1:`^H594%JX5-$,*SA.N,`30$T?$,D.&QZDY,L)CX>DMR]O3V[OQ+]^[T MUI+PM.$=W.@)1L59-!!`L(,SMAL1C/2,%2U/#I"9W")D4&!#>&/B`K#WG'M" M%#H0$[DY2"5?0=G")U)P3"IC6,;`M@)!I!S">A0_$"R1#]]\$Y:`Y8SI)18P MNG$B,X=-[;9HBH"Z#Z$,'&N"M+GN'5]UC>,[_#S4&A8?1-T*BT%NY'<(B-Q[ M/!-R!@NN,LQ"1#P#OD"=9N-#0B6E#]4,#=SN.D!S1Z]Y^-KF@BPT>P-RM6#X%PH&F/!#X+HM) MH%T1#@+_J6(Y2*`@I*C)CV0!^.8_?F!LN@/^AQ/%)+Z+Z+X*JG'BAR@8:83H M`8;MV]XW&&D*VX^!+):I1"&*)V'8."`K>"*CNZC(PWCP`"8KCP>"6XQ1S6/7 M+E@/O/,(N\\$R-""]@\`_VD)^`<=_7C]J5PU:KP"8@74D4_[YQV*HI_)ACXY_?/TXNKZ"YC.UNG_ MNSZ]O$U)?8*(#D&'W(4>C104(\(.!L`$0Q!'KC]!LJFP2/)@>B%(',$&`?T- MXT'$!"+%%5E]H`&P5GZXVQ4E:*Z^?+FZM&[OKGK_R*I=Q2Z!`-M\&$HK'1UQ M@`@=/4=ZE-B&$DP=&^T_Y@Y7W)/<)YW)W(T[B#^IE_!1D@VI(1/#"=N#AB-G MMU<&!_UY>OGUU+HY[5W]?GF.+J>Y93(K3*IB.A2R0!I*?T7:):E46\#_!%5V M\@S(>=QML'?Q2GII1H!R%LDCR0Z!EF??(2U=^V#R`BA,+V3\J"&1.Z4ED1H; M_Y@W/GP`F;DQX$U`(T" M*+=1\Z%U&`R)&DGY=&][5J?6QELP;QOMBH5;ZA#JY0PWO!*R1)$$Z,)\CIQ=]"4*(`)^X`SO)(07)[B$HOP@2>'8=J:7I[ MAYZ,Y-24(X,)MBE;FBWW@",7`=V&@XZ-`!@P!PAY=TSVA+8Y"D@?N`.\$[+C M1R-I'`Y!Y@[PV#G4+C"9Z>B@`O636U(!,G+'N)T$AAJ&1;WE]]&`)'+4KBV2 M![E@'^D[G@IVH'@RU^Z#O*<'@3<>!%AD11:C)BM)*?7):S? MKZY._CJ_N"#CZ>KN\^F-=7YYU[W\_?S3Q2F(K=O3.PY)&@2G.\,Y*/O9740V MYY"N=-RL$37/M&#?/7_L#$#44@-W-)V<$!\B/TWYIRJ>@[)3!YF0@/L8X\"] M1$FG*=OS(R(1$(,QN=LH#F%1CA1@(?OUPIT::J>:@AR(PA%/Z+,"/3E)_1S( M4Y>.D&W/DV.;\IQ`D,Z+]$="\L:!EXHC#S_BL#"@^N+HXSXKQWOY/OMKR3+`VXIH@ZSHR3\((S&AKZK@ MD`T%&TPC)X!G\">.VXW@72F#I5Q('&\\*\#A*$(5*`\0MW,@3SCY30)C+V%7 M!1Y`>SXJ/0OY8.2*YF=`NYSV?J!X7$]B;*.A![6!F)E'A24HW$IRTAH#9RCK MP&*Q312I'"DS><,+=X M#9BT&G/`):@X*T&9!B)BDF(VQ=%PFX3T_4=@&`+LMCL-,5!OD'UV(W(3<`0D M+*1Z38Y#'XTH$(">8*77%Z;%S"?=2="`@@6IP+S4B9H("]B'`AB=XT:ETSG: M2JWY*H=.)W^>WMR=WYY?_FZA098+)^?-*`*,O`=41/=V0$+1'@*;1JP%D61] M%4I(_4*N[RZND-F$\\O>U9=3ZZ[[_])6,*?]L]M@J:,_'2Y4*@!^M@1%S%G8 MFD.; M:C7\2O&1@C8`3>L/GT=TB?_&!*N*Z')XWEA$)77AB$-V4)_>)Q\4H(5MC&&G M\!-Q!H6)9YQN!(*4[",&;_%=>"IR1=7"+*SDM`<5QQ.'F2B-SQ\#,P&9$QQ[Z=$:6,Z4) M%&U.'[9J!_6:E1C#,6Q:@)YD1-:YY'VJ^4D,9&LO>7>_@B<&?]A@T<-V4@2^ M=IB-W;-6-<-4FJI89U)N@>3"Q"AT231H8S29M&IU:33@+>RR+W_'M_H"L.21 M*J`8\S!M[,6>`002FO*="`H%*(>RE(0#E4'A("!YU"F>GQY%CI`\IL_P:`_P MT'@1-NB$&IA$FM:LL("YX`_;9;Y;%C]L&P'$3_@?L.MGK3R=6/"$QWUI*T9# MAZX:5@V:48&9^$3BT2]J'0Q;DJP)GDC2/M0!Y8Z9)3-?7-W>6M>G-];MY^[- MJ:F/J=L4NSP3>7(58LZ8X=R<(0\9??I M+&+B1QAMH.#`$,?`D&QJZJIU/?N9!!DAG7L:]H2#B>3$+JY:!!UK("KBB<]: M3\BT1#KHH,,-7V8$(.D^4338.':'X0$[H60_#RO9K`F7C*J#31/%E!'%&"+J M9[UL)_N#HH%DC[)-*R61DCE5!0`CYT`]JJV4Z"%6QVN48S-4!_IHX;@#O%*& MI%4W,GP<=2B:EA-#9TA"C"+_^$6)C=MQ-G/VV?EE][)WWKVPSB]O[VZ^XHEJ MQN#.'$R#2NTP_G4ZI]5-LF1ND1/IGLY//OQC[:%ZWT?Q2V>JI&Y'@3T63W[P MC>Q3CJ\0\QJ./^>)V'0R+L\!S5P6IJ,^9M89;QFAFCEI,6D5:!HGH01>.A)H MO"96<_%@RF+(J7SY!68?PB!XDI;NF@)[5M'#=.&HF@'ER5\,;"3)MSE["@;91RL8`[2I?0FE;!I0 MF:B,YG#^'F7G]-4!(A;1ZM"7C!ZC&2&/)L@GPSP>P_JR]N!)\1WL%QIV7[D\ M,O,*,(CDXJ/VQQ*O"%2!'Z-P#;[!X,KYHZG8`PF,L3&\B[DA()1`+!@N(8`< M/:&@D^-,L&P3IR,B8@@,PB*+JFI))(%,#'W#IT#3*$$7&W(.**U@\#!E-`$- MXS[&_+2:>Z^^7S!_*@],)BV@/K5#SHV1;P!$MCQS47(4!0VF/Z@8:>C'`7I` M>WX?3TI)TS@>*+]PGT_^&O@O!DG1"C9BCOZ3EX*">6YY4%625Y\"UI1D)\-_ MC[;C2GA8_#O!(!XC*Q+`L9<'F3G8(,L$QU++ADG.3S_P;6!9!"GD/%W6=5@P MP=3\`.8%@@5TYE.^$!F3]A`%)4#_W]C'?X@F0SXF((W"2&`GFP\F!HF8,&@/ M[;LIU\[)X04K,%.("U>L0,[NV,.A^IP#>^$5J4_.,'KX0#F['ZT^280#//2V M)Z'X8*F_WB4`(2R!_HC%#_354,TM!VRT)M\_PJY[XN"!+%:8H][^I6BUT7#. M,P0XLNZ%&$NN(6;O@$()0>9 MQLG7\DPJ,R@HCUN$(0689`Y)5KBG&;I"?F4(SLJ`"P\*V+LZ$V7T9U">E#9$ M/<\?=IE=+AQVNS'Q,[!.(VW7DVHQTH&S'"3=,CP!!G92W*?YR%!3*?D"#D]/0ZIS@^+-6J.Q3\6#)&HY3+CY60%&N,\R4>E MBVE^M)&$INHY[GW-CY%1Z1%!09$MK.QCP2%:>CRU-@L#ORZJH M_M2^WH#X:A:(+\TB?2!GTV]6IS7%P0'B M,M/27HH#?B7#-/75%EK/FPT;)6A-"I]QXAJDF'H MRRLF435@*<-'M]:Z^7MYAGL3US=4E_-T[I?CA#D^,IU,Z3D`3 M11U)8B>0?)*."D%V;[]:EW[5XD+_5@6+![TA4RS09'?P@(GQ%CYG` MGG5CUE``(7^MWE:MW[O=:WKP_.SF-E2QPZ]JXOVJ97Q*COQ#XZ#A'D]-8F>H M2C$H((RA2AG>/$?#AG,Z%P2(SS%`S/$Z;X:\QB/61ZRHY5HN^0N?'VA#58:/ MX@GY<&A84?`8TV[8!AV`\0=;8U&^8";>;$PFXY<)VBJ6"G92N"M&&](H!LU5 MJ20!;2/3+*"?9`";:\L-`9<)9,NRYJ\Z\B>6RIY!),R M57XVGJ3"_J5SNGS9Z=&%9;6:(D8V9&KCU6I9)(694>VO91F+%(5ECJW)6 M.S(S35&`<6363N2U9"EIH;HN$*F'#0("R8^JVCP4`SZ?-&@1#]TT*R!>#`9W MJ'N-0KL\D0/,X1X5HYHYN-&H[7^`43&OR=9U=LENGZC`5UKGX$/9';T1($G# M4)\]Z72O<]J,*^YV`2(_'L>H&T!J.4%F.1;'%.4AHDP2E$=UY&;D!(K>.D45!KV9O\VAS9W\ M4=FW"?DI19392TPB(EA0[.M$O$OGHN7%2E?5FE(2&DJ!UN@(5>`;.(Y?JFMYOY'-R'Q=^QJ$L$<1,N<)L M:#J6Q(2L2!?3<**43O%-P>%[F:&H=P-G\V2XF^`PD/823"MMS21+5.U(,YT8 M`LPJ'CF36%;`\*HKED-EK944<^<609PM4;'CXR7X^$ST`V5X-@LM'Y./FPJ+007\$;K0X"(0L?=&\956&=Z!::6.9W8U&\(T,F0Q'9 MCBM)4">F.:9W/7RI3TO!O+RL(H8^R8Q*?EH8KR[&3B,C*1 MY11FU'E1NB$9N)18(T'H8L>#9:3,FR:Q:53I(MI/QP(GO+>H#6IHW=GA-PPN M#<0^;Z)L6(;E%MSEB?BKAX%YXH#KN.^"D22=-IO"3](L(!#2'=!NP;T-DF9D MIRIO$&.8`"P2BS*%D7PE_\D6(+00(]X/_#/?7IY5F2T`D3@6KB+7^HM^NN.J-$2U?.A'PFQA@EA:NQ^7]&09#4 MSNGH1J)N==IG1UBX9$9&%=II?(9 M3LO%,'EJK'2I0!S*E,]/K@V+O!T\^"YU?"6UA9D<*!K'/MAN*&UT&3B]DRLQ MEV#)8\-,6OD8M>[_Y'0*#<-TX;E>KT9/LI:DR#^UGD2V$1C8_2[IF*C**QVS M125U+2(G:*=1"R@?ZUR2[='[K&S(=,,R#XB"49S:OD!7Z]@RK_!]RZ@T2COF MQ=6W&&'FRD`\04GZ#W#2M)%%+5/N<5,9*'P>5)'L<`)4;'-*\2,2T03HW#PD MPO9=XW@L7^6AM+4[H@PE)BAJS#"U+NUP:/^7V8Z.[+6R5^!2`CRXZX'_734P MM=X?M6$FUT6F>E3%N#H;BDUGM0$&S1I%0TD!P]@!6_I@8$^2$@7&R91+`1#X M:"H[,:A.C;R\O`S3U7_=U7-_$X0&J?:8T)NF'9!HUF+`G$A#H^E.V'D8# M5R0X*HE-<$`V@8P*T=%Z:OG9%*:DM?*\3K.8,:6BGZT*UZ?Q(QQ[4Z(^_4.# M-N-]O5/IM&J56JU6S;7[E$78LTQ)+8:Q_TRK&6+U%"IN385>C9M7N:J MJP.!+:"5BI-3LH%)D;M$UP-C-ZJ-]LZZS$E"W3B4F[,!CX\QI*WL_J1BG?66 M\E5F932^0-G6VZ_0FI4XW?>CR!\G3\]/9.9[.=:=<[Z&46'9@&7O[^\:[]X4 MW!O&QK'&AB04WF[8=G3QK7JU#01'H;HTQRZ`X3GYZG\IB=IEB;I<><7/1\9; MLW%7THK*;5@_L'Y-;=/J4QBB?_5JB]WNKH#ZS+[NS MZ@:_36XL78/^(V[LMFWFC7(_-KF;=^#[OY1:?O[>K)=M7Q6>W8I^AA6M,,(* M3`>^(0BI^P!#S^@?^L$'Z_]ZO=/3L[-Y_"B]RU;CETT:D97<75"-);6'\H)G M@[G$5FQD,,2@J14H>K\1I#95%/"'P^$K;LAK0[N]@_W$>)PC%3G$BL M8$4]1ZC\SH"X5=VA=X/HK0%Z:_4WB.`7 M\-R>&#]Z@\-O)B!UJWH3X?!W;?UEI&"[TEHIQKL-&'HK.-Z%&W;AAE<,-S2JAR\3<-B%D[>/.>HKGN%M`X9V M)MT.-3MK=Q=IW;GX.\[>H6;;A-XN0OH6(J1;2X4[%M^AY@U+OU<.<.:K5;=# M$F)E,JQDZ,=]5VQ,%F9F>1ECLK.+E.XBI6\;O;M(Z:)(J>JK,!-';]AX_I.; M2MA%E[OOM,>F)5NEWMEICYWV>,/HW6F/;=$>K^-\Z`X;JF>1'287":I[Y&UW M$*O[3D=F,R[QX8U3SD_K,>]0LT/-FXLR;RU>=B2S0\T.-=LG:%['IOKL8)-? MA-#Z4W=*_:$-I6=9V)VCZA:43?WR0V_0UC+Z#C7;+T5?(ZYYX^!M.H$0UHT= M+=LM;!OVZ:7"-T=K*H/8R5%,$T@8!H4FSEQ_BQ;4!7F]GRTN)Y`V71Y7V<;O2:=;X%L,P>SD5 MWS<8AC'=C9]ZFF[V<]W;P((:Q"X/E7NKB6NDB6ID4_:>Z\:N;I"7< MXZ*[>MW0OS_:XG[NDDI]3<6T$-:_L2OQA;TZ:MYT0'!W)+T[DMZR M#=I&8?^%4R3 M5R!3;\038-0SVPGHCM1Z*@3:#:]&1MC3BCV'?_AZ>W)-TX7OK*$8.&/;#?_^ M[OSR[-UO7`3XMU]?%NQ<7%AOP/QY/@RY]_3'1<6EZ,C%3>_=;:R,H2`/A!B&N+GG,CWD:@2//H*Q M?NW:`YJ[+!W,4VU'[1K]3[+D0KW3::67L"(P&US3LMOR%M;4,-;4*&%;;VQ-71?EH]9A[74!7I9(>P-_+.[L[_*Y M3\(3(V=5R?D]=#YXCOOW=U$0BW?6KVE#(!&61GSJS`^NXV#P`'#W*+N0=^,-_\,[^LEW7\?@' M`_096JY^V&9,+P_]%JW;'HOPYHL#"_]FEU^Z(K*WO/3>U(L>'/N3+X)X_.96 MGI&\\'>C],JO;7"=!]]Z\`DL+?\-KKU>/Z@?*^>F?M"HE5[[)]<&H_&/OWQW MA-M^4G;QG>U9.ZJ!Q+&K-TNO_<8/Q9??0(O;7CNH-=72X>^67OI_ M8R>:JH%F+/_"QD^1M,3YE8N+GGQ(:KY__V6CV MYPCW^NW21HOHH2V-#_R[HW?T-NZ'XK\Q+/KT,;?RDJC!%*CQ&U20142Q'KRD MA4F6@+H>VIM/WLG2)-5<%^KXT528`-PC>O(EK%NPN`U:<-NPNDW9:&]Z;0NMC%=?W6N9$>M<>"KT_NR,%U#D&/H9 MP)]W/GZU_#%&??/J]K?KUK\RAPY;L?*?:$^*+(7=MKSVMA09.;M=6<>NK-\^ MV^W+>O9E[:8EY^=LW_+?W,:LURK>\%@?6.+&>P'L47^ MA(2JP)EH-)O-]>;$)QB8%;K4&\(NCDQ1_(HM87@DF4_F?0$,/KC33W;H;,,) M;^.XWNGD`Y$K+6>[<;/:*7"G,$[[XZ%GM9/B3N?M$,]KG":_+?R\_(ES8\8Y MR!HPM-(0G%OV(K&<(YUT^PQ(MW?),T(E/_:J9T0BMG_1&W'TMW_9+VNZ`DHZ MZT<)FK6NP#-0N\&4/@3-YFHWT,?=<2%]S40L/@-_FNA8> M_K[>LC9\\+N&A6G/WG;MP!$A^.9_@?OWHBY;P4K:F>3X#'0O#OVRK,,)Q=NS M@&5YI+Z!#7A99MC,"C:;ZI!90K.V_B6\XJEXH;1:^P:]2(I4=-MN;7%UK MK:LKD\V1)'-[9P;V(YH=:-Z5H9H52Z]5$:\X!]?76 M-%_]O-5ES5=*K[FJ3:JJM:Y+ILQB.BV!<^>K9-H973\VE&G_!7R\<3G+HE;+ MF:DSEK"E2[6_EUQJXV66VCJH'0$+EE,%-.@"/-SVSC_[8_%9V&[T<.X-2BRU MU5[O.C]-3[T(=VQ.*&>#%228)I#$,,J"F5ZEG[`C^;3$TFNM4A'V="WZ!`J_V43N_G\NMT:!V MM1\J-[5(8[[`?LX^`3\N$CDSH$ZO,OG^:L2%T`,'D,V'Y.%GX0X_3=75*5NS MW%KK^%@M>(D%%/@:BKTO8YQ<]A8,N?W`N7<7V%YH#S!T]/*BMS0?K[*<6:>+ MLE)PD57XFD6+9>S&.0LJRJ5G!"7JC'!X(L)!X.1[A+V,WNW):X>X"LZ.Z"J6 M";6RX=N$+%>$H0CPTYZ];[T_A.5;?F#M]?>M>KWVBW[,?Q)A9`UMQYU:?_[5 MO:ZF\^X7K3W+-#W7#D.-UZO@QKE_"+EA)"#FKP=G\"!_"_G'R&QXLRWD!!J_ M?H0-'6K-A(&>M[0T85T`%K].-,1G?B#9\R4KP'^[3HRW^0"M`?AU)T*^!=!G M)@N^%/`O?:*YXKJ$_>TJCEZ=&QJ'"?CS05H'_.MFB#<"_4R>>$'X7YHMEE^: MTCD\H1"W(G@$Y4X/Y1H:7?K>(V<,8Z9J>(=W%IJ_X\5^EW[T+P%(&/CWGO._ M8M^K5)>Q6J>>/I#8&(@SVP+@#%>CKUX@[AT8,Z"IE%M3OHMV]B3BN-,YK.=- MQ`73Y;R&-/TDUR=N]H+#C5Z0B1/T\8]ZK6IEV][32Q'Z#B.8[X,53R9@]-CR MUL,$'00JXR3?^[[_&FN;>PMIOZ"1_:M`21!=>=;5(/)!G%@=ON&S0N:[\KV% M1X1)P#A>Y%NV9PDMK"Q;B1OKR8D>+)92EA13>(DHC?7@B)'%B0_@(UM7(W"6 M8<(]B876XV97Z4JA,X1/Y#=)'R1DR1&FET0P#W%DO.U46+:\1U7>,`G?3U2T]\H3%AW[ MP/=[]0J()_S_?>D>*4",P=4B.A]#2[I2MWQ):T28D\7&B4?UGDJ2+:!L'K1J MX:6Q\^?%?US70KE':"A\)58%(G@]4`IF:_)Y3R.0UM*F7"1`#.-@-\%"F%JS"ML:< M8&;U*3%8>I9X8P^`(.S!`S]@^8]RU($?!R$!:%NMS@'_.J%`;]4ZBP.$<^P' M@C=7.:R!8"#B_G\D-FSKUOEN[77VY00H,@_BB4&Z>&FN;=T]P=]38!V0)-9> MXU`_#XKUP(]-6G>=LQ\^ M5=2-ISASQ`O&ZW3Q0?K0>\`B$OR;JG!\UXJ2B$K%0G3[\N[4$8C_F7MB$@3M M#RZ\+[`KH36*7?A6)&XE$V)I5I\$/E[`A`POMU:Q&\U-4$SLJ7K-1C(@W-G! ME/B@P31.G#`5=H!;UP<,VLY0$4M$T@Z!-K9W!O,1JNE>9'L*&',!0,07"H,< M@4PFKC.@*`&N[,%W<8^JUI>@JI?W!,P(X(`T!888".<1-V=@V!DFC%HRT1.N MB)`L@*/'DJ.'>'MO$$J9:HU8,.*4B/)//H(-*#EQ8*K(#T*>W<&A>">L/IY, MPAJ#>$#W\E!5$;+9O0]61\7R:7'`Y(PNP"FJ4#0[JIO7,DO?#/X".JX;W\,7 M5J-=3L=)H:U/_;15;>WABXG>FO6ZEE\JEL4X#(!8O3!4$1Q/^K6'\Z@!'7@6$? M'=>N6%]LZP)D*3+GC9C"?WL"Z-WQ8T!B+P#+$^C/NO4#Q_9\>-H9P'C`"ST[ MB&PF4J2A/T!Z3*T+&QC%MO;P`FJF,'?*R#0`Q->!O$T@0:.BV4O\]H0!K1D: M66E>OLD[P`BV29VO)$D[?:+,'FDHB!E1=@Q;)FZ>OR MY[5!'"1#0;&':J,RZ$.`NBECQ&@QP_0P&]%Z'^P<5G#\I<&E%<.(3,P3;>IDII,*T_79 MAJ?!$4O(J`F[!\(9]\G,,\4!,IS@'LEY&/-0F&9X&@I6J#-E.?K-8-N&%L=8 MT!+1XL)F>PI!?N+8NR.5*>R%83R`'X-C$`QDOQ'A#L7(CMUHQ^%Y+[.N-'#W MZA_6=>"#;0)6]SE%<<;DPR-$%Q<]4^?!LREU8L-F.V3D@O^F34_: MKHCV"YQ#!S:XHG3MD)0MZ$;/YOIL*SOEQ1=S2JD'$RU`(K_-1FNQ!VH`C18I M:&C@*K9V9PV4,6AI`0!(RES1&AE^D'(*5H-?R!GP$]KC8W!O?9C/\V&2C%(" MA\141>B!C.Q'/Y!P*X\D`1)D*]BH$Z`&>^S')(0(D`0%R&HX+#+($-QJ0,(? MMAD99$,S8"0 M!6Q/R<#'G0'9*M#YRH$'VS@J0C^@QG').K'QNZE%P0G>9(T7ED)!,OO3`_B1 M,'_%^`J%(DH=!\0ON1Z#02`A)%^'@80?<`^D1Q%(&JE7.IU#`RM)=D1BL[!I M`EPV!$@!GP"V3;Z/WCQT=6G280I/[/ZAVJ2-#&@7/5@Q"$1N5@!.A`>*!D0, M2@L'N5KZ?,.*]>`_@?`+*B1, MR*`S614X3W%JJ)R$L?U-,$U)$M;6EK1L2%PE?$H67,&@C[X+B[<#S&08HE!U MT;&&'P?"1A,%IA+?'5P^>0I3\NA=+:<]WP.S#ZPTED`![AH\^)]X>$]0.:'R M0$'>HCT2%0%![Z'-A8AD*&*._P#8)9`!.*C(8`]*7UH$(A<,4T])'7H&US`< MXRRP:T\!![I@,V!-?7`K@5RD)"1`1!_^RW'>J8HE$3)A&,0__"A-.(F0,`3Z MIG6CF8=0]^4]&.A_`1(<#'E\I)02YW&?51E>`H1@$-49D!F7SP(UI;#1]055R<(_-4QRV;WO?@G@2#6@&A3CXY-I/.PDE)5375(F< M,<07-R790#9K:@I0HGQ"-RT.[E$UYR#8EVR!J M(!1*WI"X$XU,*00)"$\\84Q\H*1!#&Z$")&(`S^^?T`ZVFUM@>E>>$*DW$4" M!R2J#(>FS=>^B)Z$\/+65V1&S:Q;?:"#UCH]`%;$;62/1LC"^F?M M0P"1G`!\8P*_2>`WL[:PSAB8'\?[:,U;7'*`;RQ/KDJ;0>;*,-G"^E*UDMF' MY.6FP:W7^R1+\N@` MP=(E+2/H:6Y0?*XLT*)5I\,Y>N6WV'7?.DF-G:?)Q(5DJIP;&^5%A,8J=@'! M#$A]>_#M'N2P-SP`3/K!!Q3[$1_Z2Q\34:BB/HH88(O$/9J-8PPY^62D1@\@ M%>CT-W,FM5??)^O(/`:6GA48/6#6@K5%$7DR.(J%%PN9)W26,BH,CS<)&AH= M7*-T_%N=U0UD2[V0CUR9,BMY@JX4LAP%TY!`F:=3/\$L$<<8F^KLN,!Q)(_Q MH[77,'&!-EL:W!FKMZ(G'\R_B1\ZD3(R85(4P^^/.=(*8S?-L:5YZ&*RR[#< M)#[+G\ON[4GWGVGOG4*IWYTQ>QE=\%78PI3"IP6SM_81^V&1C$B]_+X.2JT- M2'*\)/`(-D,(ECOZQ6B0L,71%P^V.\H$)="$@4%)3!$(>VUSV6@KA[(\-[7H MLCEL)Q9V?;S+^*;42"13O@J/7_^WL!^=.[A(2_N[+D'7@MP!RA9 M^O<*A<:E6,O%J_5:_:A3/TI06V[J7(J^'T;84XUC^NA4+G=[Y`K5K.VC=OVH M;J32SP)A<["6+T<];H&:KQ\O`2U3D+I`TGSP!(1HX/0I!-#EV.GL]$2=1"H- MM+L')XBF9TX01G=/_MV#'X?`G6<.N,A@]Y1!>[INL1R`K[*H6^=[R37Q%91O M8DT4%RNW*E7N_0:6=4J=ATNMJG,L.6F51>G+I3DJ&)[YP8U0A\A7(R,'=X8L M.#IHM)0L>/7*[T8Z:7KQHF9TNF,<7=O.L!NAP7XUNN`CZ3OCE'S;D=%JFK1> M?FWS52]W@[A6P7")XF)ZQYS_^C*K[%[]0YV"&H>@^3HRC%6'UWQ"1`I8_AV6 M%M>SU'OQ\N:CY(L\.L`BM1F$<7S0.#(*(>KE"&-=Z,!"NS:J[7I[UKK--92\ MFIR--G!MZ:=9MZN_[LH7UZAG&S^56FN>'MCUF\$&VW0[8IXACAM9AN#%Y&K4 MR0,\52[AMO>$`C>VG8B_+/C9';P1+H;MKC&'PBC1#D%S8H@]#L0/56)RM&R% MB<0/@4E(L@PL;7VER>N>&MQE@L:W4T\$6.7D#*S/G&!M1.G-[-;DP4S&SX!S MWUV=L8F)VER(GLY2T]EE`W*N+7#'*^"/+TPHX:/!5`;HDR?SS@SP<3E`+O=8 M0B&SORS$?Q]HA4Z1_*?"4RUSC%S2R_MZ!7SP"CCA'!L_]RQ[.'3X@+<@5]E2 MM3A^@*?S.OR#7XZ%/#Y3.87)SZFW9P7XS2V0A\?P3CS@)`(.+2:0!X;-C>$B M;7336'04&V#5C_,_#K+H^!KF!23!^#RL@,'WX-Y7P+]78+QO'%?`AZZ`Z2\3 MGD:Z6(2/?.G-PL(6F0Y#AY/2@,/G0GU&S+FB=-C-P;,/VYDJ'W$_`^&ZX<3& ML@$4_?1Y@B0C/^<@M'JP!_W`J5B?A?LH8'-M``ODV8&$[B#0#QOJT#]IYOH?Y!XK2-4\PF)U"V M/\X$EOX,RN_3\[?F94?8FO4]B]KZ6T!MW43+@.QZ?UAI+Z*]*M)>9T=[K[Z^ M9]'>8/MHKTYW\Y8@OD,^9ML1X%LFP.'V$6"GJR#]8@K6FB@:>,1_K>>]ZF3:,82CGVF2R_E\ZI4&1E7ZD8W,)IN5[$X/+[E MX:]ZIW.H^_PNM^!L!`5>)T_AAE+@\-U+$?6XDFQF#\IF?<$Q5/.P=IALYKPY MG@M/F;/A5KM]?-Q>#1YSKYZ)EJ-:RSCF+1AXQ;EGH.![Z'SP'/?O[R*@CW?6 MK]G1LT?BY]ZB^58\FC](+[S4O&N[-)7^@Q<$@5?)?>>VJV]\K=JHK>%RU'G+ M?)NX7*U?_0Z=Z^R3_R-C\S7Z\[\6/G,MQ_*3?,I.^NN=9JWS&*M5M;J]?WX]OSV_.[^Z5*GE M;7BU>V=]OOIR:G4O3ZSNQ85U>]<].SN__'VETZEM.I9:3Q5+OCI!M^DQCT4X M?;:H6(428&<4I&`*:V5>>NN>JIS,=4N1O03@(;-EBLXEIB1A(Q<<<.H\.L.8 M$I.IG#>T[@)8JM!G'OF\XAOQZ'.'(WI4UFM<^H_2M:U5K/KQ<HJ M^'PO%XW(?",7`M'(N]8/)!U<`.JBE&)=51JJXS(357Q,ECIF=$,_=SQV195? MN!V9?RR_;4V%P_L+C^)BF^>5^OM&3;%=GUJI+@ M'_1*JOF!?((>@"WW0)9'4VOON+:/]>SJY%:>CSH1MA+LR48DF,-320V:F58- M2AK,VCN2W=WT<;`:<)`;T,9J`\0":!,Q5(>'?%K,)XB`+*N/)ZF@%OLV]U'# MVD-JDJ<.'3/EZK-G#RI-9J"6MO[1G4R.#:L&4_:&8Z)&X?4 M#%X5A\NG0KER`D&]4;'X\8&L\Y7-,U0=YDQX=)6IH#IU=:9`MV!@@'3F_W0=ACE(78)0-+_G4G`KKB_9`MH)( MP2!IKB]@L5R-0;(T5Q&EN^O)`1`>V2P`%R)Y+7K"0"97Q-0;LS@NM;&JZ]<" MT2!DJK"U5Y_)R2D\:6U1."O6(FOSX)BM`V9^;%J:>=@)K3]B3UCUAFIJ$A7K M+Y_:G"+ZOOC?A&=7K/.+GUC-W`K9<.%8=52+)YRI(9-ADG*?5$>GA!M,Y"*A M%#6G9!*QOH396CGLYJB_2=43+>4[K,U%3%^5TGVT'>H/`?Q,=W27BU7."'$? MM8_;G>8ZO,`%4!:FS7)>5BCOT/!!!D_?>"+AMF;9]:Z^?`$?\/;NJO+)9"C.54G/J)6IX&V,S!G/(!_M1L"6$ M!!:.'#$LKMQ;1"9`5W_[]7L_<)T/^%_X^/\!4$L#!!0````(`'2(>$7E=,CF MY@H```M]```6`!P`86-C96PM,C`Q-#`Y,S!?8V%L+GAM;%54"0`#.ZMS5#NK M`L``00E#@``!#D!``#E76UOXS82_GY`_P//Q>%2H(I?DMUNTLT5CI-L M#>22-,GV[MN"EFA;6%I,*NB<6:=[WCW1K"_`0>@OZ^N\?>ITX'^GLQ#_3%WO^[GX,<(^ M04".YY^_^>Y%*X7R]>28\4F[U^ETV__]]^V3/24S;+F>(,DFK41*:"F2ZYZ= MG;6C;Y.BN9)O(TZ3.D[:B3E+S?"MJRB?LL1WS_W(O%MFXR"*L\ZU M%[C!NZ")SR(KP?)(S923\44K$K*2J!"5_:@C'+R_0&OQ71'L+=0VM>\24^'$ MIRDA@5]I4&'I;5KP@#G@G9+`M3$U,Z=0=$/;1#LB@@'_?GS_(CH:\'RUF]1B M6[1I@/WI#66O9B;EI#9FT/X^X2ST')/@5DIM:-$7!B/+@$%L\&I#B@IO6'_? M_BMT?5<@LB[)%,]=QC']G6`:3`<0IWW?9[8+C/BW@7-<:>%ZZK:(H1_\SF8$ MNJ$^I1!)XS%XS,AJE8(-[;R#H8Z3=$.#:BZQ[T*D/W#B0\SK!:2IHHW;,;._ M3QEU(#NY(F/7=@.-5EPJLPUK+#'B.2)Q(IZOY[0*N0VM>B04HMJ!KCUX?^88 ME-M:5E7(;6C5$%+7&7G&;Z2ZWRTHNRE3X<@G?X40C==ST9]74U0BL*=V]\`H MQ*F&J]95N)O(?\8CJF&TEO0NQM8"V?-R7KC;9F6+8Z_QH;J".]U M?#9&L!WU.QZ_-T)EHG!/_8PQGDT5;W_\-X9@H&,WO>1Z%NOKV8W5EEC,<$(J MR`^#:-4)XO?^)0J"V)1UD9CHWCFZ_Q!W,H5$J#^'$)^(?B><+2R)5H:V!]6L MHMUDA<:Q:*AG>UFCL:4:LEO.*LT;MJ8"E9TVIG9(H]BZA<^2!'D+B.<0)]$C MK%YWP0TN"^'.XE\762B12O\)+1``P8A%PLRB454#PB-*KV6UPN4ZQ=G\%B M40QB1ORZACQGCJF(XGX`^1I_AQX\ZL?*@6B*9P&FHJ?/;<0XC.07K6ZGD]2$ MN2U%37ZY.B[1AAYW$:&6"U&2R(\YFZD\'GN7K0,FS0Q8T4*OT2@`]M?*9-^9 MBS;@/[,^Y*54Y-F*`"PJK,=2KV:6%#@;Q\E52&X`8VK$A0E\9>^@EM)CZ:1F MEG20-XXNF/Z\8->Y?A.Y'JGDJ:2X'D&G-1.DQ-HX9E*9X".Q"?3-(ZKHWDJ* MZS'SH69FE%@;QTS?MED(P^3*U#L25"=`2BD]GC[6/1!I(&\>71&PJLRT.1E; MF>\+^6F:L[\PYKRZE):[>U6B*7MW4R14K9>MOR^7DY--&35@S5DE\,91 M%469^:2L5*;^*9E9`SNL65F29SW@=Y%D:>>6V?+US\M,FI0"RJ^(F3&'A^AMRN?OS2Y%E8!L74P,V MFS%/AY5\R?H;MC8E93`;QT??<:*M69@^8-<9>@/\X@98L>)2*E!_$J_-3@7H MQI'T*#9%>,2YQMQSO8D/Z6TX"Z,Y2&8[=YXO'=GZ,WMMZO1=T3@64UE!WW-, M!M=JR?I'*UUTY;FH&7&U9G4F"!4%E4`_M[,X;^'S;C<1%3\,)^TH.EEG1Q$Z MDC3_M(O=4!5/STD@3O5`K%0B-D8KI>CHJX=#&$.(\U.-FZ6^<.;[#YR-5?V_ M5*C6,6Q.O%`UCUZ5J+\W*W!M;B"2\31NN!DP/[@?QV:JTFRI6/W=;+7K"Y$5 M^-^JEX"XO_`F\1X11>@7%*WSMFOT<@0J'M-P9J[G^L%B+VYLG**OJ1*LOV&7 MDI*]7ZOG@\:U^J-ZI1[6E.J7YKB#03^[#.3$SH M1)'2ALS$Q,9%L`FRUKD+_KE\_PH(AMZ2IKX-N4/%;403'0<_?M72P1M2E+UO M7=@NMY=>%#P<%UWZ-IC"4$/\H?<0^AEVPH M@T",]B]I/D1CH*7^'5P;L[R.VQHY3\J@D!_U,B$\*UG_@SD[(+G8/8=`;,%; MMG18E<3T*/WEL"@M??W80732\>;2=7KFI:@>K9\.B]82!QT&M9EG)`S9S4GK M$7QV<`27N*EQ')>@OW$][-F;+9D4ZJAU,RJS"7%\\4#_T/=#L3'B?IS:(EB. M4$.TL4LK"BIS&U@U';2/Y9:T,:F].\EK,\I66RK%&KO8HL&3'L*&]C1IN]/O M[E(_4Z"6:NS:RGJ-KLPMC>/R$:8:[_&=!7TNU5*-75_1YU+'+8\Z/5N\3D M1Z(!^'TP)5PG6:K647_FM`F9:P`V(7/_FO!2T\F$0R[I>L<9$(6LILWZ8UCR*1K/Z4M3JE5#AXJ18M M]"*A&*TT_XP6NG>+3GEDB83G3(T'!TAHBMXG"[K02MGV`1B?89(&TNUD@2S4 M99Z9$#@BE>*ZK'07#X.4GW@BV=[-VIZ6_"?*/2*W91,51Z!(9O8*S;2B6ZJH M^';Q]BRM.A9%LO0D:RF*Q5$DCR0%V[>UZ,Z%9-]IUKZ%!,KVZL,VO_Z"A1OZ/GPG2.6I$`Y<;'LM:&CA9J=F*X MV6#F1)(^OE!LNULI@Z M/&!T>(N$.3?(ZF4Z^P*Y\8DN$MC<4&W:&^X'M,D9,!*^W`!?F#'M%8;!P3`2 ME%PN4-[/UXK&Z'`8"6$^K2A#"%_%E421NJH&Q?4L?5`3 MRV!R"7VY_?%REO@A6@1<^1]02P,$%`````@`=(AX10+8E$YG&```"'@!`!8` M'`!A8V-E;"TR,#$T,#DS,%]D968N>&UL550)``,[JW-4.ZMS5'5X"P`!!"4. M```$.0$``.U=;7/;.)+^?E7W'WC>NKK9JI-M.782>R>W);\EGO/;VLKD[I,+ M)B&)&XKP$*1?[M'XZ_;'V_[PWN3RXNMAP:H]!#`0GQEZV0;/WUO_[U7QSV MWZ__UNLYYSX.O"/GE+B]BW!$_N)8_9`]^,C9W]Y[='H]A6I_QZ%'HN]W%_-J)W'\=+2S\_+RLAV29_1" MHI]TVR5JU=V3)'+QO*[!R<6UL[?;W]\]_+#K]'?_YOSM@W-Z?KW].F)ZG**8 ME>$___O>:;_/_MCK#_L?CW;[1_T/BL^+49S0^?-V7S_O[K+_=W[V=_[GZO+>G>`IZODA)\G%6S,I M7DN57/_P\'`G_756=*GDZV,4S)[Q86<&9UXS^]6+YP+%P@<[V8_%HKZ@Z@)H MZA_15)-+XJ(X;8Y21`Y8@O^K-RO6XU_U^GN]#_WM5^IMS7A*C1V1`-_ADB=A;$?OW%&HVF*DB%/JYE$>/1E*Q7JS1H0 M?]B?5(3CMR?6L:C/^\66LU,7WS$*N!'O)QC'5`JHLK1.!+(3LX#\E(/TI+4R@RZ/\<124*O M3N,62JV(Z"MAD]`)86TCD@.I*KSB\P?N'XE/?:Y1[QA/T+-/(A1\PRB()R>L MG0XH):[/&*&7L;$!!Y;R)SBD>_ZL4(O!F5TH.GQ M&<_C:RP<4C6C2>161'6'`]:J/3:TQV_#"+'*7254$KD545VP5>X4#]$KEH^[ M%65792IYI/B/A+7&LV<^GLLI`@0ZZG>W)&#M5,%432MLI^4/T6.@`%I)NHWY M]13'R`_H-8JXL9YQL_D6JD7C_%L;J(IPI_-S;0WT5-_R_+V25G4J[&BMI!W6/^SV\).#D)W'JH&+M]^8I;00YE*::U*F[ M=>U^8'\\80NAP3-KXF,^[B33#$GJ1-*G:KT'M;,JK-T6:]:C;]58&ZF"K.95 M9?V.K5B!"">*W!G4JL)%!(#W;N9$Y&Z[@Q37A%41N9F=R@K:QSU_6,\C4^37!+TLW0'B]$F]*9X^XJ@FW+)H^UA1 M$-1#F`JTCRLD\:`NM)E,IVT2CU`2Q(T;Y4R\C)E][8?I`O.2_;.$&[_&./2P M-T/.*VSJ;V=?<^'=[+^^TW-F4L6/;.)VLBJ<4AW:(5<[U4L8]QBPN0>7?6:[ M(X^9$GO\$V7[88]/9$Y>DS.KJEVHU0[W$NX/37`[OY1J_G,+>D@<]"4=]M5T M>*_2(2/GO5+GE^\A2CR?E6E;DV6_?DF1@R:*\#J=M-*6%1&'`TJ*?.3=U*=N M0"C;P+%_O,NVW%4K0P4E;)\6L:4BSEQ&.Z2&L8$2Z,^+H`N5AU> ML?->\W\Z6=VM*B<,(934.12K@V*'UY0.\*PNY[TR[?AKAQ2*>O1W%_7(JEL8 M7[@::97\^W*E+8PVB'1:!.+NZD\DZI`NU0JV(8)7C[B_`R"2<7T4\R%-$HH3I88GOY[,55%Y].TL.E9!'29^E61'J:,XO636=K3!`-T4)_]($ M6;WB<'[)JW/F]?UYEC$T4R0@;@E]P%.62%2Y(TMW4B-$']/M5$)[8X2>=KC; M90<',9U]DSIB>KO]/$?I3_G7#_.5'#,9OF`?Y^P$Z!$'Z;,?\L)597;E%R._-9A#-P.?;4<4]?[8'/G))&+.&=A:D3V/[:#SF'V;(1A&92NV9 MVXX(-2@:F`'9S#16]O#RYREVZ2R9/A40R#]HY*#N9*^Q;V7!) M#;RZ1Q#0V`/^)U\(8N]WUEK8HH1O!!@XN@#BDK!4-^88S:V'9&RB5(ZU4T%XN:N`'5QB&-Y`,\QU^2B)W MPKT,ITG$9FO6@'SB9:J(-I4R67N)JZ<"Q-V^4>ZR`?T*QQ/B783/;%#G*M^\ M\+E^XC\Q+5SNZ1H+!D+E*JQGLIXF$*$'MLQI:HL90,!ZLD2X(6H^VD5-(6FQ M!C\%J?4C:1$\Q-0GHTRE*]X(>^?63FH)7PNA"=V%M1FH'ZVF7>@%K%8BH&7\A`V@8I-H&+] M`A7-61(,`,=O5^CO)#H)$*5`6".OI58EEH8]FJABIY]$H,*[`OS@#-#I+[=% M=44=AUQ6H$R9=)'%6HKKG0O[M\O0FE[5^`Z^H MPMJM4*^Q@#>QG/6<*3H"!C-5J(%(GCD2L!3A;*6H"CE?:$ MMFHT4L>-1*QS!X%.*LI:@(-25U3(G352P8?]=:9C00^(D/V."#EG^Z\F?+S+ M=;YMUTG'@AH0&P==L4&2J!$;<[F'C^O,1ED-B(V/3=EH[7T'<7@=%+!TZR># MK>#DLH26+$M*&BY5$#43&I=1(">LT@+6!;[;Y,[*'6<[_':\[SP.D$_Q;S]( M,(J2Z=6I>.:J+MWU7K-V5R%**M@Y)';ZNL%GRZ,W]32Q,_"F[74#V\D2X;:S MK[7PNL':D;0('IR*C#)U2<+Q$$?3V?:#J^&G@\%@2I)0$+^625K/F)("H$O" M8`R[UJG\I:CUTGEM:D?F;<+4FS#UFH>I:T6HUS`X;3HN73,J:E4T6CW.:4$, M6H^AK?0#Z"&CXWU_S5"S35'F.CYJ&V++]6.9@@"@D8CR2A973#/7'IUI$K<4 MAOJ,1)!7,[UJ&KF.;??FH$;)08U=&OEL;-:N5JQ_:#&.[:9NOK*]GIH M/,&20'I561L/9H1PZAXI-MG.C;*=F[HR-]G.FVSG3;:SEK6Y---6D)[:]!C$W?9Q%W6 M(>ZR\5]L+IK8^"\V_@N-2UN>B9"].W^%0C3.!K_+DW+:PSV.GGT7RZ]#:%:; MC3Z0YIIT%JB1'K(@28Y5$^]\OZ+"3AWL(!]F\RH[393M^@V=]A)E12_I&$Z4 M173"A@?^%U?G&04,,AW$K&U&;VRP2"]=@,E4$K>>2'4MV@P[-2?Q*R'>BQ\$ M@W#QO)V+Z1/RH^(DO\RABK3U%"HKH>"?[L294'&/KIK?8.DBV,I[=3?N@8U[ M8#W<`^!*\6SZ%)"WU!>H$DP#BUOJ%1"#[FP]7H%`',81")@(H,DL*+%V]Z$S M?0:WTG6@CY2.?0H5.,1;45#`3/Z@O'%+K&[_!8I#OA"Z&5V$GO_L>PD*Q,<) M`,4MG0_$H.W<>"R!_>''DSL<9,$KM@<>$HDW%-):5I&98P;$Y$B(5+.-=4<. MF.+8RMFM_7;0\:SW&YF$YS_8]L(/Q;/=4D%3![4W[5=$J@S8`;6G"OZ&IIC> M7?D,P$\D,WQ%VT@?R/SZ3_@Z>0OCB8^.">:G4PBM7U'4E"],A_$A M=2#;-SY!"LY*0W'DNS]/$AJCR).]HU-5V-3+XSKL#RL$,?!9.P-:3J/I&\HL MTT&"2"70[Z+_9+N5D_#[G]:7`U@AD(%/VADX1:'/^J0B!]6E'_J'Z\N"2"60 MAT/M/&2!U%JO3@A%+-WARX$K!*=:M;C$$2D6,N+]5;"F@O4->(&U$V#E?ED_ M25U[A:NQ2#S#(B&F@!'WL%++5Z"AJ`4<(>PRC_6?-EEXOT,C;Y*%+3"KE6.\ M[-:M*<8*%0]T.X2GJI`F1XO#8;1[I#X1B+@WF%(I:. MW,M`(7,?F#['FR5^A5R?+%8@]]0]=T*UA^&2=H^;Y9RZ=N M0>S=HBA^&T8HI,A-O83';\5?)!-PC3HLGZ%K6Z,B,&8-G[*TBZJRAB;T^G:' MB;,\:V8UAJQ>!NAG\1]@0]CUN87R'E%C:R@ZMK"OY=Q"#:]?9*A/R/2)A.GK M6<+92B)F]P2EI/,R59\L>#5TCE4VZ`'%SOL3T->Z^4@'.S;/2MH8 MM'GK^H._RB<(/N7E2L4>^H9R!<7]@\@0@_/1OMFMU"VK"T<1]@K7N0R2>$(B M__]$%PR)Y1[V#&73*K\-(L@YJBA'Q^=>JPF)R&NNAV,X%495C.7G'D^A3?1KXKFG]2&8&( M[41(H4-V_VS6#\L!/K*&XO$M/0XIRHP9\3@IU_KX[;W(+WW"+OLX)/RKP@#Q`_OC"2_SC",TQG>8&YU]?T+".$)NG*"`'Q7= M%SA]K<%H<2.TU%90JS]E^AFUTG8F^P]D>M27O2KS+8EK0?RO6^6)N/FMG*["MWDV/O>\@> MG('-QN&;\(J-JI/@+;TK0+Z>;52MQ<3K4P\D6?_[OTU`LO'-)U4[_.RMVN95 MVD[NRJK!"0[:CY=@@TZ`.28^P%SB9QRPC=:Y'_+&"5$G%+*='`7P<#S/[$2, M`A3YF-_D\H,M&D09)0LE+>9$B!@DHJF[#.P'@S!D:_QC$B9TB*(QCH5+X%1& M(&*QO=6@@X;7[OLJN.'2US:'9.;E$8P^@(3M9I$D_> MJO+KRTB5'B`_3=U=(#]YOGX:W0F&&*J@,G*2B,=O>;N!:*E1A>W\U%8%),IP8CL*9D-Q MYF1B_RB$MB_"PLL5PEV)U9-I(3C%U(_\)Z"*%<*M,VG8ZZF@!,F,X'R9`E,Z;TTW$XS4T M/F7JGS.C_)CX[B3_C68_QC0/DHOO75FM7HN)UZ@?V"2TNQXN68O\_C0_+.J< M1/F8+DRT$4M9S)$R>I`![6Z(2XQ^WB1Q;0K$8M9SH`(?),&"U)JE<&7=B*[% M#"G@!JDQF_^179."<7YG:K4&UR2]_!%GZ0AT2&(4%'\_(32^)O'_XO@.NV0< MBC/A6WND_0VD9=6A-J;_#?-"LB77X6;T/8SPV&>HHU29F8.A*I=M,5M37('% MI#91!*2HX%3I[GK&WE).DMH5C?N55S3VTJ;L%*NKO*7Q7=&6E>G=NQ/L)7R6 M+&2\Y#DP.;!J!0^4%60_Y0]QR,@I/,;)GS,W@1G%%Y(4!ZRY3O,$1^XK%UKA M8T,KS)[IY`]U"D]UTL>V:A3@``^UIOUI4>>\-B>MSBG4M[F!=',#:>T5HI$; M2#=G6#8XP]+LF\";,RSMM;7-QX3\M!BDLPP4''[*C3Z`!+0_NSNN=7 M6GSM:[K1YPYO\>RZ4,SN&;92)]M.RY']%X^$*&$Y)0%'KG_BC&6')?9XTJ'@R=&@GU M`;*"&BJ>NRXXNO=?5^6H5(6IJU97YVA9#8BC_:XYPL]LF%B5I7(E#X8NI-3` M4X4B$%,''3-UEGHJ5R.J7(>IVW-7YZE"#XBFC]II2EW+6?[/:1+YX3C+H<^B MVR<\PA($4-@XK4&Y`E/7ZRH&E.KI8:?WZA0_QA,FG)F\OD?75L'-_Q$/-_&5C?_J81&FZ%3\,(ZQ\S6J6S06)6,^6 M&#FX_-,_7V5'(A:!G/JL$?F/26JH*4G"JKZ3C_`JTO9R45<)<,77<3B==6XR MQ4/TBJE:G/'S8IPQJ\%)J^@J;)X\4OQ'P@^5YBLT1>2'2U'A>35.5L\F,KJ) MC/XS1487^M&0/4]R>0,D8+=/5Z*G;:O0"K@R7Z-`Q-#%#1*32PFRW`NLDR.; M/<.:>+0Y9KL`6A9$K"S^8&A=*NTW0G[>L>L>",7NDIJWMHMD3'F!E2VOID%W M#N`LE3L]6&V&`YCSL[OFH>*6SOABT+J]%76L#$X/$&1#$[B2!276;FWR[L#@ M5L[&^DCI.&Y;@4,\V(,"74^QBFU;8G3Y%&O64SKD+I*;T47H^<^^EZ!`O`$$ MBELZ&8A!Z_:,MD3(#S^>I+G\_"V$B?^4'SXCO;RT=D5F-HIBBWX)3^??B+EI5INI+`H=_*V@,<3QQY9)KD-A#M=0"%$_005] M(/-_UA_E76@5*N/;8NF'P_6E0*`11,*A=A*JW4DB-XY(PM+%NQ0WZ#/KQMQB M]X)8QH1+1\&4IXQ:O=J=_UJUGJ+5[9J]_Z`9<4N]MC M\KSC83_;>;(/BQM.]M7#)1ZC()O7@!F"E5HJ9.FD4`45LK*.4_54C2S9KK,B M1GTM`K,1`&&KKI-VS&KET%[;]%V/W2<7W\@4?\,HB"<7H2L9M2M+=SY>0ZV5 MJ$$%V[;VE?K@YK]O(\)&O_CM(CT=BS<2>GEY(C:S1*SSH+>*O54P@TMVPR<^ M3T@4\RL/>>*[0A9<=7%+ITPQ:-!Q8QZ.+&RME: M'W\V9[Q=DQC36_3&AXOT;9[\,Y7EODD$C25C2;H0J:T$.%&U>'I]1]>A]PT= M-]/&=>A]X9DT[9QWK^TZ=,N)D$('YR<+SVQ>DPM\[6T2[:H,SI/:=[M:+E>7 M7S"B^SD6MXP6]>TLPF/9C;^6D[VR:KH]MMU>>F$Y.RKH=>_ZN[[SPG8*5.!# M'#2]=\3XM20T*I(O3"CKKW?X*0=\,RHH M`W<'N:S%G-74`=QQ:X].S9<:V=$9M\CW!O'0GS)4EVQ#&E*<'FP_$N0`*M=@ M,3^--`%9LNF,I>QR]MO(#UW_B7W(6B#?OKJZ`%2J=WK,'#=*,$7 M(;]RB<9Y%&(0WS&EYK6>"]7C46L]5<'9`TLU>KGN(G0OU8T,-F)2QF MI1(I:'#M+@3652D)49`?:@?Z#!;+66Q1`5[0K@6W`'0P7/X]_X/[6=DW_P]0 M2P,$%`````@`=(AX154W<&EW/@``5F0#`!8`'`!A8V-E;"TR,#$T,#DS,%]L M86(N>&UL550)``,[JW-4.ZMS5'5X"P`!!"4.```$.0$``.U]>W/DN)'G_Q=Q MWP$W>Q=C1TC]]/H\8WLW2J]NC=625JJ>/L?$Q@1$HE389I$U)$M2^=,?'F3Q M!8`@JPK(:N^&=T8C98*9R!\2"2"1^,N_ORPB]$32C";Q7[][^^K-=XC$01+2 M^/&OWWV^/Y[?H>R',6FV7F>+W]\_?KY^?E5G#SAYR3]FKT*$KOF M[I-5&I!-6Y/3RVOT[LW;/[SYX?T;]/;-?Z#_>(_.+JY?O9[;U[^].8-^]^;-Y+]+Q&-O_[( M__&`,X*8<>+LQY>,_O6[FI;/[U\EZ>/K=V_>O'W]_SY=W0=SLL#'-.9&"LAW M)1=O1<7W]HSR`M!?^OXY+LF/_J^.V[X_=O7[UDX7=EYXL>3).(W)$9$FK^F*^7#+<9 MY;#[KOC=/"4SM3!1FK[F_*]C\L@,'O(/_<`_]/:/_$/_4OSZ"C^0Z#O$*1D: MM7K]T&BK8'KM6MA;DM(D/(_'2=WF]B0^&SMIOH4"=7[G*DR3'$>CA*]S.A?[ MFHSK\8K/?4^S286,Z^D:9U/LB/_RBOW4$)R\Y&PV(F$I.F_+X.#$IX3?+=K> MM)X$C78C[BR3M-DC.`A(=%S.34)A\:M?[]=LHGVD64Z#CTG$9^[LZNKT$UD\ MD$T30OZBC1Z&UVWA..LD+27$:="C9D'Q.DC8'+#,CR/9H9)]EB8+.SF*#DEL MJ'^-'C9?D%W(A-"HTB!+228"@$$6K.MCW;&%B(N(L?#8BL3'G^^_^[<:"RIY M$&-"OTBV__S+Z^H[8V!3Z"+TR$CPZC%Y>AT2^IH#B?\@$'7\YFTQC?X+^]6O M5VPX1.=Q3O/UY(5F+5V5%"Y08Q"-PT3Q9^^XT,O4!H*@0I(,_<()MS:]UF-, M^#]Y<$Y"%D[GJY3LLZ8\Y"]+3V<& MWZ(C=0<1L[`5/-1T0*!A%*X-"TF,?GJ%"OHC].G5V5["VAG.'H02J^SX$>.E MC&U)E&?E;]I!;O'K7T]6&8U)EDV"WU8THWR#2N%K>JE=X,A29`ZE'E+O:+*3 MKP.H@AK5R/?M8ZYH0&+VV<>-5\MN8F+P-&8&=_[&1O#*ZYBHO:/%6L1.%+QZ M7&4Y>OO^B&_9_RLPUW-!8YJ3*_I$PLLX9W+3AXA,LHSDVG-FR/80@)TAZTTAV/M!P[:"?&P"V>__>-_ZL=SU@;SA,V2OQ_TN MSUV2D4\?@."29!*R"HJ(#@P"!:&P:<%'UZA3;4^_<)'Y,% M^4APE,\_X1@_"NQ=79U.XG`21?:I#B2XIWBE"\< MDX#BG.F5AZ9];5M>AQO=P]2I[7S;,0(!YS!I.UN9&^X2DYP?50T<(=;$_K%W MOEA&R5K,^18AN(':';YZ1:X0I24%@J$^^=JHJ>A=!N,**;7AN);6*S[4(;F& M$"XV#&&Y&AG[#@>.C71M^`A:E,Q0 M1;UWOX$7)+O[1!E>OV*CZU`2.O0>!D%K#D1!Y1T*O:)UW`@G17>O4$F]_[CB M=!WG%1D0')ADZVSR2EI4$CM88_RVHOEZR'%0#X?#]8:- MZ+55AXD<"%9L9.RL0`2/EY1AC;CZ1:J)WCMP-(M5/3%LT)@6K7K([#FY!7-` MYK+Y>&*U5?0]MS>43I:Y,ZAJ203 M%['V?L-/?8O#G+O8)H5\H6Z?% MZ)K&A.'H#*\S7]>RS"FAO3R^X61(#.UA``VGWO10":=I@D[XK5`:HIN8_8^@ MCZLX3)F#PG&(SNGCW#>Z>E)(+;B\(\R42-K+`AME_>FD*IP)-N[*1$ZJ+VA= ML.X9C*PZDV]@=17HPU7%`1I6'3'[4749LQ\?:1SSW!WF_#9^[)X\L18+)S:9 MY;SR6)3PK&@/*:SFT`M&U#4DX`(2:SV1]"'9U.P9U+-PHZV!@1:,&&M(>`4^ MLAH;5+50(Z(H]"F)\[D7V/1$4%""IV%QTP&$3..C)16`"(EWC:'=;&Y]P6F* M-<J[4`T"[]`Q2=5&2T$##`^\MJF`N]R/Y65>DYC'^8;]S1X> MEWBQ$K^.'R,#&#S92*DYFZEH=[1?N1NK#((GN%J MU2!ESPP%9X,E[H"O:`&]?PNRPM/D&:19F%-_3EZU\48L?BB]2JF7KBQK,WE$U5N(^7^2@ZE*/T.+P M:ROPM5L``S^U:M8`;+(?!@25,O>!T$$))[/8Y?;U:`RV&X`"0;5BM@AL6J?[T29Q&_O0*D+OL+*1KE-+?$.+ M!#%L`$W9]TQ'&SIJCR!JBVR`44D*%4@M^7JAQ.GWOAP0^R$7_-37>+=92>=Z MHTHI9GN7JD'D'0I]DFGVIPI2!^F&IY=5V:K+.#`E&6I(':86&H6M)10JZ8!@ MP2A<7J):);`CQ!CV#XK)S=]NTV1)6%AU&3^1+!>YKSTO+?7Q.'QER4[\ MV@M+9@8@P+&3LK.S=/,W5+*A&A_`JV?724ZR(I_H)I^3M/@Y,\:]O5PN@Q=+ M%>I!3`^+=_`-D[-S-9]U#\VR)%TCW@`PQ-W/DS2?DG1Q1AYZ@V,UK=/0V"1N M(S!6$8)!DDFZS@3(:8]S1HPX]9&3H+A96+9]OCB)P_LY?H[/AA?YM6_*5QG@ MHA*L1/F,.#P7+\)>QK,D76#Q1-9#EJD MI;:>S-43T"8ARW>@533>$=,C6"<)6T*BHD6K7^[@H-2K%*%#3^",+Z*HFZRY."!G$B'[8^7:6I6$AE M`8[^3G"J=P9Z4E<(Z!.V!(..#@0N>H3KE/*5Y$C2(\[@U3G(8.6"1B0]92(\ M)JD^>&Q1N0T=E2(V`\<&"0APZ.72!(V"%)6T'M<3R6*1Q&*7YGZ.69?*5AH4!KV6'@``0F"S%U"Q+!B03K$9+,J,;M,W*5[E`&2Q?L M=^VCJ1Y:UQ&L5MQV%-LA!(&D/NFTT6PQ:Q5!K6#QCQH^A]IAID;I!S$=4=5X MV9`!1$M;MCZLB`AGYTC902&,F]D%C7$<4#8"DHP:MN^'L7HIBV&AC+(ZAH'/ M._9&"-LY4R]9^3LZ&V940X)"L5RT0D2'UCTP-.)V\=$B!`83M72ZI;SD@8&:4YS-)W'( M_\7K!#WAB&=`3O)3G*9K%N/_C*-5>S-H(*]+5`U2IXXR*T8PJ!LB;0>%C`D& M]B9!P+,SLCL2$*;#0T2N25X,$MUP,[(X]5\6PC?#*XLA.Q,@04+2C<\ M1R@F.1"(A4\LA"/9-)G,9C2BW9UM(Z530.E%;>"H2P8'/EK9.J@I*%&>H(1G M3`.9#L]6Y()9I?8*""69V26965PBR$;X.I1,]&`P92&D"5QI\5#+4C+"0-EM M2I:8AN"(*X"2#NK%EM)2HI78+$(&H=*@HR,/Y$+UL; M,8)2(@4&4#XD2?A,(YUFU9]=0J(M5!T'Y=_`&+\E4-OBY9]AF%N"U.CR?$P1 M^KD!XJ2@FPUNII,K!.D`X8KB![9HY\LD?JN/9WW,DRAD:W-90;YG:K!G=XF8 MH4K5,67+"\:Y#!2X\Q+OY>3D\NIR>GE^CR;79^A^>G/ZMX\W5V?G=_??H[/S MB\O3RRDXK-J=>)D8/.'1XNQ+3PT1<\-.P6J,,#!5[F07Q1OL#B+:Q#Z.(-0" MJPX?FI1@,&043WO@4%##`,_9BDR3F]F,!LS;WJ1UW]N[?=S+Z'@3V5*1UE9R M#Q<8L%F+VDE46Q&^HYS5&&!@KUY^Q@PV):6O(D`&."G(P.!'+YNZ0`NOYB(+ M_,!S6`//N;0,SAW4D#,N#3480/6*J#W?XAT#\X2+3=+IBH3=X%`?`>CH'4=4 M9K%;096:&`RR^B14A%:<'MBIES6(?*/'#C:>\=*[:V6-EN9Y!KCEW%42/Y:5 MU'2J-DB<0D4A7`,DM;^#<2<*H3I;2(Q$EJ3+5@])&M)8S$TKYDV"%7_'/>;1 M$YNK`$5"->3V#PEO'J7'E8#U(<;M[]J.(PPL#-[UAK+//6QG^P#VL@?O7M<9 MOD=GA"WP*9!CTUO6%F'3I-R2-Z74*RD=YWKI1&UE>K7)P"!'+YLBRTM2RDV= M/Z/__>;5FS=OWO*U%'KBC']&;]\9O`&-5SE;V--_D/#/:/-+FF4\ MXHY'=0/<>)VC0^;TYH9&R,8EC18-&,AI!.L_>._>>[HW]E_VF$'\(YNF?]7CSD\T8\Y/,' M0=5^WN?]$6+M+$F0TR<2[;20Q#;9^Z&X=HDC7KKS,C[%2\HB#]UJ5T?M-HO? M*'(SDU])"@;49OFZFU(E-1*9LS1&@62`@:4[DF,:D_`V=]JMT\A_0)8QPEF3ATD;L\R^:A:L4"$I:Q3-MFLGJQZI,OD M#X8Z!?3P:W,`A9U&S%ZX=?9=X,+N4JS#!_1&R>`;;DW!^Z`FJ4'#K"&B+<3D M-@I<>.F+:EIS^0::IJRF)0MHR/47UM3A#O*6\<`PSXK3T\;RD`#/@@T,&.UE M->U(@XOK.I5K>X,Z(X&5D;XCCR1>*7-?ZS^[/:@LRE4\SA3_@T, M(%H"=>L"R3_#,/=IDN4WLT(FK>-LT+B=B!3B-6>>&@$8"*BDZLXMF2@MGH+" MPX)P M$BYH+!XJY>E@1<4\G:9]7$[A8J="`T)F%C#NQ4[.#LHDE\CYPPT^&)@30?D) MSDC(PFZNB'@N69?8H2%VFB)C%+B1)J.D!(,GHWC*Y'H4U`AAP.=F23B:X\=B M%.@B6`6=TZIU.C$;->O:1+!F-)UXZFN!&VIT#NHR:5E@C;G1RY@MZ!_I0T1$ MH:[+Q1+3=*&_7FK'ZJ/RG8TRJJIX)CXP?FJ`L+IJ>HAN*&&@<%-2MA@<)VR6 MU@??6FHOQ7S5(BO+^39)P2#*+)]F\X:1\V#]B69@)K]K-@2$<%=L):'1M47C MM-:+2KQ&E9>T6B5:\^S M>KE<`L92A3J$>EC`N!P[.=L(.YG<7YZ*I."SRZO/T_,S@3=T>WZ'[C].[LYA M(.\+H8]SIL3DB85\C^1ZQ>^5WW3S>7H_9:/A\OH##.37'IKD MKVI=1,ES7P%U,XNGIT"UPFN>`.W0@T&DA9#&)S\Y$Q)03%#<$Q#CN/&D8JV@LN!K8`!\6C1.^\'L$AA,F7N M$DU.IY<_]]99@;,8>`?)&`JY.FL!DJ.($>2W%8S)%$.DWO(0`/+1L=NHB"WJ'Y*,F`S3(Z?Z%/F! MTP,\2V9354J8;&=$_IM-3OS]KF/Q]I-(NXFJEL3+V'R?@AN@I-]C83RT0WF M@47]>YOG1PE M-&$MA?R\L]ZY%P_/#)X4-GPPYN>6&G:30-DUMU M0B=.]S\71P)5AGK%"QJZE_$3R79QTF]L"`"4+12U@+2A%3`.>+3H'7=\_?/Y M_8"3_JT.NIBX`2%A=L&,6;Y%UW[!;A*'8C]->1XSK`%W!V!C%*L.PX9P>T?@ M:)&UCQ&*P]C&4X3R.0+."]JO7M"8:;`#OVIL"(!?M5#4PJ\:6O&.ZJU%;Z/[ MXO)Z*;3S.++6^F$USFJ-CVT7`X+60_P(>H[LL1KD9?(2_-8PGIH)W\6LG8F1$+CJQRUN MM\H]B`UQO=S:#?&R"?2P1AMV<)OB7-1)'/)_\4>5GMB2B)^9DI0F87O\:KIL M6!-.*QZ.4*Y1$'$`/RP8CY!"B/B=Y%G&=H0>R".->8$$'MO)[WZ;%GSOP8+GL3$0'R:X MVGZ$;_3;6,[M?,$O>OC0EY\[@BF39^0M)`YJ1FYG0^&:IO[D[ MHAF'=WE'*UF[W3NX#>]PW5)PW5,@]9=FT"Q)Q1KC"$6L.42*]C8'="A9PKG4 MR+=3+V,V8:WXC%2NI%AW/-(G$A-MW4`+/I?^V%J-NMOM9?(.UZ&2=M(3*@H. MOY`UPW=Q:MOB6P<26C=Z@H.OCVFRXG>RV9!8"&??&TJ4WE)2T;O M6!LC;:<@X88;U=BA>+HG$B5+/H#N<_Q(SN.>:B!GZE938E+_E)I$^2 M&=F66X^XA;I-+SFB(6B'U]LH<4@@OTD?<4S_(23B4782T5#\!UNTWC+=^*J3 M_^?-K%C"XFA3WZXOJW%';3NMJ[_+[FC4XM]%P]Y=_CZTZ=28J[5]A!JMB\V- M>OL\1ME\H7H.#5ZMQ2OZVXJ&-%]7;J-ORC"SN!P4-L+7L6ZB!P-A"R&[A7_X MEMHI[[`4B/L^6664!^ML7?G`QH&H^='CE#L."%#TM[I3:IJ0N@8G9`Y?J()?P#L(\%1/D>G M."5HDF4)FX)S7I#H*@]?[6^/P*3*6QT*!_(ZW",8IDYMC\".T3L$QTAK1B#. MT4=>)X.'@I-(!'VS&9A'E+<*C.W=Z>X_MO>!])>U:L7,BDB3Z6V][4#^)TG%`Q1JY,_8,,,;5MVJ."&:VS9]^B,S&@`Y;'D M2@EQGW-3R[:XR\(?^L[$";0H=UM<7>E;[&_;J-,#B)UT0.,D8JL6P7C?G:C1 MN6;22"2K-XN*=I%H^`B)IH]ED>6R<7!>WKJ/3NI]U'MLMVVK(,>/N0M!U MDX38\'2&$`P1D3]#N0TQ4RVP&9[N)_-[855.R6:EU;-/&!0:2EH M&W:E>Q9\J,X(SBOK-+2/O@>U``&9EA'X`';P>+4/O[70A0'73>U>Z]L;1@XO MKVG;W;DPD(.!6[^,AI>U:^$M-*>HT*O/"YI9/./,Z.=,])"1UN?)*JB!N5JS M>LC(;RL6N)X_6>P,Z,F=[F+U"-W8M-+0@H%1CX#=>UTE.9+TX#Q56Z'>K5(] MO4]0F;="=<1@8=6[+&WC"@:8/O,;,N=93A<\3T"C:YO()6S4`M:QTJ0``Q"E M6&U4?)87BC9D,$"AJ=:01#18]WD;2UX`93?4ZEC4VV@R0CN,&2*TZIH_#`C> MD8RP?N2:U)+^B^>"I#+:];`%I]L]"6M5FGL1O6Q@?)V]K-V]!\DILAAJO.@< MU#M/W1-..V]HP>?W>-K""_8R@8&AK:2:^[_WN[B/OBOWQV+$%>%/;#_&(LG. M#F\6?&Y=GZ4:3X$,U1ABPXT=N-[-[%C+81GL&!J M.T[.1LH^PJR3+$6&2R)PR<76":BEJAM:LL54VCS+@U9\GK M$G.#U*DCSXH1#/Z&2-NI/K4IY5#C@`'&,Y(%*5W*FU77Y+EX8YG7+4R3F/T8 MR!M6UTG^=Y)/PF29DU#312/;LK?I.C=G]Y!PTXWL'?6$8T=[JU; M!3,V=J9*)W^A:%AL6/8H>L;`R)4`[( MD"NOL0L-M0=S32*W9YXJ`9L'G'4*.)!3B=6][500H5\$&90@%'1U!E0C94,%#25LT`U(X*1*T0.!2EJ*I%961Y_>7O,`GR?*BOO=- M*E[793B_7BT>2%IXX^*OFA[:5>,^JF#MID-45;*V:QD,_'>J3J?<)POQ[*>%EN-F08M_S]9!1]<;T+4YO4C'*0Q$?E'N-ZA/P7C;' MSU#99#8.$%I7XE]4[E_B%#WM(H325D3;@(Q_3R)M2N*0I.7KX"T5K;G<54&S M5J&J?];+XMUM#)/3X`\$C@JOP%^*R`7_YI43&-.JT.^.+%G/S?F"I?NDBRF1 MKH?1>=ZBE2*=Q$4CEW<\#A;5;HKB,Y1XQJ1XQ81UF2Z<9L_OOI+8`+6Z1<8LF,&`=JC$FM)D25,&8D3?FR$3TG M:10^TY"@B`;\:HJ86Y=ILDPIR7&Z1F+)&9-<5N5B8R>9Y<^\$/.2S;W\A1$8 MX\?02]=$=S&]C\EISH:5`HUD#2,'&!Q;B=E)SUB)FK`+QKM8+1`IKI*&""_X MD;9`Z>;=[)GX`D,P^P3[[2;]%O>FW^YMG2G7\T7@.^'1JSA4>:&-F+Z/%LZ\ M:RVILG"9D@7]PO]IW*L]_*@6C`''BZY]0@+7BJ63<5&OPU=QDOAQ2M)%"44> M$%*A^T1X%$UW];,Y?1W'4HG&"SD]/&#F"4M!.SGPE$-[0H2C(_X=7Y8ADE,D_%/(PTA-`&4I^8G4TF-;V?P52H(*^FVWDW M`S$XTUB(JMX#'.OOMCJC*P][&B^$7R1I?58MGQ=7ZCNL`7'/PNQ M*[@9B(&@JU_"SF.I$CJD8$%+SB,BZPS.1:[J;8)Z?O@D39DFP@>?K#O/%XA4 MUS++E2V(2<@")%ZI)V`_3A/^JUIN>&O/]8XL,(W%M=U8U%-CTL!N0WHI#=3#2>7F,)/C,\\CE:K)N.`F_L1F^7FT%F]\]JQ_1[;I8V]B*_55VQ6C&O0^ M#':I1?=R>]%6F<;U*%M#*Y&LS`]^FF.`_50TBQYXNWL;!:.TE.FPRO[;JCUW MZ-^!VA7RMV@,".JWUV#GB-_1.D@+?#['181+P.>S*U[P^"))98D5]:9>#X<[ M\%J)7L'32`X$@#8R*O)C"QZ.&((BSB6RK&:2#TCPCB.<4I)-XO`+6U%H;WIT MR)R&SAHA&Y%OB\8[='H$ZR0!<9!DG-9X1W`KKS*)XQ6.3I)XE4UQ^DAR[;:' M!;T[CV(A=N5/#,3>(6$K82>]%Y4-A0Z\?`,QU*3J%,3PI[- M'?+LE:@PU\\#!&W6@K9Q5C#*>_I55D8^QSGW@+P%B;)(%F18KG+^+PX^*I*U MDW1_VQ>%<,75<292H5,QH&S`U\_K'(&VZG1@V,<("XN6TNH`&;=O7,.`9+TX M1N&,RU05TTK`ALW+)-RCA'+ZU?``@9^UH)UL\`T!1]UFJI591>(TDF]C<9B% MF$9K])1$JP5!SV4%.5Q4D!,,>P-@)>7-[(3$9$9YS>!('MYD'TD4GJR+`:?L MGD'\[B`Y0JW:U01[9B`@'2ZQSD\N&Z@M?.6<-5#&B*7+%%MGJRB:\93YNK/\ M/F,T<0CH?23^'D\1Q:C*2%W&4WYE&`=<8OVNT8`F'&_:NM5%GS>\=[5L( MW5N"119+:,.Q10G2-^P?P$O6\CT$COXU18*[;JQ+=#[!U6MA*:DA.> M)<]K>5#E9#M0GK9)R%?[`6)4U(JM*W6U976=?FZK3#L3O8\/",0&":O)3R_\ M5'W[IGF](:Q:@C'_GD8XRS:CZB;EV799?H9S)M&W7ZSN%..J!1QVBK%KV/AIVJT1XG!0&K]BH^[S< M7(*[2-(B/-'?0>MC<>=V[82OW*V9WCNP!@C9?;8I^(I6R^KVO%CB9#BJK83V MAR&"O]ZL\F$@ZN-QB"([\6LP,C-`P9&5E!T@,2Z4K&3)AA%`I$\T(&H=KY-8YL*) MI.ILFN0XJO^=OY8I7U(JGJO^A[;2^AZ_Y[2,Y[Z[K5$@:5\?\^[Y7&G82:K9 M%&F7)7"9JUS%*7FD&:\('[;6./NM`UZ[F<[5OIE]KDE2.Q!HWX$=S.VENH"= M2LK2`F96[]@=)V\?$OEVH)BUC9B$,7=L>RVGMKIJW5YMW*0?-!WOX>N'=%%L M8)?N\OJ8Y:>]CUL_^IKK/XCJL2!+0-RF2<`<5,:W2"I?QS1[PCFYC;!\`U/3 MQ;;,+D?8,(7J`\2.$PR^!XG;R2O^4SXMRL[O^ M,H+(*E,/]0]IDAE?MQC3FO,G+\:KW'D'8WA38,"^G?R=!-;58L7?PG@B:(9I M6B48)L7CBL65,1C(GT2B<1*J%3V7VPV:CK-E=EK`?I!"C5+U5IQ@4#M(W,[^ MDE@E*/:79%%O7Y6@OXV-$3!E$]VIVL877\B61$V`!:P9E))(E)!G*]=57-9' MT&UY8B'/WK901I=E*2X/=ZI$6!934NX(^!/&W0:/[PZOE?OW)(GW.02$^IW3 M\/:+U-5E>\Z%?B[*&!7?Y0=7Y8>/T+E\+?X$1X"N2(_=)&AF"DZ>,(WX(O\B M244)@UWO2?1^[B`VL2P[;2>[5CW?\CZ^'2G8FZG*_I^%'&Q(BT=BRHT`62NC MN.''O\;W`Z!D@%6[[J=X25D,)+O@KM"$EV\0#^)H'EK=HAVG>5YCU=0\46?7 M")AQ,59R0SD8B>9RH!27#L3+239OMD)TJ'[+Q[E=1,E[Q/K M,?@!TNZM9N=:3F:UMPK*\T9M9M68A@"<5E@H:G%086@%#NK'BFX%Z@T3$%AO M.<19^#8CE`=?F:QZ7F37;T;]GER+Q7=IO>$V7URN-\[CT.UJ0Y=N_NUOJ5H_A;'72O+VGS^D>6)H MI^YR(-M^^]L;W0,UMQCRFQ.6;W'DU_KE,LY9!)W10&3X[-_YMK]W2&.[M]OV M-"LW/_:-[P4JE>V4<"B)D*#2G(/N?(O0G#>Q#_V+'1;]D?5>/^HX#\)!![;R M'?;X1>]+,Z=J]@Q0FYW"_W;\?;[0QS&0NV691MEQKG^W49M[OW\SJ^<5N1W9 M[6]_`[.`NCL=3`;-#\,9OS[4[AW)DN>?(*>M-UO0Q;5-ZZ\?Z!+-];5-RT]_ MX\NW$3?][YV]*?S M8.?PS:PLHD8RZR-(Y26MTB!IDH\(AI*J)U=1$==Q\_ M@"M:(SMT!U>R!GX9S@#WHO?`T7V@=Z^VZ,_AM]K>F1RW:TFCM^[KW]M(<3C"Q=9?O+KH8+8IW3P%#_\'>8D>W M+?;F#H#X@6_;`4`8^?^T0][=6#^LM<68K9C-,FR29:N%5+?5J3\GO'981//U M'5NW[7HO:(0`H':[=]ZQ.]E<'/QU[Z[!F\IMI_"1\O?*:(`C5-%_@Z/\CF9? M+U)"+F->CSG+70UN]7[(@U=>/>1JSJH]_FB#5HVAZQ)0GZ.R71GE?4NU*O MNB*K&'X.OG<`::#VW;:#U,_^CWD?9JXT;`^OBF@G,Z)^?)D*09SR17(487T" MM3VW0^P/5:F&9%M6*+@<*&^GN'B-9'>/_>TF_#HC#_EEG.7IBH^FRSA("1M= M9T3^^R:?D_2:Z(I7VC*[#(2&*52/9NPXO6-RE+B=1XA$Q7"4/,MZSC/V65[[ MGL8A:Y6$,%BEXM44*!Q/W5"S\C,Y*F)*P+=E:32XX' MI?>W974W]0Y3IIIW[?B\@VZ$L)UE$YEQ[A"E>B#VOIG@K%IS3K9F]X[;\3(KX"M:0#E^ M05BT<822LA44L6904&]G;W[SG(VC@#^+P^*+9$&82OL`7%`D%4%L/Y. M<+L`S[@FW/G1<,?F,#FU_K*&QB*D1+][D*R_ MAP&_TQ435"S7!J"OC\GIRL9*@<;RQL@!!GI68G;?C1-,>P7>GF_0W+*E&/L# M?C1LU>_T(X>3PZ;KH%W??*F^`.41LKUJUWG73CS#(%]:1$_%I97EALOQC4FI M^A7!7V]6N7BLFZMUD:3W."H?_ MNZWMO5FL]CR(T&J:W+)>F^-,,6SUM-#L9"%IVT0_EV^7!K7WXZ6]^%[OLN!' M#VOQ]CRC6N(82/Y6X43XZ=T=*26]F=5Z03-[VS`Z?73:6I'&@].]7&#")6M1 M.P]-E_AK(U2^N?N,,[3$E,T`O)=E>!5MC4YM#+7)9Y;[B;?LRY-\2A=,E2L: M\$!NRF:[;-:I+CR]!R3UA`3^$<^$=<]801VHD MFT)YT18,=]D\`YS$\0I'MRE;C-`E^T&.4*OC0QVKOY-;LS+ZLCA"V MN\OQP!>:)2\+D4L^8(<9=0T_X7R5TGQ]IL_$-#'XPY]*<#WJZM1`L:80L1=A M(9N00SBIPJ8\G&OR+/ZD?87,DAG,`TD=A:P?1=IP@D'B('$[Y1?+)TA;`>/1 MCA*IM+'A)`C2U2:OGCEG?HH\$0GVQ3K9M#(9V8:[*'&D>E6H.+`![VC<1NI. M`I5HA3E+V0R+&44[9=C(3\`V^R%MX,+PIF=DF60TUV<4E']V.P:)3&.BI.*MB5U1.X\C$[`RH6T*;S;UBA69RNC(-OD MKZ$9?R8[1&RD/Y`YCF9\D\UB@VU_/O[F;[S975Z>?2/MQ M'RN&7\,D<&8?]BT1A^HSX^VD[?CNF[^AD@W5^!!C1+](UO]\Y<=>_)\\SX>$ M/S.15BFYQ6D>,YR9;-;/!,UNUA(KYMV2$Q6LJ.1MV,^7^=R&5.#,.D)Z36A5 M-H.*=M`D%Y=TT,T,B;;X#[(U))KS-&+%%LY)$J^R*4X?26XZ+C800S-EKZ0= MLPD.],!94"YXLMHIKA_KG+!9^(DF*8X^$ASE\U.&FTF6)0'E*6I7>:CSJ9:, MP*PV3.JV!2MN)-D1YT=5`XBUX-?!GD289N2G+TDT2U>+3V=:\RGIH%G+)&3' M.((8_80*(ZU-39('71;L$1:2H M%?6P6O-,$7%DA@-9)^IWF#6V7$8TX'/Z[_W,"J=SGL#$J[T79]&B7NXD$LMO MY975/@Y@6+44MY/-*-E8Z(4VI_2RE'#%ZC.W1VSWRFWDBR0]Q=G\BF&_K'K, M0DP>!NJ>3AK>!C2CCE6@8^9B+U*TA*AH2KBB@#5VQ,8O\R>D+"7--S%K^7F> M!NQN9K:9H$5.\(%`1^G&_LMQ20JTJ3YWC"W98@I"^6>DHB)@I[+ M,INX")T$@S<#\]B1=0VOLW+%@KF(S3,7++B,`[5M]>3PS-HKJV)D%CS"?B*Z MC<1L.9-\GJRTCO,YQ2<)X4M'S2I8003-(EH).W:0E$B2^EWYGN&8,NCP!'@< MZSI?002L\_42=HXR!24J2#V?D4AA;C^PM3!^G)/4;(`V'4@;:(34F.$6;R`WF@[*Q2O(1)BZ:\3R?&36]9Q%//-[$+?:#,K): M]A%FWC0$>BC?TY)E=4#S@^#D.22HS"60EGYOX4Q+G\VA]@C.5W]VR06`(V8TVIMN, MZ:;R0)&+\2A;1OP622J."1M5D?C98?$)?AA%,S_1:M4Q14[WYS@ECVS=1%)1 M*:H\.E6\%&_-"A8+=G)KK5Y/7J^WT;KC6 MM17=-*SK^5*--`[-!6;?UOZ">44WX\4%`S%86^HD-9GN6?)XO[?P$UZ0[.X3 MC2+Z57_$K*("9@Z#B&T["%)TATIBO\'13\D\OOB"F2CZ[F^30.M[C7R=CF=T MZ`))2K^]?H7YM_/;E#[AG,AUE&$E8B0'9@T;63O5%B4/*IA0L;#TOG+8>75, M8*:RDG94:4P_TXDLA,9KI)6B9345U% MIG/VTP`;U>CA6ZDKK)6=!!L\2STG0^Q44A^`E5JBVMGH.?%L(;:V^KP<,#D9 MZ:%9R4;8CIWX@G2U!#@S?<(O=+%:2.FGUUHR`PF3^;2.O.A;W284&#PC69!2S3UG.SZ0-K,46F.^XB)S?<.]N=L> M5BWY,>DMSAFROIZNLARGH7;-H"0#9C"3C)U+D9(6E<1^5P?5><#-3#[NQ%^B MC>1+-ME'$H4GZV+25IC&GAF:P09+KHM1EHT[KL6D-F<-M%X4D9ERN)0^IQ(`XO3`G.FBKQ>@M4>NKN-`D(";,+]KM)^,0CGFR:W)&(E_'C MU?LHR29Q*-XL5YAB`#1*Q&+>4V&Q7!0-@4^JE-5NOQK>QI"=CV272'D(*[9#D65A9L];YLH>1*3LL M1Q9:L,!F9X6NDGZ#L<45O%^--91PG@P9J*&;IW^0S&%?0`@H-EN<&"[^1%.#^!W*C4=%WMM2T:@PJ!T9KH,3$R M5Q_=>JS:=I=DY-.F:DR[Z`Q;.;)^>H[/>FOJC&L'&CBV4:*#"]88^E2KR*,H MTL-7YJ)-=`:F=$^S$^SL?0#6'&8KKW/S_>EE=0GM,@YT-E#3`;."4S8%=^DG_0_=G[0?NK_`-!6G_9,L6RWDJ_<723HCE+],KKP##5%OQ3%H">R M%O1FX7G*5I,I#O(5CJ8D76B@[D,4B.#WV`\F]]X_'!X,PZ&0K#$L2ME0(1RJ M=BIJXB$NWV&.$`A#XY]^3``<#/]4@T#.=*8K^KO^PC<&8(UZ^PO%BVU@WY4$ M=M-OK3$OYJ$SM@[>+-05M5YRI9 M,[JSZZL8OQ'&EI)\*^C?33?L?C0TEIB'%G3P?$-YJ>),O`,ICR#EF>@I3S^, M(LV#A]:LT/`W4.X.8,1-+=D`DBT4![<2(QFJ-^+1K)89G'I:B(8;DLLI+04K MHU.MQ`7K+NWA7@_'05BI(ZZUK3BGYZ,_I4;#S'5`IAIG)H`6,J3G]C`KJO6QYBSV\MR$";KS][5&@U`#J]&)WTB;P_#89BL)Z57;S#?B;WW MZYBDO'@L#3XF$5^.F"IVFZBA&:I?U(Z5*A94\OBOD:<)E>C30#=8<4"SE)VX M]K$@?ZD%UCV&<7>`WO\:/43.#-70QO;V3RFB[@Y#E\6Q05;9\2/&RU\G64;R M['25IJ3Y:I62X-=WWKO>+%>[OR75$2KHO':ROG?!=6M/?WKJQBN*'VA$^65L M`V"[5("ZUR!IH@W#* MV*0@_;ZLMCS)Y8.`XGG`/.'U%D!`G5]4L;).'P\@6UF+:A@I2#R=+,@]&>E# MFF39;9K,J'(&J/T94->KI&KWLJ!!DLA3W]XL"7^N,7Y4U>[1$@'J9[ULW;IF M!24J23WU^64(>4F6.(?R`+#5* M[,[K(D4CZ'=E,[]'-$9E2\)9B;90U1@8,]^FA%]]+N!G9]HF#VAS:D2U-&'! M70Y.3T:[)ODISN;,)S_1D(0GZ\\9"2_CC>^8\!=PM:&Q/3<@0XX0NE.:E>2( MMX'*1GA.W^]X.\RROT>5YZW:\F3?>MVI6N&P]1EY4`87)GI`-K024UM-BW=1 MH_[9&G%&3R:Z(T4&:,:?"NPWD8D>D(FLQ.R622B9>(T,,";2N(P+&N,X&.LE M%=R`S#="Z(%>=]E86'\`.R\2BQVU86 M%N9AJ/BAULY1F?FF"(`\V?F,/)$H67('<\]SZL_CG*3+E&;D`XG9G!V=T2R( MDFPE:K2_Y"=1$GQ5&7Q40X`LOYW\;0C46D.B.52UAXH&4:U%]`MO$XE&71_5 MZ;?U^#*J$M)H?FMF0"8?+K/5]B9OI&9;"*;5N+4DHL'::%8K1D`F'2;O$,UYZ=KNG3`(#L2V-G#KESL;:4!PF!#NNF M^>'44?"/;$\**X'M0(`#!K+32C3?%C`5BNT'@-6'%$"K_^J*_<1^7?Z*_8,W MS'[S_P%02P,$%`````@`=(AX15/EC6+%)P``GHT"`!8`'`!A8V-E;"TR,#$T M,#DS,%]P&UL550)``,[JW-4.ZMS5'5X"P`!!"4.```$.0$``.U=;7/; M.)+^?E7W'WBYNMJYJG,2)S.[F]S.7^'11+<(\HP27]^CSZ>7ER\"EH5I'"8D13^_2,F+__ZO?_ZG@/_O+_]R=!1< M8)3$[X,S$AU=IE/RG\%UN$#O@P\H133,"/W/X)0T0NN^1J>7U\&;U\<_OG[W]G5P_/I_@_]]&YQ=7+]\F'(^SL*,MQ%_ M_KZ\?_OSZ-?__Z]8Y0QK0#:FT]Y`C&(>7\SE&&HS`Q&TXK:<^Q MB7F$!`+L9GJS%(:&2UXO)C79@&,Z#=G\(B'?S8;4H.J-8/1M1DF>QB;*K:3J M.:(/A*\LIX3K!M4/I*UQS^^/HM]RS+#@Z.@$S<-[3&B8?$1ADLU/N9Z.&",1 MYHBPJRQ^J1UAM^X&Y&&4?20+Q,W0*$FX)DVG7&)&HU9UT'.)ZZ_-\M"":JA=.7$I&_KW'U%>#;G M&Z'1/5?QF;`[^:(<2>$9&HY5LP_9V14:ZZ)A/\/M&HU'"J`=>%=I/K&!':C& MN:Q9W2O^BPT2])"A-$;QJB,Q[*X>-_YK0?RZ_-]Q:%T;1C0*".7+'`=MU6=(HPT=:'IRJQ:OEH5K\"B:XV2M/E-*%L:RK.1& M-)S4Q+?MXM]L M`93Z&Z^DWL:D2V&/$<6$)_ZZ7X6]EV@<.(CR86([I(PEF[ M_+>:`.7^HU=R;V73A;Q/&HC"3UZAH&/>W>I;I!^< M\J',"%6NO5L-@3#\T2L8%"P[W/^0Q8*DQ:GU\YRSSFHG<>5F2$D'Q.=/'N(# M$8C+E;N5"=L%_Q]2K=TMS(#A_]@H<+?ON,1&6%8Q(K3$0CW<>X]%@O06- MO[QJ=5P,[]5HS[S9<&.\"8Z"=9H'__F4\(Y3AF+Q$R,)CH6W*ZAZ"JJN^JK5 M-&1W!48Y.YJ%X;+4+91D;/6;;26K?OWK>JPWTPN<\C%A/@=(&6!0N#XJD:VV[ER@QC)=7/J2#@9WH;U1:/:-$)!:31WYAQ12[@-!@FK M?J`A,M"X;1;_.O\MQ_=A(ES&H^PTI/21[TF*H($<'2"Y,Z<*"`C2A26?0!Q% M$.G0[8*#GV`Y1:,/S)],I!D31WYLWI`(J28S]`V6`'N*]VZ+7I MLJRT<5@3/A_[%/$_QEH*=/-OMH7A9.Z8"!-[NY&GGW`]T^'EZ0FZF4QQQO;NA M=2V$>!6TM%#4K!U@C5\0/!*])AL"3J[4Q%"-KYUECC!0\^P%*H43F3CHI M#10B:Z?=;M-H#]QTW$C3G.]S&_PI5R@9"10G:T?:+HN4FG\_8#+!IP/9N9H&F%!P+:\'QX4Y. MSV5*=7%V#.#>>./KX7A?G!KCE;(5`]:DKK0VAB)E[5ALC(V"9S]`J64\ZY*) M&BVA<%@[[QK#(>/6#RQ&<5RX-,-D'.+X,CT-ES@+%;$.*0$4&6NG7&-D-+S[ M`="MN*N=HO@\I"E.9XR?)_)%7AS[MJI,-;&"T$)ALW;R-88-+A$_$&PR:+)G M@"-D[P#==NF[J$O@_Q*3_>$4-D,J@-N+GFTUS/=N/'QMLN-C^"' MC9[__7`#9#<'`RYU$8D0B!1[M#&BQ5T\Z%E!3N_Z5D*/,+:9B/Q8:S?'7-ZG M'.79G%#\CZ?ZNL)@,,I$XB]\EXSEIM"M:%Q?61@8MDU1^`N9^DJW M@L$N=[JMN<@&!L_RM>Y!W#'FZR"(V/4%B!Y(&@C'.S3ARY^2R/45B6'0\WOA M:PQ4M^I)"5S?G1@2+1_7.\/Z)3+6NJQT%EUPPV$&6^9V=FS7//>Q<63_$79D M?^HR(-/@J=/@AR]IF,>8MW%Y<"\O)*T'J3^K2PF<>KWO49JK(N9/+1P79=#( MN^&\WF3,%Z/&^-ROQJ:R8AO-7/LVS"3?RJ,?XO]`"6-C2J:J8,Y&(]?^"#/1 MM_"W[X&`\FV[1%39CQ5*!;^EJ:N3ZAF>$AYW7N;6-TH'8EG;/@9 M8(;O$E1<@;Q<+$-,%\JL8ABUZZ.2H74TD(@?$W%=SJ!2SA-NWY7;$BF!Z\OG M9DAI^/8#G&NN-\4XK_A^2@[)5C/G=]+-D&AE4S%D\91=PJG.$D MSU1^/BTA%%U/C@)`0?@QW[9>SKG.%W>(WDR+@=?\7&`PN_;G_#*\&<;]Q.:+ MM[#Y$N^&L_"G+LY"T6=0=.J)L[#F^5WS:Y3=TT+E=H$4`QI3/7S@@ ME^EZQSV*^-FTS%#3,MFE+W_JPTK1;*ZV'27FAXFVO"6R!%0/J9MMEIS>+/A[ MSK+"](F+RA%)(UR4X7P:\(0,-EOM?,VUFW4P/;$)1E]UD[Z_=CKG)V;$+M-Q M3J-YR-"8X@B-DJ*7=L==0:BG]5R=P!]/^\3\(#] MKMPRIV@F-KKNC]C/Q;F_0P4!1P;,?"[\V'='&'*O$EQB%''VSE#Y;RXC41YQ M+:CZC15(FH1Y9ZXC$SM4IA["]F/U:3*P*C#A1$0E8TMB@%]?9>GU`T\&O ME][^+SI-KC>+=)OHR3:E!Z$N:[K1+J7GJ`^U^N`FRK!!YD$HS9HFM,C']^6@ M*HS790U8D_H0E+-N^;<$Y3&N6R7:#*%M4#NO3FT978FX_``8[C0;POGO001V M2&^RH>3V/2XOX?@RO4=LH("1LB_G1;*'"QD!9&;-4\S'$B$4,_%TT=,34YO5 M4?DQI+"!,J^Q61_.JV7W0(%TYGH/S'QU@6F0J:OLRWE5Y^&F+D!F?F!>UU9Q M.5"H*^?^Z0Z:'&(`J?,BT#W@V;Y_#I333BQRK130RL1`C'`KF?,"T/TQ@C'J MZ[2K+0V/Z@+#:BKG!:.M3#:9=/8_EG*+EN%CE1H'UP$UE?.BTX/I`$0ZS]&[ M:?0X!I#<>?GKP;3"2%Y^F'HX[T/LIN%@6TO%&0QL<\GMN_.D_5WT,:*8Q-NJ M+]<6LUX\*,=M?.KJ(J?GJ1LC/D4H?>2S05?X&T;N037P@;1!(IG.:K`LM(L/ MCV:_#V7X]8T7)Q5TKOMNBNES/ M'GTZ+\L]&+PM1=I[R=E>XG_IJ-P%(N4\Y@+HSC:KO,>9CA>Y0BU>4O`"D4 MUV13JXCZ=)5??Q`9J'NG+]WPTVB,L\WF/"C=)'%";9_)0+;\08X0QGB%UE\MN M@[+?0'0OA>^XP@757OUZ)U/)E%FBMU,ZPM\ MZZ0Z?KT]J]M^U[&CC4='1<*5T00VZ,+QS.SX M%*]&(OOJBRH8/;J3%C/9F'MO6N?>45$*)=@@=^B278^OR-Q?#ZE*+Q7/6;`B MG%/P/*[23_73M6^_+KW4T*&?U(<.\5?W[=BQ*1A&5[9=VL-(V^5B7$_%GM"0 M,Q#)C<+;;:,05.1!01_4.W"9A]_*$F#BZRF=7B]H'YS1VFW4B>,I"\6Q<='` M6$XN)V!;=8^-2??C]J0K*8*2Q(-W$$S2SY1$/CSJ8#2;U%1>O+JFQ$?VPH.G M4^5S?L?0;SGOY_Q>+*3M\^6GQLYU3194=`Z/7ULL`"J)2RE"%"SW).M]L]8W=KNTC\2.^4W)$2,^T18'^!Y*[K_MM$UTB"S^$^.D-\_(+E M6NY=55"RY%IU4`00NR[^;U-9#*3GAWUH^K'!M@%`ZOH]`)M0@R7G!]#5`\VB M5O4LQ>O='`1H`*GKZO]VYS10`*7FQV2_"#$MBE#4.'VZ4LIT M1VT@N?-Z^#;Q-A*A'ZB?(191O"PYOD;?JY+^HDP`)2G_,2HYOR;9WU`VBLE2 M^?)QQ^ZTD,9?&/5!9PEWP0]F-R]C*(?.NZ7Z+ MYBC.$U2]XMUX,ZY6-H)590H>"R`A_KD!^GZ.^7?#R=R/):6-GTH4H^\AC>O\ MB-6R!(^Q?%'^KH\^]?F.ZZ#1SI2K/QC>51$Y0UF($W8=4A'7OT?MJU/C8G-[ M59'@AZJ[8-U?MV7J]UQI9+T]FJC?T-INIYN%#04<=BX.4")DFZ/ZD<8'0/C, M0Y?\1T6R1%M;Q\!(A*M&H#;\>IWYWB@P%+V-L`]60V:9(`4,? M9O\LE?5(_%.D'*+X%\X'7T-$8C\?D%[D(%)G>0T0R1LP[\%%6]H\>8.MX[7N>"BVF-7?Y6OKD/U[_K`(M]12,JT#"-0/Y2D M]L@25^<;6@@C+KR_*W>_*K\!0.PZ+PT,KX$H7$;"I-9YK6R"@U+C)N(H2E=/ M:LEL,X#0=<:9'D0H)SY-OF*8MVB9TV@N/!K-PL::-$$-K>OT,?#4@PO"#^!* ML_\)97/Q)(:H?5N40/\N=@-SO.0#CX2<9PK;:="%ZU0Q,(S&8O$#S9KAA^U\ MI`2N$[RZK'6:O9GHT&+S),Y:%:5PK4@<`=H/*=4)7=W1;F/=CZA5;::Y< M%SC%&;K"]ZB1/?@5X=F<;\1&7+>XZ?C"T#1/KO!485O[]>HZQ0L,\Q#"6_OR`]<.^@S'/1V MQFT%HZXP/^"*2Q&C&46EI;])D3HRHJ9Q[3WMJ)P;7CF(5*S%K%H^/OE.C"&I MT;CVA5J"I"&5G4+"2G+5B:DO'CZ'XKSEHIBE>W0T91E"_R(L=O MJY!PV]5G/>W>A`7A@O`#.(6B7B,%:#HZUTL5&#"8`'QY9D/__`W(=_*F\5Y` MI^=P//.Q>/-.Q\$CTNGEFX.CP_6!V8JC0YZM5V175&'>]29'XJHH$]X4%/L@ M9BT3?9T0AK*6.A$4`_7$7Z`5)5CRUI-26[^J24I5TCC;#0.D"!;[CLZ7[1_7 M.F*T9,X._D-BL#O/2_OWMU@, MP;C@IZ@N6-3IG*4>#0E%4Q"[1H+DM!,2-3IG:4*#(M$0A!_.JY8@<`;(LM6T>/DR3$#/WU*TFF-%]\.E-; M,UEKU\YWL$IMOOVJY-T/`^9EZKC[($J?U/'GDJ)L.^W3ED'8.`[9+VKG# MNU=[EW9^1=+9!-'%:MLK1HX+BS-:B*)FAS3ATAB]-W*&N@I;F@;(!8F260I6]Y+V[ MR%B7H-@@\3!+H;9WPH-:(__Y0:L[V8GA+&/KT(4R2<#9'FC!A M>UNO2\NIV-MQ&/:0$%BNS8>$P&>2$&B>C39`(MKP_OYN&09&.6A[ZOCWP*/L M/HBW#QYEZ*/L,,_RF[Z/LWOE83Y4+'G6/NM#Q9*#<_MPA#]4B_\='^%%G+>\ MWOHI3,-9.5^N3C>#RI\1O<<1TA.3%*NZKW1FRW\^&4NI=NA7:!'_P#OIQ:G22_G2^6"2G?YX0$ M]:3-]T'`:@ZLI<"U?%$=RU,0^!#(TZB,3MJV70O(#P25VJ@#4L>B+0OW5S)/+[Z&"6^KMFPM#5T?^#HJW(:ED_)OS:GY MUW"!V.TG?O[$WT*=T%O;NGX;:A"Y*Z1@3?2GCVDVQ^$)0>*JN%+RK4U=/P8T MA.`5,K"7=!UF%$??3G.6A336I;BW-P;*_IW/LE?*P5X49:?5(:R]4#IRUJ#8Q,^RU\M"FL(E+Y"HWQO)8D?NWV( M>TC%A;6,;\E7-6XB-9$7KB*]&D&D;]UEU/Y9C=M(302U_I:N4H(T"B+[PU4S M)WEJ/Q[RU/8A3^TJ%+,C&U-\SX$NIY`V'4U#Y,YR0%*;0!S[X6J^#=,94KN7 M:TWVP6`T1UWS&[F6M%3IZZ.&*OENI-W0D#9!KX;.09H\3&J8L MC(I3\\EC_2\:XV[0AQ_V"&;]#=BJ51/W!$Q=(+&MK1_@F*ND`KC]VYC^^@9N MTZP5391K$GR3*ACQR=2M)WTYSE.R6)*TR$Y66C<-F1]SQBSCK9V36H3.^>V( M]=AT9DS2W#-45!K7>@VBP9`7F^*O(I]9X:^KVFTU@QHS:S%YI4IMB;^513_L MUWB58U^K*#S*LSFA^!^J,MDZ.B`^SJ\FP/CW$2N^C-[0@L^XN/\R1K08/A0S M.?W>W.XR$XB/(,)JTJMH]N82EYYQ/P!J%%B'F$,ED>NTO>ZUY7VUA+6!FIM! M$/'>%)@W$(5WV.WF10YK6\##BQQ23'?W(H>U]#>O7N20NHJ$)H5IA&ZFQ0!N MED(\%X36JX/QP17CDGF.S/IPG9.KQZ4#4Y91*K]^_H!HA!D:4QRIUJF"1DD" MQ,!:G)"UN].9A(HKZ M'2MJ=2) MGL43R52KS:GK7.T+MO`IYTD69JID0\X[V*.NK6.Y[_H@O.(H_I)RV9:C*^WM M3?J)6\]Y\EC4<]5O6SMVZSS)PW@KVTM^]F[;=!D5-V.8M)WZRYLK?;J$XNK0 MX=:?2NT#U*^.&I+%DK/;-HB)PG(`!Q`?'NR:(;)B'%2)37 M_LIW!*J,@T9+YR%4^)(GX=*:]H_2E._;3TB:LTE(9RA3;G(+&B6)\[N<0,T' M\&W3XJS<:,7]E0E9N6H4YD9*`96X:S>5GFL'`C]Y+&\2J-=H.+WSR[2]P6B7 MB#5HJMS>(HI3.3#%HA2FY3"2UG!)00JAA,+AT'T#YF4W0)0;M,D\S*H!5.H! M1$-/[ORZLQDD4'GLPG:MINC*O:Q9IR&44#0<.@/`O%@&XNE3-],3E!;%2L,D M*5T0["-*XI/'2D=DB!AU`87&]9F]@UR\.5&LC&WI'N+_48M97Z:U['GE:<.@ M%RBH[C-DNDAG!WZU*L%4;_V4)%`87)_/`7Q;CN26:#]M#PN%.$,LHG@IF1BU M@*B>&HJ$PZ.Y$3\^&;C3)&1LK3HW5$156';&^;W@4O@ZQ]&\^ALK_YBQ*H*M MKAO=MU\HYAXDO`PB06M3](IKWY?EN@;&!:&5U58FP>BHH/"X=BC`N+(GP6GSSK7*NMQW MD3XJ!GTS_9)2-,-\F+08_L`BJ=KKXJQ3%K0V>VS,T>-S"+8 MTS,_MCX]SNW;KW=+.3PKJ+9! MW\IHW$C?-=T;6!B`Z]N)PRC?P$E=AO#YL?T<4Q(A%#-Q:GPRNE7=AW$21DC] M2AJ4WO4522L:8R8\/P`OEI?26W264YS.RG!J$>!KGP$?*&'*,AH=.W1])=.. M$>DG7C]T9)04G:.X?<0B#S]M30FI.H#2N[[@:44#S(3G!^"_RT.K-<>]%;7: MY?EVYS=@I6?CSGF3[>U\[-@,?H_N M0YR(L\<%H446NX5CHO:+KN\E^W4N!`+DAQK6G&JGX1+SA:,<]BU'D-ZC6&3? MYQF7[.J@HXC"FG?E^C*U%<7I+%(/G9E'GZ,YBG,11:L9W,H$5X[)=@?G3V`' M)_]3]9&`3(/:9X+J.VL7Z,'Q^:PO,E=(')]0E?'\FQP7A7M4<;LK'[W>7FO=R2T9[K!=6XW#3:\UNZ"[)?E M]&7CNWO+>3.MA])W;D"W/^^\EN@^&=)V[`Z[6%5&R([RZ,$#<%[]TG=#;9A( M_YQ#4LPH^&%)\8<VFNK[<4SKOMLM_=CN]TE+W7#\[@E M@F):%_4Y0DR+#9ST/N_NON^\_*Q/6<4=T7LV.^X>,C//P7ZCL>.['HSS\JCV M++H;7*V52^C+4^6`].!.2/\!.:\BZZ'][HVOMYKKC\I:U%5[Y74]U-7GI*2_ MUQMW]BH0^Z2P]J[<>72S98N9$6/YHCH4B"V_\IK+'SM>6:W7M9GR!K46ZKW"^'LXP1GC[=<#!9\7AW&<+@G,P2&>^ZL;>/[%K-O M%Q2ARU249V/9#E6V_=.'RS%]('N&&KI*`3W#]SCFFX4=:FC[IY_G19Q=06;W M\#,4!T^7/"3JUB\_!/+)YW7YQKZ\W!]2*LF,0YH]UMZQ@-42_=/V&:3J+2BZ M"VK]>59,5,(UX/R@IW1ZW;,J=CM1/UNPW4XW;1MJ:F7R0D%I7,?<9*:>M.<# M%E?;A8<5>-3:^H%)NT;)$*@-O^Y==8C"K;#2HX?6!Z57:O?49(]D7AMU[73A M6M*?D/J*VD8C/Z3=T)`V0:^&_.1R<"CI3S@5[_'I9+W5S/4)H$4_MB3=RI;N=X-`T3>QIUIUZ>G^#$7%Q)K,,=_27F#*LLEW,IF3G(5I?(&G M&4*IU*84?1AUX;KL@$1Y-H[3'61BS?NB'LMG_-`7GZTN7%^;[X]/JTQ+(Y3.BQ!5/Y"V^W!]3[\_1NU2L>=F5E6L.A650),D MK-_J:SB-X1VXCH4!'WPR%HD?N^(S=)==IBRCN6#Q,HTH"AGBRE;\^R:;(WJ- M5.D/0'K7IT7P,VQF`O$#1!&&N)G>(KRXRVGQ?H_VA0L%B>M3)OP)61W;%I>H M\II$_=MGF"L-OLL+,2U(WEK`O#+E,&K7VV^@Y3,3ALO8%)_-9($FX0-BL'C4 MG[?C464/0=&%9R&H-7-/`]9'GY1$3I>E4J?XR$:,H8S=+)$0<3J[(HPOIY0^ M3@DMW@A1K4T&G3A.#@.@UUBHC$5DS1Z>3Z?3%F.E;>NA5TOM"4K1%"LWB!I"USO#[C-/(PL_@#O- M*2TWLF:XZ>A<[Q+-88-)PFF"?W['T&\Y[^=YD+'M'2A>?BWRV%=?EBP/Y3%9UMP3(Z1<'-0<],W),1&QU-K+ MANB)K5=+$"9MVXDX+9]4VQ(%@3,#KA,>3-0^IOI-Q/GX9GJ9QN+N51XFZMVH MI/D^F!LU!S4?C$]H?,79O+B;(2YCS/%R0L[3#&>/NOVI<4=^(*C41AV0.A:M MI1J&*4:)N&&["'6Y-FU-76]+.RK=9F!3+@-K>Z5;PM"G#V&2A+,YHN4(QNO_ M'J4BH>1[>K;^C1J:KKVY3H@:`KU^DMP1P";P&8)CK63:\.#L*K%P2P<@9JW9 MVGF-_^%,FTP4.SZ&JPZ#*@H_EG?`>5#%1"V)9Q>R5I\*U30^'`SU&@20O.W- MT]#>)H.*WL5FH5) M:2`EAH>W:C3:!UO3-NZ:&W)G$M:V4`+*P=J*(NYZB6M=-]-B MKUM6%KX@=+7I/26+!4G+^U^RY<6L#]<^5>!]D"Z"L892^?6-YWO&B!8?EX&B M)'&=K0S$`,"V+ZM^QVIXS4K>MI^S[_YNO?NK29>]7D+C21P*0F;I\ MY:#?V9-K>[8$7-,(L^>D[A&](PQ9>1%M7=:_7':J)U:^I!R)DIWJ>8#T$TFS M>?+(YP%FY0UN:7"F3Y?.MUHP'1E`;-8,Q!7?6WQ9KEV+?(/Q.11Q$?6.2T?E MNEP'$!@8\_9DC\)O?$DP%KZ.S'7<&2I]&/LN+>%`N[,P"2E&;)3&7[F)5[EC M&BV!6%I[CPZ^-Y(P:6WV5`<@<3@J5&A"5DDW!CU`H7'MG#&7BA]^@LVR/*,TS<-D3'$:X27_H=0V^>2"44,Q M]*U(D5H:/N+W*_$EYO19&#T7. MH7_$D"/;H>LHHOGZH:,JRC$J7CRJ3ARZ+489##;M!@J4:R=%1_GX,>O.T)(P MG"FK&*U:0`%QZ)QHC-GRW.`SDI$T3*I:'E+/0[,=5)BN?0TR#HWJE%1_$?\0 M[ES^F_\'4$L#!!0````(`'2(>$7%,ML0>PT``+2"```2`!P`86-C96PM,C`Q M-#`Y,S`N>'-D550)``,[JW-4.ZMS5'5X"P`!!"4.```$.0$``.T=:V_;./+S M'7#_01?@<#W@'-M)VVVSR1[\B%OO)HTW<=K=_;*@)=HF(I,N227V_?H;DI*M MEV7)22KUG&)1N.+,PZ)U:7V;4^';,?K4]HAD^L#YABCB3C M/UJ?D>NI)ZQ'7,RM#IO-72PQ#)B93JS7ATOWAX>&0LGOTP/B=.+19/G(WS.,V7M%J=?J?K*-&\W7C_7'#:C9^M7X]MKJ] M3X>+,_,%^6%R3WR97])W7^N.X:=^@HP_>:"`?YF^.CWYWV^)(_G=D MNV]'RUOB_''.O&7]TNM>?[F\?MTQ4YX*>XIGR`++4W%V$-+FP_$AXY/Z4:/1 MK/]V>7&CX0X,X,G")?0N#;SY_OW[NAX-0!.0BQ%W`]+'=34\0@*O*,,HR8`G M5$A$[0B\(U<(8>`W=3,8`26IH&\-*`E`'1R#$]@^G+#[.@S4U1*H-9JUXV8` M[HG:!*'Y"F6,Q$B3]@?243ASL4C%T2,I2)11ZLW2M>-(7I?+.:X#4`V@,"?V M"F\[4A0!>%"/T[G3(RG<(=O&[@I#_ZL>>!-$$A?/,)4]QF==/$:>"T;[ZB&7 MC`EV#BR)^`1+M<[%'-EX$YG`2Q"E#)P)PH?_1#V;SPEX"SSXRZE:5B=*C4-@ MUE(_(&C$B*JG=?`Q3_'5HLXYE40NE M&N9/TZI9`7KX)Z*.96A9(6*G]3B9$'%/8.>*_J1_SSD60$8C7<`#']$'V8!D M(]?VW&(X:U924?P'@9J+*;Z-7.7'-U.,I3":CC[*5NT1Z%.%4^SKML.H@RFP MIGX)YA('QAS+)VD9FGNLX0'B(-`42P)LIJ@[.IZM^^-==&^]BDSQK_VRQ4I= MXFI\-5>I$4SC+_L-8]DV>)W/!FO:%AM;:^K6JUN*/(<`S!Y;HH/$M.>RAQ1# MK(>R[?!F%SLHXI:FOK]V:"/[;L*91YW$CIL^E&V'MVI_A?S89<+C&/ZQ)K*_ M>^P'!J4;K$,;BXC02!C780$M!8)#=TIF6:C;AE#-U8'J0,HVFKYV'J^V6A&\GLNRES')O%/RR>RA^JMJ3Z7H_J?D""&UONFP6PU'Z6JN=9& M)O=-`_<=ZNF-*'2#9@',-M6B6(_ MM7OU8I(-"7B&67(`9YLFT3/8G+>_6"=5X35UBL_Q7!7B/*D.TJFSG5=S'8!\ MG65:+!>!;"LF.Q6;K`A#_FPZ4J[GL_P)5W9^L6[,.%\PF4PE=EKWL+U,5&+I MS8S.].G1@J;.22W;[HEF2$Z[!Y-;_NQ6:'IS%G9?E\&&;G9Z",X+G&W$1.MD M8R?\)0:'FN'I)LD"R#9#HF42[IZ_:#[>.]^0E&R#RK9!HF&2Z+C_?QM"_:4V MC6L\MO2!_Q-U+OSL0!!UO^/`?S;E>'QVH&U3"PYQ_PFR'2YF;@"C:&><^-2>#N:I*PO/Y-B?KZ MJH3_[_AUBE.0G'%IT<2%C*PK.>8RT06S-:D,%/6O6H!74X]JS:/:Q1'&_&00U2)YKQ9G\^TCF=F-D6U< M^'>[=%JEX^.?-U/$<3M>4[8@#:(3#=M>KD$&:*DO6#T@[OBE?:C:[U/)(500 M6Q=['X""5!?&E,B0Q#W_/,1UU5O@LP/)/15EU07%$XB^A#E#O4LX'O=/'?<0 MX5K(4"G=8WR,B6I+7T-!]VCUYIJB@&:-#F$AJG$;9GD*!9Z/Q]A6:?FJ$M,7 M="7C2\6A.%_,B6'@=XQXH)/"6(7%-!!"+-R>@JD&X,VX MY;J^^P>2Y8"KK#,,.+,Q=D2/LUG+N5=SBB$+=3T@5VI1YTI.\KK(00?8"<#C6B#Q$%.Q!,U"VJ"RS`X2`D$(&OQEHJ$]E7:WH7 MS,KJ`?*!$>8^NT:H(:9@1"6:R<&-V'D`=XU+1I=/M8$E&L_)W66T8?/^C`4X M:JP[K3=N]:V&U1;4C.QFWV:^K;HUQ8^,[6QZ^E)S@VUYT=78:"'J9=]NNOR* M+2$9>\3:\O/-D")BZ^P:\G6HZ/7Y+LF1+3WD#C&?/=7B?@P#.T:2X&FI^@^O M+U&"^A\___>L_?+T_IUK/-C'(ZD+I#9!ZA[.>P)=%<0I/3\P#`9)FBY&!OX> M&8B4#;)K@?FTV_"C,XZ!*7EA33YM)A.A6W8QOEZ<*\G@U2MK/Z.X7:15H3CO&0!7M(K.Y.A]@Y MB;S"^L--?*A1`UO+KKMGHNR,I: MT>?>;WM,D?1Y]TVT0=@&4+++=*B38:/7)`[-BF>*HBL>;D:MS'5 M)ZN1ZYK,17S$KM->^J98M3`+H90LWSH5^:+._]"4*)\-4G:4-ZF"Z9JN(YM> M5%TL;$XB/:#('7.-5HM;86J0$2_P.@.*MBMHFP% MJX`LH>I4<74UOJ4<3PCDJ5R7.4$\:R:=9SM"9?'>"';;DC"_.#%4Q;]2>L3&=!XDIBZI)BKC8#8'YFK6KOBXJ)SB=4KT548 MS8;950Z'*7=^HL4(#[DZBO`91D#1ZD0",)V4)1]H^2)%RI%5,A*S2S9,^4*T M740$_OD+<\?LE`50/OL_LRGM M?0%?(33*=MI`!=A5!^6O+X$1/E<]T9TGEE*`VPRJGB/"-%@^V^=?/?7.)GM;VP94OA@72+$B!YS<0\`S_":V@VU` MY8N17@LDDM;M8%45)9&Z;@>KK"C)!#8/8%7%Z3&/YY$F`E>^,-N=I>)^LMU% M*NX=>1RC\C[1191@=["A/-HX6@'&L:V9&4X)E\L>X4(MC^&4>0)1IT?&$N-8 MUE<,I>HBWI!%41'C*)47$:NO:Q05,H%4=3'/]6'D8E(F<"H@I`X6/17HXO56 M^E#Y+-]T^NM629_:L3Q@TVCYC+>N?AF8#T,L^_0>"ZF;ALG7!5O!RA`>SR!=^09I+[7,EU!*Y\8;+^UZDM(*IN5:RB02Y8Y/\* MA"K_,%'Z)]!7;T?C8N8&KYZDZ4NNM5@?OL^"^,;R./+$(3/U`L6<3MI!LJ[V M@VS9`IC'2_?\E4C84M^AD;;8YWLR34I+/VR&UL550% M``,[JW-4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`=(AX1>5TR.;F"@`` M"WT``!8`&````````0```*2!)'X``&%C8V5L+3(P,30P.3,P7V-A;"YX;6Q5 M5`4``SNK`L``00E#@``!#D!``!02P$"'@,4````"`!TB'A%`MB43F<8 M```(>`$`%@`8```````!````I(%:B0``86-C96PM,C`Q-#`Y,S!?9&5F+GAM M;%54!0`#.ZMS5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`'2(>$55-W!I M=SX``%9D`P`6`!@```````$```"D@1&B``!A8V-E;"TR,#$T,#DS,%]L86(N M>&UL550%``,[JW-4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`=(AX15/E MC6+%)P``GHT"`!8`&````````0```*2!V.```&%C8V5L+3(P,30P.3,P7W!R M92YX;6Q55`4``SNK`L``00E#@``!#D!``!02P$"'@,4````"`!TB'A% MQ3+;$'L-``"T@@``$@`8```````!````I('M"`$`86-C96PM,C`Q-#`Y,S`N M>'-D550%``,[JW-4=7@+``$$)0X```0Y`0``4$L%!@`````&``8`(`(``+06 $`0`````` ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation - Schedule of Outstanding Options (Details) (USD $)
 9 Months Ended 12 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Options outstanding, Beginning Balance 5,400,000 3,000,000
Options outstanding, Granted 1,000,000 3,185,000
Options outstanding, Exercised    (785,000)
Options outstanding, Forfeited / expired      
Options outstanding, Ending Balance 6,400,000 5,400,000
Options outstanding Vested, Ending Balance 4,160,000   
Intrinsic Value, Options outstanding, Beginning Balance $ 4  
Intrinsic Value Granted   4
Intrinsic Value, Options outstanding, Ending Balance 4 4
Intrinsic Value, Vested Options outstanding, Ending Balance $ 4  
Weighted Average Exercise Price, Options outstanding, Beginning Balance $ 0.0001  
Weighted Average Exercise Price, Granted   $ 0.0001
Weighted Average Exercise Price, Options outstanding Ending Balance $ 0.0001 $ 0.0001
Weighted Average Exercise Price Vested, Options outstanding, Ending Balance $ 0.0001  
Weighted Average Remaining Term, Granted   3 years
Weighted Average Remaining Term, Options outstanding, Ending Balance 2 years 3 months  
Weighted Average Remaining Term Vested, Options outstanding, Ending Balance 2 years 3 months 2 years 8 months 12 days
XML 15 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisition - at Home and All Staffing
 9 Months Ended
Sep. 30, 2014
Business Combinations [Abstract]  
Acquisition - at Home and All Staffing

4. ACQUISITION – AT HOME AND ALL STAFFING

 

On December 13, 2013 Accelera entered into a Purchase Agreement with At Home Health Services LLC, All Staffing Services, LLC (together, the “Subject LLCs”) and Rose Gallagher, individually and as Trustee of the Rose M. Gallagher Revocable Trust dated November 30, 1994 (“Gallagher”), pursuant to which Accelera agreed to purchase and Gallagher agreed to sell, all of Gallagher’s interests in the Subject LLCs. The Company also entered into an Operating Agreement with the Subject LLCs.

 

Pursuant to the Purchase Agreement, Accelera agreed to pay Gallagher or her assignee of $1,420,000 dollars, with the sum of $500,000 dollars within ninety (90) days of the Initial Closing Date, the sum of $420,000 dollars within eight (8) months of the Initial closing Date, the aforementioned payments dates has been verbally extended until the Company receives financing. Furthermore, Accelera shall pay a sum equal to the Net Accounts Receivable, meaning the amount applicable to the Subject LLCs as of the Initial Closing Date equal to (a) the bank account balances plus (b) accrued accounts receivable balances, plus (c) a proration through the Initial Closing Date of the prepaid expenses, bonds, and licensing fees of the Subject LLCs, plus (d) an amount equal to the security deposit on the lease for the business address minus (d) the balance of the accounts payables of the Subject LLCs as of the Initial Closing Date. For the above purposes, the terms accounts receivable and accounts payable shall be determined in accordance with standard accounting principles within twelve (12) months of the Initial Closing Date and the sum of $500,000 dollars within eighteen (18) months of the Initial Closing Date. The Initial Closing Date was December 9, 2013, the Final Closing Date is June 12, 2015 at Gallagher’s office in Mokena, IL.

 

See Note 9 for an update on the acquisition of the Subject LLC’s and employment agreements with Ms. Gallagher and Mr. Gallagher.
EXCEL 16 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C934P83%F-E\R8V,Q7S1D,&9?.64Q.5\Y96$V M83%F83(T-#$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D%C<75I#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C M<75I#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYA='5R95]O9E]/<&5R871I;VYS7V%N M9%]"87-I#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-T;V-K:&]L9&5R#I%>&-E;%=O#I7;W)K#I% M>&-E;%=O&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I7;W)K#I%>&-E M;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C<75I#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E)E;&%T961?4&%R='E?5')A;G-A8W1I M;VY?1&5T83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DEN8V]M95]487AE#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-U8G-E<75E;G1?179E;G1S7T1E M=&%I;'-?3F%R#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C M=%-T#I0#I0 M#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T* M("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I M=&@@36EC'1087)T7V-E-3!A,68V7S)C8S%? M-&0P9E\Y93$Y7SEE839A,69A,C0T,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B]C934P83%F-E\R8V,Q7S1D,&9?.64Q.5\Y96$V83%F83(T-#$O M5V]R:W-H965T'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^ M)T%#0T5,15)!($E.3D]6051)3TY3+"!)3D,N/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)RTM,3(M,S$\'0^)SQS<&%N/CPO'0^)U$S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPP,#`\'0^)SQS M<&%N/CPO6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQAF5D.R`P('-H M87)E'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]C934P83%F-E\R8V,Q7S1D,&9?.64Q.5\Y96$V83%F83(T-#$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V4U,&$Q9C9?,F-C,5\T9#!F M7SEE,3E?.65A-F$Q9F$R-#0Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!E;G-E'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO6UE M;G0@;V8@1'5E('1O('-T;V-K:&]L9&5R/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B@T,3DL,#@T*3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C934P83%F-E\R8V,Q7S1D,&9? M.64Q.5\Y96$V83%F83(T-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO8V4U,&$Q9C9?,F-C,5\T9#!F7SEE,3E?.65A-F$Q9F$R-#0Q+U=O'0O:'1M;#L@ M8VAA2!I;F-L M=61E(&$@<&]S'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU2`V+C@U)2!O9B!T:&4@=&]T86P@:7-S=65D(&%N9"!O=71S=&%N9&EN M9R!S:&%R97,N(%-I;75L=&%N96]U2!A<'!O:6YT960@=&\@=&AE($-O;7!A;GDF(S$T M-CMS#0I";V%R9"!O9B!$:7)E8W1O'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^06-C96QE2!W:&EC:`T*:7,@9F]C M=7-E9"!O;B!I;7!L96UE;G1I;F<@:71S(&QI8V5N2!B>2!O=7(@;6%J;W)I='D@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU28C,30V.W,-"F%B:6QI='D@=&\@ M8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N(&ES(&1E<&5N9&5N="!U<&]N M('1H92!#;VUP86YY)B,Q-#8[2X@ M5&AE($-O;7!A;GD@:6YT96YD2!S96-U2!I2!D97!E;F1E;G0-"G5P;VX@=&5C:&YO;&]G>2!L:6-E;G-E M9"!F2!D;V5S(&YO M="!R86ES92!A(&UI;FEM=6T@;V8@)#$R+#4P,"PP,#`@8GD@075G=7-T(#$S M+"`R,#$U+"!A;B!A9&1I=&EO;F%L#0HD,3`L,#`P+#`P,"!B>2!!=6=U6UE;G0@ M;V8@:71S(&QI8V5N2!W:6QL(&QO2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN86YC M:6%L('-T871E;65N=',-"F]F('1H92!#;VUP86YY(&1O(&YO="!I;F-L=61E M(&%N>2!A9&IU7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQP('-T>6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&(^,RX@04-154E3251)3TX@)B,Q-3`[($)%2$%624]204P@2$5!3%1( M#0I#05)%($%34T]#24%415,L($Q41"X\+V(^/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU&5C=71E9"!A(%-T;V-K#0I0=7)C:&%S92!!9W)E96UE;G0@*'1H92`F M(S$T-SM34$$F(S$T.#LI(&%N9"!I=',@=VAO;&QY(&]W;F5D('-U8G-I9&EA M2!O=VYE9"!S=6)S:61I87)Y(&]F($%C8V5L M97)A('=I;&P@;W!E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^4'5R0T*5&AO=7-A;F0@ M1&]L;&%R2`H,3@P*2!D87ES(&9R;VT@0VQO6UE;G1S(&1A=&5S(&AA2!E M>'1E;F1E9"!U;G1I;"!T:&4@0V]M<&%N>2!R96-E:79E6UE;G1S(&]F(%-E M=F5N($AU;F1R960@1FEF='D@5&AO=7-A;F0@1&]L;&%R7,@869T97(@8VQO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0M86QI9VXZ(&IU'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU2!A M;'-O(&5N=&5R960@:6YT;R!A;B!/<&5R871I;F<@06=R965M96YT('=I=&@@ M=&AE(%-U8FIE8W0@3$Q#6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^4'5R6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M4V5E($YO=&4@.2!F;W(@86X@=7!D871E(&]N('1H92!A8W%U:7-I=&EO;@T* M;V8@=&AE(%-U8FIE8W0@3$Q#)B,Q-#8[3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M934P83%F-E\R8V,Q7S1D,&9?.64Q.5\Y96$V83%F83(T-#$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V4U,&$Q9C9?,F-C,5\T9#!F7SEE,3E? M.65A-F$Q9F$R-#0Q+U=O'0O:'1M;#L@8VAA2<^ M/&(^-2X@3D%455)%($]&($]015)!5$E/3E,@04Y$($)!4TE3#0I/1B!04D53 M14Y4051)3TX\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO M2<^06-C96QEF%T:6]N($Q,0R!T:&%T M('=I;&P@;W!E2!A8W%U:7)E9"!"96AA=FEO3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'!E;G-E2<^0T%32"`F(S$U,#L@06QL(&-A2!E>&-E960@=&AE(&%M;W5N=`T*;V8@:6YS=7)A M;F-E('!R;W9I9&5D(&]N('-U8V@@9&5P;W-I=',N(%1E;7!O2!C87-H M(&EN=F5S=&UE;G1S('=I=&@@86X@;W)I9VEN86P@;6%T=7)I='D@;V8@=&AR M964@;6]N=&AS(&]R(&QE6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T+VYO'!E M;F1I='5R97,@9F]R(')E'!E;G-E9"!A6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2<^4D5614Y512!214-/1TY)5$E/ M3B`F(S$U,#L@4F5V96YU90T*F5D(&%T M('1H92!T:6UE('-E28C,30V.W,@&5D(&%N9"!D971E2!A&5S+CPO<#X-"@T*/'`@3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`Q,'!T+VYO2!R96-O9VYI>F5D+B!';V]D=VEL M;"!I2!I;B!A8V-O6EN M9R!V86QU92P@86X@:6YD:6-A=&EO;B!O9B!G;V]D=VEL;"!I;7!A:7)M96YT M#0IE>&ES=',@9F]R('1H92!R97!OF5D(&=O;V1W:6QL(&EM<&%I2<^041615)425-)3D<@0T]35%,@)B,Q-3`[(%1H92!#;VUP M86YY)B,Q-#8['!E;G-E(&%D=F5R=&ES:6YG('=H96X@:6YC=7)R960N/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2<^24Y#3TU% M(%1!6$53("8C,34P.R!);F-O;64@=&%X97,@87)E#0IP"!E9F9E8W1S(&]F('1R86YS86-T:6]N&%B;&4@;W(@9&5D=6-T:6)L92!W M:&5N('1H92!A2<^ M5&AE($-O;7!A;GD@861O<'1E9"!T:&4@<')O=FES:6]NF5D(&EN=&5R97-T#0IE>'!E;G-E(&]R('!E;F%L M=&EEF4@:6YT97)E'!E;G-E6QE/3-$)V9O;G0Z(#$P<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2!C;VYS:7-T(&]F(&EN8W)E;65N=&%L('-H87)E&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&%N9"!W M87)R86YT2!D:6QU=&EV M92!C;VUM;VX@&-L=61E9"!F2!D:60@;F]T(&AA M=F4@86YY('!O=&5N=&EA;&QY(&1I;'5T:79E(&-O;6UO;B!S:&%R97,N/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2<^ M1DE.04Y#24%,($E.4U1254U%3E13("8C,34P.R!);B!397!T96UB97(-"C(P M,#8L('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A'!A;F1E9"!R97%U:7)E9"!D:7-C;&]S=7)E#0IA M8F]U="!F86ER('9A;'5E(&UE87-U2!A9&]P=&5D('1H92!S=&%N9&%R9"!F M;W(@=&AO2!I;B!A M;B!O28C,30V.W,@;W=N(&%S2!C;VYS:7-T2!T;R!U;F]B6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T M($-A;&EB6QE/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(&IU6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@2P@:6YC;'5D:6YG('%U;W1E9"!P6QE/3-$ M)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^1F%I2<^4D5#14Y4($%#0T]53E1) M3D<@4%)/3D]53D-%345.5%,\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2`R,#$R+"!T M:&4@0V]M<&%N>0T*861O<'1E9"!!4U4@3F\N(#(P,3$M,#0L($%M96YD;65N M=',@=&\@06-H:65V92!#;VUM;VX@1F%I&ES=&EN9R!R97%U:7)E;65N=',@=6YD97(@05-##0I4;W!I8R`X,C`L M($9A:7(@5F%L=64@365A2<^169F M96-T:79E($IA;G5A2<^06UE;F1M96YT65A2<^26X@ M1&5C96UB97(@,C`Q,2P@5&AE($9!4T(@:7-S=65D($%350T*3F\N(#(P,3$M M,3$L($)A;&%N8V4@4VAE970@*%1O<&EC(#(Q,"DZ($1I6QE/3-$)V9O;G0Z(#$P<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2`R,#$S+"!T:&4@1D%30B!I2!I2P@=&AE M(&%D;W!T:6]N(&]F($%352`R,#$S+3`R('=I;&P@:&%V90T*;VX@:71S(&-O M;G-O;&ED871E9"!F:6YA;F-I86P@6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`Q,'!T+VYO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C934P83%F-E\R M8V,Q7S1D,&9?.64Q.5\Y96$V83%F83(T-#$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO8V4U,&$Q9C9?,F-C,5\T9#!F7SEE,3E?.65A-F$Q9F$R M-#0Q+U=O'0O:'1M;#L@8VAA2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2!H87,@='=O(&-L87-S97,@;V8@F5D+B!4:&4@0V]M M<&%N>2!H87,@,S0L,S@P+#`R,B!A;F0@,C(L,S@R+#4R,B!I3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#LF(S$V,#L\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU2!E;G1E6UE;G0@86=R965M96YT('=I=&@@2F]H;B!&+B!786QL:6XL M(%!R97-I9&5N="!A;F0@0VAI968@17AE8W5T:79E(&]F9FEC97(@)B,Q-#<[ M0T5/)B,Q-#@[(&]F('1H92!#;VUP86YY+B!);B!C;VYS:61E65A2!B87-I2!V97-T(&%N M9"!B96-O;64@9G5L;'D@97AE2!T:&4@0F]A28C,30V.W,@ M9FEN86YC:6%L('-T871E;65N=',@9F]R(&5A8V@@9G5L;"!F:7-C86P@>65A M2!T:&4@0V]M<&%N>2!A;F0@=VEL;"!B92!A M9&IU3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`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`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU2!E;G1E6UE;G0@86=R965M96YT('=I=&@@0WEN=&AI82!";V5R=6TL(&%S M('1H92!#:&EE9B!3=')A=&5G:6,@3V9F:6-E2!R M97!O65A2!B87-I2!V97-T(&%N9"!B96-O;64@9G5L;'D@97AE2!T:&4@0F]A6%B M;&4@:6UM961I871E;'D@9F]L;&]W:6YG(&-O;7!L971I;VX@;V8@=&AE($-O M;7!A;GDF(S$T-CMS(&9I;F%N8VEA;"!S=&%T96UE;G1S(&9O6QE/3-$)V9O M;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M+VYO2!A9W)E960@=&\@:7-S=64@82!S M=&]C:R!O<'1I;VX@=&\@<'5R8VAA28C,30V.W,-"F-O;6UO;B!S=&]C:R!A="!A;B!E>&5R8VES M92!P2!A9G1E2!O;B!A(&UO;G1H;'D@8F%S:7,@*#$V+#8V-B!S:&%R97,- M"G!E2!T:&4@0F]A6UE;G0@86=R965M96YT+"!H92!W:6QL(&)E(&5L M:6=I8FQE(&9O6QE/3-$)V9O;G0Z(#$P M<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2!0=7)C:&%S M92!!9W)E96UE;G0@=VET:"!,86UB97)T(%!R:79A=&4@17%U:71Y+"!,3$,L M(&$@1&5L87=A2`H=&AE("8C M,30W.SQI/DEN=F5S=&]R/"]I/B8C,30X.RDN#0I0=7)S=6%N="!T;R!T:&4@ M26YV97-T;65N="!!9W)E96UE;G0L('1H92!);G9E'1E;F1E9"!T;R`D,C`P+#`P,"PP,#`@=6YD97(@=&AE('-A;64@ M=&5R;7,I(&]F('1H92!#;VUP86YY)B,Q-#8[2!T:&4@26YV97-T;W(@<'5R6QE/3-$)V9O;G0Z M(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T+VYO2!M87D@ M9')A=R!O;B!T:&4@9F%C:6QI='D-"F9R;VT@=&EM92!T;R!T:6UE+"!A&EM=6T@86UO=6YT('1H870@=&AE M($-O;7!A;GD@:7,@96YT:71L960@=&\@<'5T('1O('1H92!);G9E2!P97)C M96YT("@Y,"4I(&]F('1H92!L;W=E28C,30V.W,@ M8V]M;6]N('-T;V-K(&1U2!P;W)T:6]N(&]F(&%N>2!P=70L(&5X8V5P="!T:&%T('!O2!B965N('-O;&0@=&\@ M82!T:&ER9"!P87)T>2P@:6YC;'5D:6YG(&%N>2!P;W)T:6]N(&]F(&$@<'5T M('1H870@:7,@8F5L;W<@=&AE(&UI;FEM=6T@86-C97!T86)L92!P2!S:&%L;"!N;W0@ M8F4@96YT:71L960@=&\@9&5L:79E2!I2!U;FQE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!M87D@2!B2!P28C,30V.W,@97AE8W5T:6]N+"!D M96QI=F5R>2P@<&5R9F]R;6%N8V4@;W(@96YF;W)C96UE;G0@;V8@=&AE($EN M=F5S=&UE;G0@06=R965M96YT+CPO<#X-"@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!B92!S=6)J96-T('1O(&$@ M8V]N=')A8W1U86P@6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2!I2!T:&4@4T5#('=I=&AI M;B`Q.#`@9&%Y6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2`H,S`I('1R861I;F<@9&%Y6QE/3-$)V9O;G0Z M(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO M2!A9W)E960@ M=&\@:7-S=64-"F$@"!(=6YD M6UE;G0-"G-O(&QO;F<@87,@:&4@65E(&]F M('1H92!#;VUP86YY+B!&=7)T:&5R;6]R92P@=&AE('-H87)E2!3979E;B`H,C2!E>&5R8VES86)L92X- M"E1H92!E;7!L;WEM96YT(&%G2!A;B!!8V-E;&5R82!A M<'!O:6YT960@875D:70@9FER;2X@5&AE($)O87)D(&]F($1I6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU6UE;G0@06=R965M96YT M('=I=&@@4F]S92!-+B!'86QL86=H97(@87,@=&AE(%!R97-I9&5N="!O9B!! M8V-E;&5R828C,30V.W,@070@2&]M92!(96%L=&@@0V%R92!B=7-I;F5S2!F;W(@-"!Y96%R2!3979E;B`H M,C6%B;&4@8FDM=V5E:VQY M(&EN(&%C8V]R9&%N8V4@=VET:"!T:&4@0V]M<&%N>28C,30V.W,@8W5S=&]M M87)Y('!A>7)O;&P@<')A8W1I8V5S+B!4:&4@0V]M<&%N>2!H87,@;F]T('!A M:60@37,N($=A;&QA9VAE<@T*=&AE(&%M;W5N=',@9'5E('5N9&5R('1H:7,@ M86=R965M96YT+CPO<#X-"@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#LF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!E;G1E6UE;G0@86=R965M96YT M('=I=&@@1&%N:65L(%`N($=A;&QA9VAE2!A M9W)E960@=&\@:7-S=64@82!S=&]C:R!O<'1I;VX@=&\@<'5R8VAA28C,30V.W,@,C`Q,2!3=&]C:R!/<'1I;VX@4&QA;B!A="!A;B!E>&5R M8VES92!P65A2P@ M870@5'=O($AU;F1R960@5&AO=7-A;F0@*#(U,"PP,#`I('-H87)E"`H-BD@;6]N=&@@;&]C M:RUU<"!A9W)E96UE;G0-"F%N9"!A(%1W96YT>2!3979E;B`H,C2!H87,@;F]T('!A:60@37(N($=A M;&QA9VAE2<^4V5E($YO=&4@.2!F;W(@86X@=7!D871E(&]N('1H92!A8W%U:7-I=&EO M;@T*;V8@=&AE(%-U8FIE8W0@3$Q#)B,Q-#8[6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2<^/&(^-RX@/&9O;G0@2<^5&AE($-O;7!A;GD@6QE/3-$)V9O;G0Z(#$P<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2!H87,@97-T:6UA=&5D('1H92!V M86QU90T*;V8@8V]M;6]N('-T;V-K(&EN=&\@=VAI8V@@=&AE(&]P=&EO;G,@ M87)E(&5X97)C:7-A8FQE(&%T("0T('!E2!M M;W-T(&5Q=6ET>2!A;F%L>7-T'!E;G-E(&ES(&%N(&5S=&EM871E(&%N9"!S:6=N:69I8V%N="!J M=61G;65N="!W87,@:6YV;VQV960@:6X@871T96UP=&EN9PT*=&\@9&5T97)M M:6YE('1H92!V86QU92!O9B!C;VUM;VX@2P@ M86YD(&YO('-T;V-K(&AA2!S=6)S97%U96YT;'D@;&EC96YS M960@2!D;V5S(&YO="!H879E(&%N>2!O9F9E M2!S M=&%G92P@86YD(&YO('-T;V-K(&ES(')E9VES=&5R960@9F]R(')E&-H86YG92!#;VUM:7-S:6]N+CPO M<#X-"@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU65A2P@=VAI8V@@=V5R90T*:6YC;'5D960@:6X@9V5N97)A;"!A M;F0@861M:6YIF5D(&-O;7!E;G-A=&EO;@T*8V]S="!R96QA=&5D('1O('5N=F5S=&5D M('-T;V-K+6)A2`R+C(U('EE87)S+CPO<#X-"@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`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`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q,B4[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^ M#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M65A6QE M/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&QI;F4M:&5I M9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E65A6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE65A6QE/3-$)W9E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&QI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H-"@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2!4'0^)SQS<&%N/CPO2!4'0^)SQP('-T>6QE/3-$)VUA6QE M/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M=')A;G-F;W)M.B!U<'!E6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T+VYO2!A;F0@4WEN97)G:7-T:6,@2&]L9&EN9W,L#0I,3$,@*"8C,30W.U-Y M;F5R9VES=&EC)B,Q-#@[*2P@82!C;VYT2P@86=R965D('1O(&-A;F-E;"`W.38L-C28C,30V.W,-"F-O;6UO;B!S=&]C:R!O=VYE9"!B M>2!3>6YE2!E;G1E6YE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C934P83%F-E\R8V,Q7S1D,&9?.64Q.5\Y96$V83%F83(T-#$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V4U,&$Q9C9?,F-C,5\T9#!F7SEE M,3E?.65A-F$Q9F$R-#0Q+U=O'0O:'1M;#L@8VAA'0M M86QI9VXZ(&IU6QE/3-$)W1E>'0M=')A M;G-F;W)M.B!U<'!E2!H M87,@;F]T(')E8V]G;FEZ960@86X@:6YC;VUE('1A>`T*8F5N969I="!F;W(@ M:71S(&]P97)A=&EN9R!L;W-S97,@9V5N97)A=&5D(&)A2!T;R!G96YE2!A M('9A;'5A=&EO;B!A;&QO=V%N8V4@97-T86)L:7-H960@86=A:6YS="!D969E M0T*=&AA;B!N;W0N($EN(&9U='5R92!P97)I;V1S+"!T M87@@8F5N969I=',@86YD(')E;&%T960@9&5F97)R960@=&%X(&%S&EM871E;'D@)#(L-3DP+#`P,"!A="!T:&4@ M969F96-T:79E('-T871U=&]R>2!R871E2!T:&4@>65A3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C934P83%F-E\R8V,Q7S1D,&9? M.64Q.5\Y96$V83%F83(T-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO8V4U,&$Q9C9?,F-C,5\T9#!F7SEE,3E?.65A-F$Q9F$R-#0Q+U=O'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^/&(^)B,Q-C`[/"]B/CPO<#X- M"@T*/'`@2<^3VX@3V-T;V)E2!E;G1E6UE;G0@86=R965M96YT('=I=&@@1&%N:65L($9R M965M86X@87,@=&AE($-H:65F($9I;F%N8VEA;"!/9F9I8V5R("@F(S$T-SM# M1D\F(S$T.#LI(')E<&]R=&EN9R!T;R!*;VAN(%=A;&QI;BP@0T5/#0IO9B!! M8V-E;&5R82X@26X@8V]N2!B87-I2!3979E M;B`H,C2!$86YI96P@82!B87-E('-A;&%R>2!O M9B`D,C`P+#`P,"!P97(@>65A6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYOBP@5FER9VEL:6$@079I;&$L($UA($QO=7)D97,@4F5Y97,@ M0V5L:6-I;W5S+"!#2!,86-A8F$@*&-O;&QE8W1I=F5L>2P@=&AE("8C,30W.U-E M;&QE2!A M9W)E960@=&\@<'5R8VAA6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU2!W:71H(&5X96-U=&EO;B!O9B!T:&4@4W1O8VL@4'5R M8VAA2!T:&4@26QL:6YO:7,@1&5P87)T;65N="!O9B!0=6)L M:6,-"DAE86QT:"X@4'5R'!E;G-E6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2!);G9E2!O9B!A;B!A9V=R96=A=&4@;V8@)#4P M,"PP,#`@=&\@=&AE($-O;7!A;GD@86YD($%,32P@=&AE($-O;7!A;GD-"F%N M9"!!3$T@97AE8W5T960@86YD(&1E;&EV97)E9"!A('!R;VUI2`Q-2P@,C`Q-2!A;F0@8F5A28C,30V.W,@8V]M;6]N#0IS=&]C:RP@=VAI8V@@:6YT97)E M2!A;F0@04Q-(&9A:6P@=&\@<&%Y(&%N M>2!P;W)T:6]N(&]F('!R:6YC:7!A;`T*;W(@:6YT97)E2!P3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!T:&4@ M3F]T92!W:&5N(&1U92P@*&EI*2!T:&4@0V]M<&%N>2!O&ES="P@;W(@86YY(&9I M;F%L#0IA;F0@;F]N87!P96%L86)L92!O2!T;R!P87D@:71S M(&1E8G1S(&%S('1H97D@8F5C;VUE(&1U92P@;W(@;6%K97,@82!G96YE2!O2!B86YK M3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!I;G1E;F1S M('1O(&]P97)A=&4@=&AE#0IN97=L>2!A8W%U:7)E9"!B=7-I;F5S6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO2!R M96-E:79E9`T*3F]T:6-E(&]F($1E9F%U;'0@=6YD97(@=&AE(%!U6UE;G0@06=R965M96YT(&)E M='=E96X-"G1H92!#;VUP86YY(&%N9"!2;W-E($TN($=A;&QA9VAE6UE;G0@06=R965M96YT)B,Q-#@[*3L@3F]T:6-E(&]F#0I$ M969A=6QT('5N9&5R('1H92!%;7!L;WEM96YT($%G3L@8F%C:V=R;W5N9"UC;VQO M2!T:&4@0V]M<&%N>2!I2!!<')I M;`T*,3,L(#(P,30[("@T*2!O=V5S(%)O&EM871E;'D@)#$Q-"PU,#`@:6X@97AP96YS97,@<&5R2!F=6YD M960@;VX@8F5H86QF(&]F('1H92!#;VUP86YY(&)Y(&AE2!S86QA2X@5&AE M($-O;7!A;GD@:7,@:6X@9&ES8W5S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQP('-T>6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0^)SQP('-T>6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T+VYO'0^)SQP('-T>6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!B M96QI979EFEN9R!R979E;G5E(&%T('1H92!T:6UE M('1H92!S97)V:6-E2<^0T]35"!/1B!2159%3E5%4R`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`@3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU2!I;B!);F-O;64@5&%X97,F(S$T.#L@ M*$%30R`W-#`M,3`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`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@=&]P.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&IU3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M2<^4D5#14Y4 M($%#0T]53E1)3D<@4%)/3D]53D-%345.5%,\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T+VYO2`R,#$R+"!T:&4@0V]M<&%N>0T*861O<'1E9"!!4U4@3F\N(#(P,3$M,#0L M($%M96YD;65N=',@=&\@06-H:65V92!#;VUM;VX@1F%I&ES=&EN9R!R97%U:7)E;65N=',@=6YD97(@05-##0I4 M;W!I8R`X,C`L($9A:7(@5F%L=64@365A2<^169F96-T:79E($IA;G5A2<^06UE;F1M96YT65A2<^26X@1&5C96UB97(@,C`Q,2P@5&AE($9!4T(@:7-S=65D($%350T* M3F\N(#(P,3$M,3$L($)A;&%N8V4@4VAE970@*%1O<&EC(#(Q,"DZ($1I2!F;W(@9FES8V%L('EE M87)S+"!A;F0@:6YT97)I;2!P97)I;V1S('=I=&AI;B!T:&]S92!Y96%R6QE/3-$)V9O;G0Z M(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO M2`R,#$S+"!T:&4@ M1D%30B!I2!I2P@=&AE(&%D;W!T:6]N(&]F($%352`R,#$S+3`R('=I;&P@:&%V90T* M;VX@:71S(&-O;G-O;&ED871E9"!F:6YA;F-I86P@6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T+VYO28C,30V.W,-"G!R97-E;G0@ M;W(@9G5T=7)E(&-O;G-O;&ED871E9"!F:6YA;F-I86P@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M934P83%F-E\R8V,Q7S1D,&9?.64Q.5\Y96$V83%F83(T-#$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V4U,&$Q9C9?,F-C,5\T9#!F7SEE,3E? M.65A-F$Q9F$R-#0Q+U=O'0O:'1M;#L@8VAA2!O9B!T:&4@ M;W5T6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T($-A;&EB M6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,B4[('1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,B4[('1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!C96YT97([(&QI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'!I6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'!I6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q+C5P="!S;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&QI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3PO9F]N=#X\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M/"]T6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6YE'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO2!);G1E'0^)S,P('EE87)S/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!B M>2!T:&4@96YT:71Y(&%S('!E6%B;&4@5VET:&EN($5I9VAT M965N($UO;G1H'0^)SQS<&%N/CPO2!B>2!T:&4@96YT:71Y(&%S M('!E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO2!T:&4@96YT M:71Y+"!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S,V(&UO;G1H'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)T-O;6UO;B!S:&%R97,@870@=&AE('!R:6-E(&]F('1H92!L97-S M97(@;V8@*&$I("0W+C`P(&]R("AB*2`Q,3`E(&]F('1H92!L;W=E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^4V5P(#,L#0H) M"3(P,3@\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(W M(&UO;G1H'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8U,"PP M,#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)S(@>65A'0^)S(@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO&5R M8VES92!0&5R8VES92!0'0^)SQS<&%N/CPO7,\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&EM=6T@6TUE;6)EF%T:6]N(&5X<&5N'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!$:7-C;&]S=7)E M(%M!8G-T"!A"!S=&%T=71O65A'0^)SQP('-T>6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0O,3$U)2!#86QI8G)I+"!(96QV971I8V$L M(%-A;G,M4V5R:68[(&UA'!I"!E>'!E;G-E("AB96YE9FET M*3PO=&0^#0H@("`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO2!C;VUP M86YY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO&UL/@T*+2TM+2TM/5].97AT4&%R=%]C934P83%F-E\R >8V,Q7S1D,&9?.64Q.5\Y96$V83%F83(T-#$M+0T* ` end XML 17 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details Narrative) (USD $)
 0 Months Ended 0 Months Ended 12 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 13, 2013
Employment Agreement [Member]
Rose M. Gallagher [Member]
Dec. 13, 2013
Employment Agreement [Member]
Daniel P. Gallagher [Member]
Oct. 01, 2014
Subsequent Event [Member]
AOK Property Investments LLC [Member]
Promissory Note [Member]
Aug. 25, 2014
Subsequent Event [Member]
Stock Purchase Agreement [Member]
SCI Home Health, Inc [Member]
Oct. 06, 2014
Subsequent Event [Member]
Employment Agreement [Member]
Daniel Freeman [Member]
Dec. 13, 2013
Subsequent Event [Member]
Employment Agreement [Member]
Rose M. Gallagher, Daniel P. Gallagher And Shawn D. Gallagher [Member]
Dec. 13, 2014
Subsequent Event [Member]
Employment Agreement [Member]
Rose M. Gallagher, Daniel P. Gallagher And Shawn D. Gallagher [Member]
Dec. 13, 2013
Subsequent Event [Member]
Employment Agreement [Member]
Rose M. Gallagher [Member]
Dec. 13, 2014
Subsequent Event [Member]
Employment Agreement [Member]
Daniel P. Gallagher [Member]
Oct. 01, 2014
Stock Purchase Agreement [Member]
AOK Property Investments LLC [Member]
Promissory Note [Member]
Issuance of stock option to purchase of common stock, shares       1,000,000 1,000,000     1,000,000 3,000,000        
Option exercise price per share       $ 0.0001 $ 0.0001     $ 0.0001          
Issuance of Stock option vested shares, number 6,400,000 5,400,000 3,000,000 250,000 250,000     1,000,000          
Stock option vested, percentage               23.33%          
Remaining shares granted under the option vested on Monthly basis period               46 months          
Lock up agreement for sale of shares       6 months 6 months     6 months          
Leak out agreement for sale of shares       27 months 27 months     27 months          
Base salary               $ 200,000     $ 73,500 $ 36,000  
Value of common stock agree to purchase by the company             450,000            
Purchase of common stock value was paid, concurrently             20,000            
Remaining amount paid at the time of license transfer             430,000            
Debt instrument, principal amount                         500,000
Debt instrument, due date           Jan. 15, 2015              
Issuance of common stock, shares           500,000              
Accrue interest payable at the rate of share of common stock           1,667              
Deposits                   920,000      
Personal expenses funded on behalf by company                       $ 114,500  
XML 18 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details Narrative) (USD $)
 9 Months Ended
Sep. 30, 2014
Income Tax Disclosure [Abstract]  
Deferred tax assets, operating loss carryforwards $ 2,590,000
Effective income tax statutory rates, expiration year

Effective statutory rates which will expire by the year 2032.
Deferred income tax expense (benefit)   
Current income tax expense (benefit)   
XML 19 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisition - Behavioral Health Care Associates, Ltd.
 9 Months Ended
Sep. 30, 2014
Business Combinations [Abstract]  
Acquisition - Behavioral Health Care Associates, Ltd.

3. ACQUISITION – BEHAVIORAL HEALTH CARE ASSOCIATES, LTD.

 

On November 20, 2013, Accelera executed a Stock Purchase Agreement (the “SPA”) and its wholly owned subsidiary, Accelera Healthcare Management Service Organization LLC (“Accelera HMSO”), executed an Operating Agreement with Blaise J. Wolfrum, M.D. and Behavior Health Care Associates, Ltd. (“BHCA”). Accelera acquired 100% of the 100,000 issued and outstanding shares of BHCA from Dr. Wolfrum. Accelera HMSO as a wholly owned subsidiary of Accelera will operate BHCA in accordance with the Operating Agreement.

 

Pursuant to the SPA, the Company shall pay to Dr. Wolfrum Four Million Five Hundred Fifty Thousand Dollars ($4,550,000), (the “Purchase Price”), of which One Million Dollars (1,000,000) shall be payable Ninety (90) days from the date of Closing and, the amount of Seven Hundred Fifty Thousand Dollars ($750,000) shall be paid One Hundred and Eighty (180) days from Closing, the aforementioned payments dates has been verbally extended until the Company receives financing. The balance of the Purchase Price, Two Million Eight Hundred Thousand Dollars ($2,800,000), shall be paid in Three (3) payments of Seven Hundred Fifty Thousand Dollars $($750,000) and a final payment of Five Hundred Fifty Thousand Dollars ($550,000) beginning Two Hundred Seventy (270) days after closing, and every three months thereafter until the Purchase Price is paid in full.
XML 20 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current Assets    
Cash $ 274,857 $ 185,744
Accounts receivable, net 455,995 753,707
Advances to others 17,540   
Advances to related parties 18,253   
Prepaid expenses 3,785   
Refundable income taxes 12,000   
Total Current Assets 782,430 939,451
Other Asset    
Goodwill 4,403,819 5,030,576
TOTAL ASSETS 5,186,249 5,970,027
Current Liabilities    
Accounts Payable 50,174   
Due to stockholders    419,084
Short-Term Note Payable    8,041
Advances from related parties 96,586   
Accrued expenses 132,628 35,418
Total Current Liabilities 279,388 462,543
Long-term subordinated unsecured notes payable 5,970,000 5,970,000
TOTAL LIABILITIES 6,249,388 6,432,543
Stockholders' Deficit    
Preferred stock; $0.0001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding      
Common stock; $0.0001 par value, 100,000,000 authorized, 34,380,022 and 22,382,522 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively 3,439 2,239
Additional paid in capital 18,492,738 12,227,526
Accumulated deficit (19,559,316) (12,692,281)
TOTAL STOCKHOLDERS' DEFICIT (1,063,139) (462,516)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 5,186,249 $ 5,970,027
XML 21 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Background Information
 9 Months Ended
Sep. 30, 2014
Background Information  
Background Information

1. BACKGROUND INFORMATION

 

Accelera Innovations, Inc., formerly Accelerated Acquisitions IV, Inc. (“Accelera” or the “Company”) was incorporated in the State of Delaware on April 29, 2008 for the purpose of raising capital intended to be used in connection with its business plan which may include a possible merger, acquisition or other business combination with an operating business.

 

On June 13, 2011, Synergistic Holdings, LLC (“Purchaser”) agreed to acquire 17,000,000 shares of the Company’s common stock par value $0.0001 per share. At the same time, Accelerated Venture Partners, LLC agreed to tender 3,750,000 of their 5,000,000 shares of the Company’s common stock par value $0.0001 for cancellation. Following these transactions, Synergistic Holdings, LLC owned 93.15% of the Company’s 18,250,000 issued and outstanding shares of common stock par value $0.0001 and the interest of Accelerated Venture Partners, LLC was reduced to approximately 6.85% of the total issued and outstanding shares. Simultaneously with the share purchase, Timothy Neher resigned from the Company’s Board of Directors and John Wallin was simultaneously appointed to the Company’s Board of Directors. Such action represented a change of control of the Company.

 

On October 18, 2011, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware and changed its name from Accelerated Acquisition IV, Inc. to “Accelera Innovations, Inc.”

 

Accelera is a healthcare service company which is focused on implementing its licensed proprietary Internet-based software for use in the healthcare industry The technology was licensed to the Company by our majority shareholder, Synergistic Holdings, LLC (“Synergistic”). Synergistic granted the Company a 30-year exclusive, non-transferrable worldwide license for a proprietary Internet-based, software platform that is fully functional in its current state (“Accelera Technology”) and that is designed to provide interoperable technology that is intended to improve the quality of care while reducing healthcare costs.
XML 22 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Operations and Basis of Presentation (Details Narrative) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Apr. 11, 2013
Home Health Management LLC And All Staffing Services LLC [Member]
Nov. 29, 2013
Behavioral Health Care Associates, Ltd [Member]
Equity ownership percentage             100.00% 100.00%
Cash $ 274,857 $ 50 $ 274,857 $ 50 $ 185,744       
Goodwill impairment loss $ (692,668)    $ (692,668)           
XML 23 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details Narrative) (USD $)
 9 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]        
Option exercisable price per share $ 4      
Proceeds from issuance of private placements $ 85,000,000      
Cumulative fair value of options granted 16,640,000 16,640,000   16,640,000
Share based compensation amount 4,700,000 6,940,000   5,000,000
Unrecognized compensation cost related to unvested stock-based compensation awards $ 10,610,000      
Weighted Average Remaining Term Vested, Options outstanding, Ending Balance 2 years 3 months   2 years 8 months 12 days  
Number of shares reserved for issuance under stock award plan 8,595,630      
Remaining stock available for future issuance 8,595,630      
XML 24 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Going Concern
 9 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern

2. GOING CONCERN

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has had minimal revenue since inception and had an accumulated deficit of $19,559,316 as of September 30, 2014. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes until such time that funds provided by operations are sufficient to fund working capital requirements.

 

The Company is currently substantially dependent upon technology licensed from Synergistic. The events or circumstances that may prevent the accomplishment of our business objectives, include, with limitation, (i) the fact that, if the Company does not raise a minimum of $12,500,000 by August 13, 2015, an additional $10,000,000 by August 13, 2016, and an additional $7,500,000 by August 13, 2017, equaling the minimum funding requirement of $30,000,000 for the deployment of its licensed technology over the next three years the Company will lose the rights to the licensed technology.

 

The condensed consolidated financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.
XML 26 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common Stock, shares issued 34,380,022 22,382,522
Common stock, shares outstanding 34,380,022 22,382,522
XML 27 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Outstanding Options

The following is a summary of the outstanding options, as of September 30, 2014:

 

          Weighted Average
    Options
Outstanding		     Intrinsic
Value		     Exercise
Price		     Remaining
Term
                       
Options, December 31, 2012     3,000,000                      
Granted     3,185,000       4.00       0.0001     3 years
Exercised     (785,000 )                    
Forfeited/expired     -                      
Options, December 31, 2013     5,400,000       4.00       0.0001     2.7 years
Granted     1,000,000                      
Exercised     -                      
Forfeited/expired                            
Options, September 30, 2014     6,400,000       4.00       0.0001     2.25 years
Vested at September 30, 2014     4,160,000       4.00       0.0001     2.25 years
Schedule of Weighted Average Assumptions Value

Weighted average assumptions in the calculation of option value:              
               
Historical Volatility     268.0 %      
Risk Free Rate     0.83 %      
Dividend Yield     0.00 %      
Forfeiture Rate     0.00 %      
XML 28 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
 9 Months Ended
Sep. 30, 2014
Nov. 17, 2014
Document And Entity Information    
Entity Registrant Name ACCELERA INNOVATIONS, INC.  
Entity Central Index Key 0001444144  
Document Type 10-Q  
Document Period End Date Sep. 30, 2014  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   34,882,522
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2014  
XML 29 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Background Information (Details Narrative) (USD $)
 0 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Jun. 13, 2011
Synergistic Holdings LLC [Member]
Jun. 13, 2011
Accelerated Venture Partners, LLC [Member]
Number of shares agreed to acquire by entity     17,000,000  
Common stock par value $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Number of stock shares for tender issuance       3,750,000
Number of shares agree to issue for cancellation       5,000,000
Equity ownership percentage     93.15% 6.85%
Common stock, shares issued 34,380,022 22,382,522 18,250,000  
Common stock, shares outstanding 34,380,022 22,382,522 18,250,000  
Non transferrable worldwide license for proprietary Internet-based, software platform     30 years  
XML 30 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
Revenues $ 844,008    $ 2,500,341   
Cost of revenues 600,928    1,726,509   
Gross Profit 243,080    773,832   
General and administrative 1,261,062 1,005,050 2,248,199 3,724,265
Stock compensation 1,650,000    4,700,000 3,650,100
Total Operating Expenses 2,911,062 1,050,050 6,948,199 3,724,265
Goodwill impairment (692,668)    (692,668)   
Income Tax Provision            
NET LOSS $ (3,360,650) $ (1,005,050) $ (6,867,035) $ (3,724,265)
BASIC AND DILUTED LOSS PER SHARE $ (0.10) $ (0.05) $ (0.21) $ (0.17)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING 34,380,022 21,511,812 32,380,439 21,509,614
XML 31 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation

7. Stock-based Compensation

 

The Company recognizes stock-based compensation expense in its statement of operations based on estimates of the fair value of employee stock options and stock grant awards as measured on the grant date. For stock options, the Company uses the Black-Scholes option pricing model to determine the value of the awards granted. The Company amortizes the estimated value of the options as of the grant date over the stock options’ vesting period, which is generally four years.

 

The Company has estimated the value of common stock into which the options are exercisable at $4 per share for financial reporting purposes. This amount was determined based on the price our stock was sold for in past private placements, the minimum stock price required for listing on any Nasdaq market, and the amount also approximates a $85 million valuation for the entire Company, which is considered “micro-cap” by most equity analysts. The stock based compensation expense is an estimate and significant judgment was involved in attempting to determine the value of common stock. The Company’s common stock has never traded publicly, and no stock has traded in private markets either, except for privately negotiated sales to the founder and other private investors of the company and the founder of the technology from which the company subsequently licensed rights. The Company does not have any offers for purchase of its common stock in any stage, and no stock is registered for resale with the Securities and Exchange Commission.

 

The Company believes the only material estimate used in estimating the value stock options was the estimated fair value of the common stock, and that assumed volatility, term, interest rate and dividend yield changes would not result in material differences in stock option valuations. Based on the assumed value of common stock, the grant-date cumulative fair value of options granted during the nine months ended September 30, 2014, year ended 2013, and the year ended 2012 was $16,640,000. The Company recognized stock-based compensation expense of $4,700,000, $6,940,000 and $5,000,000 for the nine months ended September 30, 2014, and years ended 2013 and 2012, respectively, which were included in general and administrative expenses. As of September 30, 2014, there was $8,960,000 of total unrecognized compensation cost related to unvested stock-based compensation awards, which is expected to be recognized over the weighted average remaining vested period of approximately 2.25 years.

 

The following is a summary of the outstanding options, as of September 30, 2014:

 

          Weighted Average
    Options
Outstanding		     Intrinsic
Value		     Exercise
Price		     Remaining
Term
                       
Options, December 31, 2012     3,000,000                      
Granted     3,185,000       4.00       0.0001     3 years
Exercised     (785,000 )                    
Forfeited/expired     -                      
Options, December 31, 2013     5,400,000       4.00       0.0001     2.7 years
Granted     1,000,000                      
Exercised     -                      
Forfeited/expired                            
Options, September 30, 2014     6,400,000       4.00       0.0001     2.25 years
Vested at September 30, 2014     4,160,000       4.00       0.0001     2.25 years
Weighted average assumptions in the calculation of option value:                            
                             
Historical Volatility     268.0 %                    
Risk Free Rate     0.83 %                    
Dividend Yield     0.00 %                    
Forfeiture Rate     0.00 %                    

 

The Company has reserved a total of 8,595,630 shares of common stock for issuance under its stock award plan, and 8,595,630 of these shares remained available for future issuance as of September 30, 2014.
XML 32 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Deficit
 9 Months Ended
Sep. 30, 2014
Equity [Abstract]  
Stockholders' Deficit

6. STOCKHOLDERS’ DEFICIT

 

The Company has two classes of stock preferred stock and common stock. There are 10 million shares of $.0001 par value preferred shares authorized. There have been no shares issued as of September 30, 2014. Preferred shares have not been defined for any preferences. There are 100 million shares of $.0001 par value common shares authorized. The Company has 34,380,022 and 22,382,522 issued and outstanding shares as of September 30, 2014 and December 31, 2013, respectively.

  

On April 26, 2012, the Company entered into an employment agreement with John F. Wallin, President and Chief Executive officer “CEO” of the Company. In consideration of the services, the Company agreed to issue a stock option to purchase 1,750,000 shares of the Company’s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (350,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (29,166 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Wallin provides that, upon completion of two million dollars in financing, the Company shall begin to pay John a base salary of $250,000 per year, to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at least annually, and increased as determined by the Board. So long as Mr. Wallin has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completion of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Wallin’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan targets to be determined by the Board.

 

On April 26, 2012, the Company entered into an employment agreement with James R Millikan, as the Chief Operating Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares if the Company’s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,000 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Millikan provides that, upon completion of two million dollars in financing, the Company shall begin to pay Jim a base salary of $175,000 per year, to be paid at the times and subject to the Company’s standard payroll practices subject to applicable withholding. Base salary shall be reviewed at lease annually, and increased as determined by the Board. So long as Mr. Millikan has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completing of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Millikan’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan Targets to be determined by the Board.

 

On April 26, 2012, the Company entered into an employment agreement with Cynthia Boerum, as the Chief Strategic Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $.0001 per share, vesting over a four year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,666 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Ms. Boerum provides that, upon completion of two million dollars in financing, the Company shall begin to pay Cynthia a base salary of $150,000 per year, to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at lease annually, and increased as determined by the Board. So long as Ms. Boerum has not been terminated for cause, as defined in the employment agreement, she will be eligible for bonus compensation, payable immediately following completion of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Ms. Boerum’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan Targets to be determined by the Board.

 

On January 1, 2013, the Company entered into an employment agreement with Patrick Custardo, as the Chief Acquisitions Officer of the Company reporting to the President and CEO. In consideration of the services, the Company agreed to issue a stock option to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $.0001 per share, vesting over a four-year period. The stock option shall vest with respect to 20% of the total number of shares which are the subject of the option (200,000 shares) immediately after the effective date of the agreement, thereafter the remaining shares granted under the option shall vest ratably on a monthly basis (16,666 shares per month) at the end of each month over a 48-month period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from this agreement and others shall immediately vest and become fully exercisable. The employment agreement with Mr. Custardo provides that, upon completion of two million dollars in financing, the Company shall begin to pay Patrick a base salary of $150,000 per year, to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Base salary shall be reviewed at least annually, and increased as determined by the Board. So long as Mr. Custardo has not been terminated for cause, as defined in the employment agreement, he will be eligible for bonus compensation, payable immediately following completion of the Company’s financial statements for each full fiscal year, commencing with the 2013 fiscal year. Mr. Custardo’s annual bonus targets are still being developed by the Company and will be adjusted from time to time, based upon the Company’s achieving 100% of certain financial metrics plan Targets to be determined by the Board.

 

On October 4, 2013, the Company entered into a Standby Equity Purchase Agreement with Lambert Private Equity, LLC, a Delaware limited liability company (the “Investor”). Pursuant to the Investment Agreement, the Investor committed to purchase, subject to certain restrictions and conditions, up to $100,000,000 (which can be extended to $200,000,000 under the same terms) of the Company’s common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by the Investor pursuant to the Investment Agreement (the “Equity Line”).

  

The Company may draw on the facility from time to time, as and when it determines appropriate in accordance with the terms and conditions of the Investment Agreement. The maximum amount that the Company is entitled to put to the Investor in any one draw down notice is no more than $2,000,000 and not exceeding 285,710 shares. The purchase price shall be set at ninety percent (90%) of the lowest daily volume weighted average price (VWAP) of the Company’s common stock during the fifteen (15) consecutive trading day period beginning on the date of delivery of the applicable draw down notice. The Company has the right to withdraw all or any portion of any put, except that portion of the put that has already been sold to a third party, including any portion of a put that is below the minimum acceptable price set forth on the put notice, before the closing. There are put restrictions applied on days between the draw down notice date and the closing date with respect to that particular put. During such time, the Company shall not be entitled to deliver another draw down notice. In addition, the Investor will not be obligated to purchase shares if the Investor’s total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company’s common stock as determined in accordance with Rule 13d-1(j) of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the facility unless there is an effective registration statement (as further explained below) to cover the resale of the shares.

 

The Investment Agreement further provides that the Company and the Investor are each entitled to customary indemnification from the other for, among other things, any losses or liabilities they may suffer as a result of any breach by the other party of any provisions of the Investment Agreement or Registration Rights Agreement (as defined below), or as a result of any lawsuit brought by a third-party arising out of or resulting from the other party’s execution, delivery, performance or enforcement of the Investment Agreement.

 

The Investment Agreement also contains customary representations and warranties of each of the parties. The assertions embodied in those representations and warranties were made for purposes of the Investment Agreement and are subject to qualifications and limitations agreed to by the parties in connection with negotiating the terms of the Investment Agreement. In addition, certain representations and warranties were made as of a specific date, may be subject to a contractual standards of materiality different from what a shareholder or investor might view as material, or may have been used for purposes of allocating risk between the respective parties rather than establishing matters of facts. Investors should read the Investment Agreement together with the other information concerning the Company publicly files in reports and statements with the Securities and Exchange Commission (the “SEC”).

 

Pursuant to the terms of a Registration Rights between the Company and the Investor (the “Registration Rights”), the Company is obligated to file one or more registrations statements with the SEC to register the resale by Investor of the shares of common stock issued or issuable under the Investment Agreement. In addition, the Company is obligated to use all commercially reasonable efforts to have the registration statement declared effective by the SEC within 180 days after the registration statement is filed.

 

As an inducement to Investor to enter in to the Investment Agreement and as consideration for the Investor making the investment the Investor received 285,710 shares of common stock and 100% warrant/option coverage. The option to purchase shares certified that for good and valuable consideration, the receipt and sufficiency of which was acknowledged, Lambert Private Equity, LLC is entitled effective as October 4, 2013, subject to the terms and conditions of the Option to purchase from the Company up to a total of 14,287,710 shares of the Company’s common shares at the price of the lesser of (a) $7.00 or (b) 110% of the lowest daily VWAP for the common stock as reported by Bloomberg during the thirty (30) trading days prior to the date the Investor exercised the Warrant prior to 5:00 pm New York time on September 3, 2018 the expiration date.

 

On November 20, 2013, the Company entered into an employment agreement with Blaise J. Wolfrum, M.D., as the President of the Accelera business unit “Behavioral Health Care Associates” reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase Six Hundred Thousand (600,000) shares of the Company’s Common Stock under the terms of the Company’s 2011 Stock Option Plan at an exercise price of $.0001 per share. The Six Hundred Thousand (600,000) shares shall vest over the course of the Three (3) years, earned annually, at Two Hundred Thousand (200,000) shares each year; after the commencement of employment so long as he remain an employee of the Company. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from the agreement shall immediately vest and become fully exercisable. The employment agreement with Dr. Wolfrum provides that the Company shall pay Blaise a base salary of $300,000 per year to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Mr. Wolfrum will begin receiving compensation at the time Accelera completes the Due Diligence, Valuation and Audited Financials of the Behavioral Health Care Associates business performed by an Accelera appointed audit firm. The Board of Directors will implement a bonus structure based on goals, objectives and performance.

 

On December 13, 2013 Accelera entered into a three-year Employment Agreement with Rose M. Gallagher as the President of Accelera’s At Home Health Care business unit reporting to John Wallin, Accelera’s CEO. In consideration of the services, Accelera agreed to immediately grant Ms. Gallagher 585,000 common shares at a price of $0.0001 per share, and an option to purchase 1,000,000 common shares at a price of $0.0001 per share, to be vested Two Hundred and Fifty Thousand (250,000) shares annually for 4 years, beginning March 12, 2014; the final vested shares on March 12, 2017, all the shares will be issued in accordance with the terms of the Accelera’s 2011 Stock Option Plan. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Additionally, Accelera agreed to compensate Ms. Gallagher $150,000 per annum, which is payable bi-weekly in accordance with the Company’s customary payroll practices. The Company has not paid Ms. Gallagher the amounts due under this agreement.

  

On December 13, 2013, the Company entered into an employment agreement with Daniel P. Gallagher, as the Director of Marketing and Business Development of the Accelera business units “At Home Health Services and At Home Health Management” reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase One Million (1,000,000) shares of the Company’s Common Stock under the terms of the Company’s 2011 Stock Option Plan at an exercise price of $.0001 per share. The One Million (1,000,000) shares shall vest over the course of the Four (4) years, earned annually, at Two Hundred Thousand (250,000) shares each year; beginning March 12, 2014; the final vested shares on March 12, 2017. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Additionally, Accelera agreed to compensate Mr. Gallagher $100,000 per annum, which is payable bi-weekly in accordance with the Company’s customary payroll practices. The Company has not paid Mr. Gallagher the amounts due under this agreement.

 

See Note 9 for an update on the acquisition of the Subject LLC’s and employment agreements with Ms. Gallagher and Mr. Gallagher.

 

During the nine month period ended September 30, 2014, the Company agreed to issue 796,671 shares of its unregistered common stock for an aggregate of $1,566,412.26 previously subscribed for by investors.
XML 33 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Deficit (Details Narrative) (USD $)
 3 Months Ended 9 Months Ended 0 Months Ended 0 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Oct. 04, 2013
Equity Purchase Agreement [Member]
Lambert Private Equity, LLC [Member]
Oct. 04, 2013
Equity Purchase Agreement [Member]
Lambert Private Equity, LLC [Member]
Warrant [Member]
Oct. 04, 2013
Equity Purchase Agreement [Member]
Lambert Private Equity, LLC [Member]
Oct. 04, 2013
Equity Purchase Agreement [Member]
Lambert Private Equity, LLC [Member]
Minimum [Member]
Oct. 04, 2013
Equity Purchase Agreement [Member]
Lambert Private Equity, LLC [Member]
Maximum [Member]
Apr. 26, 2012
Employment Agreement [Member]
John F. Wallin [Member]
Apr. 26, 2012
Employment Agreement [Member]
James R. Millikan [Member]
Apr. 26, 2012
Employment Agreement [Member]
Cynthia Boerum [Member]
Jan. 02, 2013
Employment Agreement [Member]
Patrick Custardo [Member]
Nov. 20, 2013
Employment Agreement [Member]
Blaise J. Wolfrum, M.D [Member]
Dec. 13, 2013
Employment Agreement [Member]
Rose M. Gallagher [Member]
Dec. 13, 2013
Employment Agreement [Member]
Daniel P. Gallagher [Member]
Preferred stock, shares authorized 10,000,000   10,000,000   10,000,000                          
Preferred stock, par value $ 0.0001   $ 0.0001   $ 0.0001                          
Preferred stock, shares issued 0   0   0                          
Common stock, shares authorized 100,000,000   100,000,000   100,000,000                          
Common stock, par value $ 0.0001   $ 0.0001   $ 0.0001                          
Common stock, shares issued 34,380,022   34,380,022   22,382,522                          
Common stock, shares outstanding 34,380,022   34,380,022   22,382,522                          
Issuance of stock option to purchase of common stock, shares               14,287,710       1,750,000 1,000,000 1,000,000 1,000,000 600,000 1,000,000 1,000,000
Option exercise price per share                       $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Issuance of common stock in vesting period                       4 years 4 years 4 years 4 years 3 years 4 years 4 years
Stock option vested, percentage                       20.00% 20.00% 20.00% 20.00%      
Issuance of Stock option vested shares, number 6,400,000   6,400,000   5,400,000 3,000,000           350,000 200,000 200,000 200,000 600,000 250,000 250,000
Remaining shares granted under the option vested on Monthly basis                       29,166 16,000 16,666 16,666 200,000    
Remaining shares granted under the option vested on Monthly basis period                       48 months 48 months 48 months 48 months      
Completion base level for finance                       $ 2,000,000 $ 2,000,000 $ 2,000,000 $ 2,000,000      
Base salary                       250,000 175,000 150,000 150,000 300,000    
Annual bonus targets, percentage                       100.00% 100.00% 100.00% 100.00%      
Value of common stock agree to purchase by the entity                   100,000,000 200,000,000              
Common stock agree to purchase by the entity, period                 36 months                  
Maximum value of stock that company entitled to put to the investors             2,000,000                      
Maximum number of shares that company entitled to put to the investors             285,710                   585,000  
Percentage of purchase price based on the daily volume weighted average price             90.00%                      
Maximum percentage of shares held by the company for fullfill the investor's condition             4.99%                      
Number of shares issued by the company to investors                 285,710                  
Issuance of warrant/option, percentage               100.00%                    
Option issued to purchase common stock, description                 Common shares at the price of the lesser of (a) $7.00 or (b) 110% of the lowest daily VWAP.                  
Warrant expiration date               Sep. 03, 2018                    
Lock up agreement for sale of shares                               6 months 6 months 6 months
Leak out agrement for sale of shares                               27 months 27 months 27 months
Stock-based compensation expense 1,650,000    4,700,000 3,650,100                         150,000 100,000
Agreed to issue of unregistered common stock, value 10,610,000   10,610,000                              
Agreed to issue the share of unregistered common stock $ 796,671   $ 796,671                              
XML 34 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Going Concern (Details Narrative) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Accumulated deficit $ (19,559,316) $ (12,692,281)
Future minimum estimated amount for increase finite lived intangible assets 30,000,000  
August 13, 2015 [Member]
    
Future minimum estimated amount for increase finite lived intangible assets 12,500,000  
August 13, 2016 [Member]
    
Future minimum estimated amount for increase finite lived intangible assets 10,000,000  
August 13, 2017 [Member]
    
Future minimum estimated amount for increase finite lived intangible assets $ 7,500,000  
XML 35 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
 9 Months Ended
Sep. 30, 2014
Subsequent Events [Abstract]  
Subsequent Events

10. Subsequent Events

 

On October 6, 2014, the Company entered into an employment agreement with Daniel Freeman as the Chief Financial Officer (“CFO”) reporting to John Wallin, CEO of Accelera. In consideration of the services, the Company agreed to issue a stock option to purchase One Million (1,000,000) shares of the Company’s Common Stock at an exercise price of $.0001 per share. The One Million (1,000,000) shares shall vest with respect to 23.33% immediately after the effective date of the agreement, thereafter the remaining shares granted under the agreement shall vest ratably on a monthly basis at the end of each month over the course of a 46-month period. Furthermore, the shares are subject to a Six (6) month lock-up agreement and a Twenty Seven (27) month leak-out agreement limiting the sale of shares over the period. Notwithstanding the foregoing, in the event of a closing of a Change of Control transaction, all options from the agreement shall immediately vest and become fully exercisable. The employment agreement with Daniel Freeman provides that the Company shall pay Daniel a base salary of $200,000 per year to be paid at the times and subject to the Company’s standard payroll practices, subject to applicable withholding. Mr. Freeman will begin receiving compensation at the time Accelera completes one million dollars in financing. The Board of Directors will implement a bonus structure based on goals, objectives and performance.

 

On August 25, 2014, the Company entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with SCI Home Health, Inc. (d/b/a Advance Lifecare Home Health) (“SCI”), Ethel dela Cruz, Virgilia Avila, Ma Lourdes Reyes Celicious, Cristina Soriano, Michelle Cartas and Jimmy Lacaba (collectively, the “Sellers”), pursuant to which the Company agreed to purchase, and the Sellers agreed to sell, all their SCI shares, collectively representing all of the outstanding shares of common stock of SCI, for an aggregate purchase price of $450,000 (the “Stock Purchase”).

 

Pursuant to the terms of the Stock Purchase Agreement, the purchase price was paid as follows: (i) $20,000 via wire transfer concurrently with execution of the Stock Purchase Agreement, and (ii) $430,000 via wire transfer upon approval of the required license transfer by the Illinois Department of Public Health. Pursuant to the Stock Purchase Agreement, revenues generated by SCI, but received by the Company, after the closing of the Stock Purchase will belong to SCI, and SCI agreed to reimburse the Company for expenses generated by SCI after the closing of the Stock Purchase. The Stock Purchase Agreement contains customary representations and warranties and is subject to certain events of default.

 

On October 1, 2014, AOK Property Investments LLC (“AOK”), a third party lender, lent the Company and its subsidiary, Advanced Life Management LLC (“ALM”), an aggregate of $500,000. In consideration of AOK’s delivery of an aggregate of $500,000 to the Company and ALM, the Company and ALM executed and delivered a promissory note (the “Note”) in favor of AOK in the aggregate principal amount of $500,000. The Note is due on January 15, 2015 and bears interest in the amount of 500,000 shares of the Company’s common stock, which interest is due and payable on or before January 15, 2015. If the Company and ALM fail to pay any portion of principal or interest when due, interest will continue to accrue and be payable to AOK at the rate of 1,667 shares of Company common stock per day until all principal and accrued interest is fully paid. There is no prepayment penalty; provided, however, that the interest is due in full at the time of any prepayment.

 

If an event of default under the Note occurs AOK may accelerate the Note’s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. Pursuant to the terms of the Note, an event of default occurs if (i) the Company or ALM fails to make any payment required by the Note when due, (ii) the Company or ALM voluntarily dissolves or ceases to exist, or any final and nonappealable order or judgment is entered against the Company or ALM ordering its dissolution, (iii) the Company or ALM fails to pay, becomes insolvent or unable to pay, or admits in writing an inability to pay its debts as they become due, or makes a general assignment for the benefit of creditors; or (iv) a proceeding with respect to the Company or ALM is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law.

 

A portion of the proceeds of the loan from AOK was used by the Company to fund the Stock Purchase, which closed on October 7, 2014. The Company intends to operate the newly acquired business through ALM.

 

On October 16, 2014, the Company received Notice of Default under the Purchase Agreement executed between the Company and At Home Health Services, LLC and All Staffing Services, LLC on December 13, 2013 (the “Gallagher Purchase Agreement”); Notice of Default under the Employment Agreement between the Company and Rose M. Gallagher dated December 13, 2103 (the “Rose M. Gallagher Employment Agreement”); Notice of Default under the Employment Agreement between the Company and Daniel P. Gallagher dated December 13, 2013 (the “Daniel P. Gallagher Employment Agreement”); and Notice of Default from Rose M. Gallagher as Assignee of Share Interest under the Employment Agreement between Shawn D. Gallagher and At Home Health Management, LLC (collectively, the “Notices of Default”).

 

The Notices of Default allege, among other things, that the Company (1) failed to issue shares in accordance with the Purchase Agreement, whereby the Company is alleged to owe, pursuant to options contracts there under, Rose M. Gallagher, Daniel P. Gallagher and Shawn D. Gallagher a total of 3,000,000 shares of Company stock; (2) failed to make, pursuant to the Purchase Agreement, two deposits totaling $920,000; (3) failed to become listed, pursuant to the Purchase Agreement, on the NASDAQ on or before approximately April 13, 2014; (4) owes Rose M. Gallagher approximately $114,500 in expenses personally funded on behalf of the Company by her; and (5) failed to pay salaries pursuant to Rose M. Gallagher Employment Agreement and Daniel P. Gallagher Employment Agreement in amounts totaling $73,500.03 and $36,000 respectively. The Company is in discussion with the Gallagher’s, At Home Health Services, LLC and All Staffing Services, LLC to terminate this acquisition.
XML 36 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transaction
 9 Months Ended
Sep. 30, 2014
Related Party Transactions [Abstract]  
Related Party Transaction

8. Related Party Transaction

 

The Company and Synergistic Holdings, LLC (“Synergistic”), a controlling shareholder of the Company, agreed to cancel 796,671 shares of the Company’s common stock owned by Synergistic and forgive certain indebtedness owed by the Company to Synergistic in the amount of $1,018,618. In addition, the Company entered into an oral agreement to amend the license agreement entered into between the Company and Synergistic to reduce the total amount of reimbursable distribution and commercialization expenses due under the license agreement by $585,181 to $29,414,819 and defer the commencement date of the agreement until the payment dates for the following amounts:

 

  (a) $5,000,000 no later than December 31, 2015;
     
  (b) An additional $7,500,000 no later than December 31. 2016;
     
  (c) An additional $10.000,000 no later than December 31. 2017; and
     
  (d) An additional $6,914,819 no later than December 31. 2018.
XML 37 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
 9 Months Ended
Sep. 30, 2014
Income Tax Disclosure [Abstract]  
Income Taxes

9. Income Taxes

 

The Company has not recognized an income tax benefit for its operating losses generated based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the periods presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses and other temporary differences, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not. As of September 30, 2014, the Company had a loss and for the period April 29, 2008 (date of inception) through September 30, 2014. The net operating losses resulting from operating activities result in deferred tax assets of approximately $2,590,000 at the effective statutory rates which will expire by the year 2032. The deferred tax asset has been off-set by an equal valuation allowance. There are no current or deferred income tax expense or benefit recognized for the period ended September 30, 2014.
XML 38 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Operations and Basis of Presentation (Policies)
 9 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Use of Estimates

USE OF ESTIMATES – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash

CASH – All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had cash of $185,744 as of December 31, 2013 and $274,857 as of the nine months ended September 30, 2014.
Research and Development Expenses

RESEARCH AND DEVELOPMENT EXPENSES – Expenditures for research, development, and engineering of products are expensed as incurred.
Common Stock

 

COMMON STOCK – The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.
Revenue Recognition

REVENUE RECOGNITION – Revenue related to services and administrative support services is recognized at the time services have been performed. The Company believes that recognizing revenue at the time the services have been performed because the Company’s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, Revenue Recognition: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.
Cost of Revenues

COST OF REVENUES – Costs of revenues are comprised of fees paid to members of the Company’s medical staff other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.
Goodwill and Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS – Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at lease annually in accordance with the provisions of FASB ASC Topic 350, Intangibles – Goodwill and Other (“ASC 350”). The goodwill impairment test is a two-step test. Under the first step, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed. During September 2014, the Company recognized goodwill impairment of $692,668.
Advertising Costs

ADVERTISING COSTS – The Company’s policy regarding advertising is to expense advertising when incurred.
Income Taxes

INCOME TAXES – Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settle. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

The Company adopted the provisions of FASB ASC 740-10 “uncertainty in Income Taxes” (ASC 740-10), on January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
Loss Per Share

LOSS PER SHARE – Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. At September 30, 2014, the Company did not have any potentially dilutive common shares.
Financial Instruments

FINANCIAL INSTRUMENTS – In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

  ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
     
  ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  ● Level 3 – Inputs that are both significant to the fair value measurement and unobservable.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014. These financial instruments include stock options granted to the officers in 2013.
Recent Accounting Pronouncements

RECENT ACCOUNTING PRONOUNCEMENTS

 

Effective January 2012, the Company adopted ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (ASU 2011-04). ASU 2011-04 represents the converged guidance of the FASB nd the International Accounting Standards Board (IASB) on fair value measurement. A variety of measures are included in the update intended to either clarify existing fair value measurement requirements, change particular principles requirements for measuring air value or for disclosing information about fair value measurements. For many of the requirements, the FASB does not intend to change the application of existing requirements under ASC Topic 820, Fair Value Measurements. ASU 2011-04 was effective for interim and annual periods beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.

 

Effective January 2012, the Company adopted ASU No. 2011-05, Presentation of Comprehensive Income (ASU 2011-05). ASU 2011-05 is intended to increase the prominence of items reported in other comprehensive income and to facilitate convergence of accounting guidance in this area with that of the IASB. The amendments require that all nonowner changes in consecutive statements. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05 (ASU 2011-12 defers the provisions of ASU 2011-05 that require the presentation of reclassification adjustments on the fact of both the consolidated statement of income and statement of other comprehensive income.

 

Amendments under ASU 2011-05 that were not deferred under ASU 2011-12 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.

 

In December 2011, The FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities (ASU 2011-11). The amendments in ASU 2011-11 require the disclosure of information on offsetting and related arrangements for financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. Amendments under ASU 2011-11 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after January 1, 2013. The Company is evaluating the effect, if any, adoption of ASU 2011-11 will have on its consolidated financial statements.

 

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive (ASU 2013-02). This guidance is the culmination of the FASB’s deliberation on reporting reclassification adjustments from accumulated other comprehensive income (AOCI). The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income. However, the amendments require disclosure of amounts reclassified out of AOCI in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be classified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. The Company is evaluating the effect, if any, the adoption of ASU 2013-02 will have on its consolidated financial statements.

 

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the United States Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.
XML 39 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisition - at Home and All Staffing (Details Narrative) (Rose M. Gallagher [Member], USD $)
 0 Months Ended
Dec. 13, 2013
Amount Payable Within Ninety Days [Member]
  
Amount agree to pay by the entity as per purchase agreement $ 500,000
Purchase Agreement [Member]
  
Amount agree to pay by the entity as per purchase agreement 1,420,000
Amount Payable Within Eight Months [Member]
  
Amount agree to pay by the entity as per purchase agreement 420,000
Amount Payable Within Eighteen Months [Member]
  
Amount agree to pay by the entity as per purchase agreement $ 500,000
XML 40 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation - Schedule of Weighted Average Assumptions Value (Details)
 9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Historical Volatility 268.00%
Risk Free Rate 0.83%
Dividend Yield 0.00%
Forfeiture Rate 0.00%
XML 41 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
OPERATING ACTIVITIES    
Net loss $ (6,867,035) $ (3,724,265)
Adjustment to reconcile net loss to net cash used in operations:    
Changes in purchase price allocation (65,911)   
Goodwill impairment 692,668   
Stock based compensation 4,700,000 3,650,100
Changes in operating assets and liabilities, net of effects of acquisitions:    
Decrease in accounts receivable 297,712   
Increase in prepaid expenses (3,785)   
Increase in refundable income taxes (12,000)   
Increase in accounts payable 50,174   
Increase in accrued expense 97,210   
Net Cash Used in Operating Activities (1,110,967) (74,165)
INVESTING ACTIVITIES    
Advances to related parties and other (35,793)   
FINANCING ACTIVITIES    
Proceeds from sale of stock 1,566,412  
Stockholder Advances    74,215
Advances from related parties 96,586  
Payment of Due to stockholder (419,084)  
Decrease in Short-Term Note Payable (8,041)  
Net Cash Provided by Financing Activities 1,235,873 74,215
Net increase in cash 89,113 50
Cash, beginning of period 185,744   
Cash, end of period 274,857 50
Supplemental disclosure of non-cash investing and financing activities    
Non-cash issuance of common stock 1,201   
Common shares issued for cash, less exercise of stock option    20
Forgiveness of debt by stockholders    $ 100
XML 42 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Operations and Basis of Presentation
 9 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Operations and Basis of Presentation

5. NATURE OF OPERATIONS AND BASIS OF PRESENTATION

 

Accelera was incorporated as a Delaware corporation on April 29, 2008. In 2013, Accelera acquired three companies operating in the IME industry and as of December 31, 2013, Accelera operated out of three service centers serving counties in Illinois. On April 11, 2013, the Company formed At Home Health Management LLC that will operate its planned home health care business. On November 29, 2013, the Company formed Accelera Healthcare Management Service Organization LLC that will operate newly acquired Behavioral Health Associates, Ltd. As a 100% owned subsidiaries of Accelera. The consolidated financial statements include the accounts of Accelera and its 100% owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.

 

USE OF ESTIMATES – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

CASH – All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had cash of $185,744 as of December 31, 2013 and $274,857 as of the nine months ended September 30, 2014.

 

RESEARCH AND DEVELOPMENT EXPENSES – Expenditures for research, development, and engineering of products are expensed as incurred.

 

COMMON STOCK – The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

 

REVENUE RECOGNITION – Revenue related to services and administrative support services is recognized at the time services have been performed. The Company believes that recognizing revenue at the time the services have been performed because the Company’s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, Revenue Recognition: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

 

COST OF REVENUES – Costs of revenues are comprised of fees paid to members of the Company’s medical staff other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.

  

GOODWILL AND OTHER INTANGIBLE ASSETS – Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at lease annually in accordance with the provisions of FASB ASC Topic 350, Intangibles – Goodwill and Other (“ASC 350”). The goodwill impairment test is a two-step test. Under the first step, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed. During September 2014, the Company recognized goodwill impairment of $692,668.

 

ADVERTISING COSTS – The Company’s policy regarding advertising is to expense advertising when incurred.

 

INCOME TAXES – Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settle. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

The Company adopted the provisions of FASB ASC 740-10 “uncertainty in Income Taxes” (ASC 740-10), on January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

 

LOSS PER SHARE – Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. At September 30, 2014, the Company did not have any potentially dilutive common shares.

 

FINANCIAL INSTRUMENTS – In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

  ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
     
  ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  ● Level 3 – Inputs that are both significant to the fair value measurement and unobservable.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014. These financial instruments include stock options granted to the officers in 2013.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

Effective January 2012, the Company adopted ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (ASU 2011-04). ASU 2011-04 represents the converged guidance of the FASB nd the International Accounting Standards Board (IASB) on fair value measurement. A variety of measures are included in the update intended to either clarify existing fair value measurement requirements, change particular principles requirements for measuring air value or for disclosing information about fair value measurements. For many of the requirements, the FASB does not intend to change the application of existing requirements under ASC Topic 820, Fair Value Measurements. ASU 2011-04 was effective for interim and annual periods beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.

 

Effective January 2012, the Company adopted ASU No. 2011-05, Presentation of Comprehensive Income (ASU 2011-05). ASU 2011-05 is intended to increase the prominence of items reported in other comprehensive income and to facilitate convergence of accounting guidance in this area with that of the IASB. The amendments require that all nonowner changes in consecutive statements. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05 (ASU 2011-12 defers the provisions of ASU 2011-05 that require the presentation of reclassification adjustments on the fact of both the consolidated statement of income and statement of other comprehensive income.

 

Amendments under ASU 2011-05 that were not deferred under ASU 2011-12 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.

 

In December 2011, The FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities (ASU 2011-11). The amendments in ASU 2011-11 require the disclosure of information on offsetting and related arrangements for financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. Amendments under ASU 2011-11 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after January 1, 2013. The Company is evaluating the effect, if any, adoption of ASU 2011-11 will have on its consolidated financial statements.

 

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive (ASU 2013-02). This guidance is the culmination of the FASB’s deliberation on reporting reclassification adjustments from accumulated other comprehensive income (AOCI). The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income. However, the amendments require disclosure of amounts reclassified out of AOCI in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be classified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. The Company is evaluating the effect, if any, the adoption of ASU 2013-02 will have on its consolidated financial statements.

 

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the United States Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.
XML 43 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transaction (Details Narrative) (USD $)
 9 Months Ended
Sep. 30, 2014
Cancellation of shares 796,671
Amount owed to forgive indebtedness $ 1,018,618
December 31, 2015 [Member]
  
Defferrd reimbursable distribution amount 5,000,000
December 31, 2016 [Member]
  
Defferrd reimbursable distribution amount 7,500,000
December 31, 2017 [Member]
  
Defferrd reimbursable distribution amount 10,000,000
December 31, 2018 [Member]
  
Defferrd reimbursable distribution amount 6,914,819
Minimum [Member]
  
Reimbursable distribution and commercialization expenses 585,181
Maximum [Member]
  
Reimbursable distribution and commercialization expenses $ 29,414,819
XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 66 165 1 false 44 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://accel/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://accel/role/BalanceSheets Condensed Consolidated Balance Sheets false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://accel/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://accel/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://accel/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) false false R6.htm 00000006 - Disclosure - Background Information Sheet http://accel/role/BackgroundInformation Background Information false false R7.htm 00000007 - Disclosure - Going Concern Sheet http://accel/role/GoingConcern Going Concern false false R8.htm 00000008 - Disclosure - Acquisition - Behavioral Health Care Associates, Ltd. Sheet http://accel/role/Acquisition-BehavioralHealthCareAssociatesLtd. Acquisition - Behavioral Health Care Associates, Ltd. false false R9.htm 00000009 - Disclosure - Acquisition - at Home and All Staffing Sheet http://accel/role/Acquisition-AtHomeAndAllStaffing Acquisition - at Home and All Staffing false false R10.htm 00000010 - Disclosure - Nature of Operations and Basis of Presentation Sheet http://accel/role/NatureOfOperationsAndBasisOfPresentation Nature of Operations and Basis of Presentation false false R11.htm 00000011 - Disclosure - Stockholders' Deficit Sheet http://accel/role/StockholdersDeficit Stockholders' Deficit false false R12.htm 00000012 - Disclosure - Stock-Based Compensation Sheet http://accel/role/Stock-basedCompensation Stock-Based Compensation false false R13.htm 00000013 - Disclosure - Related Party Transaction Sheet http://accel/role/RelatedPartyTransaction Related Party Transaction false false R14.htm 00000014 - Disclosure - Income Taxes Sheet http://accel/role/IncomeTaxes Income Taxes false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://accel/role/SubsequentEvents Subsequent Events false false R16.htm 00000016 - Disclosure - Nature of Operations and Basis of Presentation (Policies) Sheet http://accel/role/NatureOfOperationsAndBasisOfPresentationPolicies Nature of Operations and Basis of Presentation (Policies) false false R17.htm 00000017 - Disclosure - Stock-Based Compensation (Tables) Sheet http://accel/role/Stock-basedCompensationTables Stock-Based Compensation (Tables) false false R18.htm 00000018 - Disclosure - Background Information (Details Narrative) Sheet http://accel/role/BackgroundInformationDetailsNarrative Background Information (Details Narrative) false false R19.htm 00000019 - Disclosure - Going Concern (Details Narrative) Sheet http://accel/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) false false R20.htm 00000020 - Disclosure - Acquisition - Behavioral Health Care Associates, Ltd. (Details Narrative) Sheet http://accel/role/Acquisition-BehavioralHealthCareAssociatesLtd.DetailsNarrative Acquisition - Behavioral Health Care Associates, Ltd. (Details Narrative) false false R21.htm 00000021 - Disclosure - Acquisition - at Home and All Staffing (Details Narrative) Sheet http://accel/role/Acquisition-AtHomeAndAllStaffingDetailsNarrative Acquisition - at Home and All Staffing (Details Narrative) false false R22.htm 00000022 - Disclosure - Nature of Operations and Basis of Presentation (Details Narrative) Sheet http://accel/role/NatureOfOperationsAndBasisOfPresentationDetailsNarrative Nature of Operations and Basis of Presentation (Details Narrative) false false R23.htm 00000023 - Disclosure - Stockholders' Deficit (Details Narrative) Sheet http://accel/role/StockholdersDeficitDetailsNarrative Stockholders' Deficit (Details Narrative) false false R24.htm 00000024 - Disclosure - Stock-Based Compensation (Details Narrative) Sheet http://accel/role/Stock-basedCompensationDetailsNarrative Stock-Based Compensation (Details Narrative) false false R25.htm 00000025 - Disclosure - Stock-Based Compensation - Schedule of Outstanding Options (Details) Sheet http://accel/role/Stock-basedCompensation-ScheduleOfOutstandingOptionsDetails Stock-Based Compensation - Schedule of Outstanding Options (Details) false false R26.htm 00000026 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions Value (Details) Sheet http://accel/role/Stock-basedCompensation-ScheduleOfWeightedAverageAssumptionsValueDetails Stock-Based Compensation - Schedule of Weighted Average Assumptions Value (Details) false false R27.htm 00000027 - Disclosure - Related Party Transaction (Details Narrative) Sheet http://accel/role/RelatedPartyTransactionDetailsNarrative Related Party Transaction (Details Narrative) false false R28.htm 00000028 - Disclosure - Income Taxes (Details Narrative) Sheet http://accel/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) false false R29.htm 00000029 - Disclosure - Subsequent Events (Details Narrative) Sheet http://accel/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) accel-20140930.xml accel-20140930.xsd accel-20140930_cal.xml accel-20140930_def.xml accel-20140930_lab.xml accel-20140930_pre.xml true true XML 45 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisition - Behavioral Health Care Associates, Ltd. (Details Narrative) (USD $)
 0 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Nov. 20, 2013
Stock Purchase Agreement [Member]
Blaise J. Wolfrum, M.D [Member]
Nov. 20, 2013
Amount Payable Within Ninety Days [Member]
Blaise J. Wolfrum, M.D [Member]
Nov. 20, 2013
Amount To Be Paid On One Hundred and Eighty Days [Member]
Blaise J. Wolfrum, M.D [Member]
Nov. 20, 2013
Amount To Be Paid On Three Payments [Member]
Blaise J. Wolfrum, M.D [Member]
Nov. 20, 2013
Amount To Be Paid In Three Payment [Member]
Blaise J. Wolfrum, M.D [Member]
Nov. 20, 2013
Amount To Be Paid In Beginning Two Hundred Seventy Days After Closing [Member]
Blaise J. Wolfrum, M.D [Member]
Business acquisition equity ownership percentage     100.00%          
Common stock, shares issued 34,380,022 22,382,522 100,000          
Common stock, shares outstanding 34,380,022 22,382,522 100,000          
Amount agree to pay by the entity as per purchase agreement     $ 4,550,000 $ 1,000,000 $ 750,000 $ 2,800,000 $ 750,000 $ 550,000